Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,0.5810406987086957,2.1695835641043475,0.0,0.012508304071367563,0.01,12/29,15.02%,CCNH;POLR2K;TBP;POLR1F;POLR1D;ERCC2;POLR1B;POLR2F;MNAT1;POLR2H;POLR1A;TAF1C
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.642948784017938,2.039557146319172,0.0,0.1313371927493594,0.15,9/17,10.13%,METTL22;EEF1A1;VCPKMT;METTL21A;EEF2;CAMKMT;PRMT3;ETFB;VCP
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.5202300422019864,1.9577753789719723,0.0,0.16677738761823416,0.28,9/27,11.86%,CCNH;POLR2K;ERCC2;RNGTT;POLR2I;POLR2F;POLR2D;MNAT1;POLR2H
prerank,KEGG_2021_Human__RNA polymerase,0.513368819128451,1.9089646009241978,0.0,0.200132865141881,0.41,13/31,11.86%,POLR3K;POLR2K;POLR1F;POLR1D;POLR1C;POLR2J3;POLR1B;POLR2I;POLR2F;POLR3D;POLR2D;POLR3H;POLR2H
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.41106212407000975,1.868108603327623,0.0,0.24015943817025717,0.53,33/66,27.96%,SNRPG;ALYREF;EIF4A3;DHX38;ZNF473;THOC7;SNRPE;THOC6;POLDIP3;CPSF1;U2AF2;PAPOLA;SRSF1;SRSF3;UPF3B;LSM11;CHTOP;SRSF11;CSTF2;SNRPB;NUDT21;SRSF6;LSM10;CSTF2T;CSTF1;SRSF9;CDC40;SYMPK;THOC5;MAGOH;SRSF7;SRSF5;ZC3H11A
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.5837091705618428,-1.8394223773100877,0.0,1.0,0.67,6/18,9.97%,RHOB;KIF14;PPP1R12A;RHOC;RNASE1;MYL12B
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.4906171660269608,1.8144256971588966,0.0,0.33563949258169623,0.68,9/29,11.86%,CCNH;POLR2K;ERCC2;RNGTT;POLR2I;POLR2F;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.42272894833724783,1.7882904000093887,0.0,0.3788229233042747,0.75,11/44,11.86%,CCNH;POLR2K;TBP;TAF2;TAF5;ERCC2;POLR2I;POLR2F;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.6038531254282518,-1.7877807035770303,0.0,1.0,0.83,6/15,11.35%,DLAT;PDK2;PDP2;PDHA1;PDK4;PDPR
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.4856970584246306,1.78274983505787,0.024390243902439025,0.34085128594476605,0.75,9/26,11.86%,POLR3K;POLR2K;TBP;POLR1D;POLR2F;POLR3D;BRF1;POLR3H;POLR2H
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.5253376023046415,1.7654813624123737,0.02127659574468085,0.34189364461738003,0.78,6/17,10.02%,GNB2;GNG5;ARHGEF6;GNG3;GNG10;GNG7
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,0.5152933490816137,1.7652115724316335,0.022222222222222223,0.307704280155642,0.78,5/15,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.5213471918368578,-1.7618871721822602,0.0,0.8579493875520737,0.85,8/29,7.39%,CHD3;AKT1;GATAD2A;BRD1;HDAC2;PIP4P1;MAP2K6;DPEP3
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.5296591942986394,1.7413232194258987,0.0,0.3479582768944068,0.87,6/16,13.64%,GNB2;GNG5;GNG3;GNG10;GNG7;KCNJ15
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.4508994027385226,1.7316707711443429,0.0,0.3533595900161336,0.9,12/29,15.62%,GGT6;GGT7;OPLAH;GSTA4;GGT1;HPGDS;GSTO1;GSTM1;MGST2;GSTP1;GCLM;GSTO2
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.47778422653822605,1.7300542033144584,0.047619047619047616,0.3300267920368518,0.9,9/27,11.86%,POLR3K;POLR2K;TBP;POLR1D;POLR2F;POLR3D;BRF1;POLR3H;POLR2H
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,-0.5714673136179582,-1.7289369427770918,0.0,0.8586457750419698,0.9,7/16,15.17%,CDH8;CDH18;JUP;ANG;CDH24;CDH13;NECTIN2
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.5226981634197968,1.726497107683807,0.0,0.31538795265662495,0.91,11/22,16.45%,ATG5;RPS27A;SQSTM1;TOMM20;TOMM5;MAP1LC3B;TOMM6;TOMM70;MFN2;MFN1;UBB
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.3769882986586007,1.701645700400884,0.021739130434782608,0.34522919236974475,0.94,27/57,27.96%,ALYREF;EIF4A3;DHX38;THOC7;THOC6;POLDIP3;CPSF1;U2AF2;PAPOLA;SRSF1;SRSF3;UPF3B;CHTOP;SRSF11;CSTF2;NUDT21;SRSF6;CSTF2T;CSTF1;SRSF9;CDC40;SYMPK;THOC5;MAGOH;SRSF7;SRSF5;ZC3H11A
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,0.5308237893088348,1.7013839689132575,0.02,0.32365236784663565,0.94,7/17,11.86%,POLR3K;POLR2K;POLR1D;POLR2F;POLR3D;POLR3H;POLR2H
prerank,KEGG_2021_Human__Glutathione metabolism,0.42441427544906096,1.690836663482515,0.0,0.339195775111791,0.96,19/45,15.62%,GGT6;GGT7;NAT8B;OPLAH;GSTA4;GGT1;HPGDS;RRM2;G6PD;GSTO1;PGD;GSTM1;MGST2;GSTP1;RRM2B;TXNDC12;SMS;GCLM;GSTO2
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.44319256785069644,1.6810702052255804,0.02127659574468085,0.34258855039912267,0.97,10/26,18.31%,BCL2L1;RPS27A;FLT3LG;HRAS;GRB2;PIK3CA;TRIP11;CBL;UBB;PIK3R1
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.41460773590534145,1.6767264937359176,0.0,0.3370658781336943,0.97,7/29,10.02%,ADCY7;GNB2;PRKCD;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.5266423591868559,-1.6651900476273158,0.03389830508474576,1.0,0.98,7/15,14.64%,PARP4;NAMPT;PARP16;NUDT12;RNLS;PARP6;NNMT
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.44532251560310593,1.66308051649843,0.02127659574468085,0.3477308531840182,0.97,10/31,17.59%,UBA7;RPS27A;RFC5;REV1;POLR1B;ISG15;POLD4;POLR1A;UBB;SLC19A1
prerank,KEGG_2021_Human__TNF signaling pathway,-0.37578030468322265,-1.6614203816070883,0.0,1.0,0.98,32/100,19.30%,AKT1;MAP3K8;IL6;MAP3K5;MAPK8;RPS6KA4;MAPK14;FADD;JAG1;PIK3R3;TRAF1;CASP8;JUNB;FAS;MAP2K6;RPS6KA5;IL15;CCL2;MAPK1;ATF2;CREB3L2;JUN;MMP9;MAP3K7;CREB1;MAP2K4;ITCH;CFLAR;BCL3;TRAF2;MLKL;TRADD
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.48167741966046296,1.6586404077524104,0.0,0.3401067440357561,0.98,5/16,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.5204998080420271,-1.651255018925661,0.0,0.9538518933034882,0.98,11/19,27.93%,IDH3G;SUCLG1;IDH3A;SDHB;IDH2;CS;NNT;SDHD;SDHA;SUCLA2;SUCLG2
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.454762718781092,1.64408137156019,0.023809523809523808,0.35762378458591804,0.99,7/23,10.02%,ADCY7;GNB2;GNG5;GNG3;PRKACB;GNG10;GNG7
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.46500941312114313,-1.6394004288365571,0.0,0.92758813654169,0.98,14/27,24.41%,DLAT;IDH3G;SDHC;IDH1;PDHA1;SUCLG1;IDH3A;ACO1;SDHB;IDH2;CS;SDHD;SDHA;SUCLA2
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.4544772009779312,1.636884912719511,0.022222222222222223,0.3589339429175039,0.99,7/23,13.64%,ADCY7;GNB2;GNG5;GNG3;GNG10;GNG7;KCNJ15
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.34701713857019406,1.6366235710713748,0.0,0.3444995412989149,0.99,19/63,15.62%,GGT6;GGT7;OPLAH;GSTA4;SULT1B1;GGT1;SLC38A1;BPNT2;HPGDS;COMT;MAT2B;UGT2B4;MTRR;GSTO1;GSTM1;MGST2;GSTP1;GCLM;GSTO2
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,0.48441975489787426,1.6296278303891882,0.0,0.35123317832400114,0.99,7/21,17.59%,FEN1;APEX1;RFC5;POLR1B;POLD4;POLR1A;SLC19A1
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,0.4729930023549,1.6281085401852753,0.0,0.3396485643994423,0.99,7/20,11.86%,POLR3K;POLR2K;POLR1D;POLR2F;POLR3D;POLR3H;POLR2H
prerank,KEGG_2021_Human__Chagas disease,-0.3488880830343401,-1.6203121491161163,0.0,0.9665858359758752,0.99,19/91,12.06%,GNAO1;AKT1;IL6;MAPK8;CXCL8;PPP2CB;MAPK14;CD3D;CD3G;FADD;PIK3R3;CASP8;FAS;TLR2;CCL2;MAPK1;CCL3;JUN;IL10
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.4922938560756365,1.615456322490395,0.0196078431372549,0.3659837117177916,0.99,7/16,17.59%,RPS27A;RFC5;REV1;POLR1B;POLR1A;UBB;SLC19A1
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.5295643012702826,-1.6103658811294683,0.015873015873015872,0.9476440962506996,1.0,6/15,18.57%,XRCC5;DTX4;STAT6;CGAS;TREX1;MRE11
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.32789747915975986,1.605927154942261,0.023255813953488372,0.37167532097777894,1.0,17/71,14.70%,ALYREF;NUP205;EIF4A3;DHX38;THOC7;NUP35;NUP214;NUP37;THOC6;POLDIP3;U2AF2;NXF1;SRSF1;SRSF3;UPF3B;CHTOP;SRSF11
prerank,KEGG_2021_Human__Galactose metabolism,-0.48521705784769076,-1.6039371105316824,0.03225806451612903,0.9040375777924742,1.0,9/24,12.59%,GANC;PGM2;GLA;GALT;B4GALT2;GALK1;HKDC1;HK3;GALM
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.36678648484043763,1.5999943835932022,0.0,0.37093591384055524,1.0,18/57,16.02%,CCNH;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;ERCC2;POLR1B;POLR2F;MNAT1;H2AZ2;POLR2H;H2BC3;POLR1A;TAF1C;H2BC11
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.466559730466835,1.599012190636987,0.06,0.3490220329591271,1.0,5/17,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.466559730466835,1.599012190636987,0.06,0.3490220329591271,1.0,5/17,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.42629611951562135,-1.5930743502188534,0.0,0.9039109618852206,1.0,22/46,28.04%,DLAT;PDK2;IDH3G;PDP2;PDHA1;SUCLG1;BSG;IDH3A;PDK4;D2HGDH;PDPR;SDHB;SLC16A3;IDH2;CS;NNT;SDHD;SDHA;SUCLA2;RXRA;SUCLG2;VDAC1
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.35487690317468723,1.592543110955657,0.0,0.3517960520072127,1.0,15/66,11.86%,CCNH;POLR2K;TBP;TAF2;TAF5;ERCC2;NELFA;SUPT16H;RNGTT;POLR2I;POLR2F;SSRP1;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.40565237310227964,1.5919049069060138,0.0,0.34416788172126506,1.0,13/29,23.97%,SNRPG;ZNF473;SNRPE;CPSF1;PAPOLA;LSM11;CSTF2;SNRPB;NUDT21;LSM10;CSTF2T;CSTF1;SYMPK
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.4251446794154776,1.5840829356337043,0.05405405405405406,0.35023251399829175,1.0,9/33,11.86%,CCNH;POLR2K;ERCC2;NELFA;POLR2I;POLR2F;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.3726286702702459,1.5774009325168046,0.044444444444444446,0.3566653560921379,1.0,8/31,10.02%,ADCY7;GNB2;GNG5;GNG3;PRKACB;AQP9;GNG10;GNG7
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.31220966230853203,1.572161993567919,0.027777777777777776,0.3564866660339755,1.0,16/80,11.75%,ALYREF;NUP205;EIF4A3;DHX38;THOC7;NUP35;NUP214;NUP37;THOC6;POLDIP3;CPSF1;U2AF2;NXF1;SRSF1;SRSF3;UPF3B
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.38627326591508765,1.5691021447249427,0.046511627906976744,0.35462732353688037,1.0,13/34,23.61%,GGCX;DPH6;STS;EEF2;ARSB;TTF2;DHPS;DPH3;PROS1;DPH7;EIF5A2;ARSG;F8
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.4811185380744516,1.563442088265333,0.0392156862745098,0.35879082731028006,1.0,7/17,17.59%,RPS27A;RFC5;REV1;POLR1B;POLR1A;UBB;SLC19A1
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,0.439110912359105,1.561534453532412,0.046511627906976744,0.355043400179587,1.0,8/25,17.59%,FEN1;APEX1;RFC5;POLR1B;POLD4;POLR1A;PARP2;SLC19A1
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.4133961168290971,1.5561216463578476,0.030303030303030304,0.36117728006073835,1.0,16/27,31.06%,CTSL;SDC2;VCP;MAP1LC3B;HAVCR1;NRP1;UVRAG;BECN1;HSPG2;CHMP2A;ZCRB1;CHMP6;VHL;FURIN;GPC2;PIK3R4
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.38357412970129046,1.55174431860352,0.044444444444444446,0.36609670452783105,1.0,7/28,10.02%,ADCY7;GNB2;GNG5;GNG3;PRKACB;GNG10;GNG7
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.3945106276518944,1.5427973690357244,0.023809523809523808,0.3826945412311266,1.0,15/37,18.31%,UBXN11;TXNL1;ARHGAP35;NUDC;ANKRD26;ARHGAP5;FNBP1;KIDINS220;KTN1;VANGL1;RBMX;ALDH3A2;DLG5;PLXND1;PIK3R1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.501546205773441,-1.5419784450884366,0.05660377358490566,1.0,1.0,4/16,4.25%,PPP2CB;MAPK14;PLA2G4A;PECAM1
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.47171356078712684,-1.5314094249386314,0.03636363636363636,1.0,1.0,10/20,23.46%,SLC25A17;PEX14;PEX12;ATAD1;PEX2;PEX26;FIS1;PEX3;PXMP4;ABCD2
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,-0.377500111723734,-1.5303453136922216,0.015625,1.0,1.0,14/41,17.87%,PRKAG2;RPS6KA1;NEFL;PRKAR1B;RNASE1;MAPK1;NRAS;PRKAG1;PRKAR2B;RASGRF2;CREB1;GIT1;RPS6KA3;MAPT
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.4388515471624579,-1.529272310634753,0.03389830508474576,1.0,1.0,9/34,10.66%,FUT1;ST6GALNAC4;FUT4;GBGT1;ST3GAL4;FUT7;GLA;B4GALT2;A4GALT
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.46474492924119454,1.5291371813798502,0.022222222222222223,0.4107377988086279,1.0,8/19,17.81%,RPS27A;RFC5;POLR1B;VCP;POLR1A;UBB;SLC19A1;NPLOC4
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.4279012501062329,-1.5257461196243234,0.01639344262295082,1.0,1.0,14/24,26.55%,GANC;AMY2B;PGM2;GYG1;HKDC1;HK3;PGM2L1;GBE1;PGM1;ENPP3;HK1;HK2;PYGM;ENPP1
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,0.3736955426677598,1.5253416095889378,0.0425531914893617,0.41277403435512955,1.0,13/42,16.96%,CCNH;ERCC4;RPS27A;ERCC2;USP45;POLR1B;CUL4A;MNAT1;POLR1A;PARP2;RAD23B;UBB;CETN2
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.4123683301690794,1.5231882698993942,0.0,0.4080486750392796,1.0,12/38,17.81%,UBA7;RPS27A;RFC5;REV1;POLR1B;ISG15;VCP;POLD4;POLR1A;UBB;SLC19A1;NPLOC4
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.39818913788168,1.5228626002892693,0.06521739130434782,0.3997218909763112,1.0,8/24,12.35%,AGO1;POLR2K;AGO4;POLR2I;POLR2F;POLR2D;POLR2H;RAN
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.39590589314683877,1.52108667577418,0.0,0.39627371834609143,1.0,12/35,18.45%,UBA7;ATG5;RIGI;UBE2D2;RPS27A;TRIM4;ISG15;CYLD;RNF216;TAX1BP1;UBB;UBE2K
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.3929749503347982,1.5155293521625577,0.043478260869565216,0.40235044762898986,1.0,6/25,9.36%,ATP6V1E2;ATP6V1A;HFE;ATP6V1E1;ATP6V0A1;TFR2
prerank,KEGG_2021_Human__Basal transcription factors,0.3694264490562948,1.5116567109924643,0.0,0.4063922465636155,1.0,6/41,5.02%,TAF8;CCNH;TBP;TAF2;TAF5;ERCC2
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,-0.46179384090328535,-1.5107874081152244,0.05263157894736842,1.0,1.0,7/23,9.97%,RHOB;ERBB2;RRAS;ROCK2;RHOC;RNASE1;MYL12B
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,-0.443395531199252,-1.509652974619998,0.03225806451612903,1.0,1.0,8/29,13.22%,AKT1;TP53BP2;MAPK8;DYNLL2;REXO2;BAD;YWHAQ;YWHAB
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.4476161830534535,1.5081546464955784,0.022727272727272728,0.4092717092151466,1.0,5/18,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.4619582161483418,1.4985856453078459,0.041666666666666664,0.4255275992906416,1.0,7/17,17.59%,RPS27A;RFC5;REV1;POLR1B;POLR1A;UBB;SLC19A1
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.37666944665409235,-1.4981708071516648,0.057971014492753624,1.0,1.0,13/46,15.43%,RHOBTB3;PLIN3;SCOC;ARFRP1;GOLGA4;IGF2R;SYS1;USP6NL;COG2;VAMP4;STX16;VPS51;NAA30
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.44311308376980224,1.4971859666688156,0.10204081632653061,0.42215526240865525,1.0,8/17,18.31%,RPS27A;HRAS;SHC1;GRB2;PIK3CA;CBL;UBB;PIK3R1
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.4514403016424264,1.4954431108004116,0.023255813953488372,0.4186741777850199,1.0,6/19,16.45%,TICAM1;UBE2D2;RPS27A;RIPK3;TRAF6;UBB
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.4416338425985005,-1.4944696154561157,0.04411764705882353,1.0,1.0,8/25,14.48%,DLAT;PDK2;PDP2;PDHA1;BSG;PDK4;PDPR;SLC16A3
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.34959726028050264,-1.4919718498106107,0.03225806451612903,1.0,1.0,19/58,17.50%,AKT1;ERBB2;PDK1;PTEN;PIK3R3;NTRK1;PGAM1;IDH1;PDHA1;MAPK1;PGAM2;NRAS;HKDC1;HK3;FGFR1;SLC16A3;SCO2;IDH2;GLS2
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.41513162459574815,1.4905150118426957,0.021739130434782608,0.42574560894765884,1.0,4/20,4.85%,ATP6V1E2;ATP6V1A;ATP6V1E1;ATP6V0A1
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,-0.490298100321675,-1.4879263566439358,0.05,1.0,1.0,4/15,5.93%,FUT1;FUT4;ST3GAL4;FUT7
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.5247773911427419,-1.4873470808237914,0.03508771929824561,0.9979232730212025,1.0,7/15,24.48%,AKT1;REXO2;BAD;YWHAQ;YWHAB;YWHAZ;PPP3CC
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.3176761847216031,1.483901718590886,0.0,0.4359712528147566,1.0,24/74,23.47%,MED18;EBF1;MED23;MED12;SREBF1;MED9;CEBPA;MED30;LPL;LIN9;CARM1;MED4;PPARG;MED26;TBL1X;CDK19;NFKB1;MED7;MED6;WNT10B;MED17;MED27;MED14;KLF5
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.39914292745805735,1.4740734481976936,0.05128205128205128,0.4549895605959951,1.0,9/31,14.38%,HS3ST3B1;SDC2;HPSE;B4GALT7;GLB1;HS6ST1;IDUA;HS3ST3A1;HS2ST1
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.34285266767901734,-1.4737316207348197,0.027777777777777776,1.0,1.0,17/84,11.85%,AKT1;MAP3K8;IL6;TLR5;MAPK8;CXCL8;TLR8;MAPK14;FADD;PIK3R3;CASP8;MAP2K6;TLR2;TIRAP;MAPK1;CCL3;JUN
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.28598325518080886,1.4703040503173836,0.0,0.45929614774337385,1.0,23/129,10.19%,VPS37A;CCNH;NUP205;POLR2K;TBP;NUP35;TAF2;RPS27A;UBAP1;NUP214;TAF5;ERCC2;NUP37;NELFA;SUPT16H;RNGTT;POLR2I;POLR2F;XPO1;VPS37B;SSRP1;POLR2D;MNAT1
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.28662399069922306,1.4696833343054672,0.0,0.4522398903044444,1.0,26/142,10.38%,VPS37A;FEN1;CCNH;NUP205;POLR2K;TBP;NUP35;TAF2;RPS27A;UBAP1;NUP214;TAF5;ERCC2;NUP37;NELFA;CD4;SUPT16H;RNGTT;POLR2I;POLR2F;XPO1;VPS37B;SSRP1;POLR2D;MNAT1;HMGA1
prerank,KEGG_2021_Human__Lysine degradation,0.34067962504317517,1.466992584779986,0.02702702702702703,0.4509349620304882,1.0,14/58,12.86%,PLOD1;ALDH7A1;KMT5B;ACAT1;EZH1;DOT1L;CAMKMT;EHMT1;KMT2C;KMT2D;KMT2E;ALDH3A2;COLGALT1;AASS
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.4428366361507454,1.4669652908068245,0.06521739130434782,0.44362785106450286,1.0,6/18,13.64%,GNB2;GNG5;GNG3;GNG10;GNG7;KCNJ15
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,0.45269903928602434,1.4667509705872288,0.05555555555555555,0.4371754800025516,1.0,7/19,12.64%,GGT6;GGT7;GGT1;SLC38A1;ABCC2;GSTM1;GSTP1
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.3744166893010178,1.4664846811995678,0.1111111111111111,0.4307295031027378,1.0,11/42,11.86%,CCNH;POLR2K;ERCC2;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.45378868682303153,-1.4625358874887158,0.08928571428571429,1.0,1.0,9/17,22.50%,RPS6KA1;NEFL;MAPK1;NRAS;RASGRF2;CREB1;RPS6KA3;CAMK2A;DLG1
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.45374544288880214,-1.4621790652527569,0.08064516129032258,1.0,1.0,5/19,9.97%,RHOB;ERBB2;ROCK2;RHOC;MYL12B
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.40591538175520653,1.4583809241913748,0.02040816326530612,0.44394552227901374,1.0,5/20,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.3737792720768688,1.4528501442422521,0.0425531914893617,0.45010350431811713,1.0,8/31,9.31%,ADCY7;LYN;ITPR3;YES1;SYK;FGR;PRKACB;FCGR1A
prerank,KEGG_2021_Human__Malaria,-0.3622406373027471,-1.4510618440029124,0.07407407407407407,1.0,1.0,14/43,18.96%,IL6;CR1L;CXCL8;PECAM1;TLR2;CCL2;HGF;COMP;IL10;GYPB;THBS4;ITGB2;TGFB3;KLRC4-KLRK1
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.36153486926420586,1.445713820643435,0.08695652173913043,0.4599207189318226,1.0,7/30,7.54%,LYN;LIMK2;ROCK1;SDC2;YES1;ACTG1;HRAS
prerank,KEGG_2021_Human__Axon guidance,-0.3067339040364576,-1.4455129368653357,0.0,1.0,1.0,41/126,21.97%,LRRC4;PLXNA4;SEMA6C;ITGB1;PLXNB2;RRAS;SSH2;SRGAP3;TRPC6;PIK3R3;PAK1;SEMA4F;ROCK2;SEMA5B;RASA1;EPHA4;EPHB3;MAPK1;RAC2;NRAS;MYL12B;PPP3CB;EPHB2;RAC3;NCK1;NCK2;CXCR4;FES;BMPR2;EPHB1;NTNG2;SEMA6A;PRKCZ;SEMA4B;PAK6;RGS3;PTK2;CAMK2A;ABLIM3;GNAI1;SRGAP2
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.35664927931576884,-1.437857724524998,0.06349206349206349,1.0,1.0,15/55,14.67%,CHD3;ATN1;PHC3;GATAD2A;HDAC2;PTEN;RING1;DPEP3;PHC2;MAPK1;EZH2;LAMTOR4;JUN;CBX4;RBBP4
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.4813270025482702,-1.4356331748055322,0.05084745762711865,1.0,1.0,8/16,23.98%,ATP5PD;ATP5F1D;ATP5F1E;ATP5MG;ATP5F1C;ATP5MF;ATP5F1B;ATP5PF
prerank,Reactome_2022__Drug ADME R-HSA-9748784,0.36185365218206333,1.4323146453522377,0.06060606060606061,0.4927513725084191,1.0,12/44,12.64%,GGT6;ABCB1;GGT7;SLC28A2;GGT1;SLC38A1;CYP2C9;ABCC2;UGT2B4;SLC29A1;GSTM1;GSTP1
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.351286593047608,1.4312681401864282,0.024390243902439025,0.4876371676777921,1.0,14/47,17.97%,UBA7;RPS27A;RFC5;REV1;POLR1B;CUL4A;ISG15;VCP;POLD4;POLR1A;UBB;SLC19A1;NPLOC4;USP1
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.3985434562901608,1.4312022440300842,0.10869565217391304,0.4808339241552178,1.0,5/20,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.3667884204550592,-1.4308623002210423,0.016666666666666666,1.0,1.0,15/49,21.24%,AKT1;PRKAG2;RAB4A;REXO2;RNASE1;RAB14;PRKAG1;EXOC7;YWHAQ;YWHAB;EXOC5;EXOC2;YWHAZ;RALA;RHOQ
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.39978720552701297,-1.4299476498356458,0.08196721311475409,1.0,1.0,15/31,22.12%,FLOT2;FADD;CASP8;SDCBP;PELI1;TANK;GNL3;PDCD6IP;CFLAR;MLKL;HSP90AA1;TRADD;XIAP;RRM1;UBC
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.3401309936687176,1.4210263018437463,0.03125,0.5079459131590132,1.0,7/40,8.00%,NAPSA;CYTH4;CYTH1;YKT6;CYTH2;MAN2A2;COG8
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4388299046325388,1.420114423179276,0.0975609756097561,0.5040846540761128,1.0,4/17,5.39%,CCND2;AGO1;AGO4;CBFB
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.4066591496771296,-1.419175936965355,0.06557377049180328,1.0,1.0,13/29,26.09%,ATP5PD;ATP5F1D;DNAJC11;SAMM50;ATP5F1E;CHCHD3;ATP5MG;ATP5F1C;ATP5MF;ATP5F1B;MICOS10;ATP5PF;TMEM11
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,0.3022957866081548,1.4168859898969315,0.1,0.5082599612097946,1.0,16/77,13.49%,CCNH;POLR2K;TBP;TAF2;TAF5;ERCC2;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;MNAT1;POLR2H;EAF1;CDC73
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.3614160667943398,1.4166747673987876,0.08823529411764706,0.5017219744181878,1.0,11/44,11.86%,CCNH;POLR2K;ERCC2;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.3100010683814938,-1.4148451300314895,0.05,1.0,1.0,22/87,16.86%,POU2F1;AKT1;IL6;RORA;ITGB1;CXCL8;IRF4;STAT6;NANOG;BIRC5;IL2RG;FSCN1;CCL2;IL10;F13A1;MMP9;FOXO1;GATA3;IL13RA1;POMC;IL6R;ITGB2
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.31952329464433354,-1.4128649117079257,0.016129032258064516,1.0,1.0,24/92,15.33%,CUL1;MAP3K8;RPS6KA1;TLR5;MAPK8;PPP2CB;MAPK14;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;PELI1;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.30612244456078025,1.4124961528068594,0.06976744186046512,0.507871414623746,1.0,12/51,13.84%,SNRPG;NUP205;NUP35;GEMIN8;GEMIN5;SNRPE;NUP214;NUP37;LIN9;PHAX;SMN1;SNUPN
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,-0.4189813555238757,-1.4124646605668425,0.10606060606060606,1.0,1.0,10/25,17.55%,RPS6KA1;RPS6KA4;AP2B1;KIF4A;RPS6KA5;MAPK1;EZR;AP2M1;RPS6KA3;CLTC
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.38363343454020826,-1.4100650512119048,0.05660377358490566,1.0,1.0,8/34,15.17%,CDH8;CDH18;JUP;ANG;CDH24;CDH13;CLDN15;NECTIN2
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.37468751539448875,1.4097440854534113,0.046511627906976744,0.5101359687484771,1.0,7/27,13.64%,ADCY7;GNB2;GNG5;GNG3;GNG10;GNG7;KCNJ15
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,-0.45688490269071336,-1.4041461236774362,0.11666666666666667,1.0,1.0,4/16,7.42%,AKT1;COQ9;COQ2;IDH1
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.46320234581466124,-1.4028501783312988,0.08064516129032258,1.0,1.0,6/17,16.30%,ARF4;PKD1;EXOC7;EXOC5;EXOC2;RAB11FIP3
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,0.4284805064589697,1.401769083534785,0.02127659574468085,0.5263494353231469,1.0,7/21,11.86%,POLR2K;TDRKH;PIWIL2;POLR2I;POLR2F;POLR2D;POLR2H
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.4028447492704735,1.4005908867298589,0.1282051282051282,0.516901604611579,1.0,5/18,11.86%,POLR2K;POLR2I;POLR2F;POLR2D;POLR2H
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,0.4028447492704735,1.4005908867298589,0.1282051282051282,0.516901604611579,1.0,5/18,11.86%,POLR2K;POLR2I;POLR2F;POLR2D;POLR2H
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,-0.45191573943818564,-1.3994772947212113,0.08196721311475409,1.0,1.0,5/18,9.97%,RHOB;ROCK2;PPP1R12A;RHOC;MYL12B
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.4549445076612854,1.3991052919400115,0.08888888888888889,0.5152459100167177,1.0,6/15,16.45%,RPS27A;FLT3LG;SOCS6;SEPSECS;CBL;UBB
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,0.4262136378637798,1.3981925323082953,0.14,0.511257137296783,1.0,7/15,25.01%,NAPSA;ZDHHC2;CCDC59;CSF2RB;TTF1;SFTPD;ADORA2B
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.34377619505134344,-1.3964692976873587,0.06779661016949153,1.0,1.0,18/60,20.67%,WDR43;RRP7A;RCL1;NOP2;SPPL2A;UTP11;NOL6;RRP36;RPS14;TRMT112;RPS6;WDR75;NOC4L;UTP4;RPS7;WDR3;DIMT1;EMG1
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.3862077179865506,1.3950813040273788,0.04878048780487805,0.5156548353421277,1.0,5/21,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.28285494585442655,1.3914144628588205,0.029411764705882353,0.5205616422787661,1.0,16/73,12.52%,NUP205;AGO1;H2BC15;H2BC17;POLR2K;NUP35;H2AC4;NUP214;NUP37;POLR2I;POLR2F;POLR2D;H2AZ2;POLR2H;RAN;H2BC3
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,0.35555983789261203,1.3910504189103885,0.022727272727272728,0.5154336519164755,1.0,10/28,15.96%,GCSH;ACAT1;MDH1;GLYCTK;MCEE;AFMID;MMUT;AGXT;ACSS1;PGP
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.3863678188929044,1.3893027236211584,0.08823529411764706,0.5135939792195259,1.0,8/27,12.06%,POLR2K;POLR2I;HRAS;POLR2F;GRB2;POLR2D;POLR2H;PIK3CA
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.30735996571434415,1.3872865864048751,0.02631578947368421,0.514478459125892,1.0,11/46,12.21%,POLR3K;POLR2K;IL18;POLR1D;RIPK3;POLR1C;POLR2F;POLR3D;POLR3H;POLR2H;CXCL10
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.3660511109675703,1.3866812181477892,0.02631578947368421,0.5106331191487699,1.0,11/28,16.45%,ATG5;RPS27A;SQSTM1;TOMM20;TOMM5;MAP1LC3B;TOMM6;TOMM70;MFN2;MFN1;UBB
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,0.38100170534892147,1.3840413995468683,0.041666666666666664,0.5151675932649292,1.0,8/29,9.65%,LYN;UBE2D2;RPS27A;CUL5;SYK;SHC1;GRB2;SOCS1
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.33270841394585055,-1.3832335264087834,0.1016949152542373,1.0,1.0,20/69,20.21%,IL6;MAPK8;MAPK6;CXCL8;MAPK14;FADD;CASP8;CCL2;MAPK1;IL17RA;TRAF3IP2;JUN;ANAPC5;MMP9;S100A9;MAP3K7;TRAF2;HSP90AA1;TRADD;IL17RE
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.27403241367508757,-1.3828683064616405,0.014084507042253521,1.0,1.0,48/225,14.63%,DUSP2;DUSP1;AKT1;MAP3K8;RPS6KA1;MAP3K5;DUSP10;MAPK8;CACNA1I;ERBB2;RPS6KA4;MAPK14;RRAS;HSPA6;PLA2G4A;PAK1;PDGFD;FAS;NTRK1;RASA1;CDC25B;MAP2K6;SRF;RPS6KA5;PPM1A;NF1;MAP3K12;MAPK1;RAC2;MAP3K6;IL1R1;MAP3K4;NRAS;ATF2;MRAS;HGF;PPP3CB;JUN;MKNK1;MAPKAPK5;TAOK2;RAC3;AREG;RASGRF2;FGFR1;MAP3K7;MAPK8IP3;DUSP6
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.37172187984430527,-1.3823918050429498,0.06666666666666667,1.0,1.0,11/30,14.02%,UBE2T;UBE2L3;USP7;UBE2E3;UBE2E1;UBE2R2;USP5;USP9X;UBA6;UBE2W;UBE2S
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,-0.45042579215151646,-1.3814350620452132,0.10714285714285714,1.0,1.0,8/20,21.79%,ITGA3;PPIL2;ITGB1;PPIA;BSG;SLC16A3;SLC7A6;ITGA6
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.35043089418914974,1.3775244642828728,0.06382978723404255,0.5302370737379721,1.0,5/28,4.85%,ATP6V1E2;ATP6V1A;ATP6V1E1;HVCN1;ATP6V0A1
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.4248485031573389,1.3750933960255485,0.044444444444444446,0.5316029230331214,1.0,4/16,8.55%,VPS37A;RPS27A;UBAP1;VPS37B
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.3719091996778153,-1.3746803672269876,0.1206896551724138,1.0,1.0,10/34,13.36%,SDSL;GCAT;AOC2;BPGM;PGAM1;DMGDH;SRR;PGAM2;GNMT;AMT
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.29154335504130374,-1.3741678033202922,0.0,1.0,1.0,48/153,22.39%,ATP5PD;NDUFS7;ATP5F1D;NDUFB3;DLAT;UCP2;NDUFAF6;PDK2;IDH3G;NDUFAF1;PDP2;COX5A;NDUFA5;COX7B;UQCR10;PDHA1;ATP5F1E;SUCLG1;BSG;NDUFC1;ETFDH;IDH3A;NDUFS1;PDK4;D2HGDH;PDPR;COX6A1;COA1;NDUFB1;NDUFAF2;SDHB;NDUFS3;ATP5MG;SLC16A3;SCO2;IDH2;TACO1;CS;NDUFA11;NDUFB7;ATP5F1C;NNT;ATP5MF;COX8A;NDUFB4;ATP5F1B;SDHD;SDHA
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.3214246300391095,1.3736776561338722,0.10204081632653061,0.529846138753435,1.0,14/37,21.84%,ERCC4;FANCB;FAAP20;RPS27A;POLR1B;FANCE;POLR1A;FANCD2;FANCI;UBB;USP1;FANCM;MUS81;FANCF
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.4461181990255346,-1.3721860297966748,0.15,1.0,1.0,5/17,7.98%,AKT1;KHSRP;MAPK14;EXOSC9;EXOSC8
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,0.3488327059273161,1.371737460577683,0.07317073170731707,0.5295182056878935,1.0,13/46,15.02%,CCNH;RBBP7;POLR2K;TBP;POLR1F;POLR1D;ERCC2;POLR1B;POLR2F;MNAT1;POLR2H;POLR1A;TAF1C
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.3267547194606442,1.3714905911648134,0.1282051282051282,0.5246615015429669,1.0,5/31,5.18%,NUP205;NUP35;MAP4K2;NUP214;NUP37
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.33124192127937657,-1.3701920135116934,0.0625,1.0,1.0,17/54,23.94%,IL6;FOXP3;TLR5;RORA;STAT6;IL2RG;TLR2;JUN;IL10;GATA3;IL18RAP;TGFB3;HLA-DRB3;IL12RB1;IL23A;STAT4;MAF
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.29712201161938345,-1.3691349546065046,0.047619047619047616,0.992475065012015,1.0,26/104,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;TLR2;TIRAP;MAPK1;TIFA;JUN;PELI1;TANK;IKBIP;S100A9;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,KEGG_2021_Human__Insulin secretion,0.3106785261422059,1.367718500690299,0.06521739130434782,0.5295635256301809,1.0,9/51,9.22%,KCNMA1;ADCY7;RAB3A;KCNN4;CREB3L4;ITPR3;ATP1B2;CHRM3;PRKACB
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.3081727151844689,1.3670537823150242,0.05555555555555555,0.5256177667839186,1.0,13/59,11.86%,CCNH;POLR2K;FOS;MLH1;ERCC2;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;MNAT1;POLR2H
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.28433510799813905,1.3658780668197454,0.0,0.5230866308994243,1.0,17/85,11.16%,PSMA5;ADCY7;IFT172;PSMA4;PSME1;MKS1;RPS27A;SKP1;PSMC6;SUFU;RPGRIP1L;WDR19;PRKACB;TTC21B;IFT122;PSME2;PSMD11
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,0.35663599037574206,1.3634752053435533,0.07142857142857142,0.5248221055628537,1.0,11/41,17.59%,ERCC4;RPS27A;RFC5;ERCC2;POLR1B;CUL4A;POLD4;POLR1A;PARP2;UBB;SLC19A1
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.3376595302718738,1.3624275635418848,0.06818181818181818,0.5227428743159027,1.0,11/35,12.44%,UBXN11;TXNL1;ARHGAP35;EPSTI1;ANKRD26;ARHGAP5;KIDINS220;VANGL1;RRAS2;RBMX;ALDH3A2
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,0.4037096238152866,1.3608152182486721,0.11764705882352941,0.5213512717581346,1.0,6/16,15.11%,CABIN1;ASF1A;H1-3;EP400;HMGA1;H1-2
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.4170971101557308,-1.3605782568530989,0.09523809523809523,1.0,1.0,5/22,7.58%,COX10;MMAB;UROS;EARS2;CPOX
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.30359717650679574,1.3570810302510428,0.1,0.5282843933815341,1.0,7/42,9.52%,ALYREF;NUP205;NUP35;NUP214;NUP37;CPSF1;NXF1
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.4121844653926332,-1.353104748283048,0.15254237288135594,1.0,1.0,10/21,19.64%,QARS1;AARS2;EARS2;KARS1;DTD1;CARS2;PARS2;IARS2;GARS1;TARS2
prerank,KEGG_2021_Human__Fat digestion and absorption,0.3849222809790657,1.3526181271062188,0.15,0.535835530976463,1.0,3/19,6.17%,PLA2G2C;ACAT1;DGAT2
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.4232600873786331,-1.3519620011202647,0.140625,1.0,1.0,4/18,3.14%,SLC39A14;SLC39A1;SLC39A6;SLC11A2
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.372121839998913,-1.3506124155068837,0.15151515151515152,1.0,1.0,13/29,22.12%,FLOT2;FADD;CASP8;SDCBP;PELI1;TANK;PDCD6IP;CFLAR;MLKL;HSP90AA1;TRADD;XIAP;UBC
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.32467138583509775,-1.3481801594805194,0.04838709677419355,1.0,1.0,15/47,18.14%,PRKAG2;RPS6KA1;NEFL;PRKAR1B;RNASE1;MAPK1;NRAS;PRKAG1;PRKAR2B;RASGRF2;CREB1;GIT1;RPS6KA3;MAPT;PPM1F
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.3150133800576629,1.3476797585605946,0.12121212121212122,0.5457373066337667,1.0,5/35,5.18%,ALYREF;NUP205;NUP35;NUP214;NUP37
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.2915319150744219,-1.34633827869056,0.030303030303030304,1.0,1.0,24/99,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;TLR8;PPP2CB;MAPK14;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;PELI1;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.4144231271811168,1.3459846601895493,0.1111111111111111,0.544668527780936,1.0,8/18,18.31%,LYN;YES1;SYK;GRB2;PIK3CA;CBL;PIK3CB;PIK3R1
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.2610010774283532,1.3416935434395225,0.027777777777777776,0.5523274660533284,1.0,18/95,10.02%,ADCY7;PPAN-P2RY11;LYN;GNB2;HRH2;RAMP1;GGT1;ITPR3;YES1;GNG5;SYK;CYSLTR1;FGR;GNG3;PRKACB;FCGR1A;GNG10;GNG7
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.3108049177857492,1.3414075586494731,0.11764705882352941,0.5480580220784642,1.0,13/57,13.49%,CCNH;POLR2K;ERCC2;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;MNAT1;POLR2H;EAF1;CDC73
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.3500743187982584,1.340604551212685,0.12195121951219512,0.5465166701951366,1.0,8/30,10.02%,GNB2;RAP1A;ITPR3;GNG5;GNG3;PRKACB;GNG10;GNG7
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,0.3449379904562069,1.3367404173449462,0.07692307692307693,0.5519140263109136,1.0,8/29,9.49%,LYN;FOS;MAP2K7;GRAP2;SYK;HRAS;SHC1;GRB2
prerank,KEGG_2021_Human__Legionellosis,-0.3245947101397538,-1.3335650101405048,0.08196721311475409,1.0,1.0,10/56,7.86%,IL6;TLR5;CR1L;CXCL8;HSPA6;PYCARD;CASP8;EEF1G;BCL2L13;TLR2
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.33876251530464646,-1.3327245930538123,0.10714285714285714,1.0,1.0,11/33,23.23%,RUNX1;PHC3;CSNK2A2;PCGF5;RING1;PHC2;CBX4;SCMH1;RYBP;ARID1A;ACTL6A
prerank,KEGG_2021_Human__Measles,-0.2762366564815847,-1.3320487958261198,0.04285714285714286,1.0,1.0,19/117,9.61%,AKT1;IL6;MAPK8;CD3D;NFKBIB;HSPA6;CD3G;FADD;CSNK2A2;PIK3R3;CASP8;MX1;FAS;IL2RG;EIF2AK1;TLR2;BAD;CBLB;IRF9
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.322790356522069,1.3308673364251293,0.14634146341463414,0.5649977348463009,1.0,8/33,10.02%,ADCY7;GNB2;GNG5;SHC1;GNG3;PRKACB;GNG10;GNG7
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.45186981373290436,1.3292984275067423,0.1111111111111111,0.5635750834398413,1.0,6/15,16.31%,LYN;YES1;GRB2;SOCS1;SOCS6;CBL
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.3062823703715883,1.3291774145019435,0.10714285714285714,0.5584726132605035,1.0,7/41,9.52%,ALYREF;NUP205;NUP35;NUP214;NUP37;CPSF1;NXF1
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.33099780604357243,-1.3277236976325149,0.11290322580645161,1.0,1.0,20/59,21.00%,RHOB;H2AX;H2BC14;H2BC4;H3C13;PPP1R12A;RHOC;REXO2;RNASE1;MYL12B;H2AZ1;YWHAQ;H3-3B;YWHAB;AREG;KLK2;PPP1R14A;H2AC7;YWHAZ;CDC25C
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.3791768574704646,1.32744281935832,0.10638297872340426,0.5605785815470691,1.0,4/19,4.85%,ATP6V1E2;ATP6V1A;ATP6V1E1;ATP6V0A1
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.3559262698699823,-1.3233172519162484,0.1206896551724138,1.0,1.0,7/27,15.63%,AP2B1;AP1S2;RNASE1;HCK;LCK;AP2M1;AP1M1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,-0.30877065971783824,-1.322554903525132,0.08695652173913043,1.0,1.0,29/71,25.38%,RPS6KA1;SPTAN1;ITGB1;RPS6KA4;AP2B1;CSNK2A2;KIF4A;RPS6KA5;ITGA9;RNASE1;MAPK1;EZR;AP2M1;SDCBP;EPHB2;FGFR1;RPS6KA3;CLTC;NRP2;ITGA5;ITGA1;RDX;ANK1;DLG1;SCN11A;ALCAM;LAMC1;MAP2K1;PKN1
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.3025849509526227,1.3193337888363073,0.1282051282051282,0.5826595460153399,1.0,7/49,5.50%,CAPZA2;KCNMA1;RAB3A;EPS8L2;MSN;TRIOBP;CAPZB
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.3661486018861933,1.3191057272161153,0.07894736842105263,0.5781991728845671,1.0,6/23,11.86%,POLR2K;NELFA;POLR2I;POLR2F;POLR2D;POLR2H
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.3178167310114658,1.3187512232444507,0.1,0.5734834054149324,1.0,5/34,5.18%,ALYREF;NUP205;NUP35;NUP214;NUP37
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,0.3866052953560052,1.3178029239459899,0.1794871794871795,0.5726146633733132,1.0,7/20,17.59%,FEN1;RFC5;POLR1B;POLD4;POLA2;POLR1A;SLC19A1
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.34744754933454886,1.3167717408141781,0.14583333333333334,0.5707736647302987,1.0,7/32,6.90%,CAPZA2;DYNC1LI2;GALNT2;DCTN2;CAPZB;BICD1;ACTR10
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.38511728806104106,1.316053229091431,0.10638297872340426,0.5673331655326366,1.0,6/24,9.65%,LYN;UBE2D2;RPS27A;CUL5;SYK;SOCS1
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.38137215597272844,1.3151815305842112,0.16666666666666666,0.5642754759091936,1.0,8/18,23.95%,SCN1B;FGF12;FGF11;CACNG6;SCN9A;CACNB2;RANGRF;SCN7A
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.3015782455086298,1.314389085237569,0.11627906976744186,0.5613769630662484,1.0,16/56,16.02%,H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;POLR1B;POLR2F;H2AZ2;POLR2H;DDX56;H2BC3;POLR1A;TAF1C;H2BC11
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.3574475795175094,1.3130860326751859,0.14893617021276595,0.5611776419815244,1.0,9/27,13.62%,POLR3K;POLR2K;TBP;POLR1D;POLR2F;POLR3D;POLR3H;POLR2H;SNAPC1
prerank,KEGG_2021_Human__Protein export,-0.42431939711960864,-1.3110695149081626,0.13793103448275862,1.0,1.0,8/23,11.23%,SEC61B;SEC61A2;SRP72;SEC11A;SRP68;SRP19;SRP14;SRPRB
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.40810855904050075,1.3103672346373993,0.16,0.5657117017823549,1.0,4/17,7.12%,LTBP1;ITGB3;ITGAV;LTBP4
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.3141372942241821,1.3097442187241686,0.14705882352941177,0.5620397962734491,1.0,7/46,5.50%,CAPZA2;KCNMA1;RAB3A;EPS8L2;MSN;TRIOBP;CAPZB
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.3606672540048505,1.3085092805207568,0.1568627450980392,0.5610129437629071,1.0,5/24,7.12%,LTBP1;ITGB3;LOXL3;ITGAV;LTBP4
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.35239474474385774,-1.3068014442893776,0.11666666666666667,1.0,1.0,10/37,15.97%,CCRL2;CXCL8;CXCR3;ACKR2;CCL2;CXCL16;CCL3;CXCR1;CXCR4;CXCR2
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.3978819900012685,-1.304563141655525,0.11538461538461539,1.0,1.0,7/21,16.66%,DUSP2;IL6;DUSP10;MAPK1;DUSP6;CDK1;IL6R
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.3976619682933023,1.3038287654987122,0.2,0.5723061748063422,1.0,3/18,4.19%,COL6A2;COL6A3;COL28A1
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,0.3670603710991919,1.3030348834043524,0.19148936170212766,0.57080577847631,1.0,4/23,5.07%,TICAM1;UBE2D2;RPS27A;RIPK3
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.24581579128558023,1.301690357617405,0.08108108108108109,0.5707418099661101,1.0,39/128,21.47%,PSMA5;FCER1G;PSMA4;LYN;PSME1;FOS;MAP2K7;UBE2D2;RPS27A;SKP1;GRAP2;ITPR3;FCER1A;PSMC6;SYK;HRAS;SHC1;GRB2;SLC7A8;PSME2;PSMD11;PIK3CA;MAP3K1;TRAF6;PSMD6;NFATC2;LCP2;UBB;PIK3CB;NFKB1;PIK3R1;PSMC1;PDPK1;NFKBIA;BCL10;BTK;PSMA7;RASGRP1;PSME4
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.4471272761075429,-1.3014993036918594,0.11475409836065574,1.0,1.0,3/18,5.34%,RFNG;ST3GAL4;LFNG
prerank,KEGG_2021_Human__Drug metabolism,0.28844481306974346,1.3009899473230166,0.1111111111111111,0.5677769384075163,1.0,18/59,16.47%,UCKL1;GSTA4;UMPS;NME3;HPGDS;CYP2C9;RRM2;UGT2B4;TK1;GSTO1;GSTM1;MGST2;GSTP1;RRM2B;CES1;FMO5;GSTO2;FMO4
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.3363218569882537,1.2994960923011765,0.15384615384615385,0.5679365681928081,1.0,8/30,11.86%,POLR2K;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;POLR2H
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.26162611684063575,1.299369951150959,0.04878048780487805,0.5640555702104096,1.0,21/108,11.16%,PSMA5;ADCY7;IFT172;PSMA4;PSME1;MKS1;RPS27A;SKP1;PSMC6;HHAT;SUFU;RPGRIP1L;WDR19;PRKACB;TTC21B;IFT122;PSME2;VCP;GRK2;SPOPL;PSMD11
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.3287586171899282,1.2989905462966618,0.06818181818181818,0.5613101452026193,1.0,9/44,10.02%,KCNMA1;GNB2;KCNN4;GNG5;KCNQ5;GNG3;KCNG1;GNG10;GNG7
prerank,KEGG_2021_Human__RNA transport,0.23518622599276312,1.2964140122034726,0.0,0.564909918758042,1.0,31/164,13.95%,ALYREF;NUP205;EIF4A3;RPP25;EEF1A1;RPP14;THOC7;NUP35;GEMIN8;GEMIN5;NUP214;FXR2;EIF5;NUP37;EIF3B;THOC6;RNU5A-1;STRAP;XPO1;EIF4EBP2;NXF1;EIF4A2;NXT2;PHAX;EIF2B3;UPF3B;RAN;SMN1;SNUPN;POP4;EEF1A2
prerank,KEGG_2021_Human__Nucleotide excision repair,0.3267345526993445,1.2959519149008762,0.14705882352941177,0.5616228528044035,1.0,9/46,10.90%,CCNH;ERCC4;RFC5;ERCC2;RFC1;CUL4A;LIG1;MNAT1;POLD4
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,-0.4014738250810639,-1.2951877789995747,0.19607843137254902,1.0,1.0,7/17,24.59%,ITGA3;ITGB1;LAMC3;ITGA1;ITGA6;LAMC1;LMNB2
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.35451569098221913,-1.2939217822362479,0.125,1.0,1.0,16/42,20.57%,QARS1;AARS2;EARS2;EEF1E1;FARSA;DARS1;KARS1;MARS1;DTD1;NARS1;CARS2;PARS2;IARS2;GARS1;TARS2;VARS1
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.41345282525847715,1.2924882051502877,0.11627906976744186,0.5676478450708409,1.0,5/18,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.3806432953455945,-1.288136824376628,0.1694915254237288,1.0,1.0,10/27,17.02%,RPS6KA1;MAPK8;PPP2CB;MAPK14;RPS6KA5;MAPK1;JUN;DUSP6;CREB1;RPS6KA3
prerank,KEGG_2021_Human__Salivary secretion,0.3010263639300334,1.2880272589073776,0.045454545454545456,0.5756662669208935,1.0,10/53,9.22%,KCNMA1;ADCY7;LYZ;KCNN4;ITPR3;BST1;ATP1B2;CALML4;CHRM3;PRKACB
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.28074120194194185,-1.2870969426658097,0.06060606060606061,1.0,1.0,23/97,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;PELI1;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,-0.36636735529064185,-1.2863312583854738,0.15789473684210525,1.0,1.0,8/30,13.84%,AGAP2;MAPK8;MAPK14;TRPC6;RNASE1;WASL;EZR;NCK1
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.2747161200406126,-1.2836350691144294,0.05084745762711865,1.0,1.0,22/114,12.33%,RHOB;FMNL1;CLASP1;ITGB1;NUP133;PPP2CB;CENPN;DYNLL2;CENPF;CENPI;NUP85;DIAPH1;RHOC;CENPM;BIRC5;SRF;RNASE1;EVL;KNTC1;CENPO;CENPE;SCAI
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.27800779504725154,-1.2807855824061039,0.07575757575757576,1.0,1.0,23/98,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;PELI1;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,0.3296891616654554,1.2797260625592115,0.16666666666666666,0.5971069364594936,1.0,10/35,13.62%,POLR3K;POLR2K;TBP;POLR1D;POLR2F;POLR3D;BRF1;POLR3H;POLR2H;SNAPC1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.3370234923306129,1.2794652952061023,0.18181818181818182,0.5934910245205595,1.0,9/34,11.19%,UBXN11;TXNL1;ARHGAP35;ROCK1;ANKRD26;ARHGAP5;KTN1;VANGL1;RBMX
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,0.25714205270029045,1.2792170066551376,0.030303030303030304,0.5899286816473872,1.0,26/107,13.83%,FCER1G;LYN;ITGB3;JAML;JAM3;CD44;SDC2;YES1;GLG1;SELPLG;ITGAL;ITGAV;TNFRSF10D;ATP1B2;ITGA4;HRAS;SHC1;GRB14;GRB2;SLC7A8;TTF2;DOK2;ITGAX;PIK3CA;PROCR;ITGAM
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.396416918755653,-1.2785823430377063,0.15625,1.0,1.0,8/22,18.73%,VAMP1;ANTXR2;CD9;MAP2K6;STX1B;MAP2K4;PDCD6IP;HSP90AA1
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.37710937279359374,-1.27480511319759,0.18181818181818182,1.0,1.0,9/21,23.47%,MARCHF6;DERL2;UGGT2;AMFR;RNF139;SYVN1;RNF185;UBC;EDEM1
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.253413521867268,1.2726599927903528,0.075,0.6053651279245683,1.0,18/79,12.52%,RBBP7;H2BC15;H2BC17;POLR2K;RARA;RARG;H2AC4;MEIS1;POLR2I;POLR2F;SUZ12;KMT2C;KMT2D;POLR2D;CNOT6;H2AZ2;POLR2H;H2BC3
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.34394176676608146,1.2705570429693647,0.13953488372093023,0.607702714591405,1.0,9/30,16.45%,ABRAXAS1;UIMC1;RPS27A;H2AC4;MYSM1;H2AC12;H2AC25;H2AC21;UBB
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.24786719163185958,1.2687209424404613,0.08333333333333333,0.6099157833060314,1.0,42/121,24.16%,VPS37A;GFAP;ATG5;DYNC1LI2;TSC2;EEF1A1;ATG10;GABARAPL2;RPS27A;UBAP1;SQSTM1;TOMM20;SLC38A9;VPS37B;ATG4C;VCP;RRAGB;TOMM5;MAP1LC3B;LAMTOR2;TOMM6;UVRAG;RPTOR;TOMM70;WIPI2;MFN2;MFN1;UBB;PLIN2;MTMR3;WDR45B;PRKAA1;DYNC1H1;BECN1;ATG4D;PCNT;MVB12A;PGAM5;CHMP2A;TOMM7;MTOR;RRAGD
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.23706799347302432,1.2666510406207279,0.0,0.6128169116979361,1.0,34/220,10.38%,VPS37A;PSMA5;FEN1;CCNH;NUP205;PSMA4;POLR2K;TBP;PSME1;NUP35;TAF2;RPS27A;SKP1;UBAP1;CUL5;NUP214;TAF5;ERCC2;NUP37;NELFA;PSMC6;CD4;SUPT16H;RNGTT;POLR2I;POLR2F;XPO1;VPS37B;SSRP1;B2M;POLR2D;PSME2;MNAT1;HMGA1
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",0.41507648695152166,1.2654520208591147,0.1568627450980392,0.6116560690898738,1.0,5/15,9.87%,TCN1;AMN;MTRR;MMUT;LMBRD1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.29374832359232217,1.2649473927793562,0.12121212121212122,0.6090923103121253,1.0,16/52,19.48%,ATP6V1E2;ATP6V1A;ATP6V1E1;FLT3LG;ATP6V0A1;HRAS;SHC1;GRB2;TRIB3;PIK3CA;FGFR4;ATP6V0E2;PIK3CB;PIK3R1;ATP6V0D1;PDPK1
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.2947328598688971,-1.2641769500197628,0.20588235294117646,1.0,1.0,15/62,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;MAP2K6;RPS6KA5;MAPK1;IL17RA;JUN;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,KEGG_2021_Human__GABAergic synapse,0.28365763696751045,1.2597763835209221,0.11904761904761904,0.6218036509843916,1.0,11/53,11.51%,ADCY7;GNB2;GABARAPL2;ABAT;GNG5;SLC38A1;GNG3;PRKACB;GNG10;GNG7;SLC6A13
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.24899793823934668,1.2595675805908242,0.11904761904761904,0.6182426096253562,1.0,33/102,22.61%,MED18;BMAL1;HMGCR;MED23;MED12;SREBF1;MED9;ACOX1;MED30;CPT1A;LIN9;CARM1;MED4;ABCB4;TRIB3;PEX11A;CPT2;PPARG;MED26;TBL1X;AGXT;HMGCS1;NRF1;CDK19;PLIN2;CLOCK;MED7;MED6;G0S2;PPARGC1B;MED17;MED27;MED14
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,-0.30271201941404446,-1.2580521878686546,0.14545454545454545,1.0,1.0,14/54,21.79%,CDH8;CDH18;JUP;ITGB1;DST;ANG;CDH24;CDH13;CLDN15;NECTIN2;RSU1;VASP;PVR;ITGA6
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.28297230788031913,-1.2572294296794944,0.11940298507462686,1.0,1.0,17/85,11.85%,AKT1;MAPK14;CD3D;NFKBIB;BATF2;CD3G;CSNK2A2;PTEN;PIK3R3;MAP2K6;TLR2;TIRAP;MAPK1;NRAS;LCK;PPP3CB;JUN
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.33737322434196126,-1.2564067254262083,0.14516129032258066,1.0,1.0,9/48,6.01%,SLC22A16;SLC39A14;SLC39A1;SLC39A6;RUNX1;SLC11A2;EMB;SLC13A5;SLC22A1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,-0.3638563236851543,-1.2563455318335675,0.13793103448275862,1.0,1.0,6/26,13.15%,ST6GALNAC4;NANP;ST3GAL4;NEU3;CMAS;ST8SIA6
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.3148652817350046,-1.2537125852987525,0.18181818181818182,1.0,1.0,12/54,13.22%,AKT1;UACA;TP53BP2;MAPK8;DYNLL2;CASP8;REXO2;BAD;MAPK1;GZMB;YWHAQ;YWHAB
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.2741978912797558,-1.2533825847275801,0.07142857142857142,1.0,1.0,23/99,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;FADD;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,KEGG_2021_Human__VEGF signaling pathway,-0.31982833179532366,-1.2533714105862412,0.17391304347826086,1.0,1.0,11/52,11.10%,AKT1;MAPK14;PXN;PLA2G4A;SPHK2;PIK3R3;BAD;MAPK1;RAC2;NRAS;PPP3CB
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.27469470231016185,1.2513052032167038,0.07692307692307693,0.6406162675439984,1.0,19/72,16.02%,CCNH;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;ERCC2;POLR1B;POLR2F;MNAT1;H2AZ2;POLR2H;SAP30L;H2BC3;POLR1A;TAF1C;H2BC11
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.35865911037663123,-1.2509926256894677,0.21666666666666667,1.0,1.0,9/31,13.09%,H2AX;DNMT3B;H2BC14;H2BC4;H3C13;DNMT3A;DNMT1;H2AZ1;H3-3B
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.25368668527995053,1.2503218376531788,0.125,0.6397350551259438,1.0,33/100,22.61%,MED18;BMAL1;HMGCR;MED23;MED12;SREBF1;MED9;ACOX1;MED30;CPT1A;LIN9;CARM1;MED4;ABCB4;TRIB3;PEX11A;CPT2;PPARG;MED26;TBL1X;AGXT;HMGCS1;NRF1;CDK19;PLIN2;CLOCK;MED7;MED6;G0S2;PPARGC1B;MED17;MED27;MED14
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,0.2505300827887941,1.2502406361895733,0.10810810810810811,0.6356960014352556,1.0,12/73,9.57%,NUP205;EIF4A3;UBA7;RIGI;NUP35;RPS27A;NUP214;NUP37;USP18;ISG15;EIF4A2;KPNA5
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.34079877975588024,1.2493499353149269,0.14705882352941177,0.6293029196986679,1.0,11/30,19.48%,IGF1R;FLT3LG;HRAS;SHC1;GRB2;TRIB3;PIK3CA;FGFR4;PIK3CB;PIK3R1;PDPK1
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.34079877975588024,1.2493499353149269,0.14705882352941177,0.6293029196986679,1.0,11/30,19.48%,IGF1R;FLT3LG;HRAS;SHC1;GRB2;TRIB3;PIK3CA;FGFR4;PIK3CB;PIK3R1;PDPK1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.2681493466196301,1.2488086244228283,0.07692307692307693,0.6268423255094067,1.0,18/71,14.55%,LTBP1;SDC2;PRSS23;C4A;MELTF;IGFBP6;APOE;HSP90B1;KTN1;DNAJC3;TTF2;ADAM10;SHISA5;FUCA2;APLP2;CTSG;ANO8;MXRA8
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.39797017308734206,-1.2483832900096135,0.1724137931034483,1.0,1.0,9/24,20.57%,QARS1;EEF1E1;FARSA;DARS1;KARS1;MARS1;NARS1;GARS1;VARS1
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.36975299740338496,-1.2468623470166207,0.17543859649122806,1.0,1.0,3/24,2.68%,USP8;AKT1;ERBB2
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.2693751572138301,-1.245447008466,0.12121212121212122,1.0,1.0,23/102,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;PELI1;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.32782156916453364,-1.2449408935251705,0.2,1.0,1.0,11/43,14.67%,CHD3;H2AX;GATAD2A;H2BC14;H2BC4;H3C13;HDAC2;DPEP3;H2AZ1;H3-3B;RBBP4
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.35007200173102576,1.244869933832546,0.2631578947368421,0.6350049033564266,1.0,8/24,16.45%,RPS27A;RAB5A;LTF;B2M;CTSG;VPS33B;PGK1;UBB
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.4123144113596129,-1.242010476450129,0.26785714285714285,1.0,1.0,5/17,20.25%,ACSL5;ACSL4;OXSM;ACSL1;MECR
prerank,KEGG_2021_Human__Circadian rhythm,-0.37294951095081985,-1.2408619193699593,0.23333333333333334,1.0,1.0,9/26,19.57%,CUL1;PRKAG2;RORA;CRY2;PRKAG1;CREB1;BHLHE41;CSNK1E;NR1D1
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.2855227711762425,1.2407213776700152,0.08823529411764706,0.6441362414500276,1.0,9/46,11.86%,NUP205;POLR2K;NUP35;NUP214;NUP37;POLR2I;POLR2F;POLR2D;POLR2H
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.26291242430444134,1.2405446614810152,0.13513513513513514,0.6406391262868188,1.0,21/64,21.65%,FMNL3;OPHN1;ARHGAP35;RACGAP1;PKN3;ROCK1;ARHGAP5;ARHGEF5;MACO1;VANGL1;ANLN;ARHGEF17;ARHGEF12;TMPO;PIK3R1;LBR;ARHGAP32;MCF2L;PREX1;STK10;ARHGEF40
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.27032751653575615,-1.2397735324192858,0.1232876712328767,1.0,1.0,21/96,14.34%,AKT1;MAP3K8;MAPK8;MAPK14;CD3D;NFKBIB;CD3G;PIK3R3;PAK1;TEC;CARD11;MAPK1;CBLB;NRAS;LCK;PPP3CB;JUN;IL10;NCK1;NCK2;MAP3K7
prerank,KEGG_2021_Human__Toxoplasmosis,-0.276750849467428,-1.2392682654749365,0.12903225806451613,1.0,1.0,13/102,8.87%,GNAO1;AKT1;MAPK8;ITGB1;MAPK14;NFKBIB;HSPA6;LAMC3;CASP8;MAP2K6;TLR2;BAD;MAPK1
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.2837730326604582,1.2383830640031026,0.17777777777777778,0.6434827538936868,1.0,6/51,4.19%,PLOD1;CTSL;COL6A2;COL6A3;LOXL3;COL28A1
prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.2383465381623886,1.2360318343781362,0.08823529411764706,0.6488073566369096,1.0,27/112,17.74%,H2AC17;H2BC15;H2BC17;H3C15;H3-3A;H3C1;H2AC4;H4C3;C1S;C4A;MACROH2A2;C1QB;FCGR1A;RO60;H2AC12;ACTN1;H3C10;H2AZ2;H2BC3;MACROH2A1;CTSG;CD40LG;H2BC11;H2AC21;H4C1;H2AB2;SNRPB
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.30753208237421686,1.2356794938423197,0.15384615384615385,0.6455898875544549,1.0,8/29,16.37%,LYN;GRAP2;ITPR3;SYK;SHC1;GRB2;NFATC2;LCP2
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.2466444636884222,-1.2321184964681797,0.15625,1.0,1.0,33/163,14.58%,IL6;TUBB3;TLR5;MAPK8;ITGB1;MYO1C;CXCL8;MAPK14;NFKBIB;PYCARD;FADD;PAK1;CASP8;GNA13;ROCK2;ARPC1A;FAS;MYO1F;SEC24C;TIRAP;WASL;MAPK1;IL1R1;NCKAP1L;TUBA8;ACTR3;EZR;JUN;CASP4;NCK1;NCK2;MAP3K7;CLDN15
prerank,KEGG_2021_Human__AMPK signaling pathway,0.23888568417116987,1.229751164993953,0.1891891891891892,0.6612563056190275,1.0,29/102,19.76%,STRADA;CAB39L;TSC2;IGF1R;HMGCR;EEF2;SREBF1;CREB3L4;CPT1A;PFKL;PIK3CA;LEPR;PPARG;PPP2R3A;SCD5;RPTOR;PPP2R2D;RAB2A;PPP2R5C;FOXO3;PPP2R5E;FBP1;PIK3CB;PIK3R1;PPP2R2A;PRKAA1;PDPK1;ACACA;PIK3CD
prerank,KEGG_2021_Human__Bile secretion,0.2857816489930268,1.229693929921048,0.15789473684210525,0.6570444820163585,1.0,9/43,9.40%,ADCY7;ABCB1;HMGCR;ABCC2;ATP1B2;UGT2B4;ABCB4;PRKACB;AQP9
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.2851587253245633,1.2292165802299457,0.14285714285714285,0.6542318028214021,1.0,14/65,11.86%,CCNH;ERCC4;POLR2K;RPS27A;RFC5;ERCC2;POLR1B;CUL4A;POLR2I;POLR2F;POLR2D;MNAT1;POLD4;POLR2H
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.3307187410204678,1.228772650018288,0.23076923076923078,0.6524771947668085,1.0,3/25,1.95%,ADCY7;BMP6;IGF1R
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.2764600488603833,-1.2283660789564326,0.14754098360655737,1.0,1.0,19/74,14.02%,H2BC14;H2BC4;UBE2T;UBE2L3;PEX14;USP7;UBE2E3;UBE2E1;UBE2R2;PEX12;USP5;USP9X;UBA6;RNF40;DERL1;PEX2;RNF20;UBE2W;UBE2S
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.3099490375619511,-1.2281762906870963,0.12698412698412698,1.0,1.0,19/44,25.37%,DLAT;BPGM;PGM2;ALDH1B1;PGAM1;PDHA1;PGAM2;ALDH3B1;HKDC1;HK3;GALM;ADH5;PGM1;AKR1A1;ENO3;TPI1;HK1;HK2;ALDH2
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.27569346046373117,-1.2276872037939206,0.15,1.0,1.0,25/98,20.60%,IL6;FOXP3;RUNX1;MAPK8;RORA;MAPK14;CD3D;NFKBIB;CD3G;IRF4;STAT6;IL2RG;MAPK1;IL1R1;LCK;PPP3CB;JUN;GATA3;IL27RA;IL6R;HLA-DRB3;HSP90AA1;STAT5B;IL12RB1;IL23A
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,-0.41261504987388475,-1.2274977451113784,0.15789473684210525,1.0,1.0,10/15,40.98%,PLA2G4A;PLB1;LPCAT2;PLBD1;PLA2G4C;MBOAT2;PLA2G6;TMEM86B;LPCAT3;PLA2G12A
prerank,KEGG_2021_Human__Ferroptosis,-0.3397125817430222,-1.2274356705480998,0.234375,1.0,1.0,7/39,8.28%,ACSL5;SLC39A14;SLC11A2;CYBB;ACSL4;STEAP3;MAP1LC3B2
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.36371461394481364,-1.226834870064718,0.19047619047619047,1.0,1.0,7/20,17.02%,RPS6KA1;PPP2CB;MAPK14;RPS6KA5;MAPK1;DUSP6;RPS6KA3
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.37562046139597277,1.2262774424252174,0.20930232558139536,0.6571550251494733,1.0,3/18,4.51%,PTPN4;PTPN23;PTPN9
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,-0.2806351844702238,-1.2258721730846638,0.1509433962264151,1.0,1.0,10/65,7.26%,MAMLD1;CUL1;TLE4;CCNC;HDAC2;JAG1;DTX4;HDAC6;HDAC10;PSENEN
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.294991392996401,-1.225494471558622,0.2,1.0,1.0,9/54,9.89%,USP8;ITGA3;ITGB1;RAB4A;LAMC3;STAM;RNASE1;RANBP10;NRAS
prerank,KEGG_2021_Human__Peroxisome,-0.27598263152782887,-1.225197224531124,0.12903225806451613,1.0,1.0,27/75,26.45%,ACSL5;PMVK;SLC25A17;PEX14;IDH1;ACSL4;PEX12;ACOT8;ACOX2;SOD1;NUDT12;PEX2;PAOX;PEX26;CROT;ACSL1;IDH2;PEX3;PXMP4;EPHX2;AMACR;ABCD2;NUDT7;ECI2;MLYCD;GSTK1;SOD2
prerank,KEGG_2021_Human__Antigen processing and presentation,0.2692379811411727,1.2248117731134556,0.1,0.658434018663603,1.0,9/63,9.93%,CTSL;IFI30;PSME1;PDIA3;KLRC1;CD4;HSPA4;B2M;PSME2
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.4340696157767187,1.2232585377797696,0.21428571428571427,0.6600060691484563,1.0,5/15,14.38%,HS3ST3B1;SDC2;HS6ST1;HS3ST3A1;HS2ST1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.2368826716580132,-1.223163594720727,0.08823529411764706,1.0,1.0,72/254,22.01%,RHOB;FMNL1;CLASP1;ITGB1;H2AX;NUP133;H2BC14;PPP2CB;MAPK14;H2BC4;KIF14;H3C13;CENPN;DYNLL2;CENPF;CENPI;ROCK2;PPP1R12A;ARPC1A;NUP85;DIAPH1;RHOC;CYBB;CENPM;BIRC5;SRF;REXO2;RNASE1;WASL;EVL;IQGAP1;MAPK1;KNTC1;RAC2;RHPN1;NCKAP1L;MYL12B;ACTR3;CENPO;RTKN;H2AZ1;YWHAQ;CENPE;SCAI;H3-3B;YWHAB;KIF5A;NCK1;AREG;S100A9;RHPN2;KNL1;IQGAP2;PRC1;WASF1;KLK2;RCC2;PPP1R14A;PRKCZ;WAS;CKAP5;H2AC7;YWHAZ;PTK2;CDC25C;NUF2;RHOQ;ZWILCH;KLC3;CDC20;SRGAP2;PAFAH1B1
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,-0.3055262737361881,-1.2218118804204254,0.2,1.0,1.0,12/56,19.30%,ACSL5;AKT1;PRKAG2;MAPK8;NFKBIB;ACSL4;PRKAG1;ACSL1;POMC;STK11;TRAF2;TRADD
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.2919634495774021,-1.221533386551993,0.21212121212121213,1.0,1.0,14/59,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;MAP2K6;RPS6KA5;MAPK1;JUN;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.2528801804290913,-1.220603968009233,0.15,1.0,1.0,19/145,7.39%,CHD3;AKT1;JMY;PRKAG2;RMI2;TP53BP2;RAD9B;GATAD2A;PPP2CB;MAPK14;DNA2;CSNK2A2;BRD1;HDAC2;PIP4P1;RAD9A;USP7;MAP2K6;DPEP3
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.34003401315621873,1.2198954190522926,0.25,0.6678513517368827,1.0,7/23,18.31%,LYN;HRAS;SHC1;GRB2;PIK3CA;PIK3CB;PIK3R1
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.307130867685039,1.2196550613909747,0.17142857142857143,0.6649231395986732,1.0,10/38,13.62%,POLR3K;POLR2K;TBP;POLR1D;POLR2F;POLR3D;BRF1;POLR3H;POLR2H;SNAPC1
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,-0.3387864163344597,-1.2176078268492436,0.23214285714285715,1.0,1.0,14/34,19.99%,SPTAN1;PEAK1;DST;WASL;CCP110;IQGAP1;USP9X;NCK1;NCK2;GIT1;ARHGAP12;CLTC;DEPDC1B;MYO9A
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.25956942917817993,1.2169882658522004,0.21621621621621623,0.6699144429010615,1.0,17/73,15.07%,CAPZA2;NAPSA;DYNC1LI2;YKT6;COPE;DCTN2;CAPZB;SPTB;ACTR10;COG8;RAB1B;COPB1;GOLGA2;FOLR2;TMED7;COPA;BET1L
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.2809747609970348,1.214494677613583,0.09302325581395349,0.6745442051017013,1.0,16/50,18.46%,ATP6V1E2;ATP6V1A;HFE;ATP6V1E1;SLC40A1;RPS27A;SKP1;ATP6V0A1;CAND1;TFR2;HMOX2;ATP6V0E2;UBB;IREB2;SLC22A17;ATP6V0D1
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.23049321149968718,1.213720736854846,0.125,0.6728269190005677,1.0,45/128,24.69%,FMNL3;OPHN1;ARHGAP35;RACGAP1;YKT6;PKN3;ROCK1;GMIP;ARHGAP5;ARHGEF5;ARHGAP6;ARHGAP8;BCAP31;MACO1;SNAP23;OBSCN;KTN1;VANGL1;TRIO;ECT2;HMOX2;DEF6;ARHGEF4;ARHGAP45;ANLN;ARHGEF17;PRPF38B;ARHGEF12;TMPO;PIK3R1;LBR;ARHGAP32;MCF2L;PREX1;FAF2;TEX2;STK10;ARHGEF40;FARP1;ARHGAP30;VAPB;ARHGAP31;ARHGAP18;ARHGAP42;PLEKHG5
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,0.3250307020390979,1.212990243636204,0.12195121951219512,0.6714278935451945,1.0,11/27,20.09%,GRAP2;SYK;HRAS;SHC1;B2M;GRB2;PIK3CA;LCP2;PIK3CB;PIK3R1;BTK
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.26599938324941014,1.2096674997253796,0.1,0.6783349515626256,1.0,19/75,16.02%,CCNH;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;ERCC2;POLR1B;POLR2F;MNAT1;H2AZ2;POLR2H;SAP30L;H2BC3;POLR1A;TAF1C;H2BC11
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.236008125344364,1.208725079459659,0.15789473684210525,0.6771407198164452,1.0,14/119,7.54%,CLEC6A;PSMA5;FCER1G;PSMA4;LYN;PSME1;UBE2D2;PRKCD;RPS27A;SKP1;ITPR3;PSMC6;SYK;HRAS
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.3016604199753718,-1.2085415010166938,0.24528301886792453,1.0,1.0,7/40,8.99%,RMI2;RAD9B;XRCC3;DNA2;RAD9A;RAD51AP1;TOP3A
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.25014709978717214,-1.207115903350025,0.10666666666666667,1.0,1.0,37/138,22.39%,AKT1;IL6;NDUFS7;PRKAG2;MAP3K5;MAPK8;NDUFB3;CXCL8;MAPK14;PIK3R3;COX5A;CASP8;SDHC;NDUFA5;FAS;COX7B;UQCR10;NDUFC1;NDUFS1;PRKAG1;JUN;COX6A1;NDUFB1;SDHB;NDUFS3;MLX;IL6R;NDUFC2-KCTD14;ITCH;TRAF2;NDUFA11;NDUFB7;COX8A;NDUFB4;XBP1;SDHD;SDHA
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.3005677671895184,1.205038015983802,0.25,0.6855428406833731,1.0,12/35,18.05%,BCL9;SOX13;CHD8;RPS27A;BCL9L;XPO1;TLE2;KMT2D;CTBP1;UBB;SOX4;LEF1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.2897970829492057,-1.2036629225185005,0.1836734693877551,1.0,1.0,8/51,7.26%,MAMLD1;CUL1;CCNC;HDAC2;JAG1;HDAC6;HDAC10;PSENEN
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.34130121976752,-1.2032425332370558,0.19696969696969696,1.0,1.0,8/25,19.60%,PIGW;PIGF;PIGS;PGAP1;PIGH;GPLD1;PIGB;GPAA1
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.2616929664425162,-1.2020718339779368,0.11764705882352941,1.0,1.0,23/103,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;FADD;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;MAPK1;TIFA;JUN;TANK;IKBIP;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,KEGG_2021_Human__Bladder cancer,-0.32981905822678714,-1.2020638405661512,0.24561403508771928,1.0,1.0,7/37,9.89%,UPK3A;ERBB2;CXCL8;RPS6KA5;DAPK2;MAPK1;NRAS
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.3584198400429164,1.2006535120849242,0.24444444444444444,0.6982833470539032,1.0,5/20,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.3625581054492746,-1.1999440978465399,0.25862068965517243,1.0,1.0,4/22,10.97%,AKT1;MAP3K8;PIK3R3;LCK
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.3239617746324205,-1.1985164842602747,0.2413793103448276,1.0,1.0,5/32,11.76%,IL6;FAS;PRF1;GZMB;KLRD1
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.24704159456284408,-1.1983636459299893,0.11475409836065574,1.0,1.0,20/139,8.99%,XRCC1;RMI2;RAD9B;XRCC3;MAPK8;TDP1;H2AX;H2BC14;H2BC4;DNA2;XRCC5;TP53BP1;APBB1;RAD9A;SMARCA5;POLL;PAXIP1;RAD51AP1;TIPIN;TOP3A
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.30273453730564076,-1.197657590458836,0.19298245614035087,1.0,1.0,8/47,6.83%,TDP1;H2AX;H2BC14;H2BC4;XRCC5;TP53BP1;POLL;PAXIP1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.3399919663527482,-1.1975849467168709,0.20689655172413793,1.0,1.0,9/26,22.07%,RMI2;XRCC3;DNA2;RAD51AP1;TOP3A;RAD51;MRE11;RMI1;RAD51B
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.235175430104119,-1.1967787782068422,0.10606060606060606,1.0,1.0,32/210,11.03%,RHOB;CHID1;AKT1;APBB1IP;SPARC;ITIH4;GP1BA;VTI1B;MAPK14;ENDOD1;CD9;SCCPDH;PLA2G4A;TRPC6;PECAM1;PIK3R3;GNA13;QSOX1;DGKA;PPIA;PIKFYVE;DGKQ;TAGLN2;RNASE1;MAPK1;RAC2;TEX264;ITPR1;MPL;LOC112694756;LCK;SOD1
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.24114200497441135,1.193151330017081,0.1111111111111111,0.7224449380410676,1.0,22/102,14.26%,CAPZA2;NAPSA;DYNC1LI2;RACGAP1;GALNT2;KLC1;COPE;RINT1;DCTN2;CAPZB;BICD1;ACTR10;SEC22B;RAB1B;COPB1;ZW10;KIF21B;UBE2Z;RAB3GAP1;TMED7;KIF22;COPA
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.2791791109214921,1.1923133170296003,0.21428571428571427,0.7211684278388472,1.0,17/47,21.08%,RBBP7;H2AC4;PRMT7;CARM1;PRMT3;H2AC12;SMARCA2;H2AC25;H2AZ2;H2AC21;WDR5;PBRM1;SMARCD2;ARID2;H3C7;SMARCC2;PRMT5
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,-0.37265167160830376,-1.191707020251813,0.26785714285714285,1.0,1.0,4/19,9.07%,APRT;ADA;UCK2;DGUOK
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.3108310228324473,-1.1907766265364197,0.25,1.0,1.0,14/44,22.62%,ARF4;ARL13B;PKD1;BBIP1;EXOC7;EXOC5;EXOC2;RAB11FIP3;BBS9;BBS1;CCT3;CCT2;ASAP1;MKKS
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.2874301378193289,-1.1904541734637328,0.20689655172413793,1.0,1.0,11/54,13.64%,CHD3;PHC3;NUP133;HDAC2;RING1;NUP85;NUP210;PHC2;L3MBTL2;CBX5;CBX4
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.275787599607165,-1.190216590660265,0.21212121212121213,1.0,1.0,9/76,5.34%,MAMLD1;RFNG;RUNX1;H2AX;H2BC14;H2BC4;H3C13;ST3GAL4;LFNG
prerank,KEGG_2021_Human__Pancreatic secretion,0.27953703665799207,1.1901309339148807,0.16666666666666666,0.7246953998834041,1.0,8/54,7.88%,KCNMA1;ADCY7;PLA2G2C;RAP1A;ITPR3;BST1;ATP1B2;CHRM3
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.2885360332074464,1.1895381790370254,0.225,0.7224966999404695,1.0,10/41,14.78%,HS3ST3B1;B3GNT2;B4GALT7;CSGALNACT2;B4GALT4;HS6ST1;HS3ST3A1;CHST12;HS2ST1;CHSY1
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.2143138312556645,1.188838573044324,0.1111111111111111,0.7213122014488628,1.0,11/109,5.18%,VPS37A;NUP205;RBBP7;DYNC1LI2;H2BC15;H2BC17;NUP35;H2AC4;UBAP1;NUP214;NUP37
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.31970660472689255,1.1869980661113875,0.18604651162790697,0.7233032236325075,1.0,7/27,13.96%,STRADA;CAB39L;TSC2;SLC38A9;RRAGB;LAMTOR2;RPTOR
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.3015290728172693,1.1859281908552168,0.2391304347826087,0.7237346662969488,1.0,5/29,9.90%,CYP4B1;CYP27A1;CYP2C9;FDX1;CYP51A1
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,-0.4114312942657133,-1.1858943323819968,0.2711864406779661,1.0,1.0,8/16,27.90%,LATS2;AMOT;NPHP4;YWHAB;MOB1B;STK4;LATS1;CASP3
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.276715064615853,-1.1858822239661426,0.2,1.0,1.0,21/73,20.73%,AKT1;MAPK8;ERBB2;PIK3R3;PAK1;BAD;MAPK1;CBLB;NRAS;JUN;NCK1;NCK2;AREG;ABL2;MAP2K4;TGFA;NRG4;STAT5B;PAK6;PTK2;CAMK2A
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.3596158831526665,1.1858000244237095,0.26666666666666666,0.7202698427762488,1.0,4/18,7.66%,GATD3;YES1;CBFB;HEY1
prerank,KEGG_2021_Human__One carbon pool by folate,-0.37046985725095793,-1.1857934427164125,0.24528301886792453,1.0,1.0,5/17,15.51%,MTHFD1;MTFMT;DHFR2;AMT;MTHFD2
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.2915775799824487,1.185437474221563,0.15,0.7173270511646149,1.0,13/37,18.31%,RPS27A;GRAP2;FLT3LG;SYK;HRAS;GRB2;PIK3CA;SOCS6;SEPSECS;FOXO3;CBL;UBB;PIK3R1
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,0.31996838414283313,1.1848245868987988,0.21212121212121213,0.7156536829403869,1.0,8/32,11.86%,POLR2K;NELFA;SUPT16H;POLR2I;POLR2F;SSRP1;POLR2D;POLR2H
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,0.36045318178591507,1.1847894399884817,0.2,0.7118797098540609,1.0,3/17,6.94%,CYP4B1;GGT1;LTC4S
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,-0.2896538594632119,-1.184613393110602,0.1935483870967742,1.0,1.0,9/55,9.97%,RHOB;PLXNA4;ITGB1;ERBB2;RRAS;ROCK2;RHOC;RNASE1;MYL12B
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.3003281826648025,-1.1834829027485103,0.25862068965517243,1.0,1.0,25/53,32.87%,AKT1;PLXNA4;BTG1;HDAC2;REXO2;YWHAQ;YWHAB;FBXO32;FOXO4;FOXO1;POMC;STK11;BBC3;YWHAZ;ABCA6;NFYB;DDIT3;SMAD4;CCNG2;RBL2;GADD45A;CREBBP;SIRT3;AKT2;YWHAG
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.3471035545661336,-1.1803209633208045,0.2653061224489796,1.0,1.0,4/21,7.66%,BRWD1;H3C13;PIK3R3;IL2RG
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.2699411703275215,1.180302306271267,0.1590909090909091,0.7230343592557901,1.0,11/60,11.16%,PSMA5;PSMA4;PSME1;UBE2D2;RPS27A;PSMC6;HIF1A;CUL2;PSME2;EGLN1;PSMD11
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.25953949682929,-1.1799152791946437,0.16666666666666666,1.0,1.0,9/84,4.03%,IL9R;CD33;IL6;ITGA3;CR1L;GP1BA;CD3D;CD9;CD3G
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.27608519391414077,1.1799070815271924,0.21428571428571427,0.7203430896018919,1.0,13/47,19.50%,CCNH;CCND2;LYN;RPS27A;SKP1;MNAT1;RBL1;SKP2;CCNE1;UBB;PTK6;PPP2R2A;CCNE2
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.2556350730082021,1.1782349126251463,0.21739130434782608,0.7231951719542299,1.0,18/63,21.47%,PSMA5;PSMA4;MDM4;PSME1;RPS27A;PSMC6;PSME2;PSMD11;ZNF385A;PCBP4;PSMD6;CCNE1;UBB;MDM2;PSMC1;CCNE2;PSMA7;PSME4
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.3046493103227812,1.177894168002472,0.225,0.7207993832783788,1.0,8/29,14.76%,ADCY7;PRKCD;NBEA;ITPR3;PRKACB;GRK2;KPNA2;CAMKK1
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.3405872040306073,1.1771945556494428,0.22727272727272727,0.7191609505713402,1.0,11/17,35.71%,PPCDC;PANK2;SLC5A6;SLC25A16;PANK4;PPCS;PDZD11;PANK3;VNN2;AASDHPPT;COASY
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.238637152791817,1.1761712860782436,0.20512820512820512,0.7189958488430539,1.0,17/85,11.70%,PSMA5;PSMA4;PSME1;PRKCD;RPS27A;ZFP36;NUP214;EXOSC3;PSMC6;EXOSC6;XPO1;MAPK11;SET;PSME2;EXOSC7;PSMD11;DCP2
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.22183584138700102,-1.175875712447935,0.1643835616438356,1.0,1.0,69/256,22.62%,AKAP9;ATP5PD;PRKAG2;MARK4;ARF4;CLASP1;ATP5F1D;DNAJC11;CEP76;ACTR1A;MAPK14;ARL13B;CNTRL;DCTN3;DYNLL2;IFT80;MBD4;CEP152;PKD1;B9D1;SAMM50;NEK2;HDAC6;BBIP1;CRTC1;ATP5F1E;CCP110;CHCHD3;OFD1;GLUD1;SEPTIN2;PRKAG1;EXOC7;PLK4;NPHP4;PRKAR2B;ATP5MG;EXOC5;CDK1;CREB1;EXOC2;CRTC2;RAB11FIP3;WDR35;IDH2;BBS9;BBS1;CSNK1E;CCT3;CKAP5;HSP90AA1;DYNLT2B;NR1D1;ALMS1;NINL;ATP5F1C;CCT2;CEP41;TWNK;ATP5MF;DYNC2I2;ATP5F1B;PAFAH1B1;TMEM67;MICOS10;TCTN1;ASAP1;CEP192;MKKS
prerank,KEGG_2021_Human__Notch signaling pathway,-0.2781288629499231,-1.1743849411244314,0.3076923076923077,1.0,1.0,7/48,7.26%,RFNG;TLE4;HDAC2;JAG1;DTX4;LFNG;PSENEN
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.22756906853568762,1.1711011524660508,0.17647058823529413,0.7348299476031828,1.0,32/123,18.31%,GPR68;PPAN-P2RY11;P2RY6;GNB2;PRKCD;ITPR3;GNG5;RPS6KA2;F2RL1;HRAS;DGKH;NPFF;CHRM3;CYSLTR1;UTS2B;GNG3;GRB2;GNG10;GNG7;TTF2;GRK2;TRIO;DAGLA;PIK3CA;DGKD;AGXT;CASR;ANXA1;GHRL;UTS2;MAPK7;PIK3R1
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.2461305051400321,1.1709905005429893,0.225,0.7313101129055579,1.0,24/67,23.01%,PLEKHG2;GNB2;ROCK1;ARHGEF5;GNG5;ARHGEF6;OBSCN;GNG3;GNG10;GNG7;TRIO;ECT2;ARHGEF4;SOS2;ARHGEF17;PRPF38B;ARHGEF12;MCF2L;BTK;PREX1;ARHGEF40;ADRA1A;GNB5;ARHGEF39
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.34300486748586173,-1.1708836832066718,0.27692307692307694,1.0,1.0,13/24,37.23%,AKT1;JUP;RNASE1;VAV3;HSP90AA1;RICTOR;CTNNA1;PKN1;CALM1;CTNNB1;AKT2;VAV1;PKN2
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.2710473721725027,1.1707048792125228,0.2702702702702703,0.7286087121571605,1.0,15/46,20.18%,RBBP7;KMT5B;DOT1L;EHMT1;SUZ12;KMT2C;KMT2D;KMT2E;SETD1A;WDR5;SETD6;NFKB1;H3C7;PRDM16;EED
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.2749241732311121,1.1704375381318721,0.2222222222222222,0.7257408756019377,1.0,12/57,15.00%,DEFA3;C3AR1;C1S;SELPLG;C4A;ITGAL;C1QB;FCGR1A;KRT18;DEFA4;ITGAM;CFH
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.23029622085334261,1.1696763086218753,0.17857142857142858,0.7246434508149486,1.0,9/83,5.18%,VPS37A;NUP205;H2BC15;H2BC17;NUP35;H2AC4;UBAP1;NUP214;NUP37
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.2913429545501517,1.1686365725334964,0.21052631578947367,0.7247760394993953,1.0,5/35,5.18%,NUP205;CCNB2;NUP35;NUP214;NUP37
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,-0.3607419659058775,-1.1681454189062397,0.2708333333333333,1.0,1.0,4/22,8.00%,ITGA3;ITGB1;LAMC3;RNASE1
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.25555109528367564,1.1680663675569214,0.25,0.7233756461681189,1.0,6/44,5.18%,NUP205;NUP35;TOP2B;NUP214;CDCA8;NUP37
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.220062116853761,1.16693195706205,0.18181818181818182,0.7236403121897264,1.0,27/128,15.62%,CYP4B1;GGT6;GGT7;OPLAH;GSTA4;SULT1B1;CYP27A1;GGT1;SLC38A1;BPNT2;HPGDS;CYP2C9;COMT;MAT2B;UGT2B4;MTRR;FDX1;CYP51A1;GSTO1;AURKAIP1;GSTM1;MGST2;GSTP1;CES1;GCLM;GSTO2;ACSS1
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.2540483467133774,-1.1668662430573697,0.16923076923076924,1.0,1.0,14/71,14.79%,RMI2;RAD9B;H2AX;H2BC14;H2BC4;DNA2;TP53BP1;RAD9A;REXO2;TOP3A;YWHAQ;YWHAB;BRCC3;CDK1
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,0.2732878162575736,1.1663313687298034,0.24444444444444444,0.7223229734950338,1.0,9/49,11.16%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;CD4;PSME2;PSMD11
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.2605417268641907,-1.1646570268406864,0.2537313432835821,1.0,1.0,19/100,14.70%,CHID1;SPARC;ITIH4;VTI1B;ENDOD1;CD9;SCCPDH;PECAM1;QSOX1;PPIA;PIKFYVE;TAGLN2;TEX264;LOC112694756;SOD1;ABCC4;CD109;F13A1;CYB5R1
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,0.38603528426995365,1.1639070109484946,0.2564102564102564,0.7279330123141092,1.0,5/15,14.75%,FEN1;POLR1B;POLD4;POLA2;POLR1A
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.3280622366325856,1.1635474314397445,0.23255813953488372,0.7249187624561071,1.0,7/23,14.76%,ADCY7;PRKCD;NBEA;PRKACB;GRK2;KPNA2;CAMKK1
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.38372421832215314,1.163007323237045,0.28,0.7236147250838907,1.0,4/16,10.21%,ITGB3;SDC2;ITGAV;ACTN1
prerank,KEGG_2021_Human__Apoptosis,-0.23627634387641028,-1.1628997315901262,0.14473684210526316,1.0,1.0,21/129,11.85%,AKT1;PARP4;SPTAN1;MAP3K5;MAPK8;FADD;PIK3R3;TRAF1;CASP8;FAS;NTRK1;BIRC5;BAD;MAPK1;PRF1;ITPR1;CTSC;NRAS;TUBA8;GZMB;JUN
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,0.30477674289817114,1.162513178578134,0.2826086956521739,0.7215186091068061,1.0,10/30,15.62%,GSTA4;HPGDS;CYP2C9;UGT2B4;GSTO1;GSTM1;MGST2;GSTP1;AKR1C1;GSTO2
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.347941236602382,1.16249354232603,0.26666666666666666,0.7180875647670816,1.0,5/20,13.75%,SDC2;RDH11;LPL;APOE;AKR1C1
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.3225566007106248,1.1619934399379601,0.20512820512820512,0.7164682993820096,1.0,9/30,17.97%,RPS27A;RFC5;POLR1B;CUL4A;POLD4;POLR1A;UBB;SLC19A1;USP1
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.2834294529709649,-1.161619503275703,0.234375,1.0,1.0,23/71,22.55%,AKAP9;CLASP1;CEP76;ACTR1A;CNTRL;DCTN3;CEP152;NEK2;CCP110;OFD1;PLK4;PRKAR2B;AURKA;CDK1;HMMR;CSNK1E;CKAP5;HSP90AA1;ALMS1;NINL;CEP41;PAFAH1B1;CEP192
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.26135686422097404,1.1610277561277234,0.1956521739130435,0.7156580412344885,1.0,12/67,11.16%,PSMA5;PSMA4;PSME1;UBE2D2;RPS27A;PSMC6;HIF1A;CUL2;PSME2;CITED2;EGLN1;PSMD11
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.37138228835539105,-1.159758501079379,0.2982456140350877,1.0,1.0,5/17,13.22%,AKT1;EXOSC9;EXOSC8;DCP1A;YWHAB
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,-0.368767129847651,-1.1564844335315518,0.30158730158730157,1.0,1.0,5/21,12.29%,TPM2;TMOD4;MYH3;MYL4;TMOD2
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,0.2809205488645761,1.1561045051770715,0.2564102564102564,0.7291248314999111,1.0,10/37,17.59%,FEN1;APEX1;RFC5;NEIL1;POLR1B;POLD4;MUTYH;POLR1A;PARP2;SLC19A1
prerank,KEGG_2021_Human__Mismatch repair,0.317761923772475,1.1552043864943713,0.28888888888888886,0.7284425390354395,1.0,5/23,10.90%,RFC5;MLH1;RFC1;LIG1;POLD4
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.33274081599126043,1.1541039836557676,0.2631578947368421,0.7295107533161533,1.0,6/19,18.66%,VRK2;CCNB2;SIRT2;TMPO;LBR;PPP2R2A
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.3462193158422606,1.1537504946618782,0.3170731707317073,0.7276361765535255,1.0,5/17,13.70%,BCL2L1;PDE6D;HRAS;ABHD17A;RCE1
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.28821770561501936,1.1536156734538785,0.22916666666666666,0.7246477492012274,1.0,5/35,6.90%,CAPZA2;DYNC1LI2;DCTN2;CAPZB;ACTR10
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.26116981619267493,1.1533718927722834,0.21621621621621623,0.7219247724223421,1.0,6/51,5.18%,NUP205;VRK2;CCNB2;NUP35;NUP214;NUP37
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.2887957749057326,-1.1523536824634115,0.2631578947368421,1.0,1.0,24/55,27.90%,FLOT2;FADD;CASP8;GZMB;CHMP4B;SDCBP;PELI1;CASP4;TANK;GNL3;RNF103-CHMP3;PDCD6IP;CFLAR;MLKL;HSP90AA1;TRADD;XIAP;IRF1;RRM1;UBC;GSDMD;CYCS;TP53;CASP3
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.2651716183181812,1.1515476823248672,0.17647058823529413,0.7217232724746824,1.0,19/76,16.02%,CCNH;RBBP7;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;ERCC2;POLR1B;POLR2F;MNAT1;H2AZ2;POLR2H;H2BC3;POLR1A;TAF1C;H2BC11
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.2651716183181812,1.1515476823248672,0.17647058823529413,0.7217232724746824,1.0,19/76,16.02%,CCNH;RBBP7;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;ERCC2;POLR1B;POLR2F;MNAT1;H2AZ2;POLR2H;H2BC3;POLR1A;TAF1C;H2BC11
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.266694739699553,-1.1487253006211144,0.23333333333333334,1.0,1.0,21/69,22.94%,ST6GALNAC4;NANP;MVD;ST3GAL4;NEU3;NUS1;ALG13;ALG6;PGM3;CMAS;NUDT14;ALG5;ST8SIA6;MPDU1;SRD5A3;NANS;ALG8;UAP1;ALG10B;DOLPP1;ST6GALNAC1
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,-0.3108313519935735,-1.1484793907189816,0.2545454545454545,1.0,1.0,6/30,11.24%,DHRS9;DLAT;PDK2;PDHA1;PDK4;RDH5
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.3099250965095256,-1.148401644604014,0.22033898305084745,1.0,1.0,17/44,20.57%,QARS1;AARS2;EARS2;TARS3;FARSA;DARS1;KARS1;MTFMT;MARS1;NARS1;CARS2;HARS2;PARS2;IARS2;GARS1;TARS2;VARS1
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.27863616089868054,-1.1479430069049152,0.19298245614035087,1.0,1.0,7/45,7.24%,MAMLD1;CUL1;TLE4;CCNC;HDAC2;HDAC6;HDAC10
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.2499549835234771,-1.1467078445673047,0.18518518518518517,1.0,1.0,21/83,21.79%,CDH8;CDH18;SPTAN1;JUP;ITGB1;DST;ANG;WASL;IQGAP1;CDH24;CDH13;NCK1;NCK2;CLDN15;NECTIN2;RSU1;VASP;PTK2;SIRPB1;PVR;ITGA6
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.25979549070351937,-1.1464935383742316,0.19672131147540983,1.0,1.0,20/78,19.01%,IL6;RPS6KA1;H2AX;CXCL8;H2BC14;H2BC4;H3C13;UBE2E1;MAPK1;ANAPC11;H2AZ1;CDKN2C;JUN;ANAPC5;H3-3B;UBE2S;RPS6KA3;ANAPC15;IGFBP7;H2AC7
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.2488685303853286,1.1464602729361508,0.25,0.7359441895448083,1.0,21/65,24.87%,PSMA5;PSMA4;MDM4;PSME1;RPS27A;PSMC6;PSME2;PSMD11;ZNF385A;PCBP4;PSMD6;CCNE1;UBB;MDM2;PSMC1;CCNE2;PSMA7;PSME4;PSMD2;CHEK1;PSMB7
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,0.3141976648991022,1.1431496961709935,0.2894736842105263,0.7458439916043355,1.0,5/23,11.86%,POLR2K;POLR2I;POLR2F;POLR2D;POLR2H
prerank,KEGG_2021_Human__Hedgehog signaling pathway,-0.29157932920407154,-1.1413826480254534,0.24561403508771928,1.0,1.0,8/36,13.60%,DISP1;CUL1;GRK3;MOSMO;SMURF1;CSNK1G3;SCUBE2;SPOP
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.29673571059086207,-1.1402234513489877,0.2777777777777778,1.0,1.0,5/32,8.99%,RMI2;RAD9B;DNA2;RAD9A;TOP3A
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.2290790268248617,1.1400610371060378,0.18181818181818182,0.7536832291150408,1.0,12/81,9.57%,NUP205;EIF4A3;UBA7;RIGI;NUP35;RPS27A;NUP214;NUP37;USP18;ISG15;EIF4A2;KPNA5
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.3123941813337735,-1.1397848155988055,0.22033898305084745,1.0,1.0,16/33,33.17%,AKT1;AMY2B;PIK3R3;FXYD2;HKDC1;HK3;SLC37A4;PLCB2;ATP1A3;HK1;HK2;PLCB1;PIK3R2;CACNA1D;AKT2;PLCB4
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.2528863260837626,1.1394146224007293,0.17142857142857143,0.7529768483146287,1.0,15/62,14.55%,LTBP1;SDC2;PRSS23;C4A;MELTF;APOE;HSP90B1;KTN1;DNAJC3;ADAM10;SHISA5;FUCA2;APLP2;ANO8;MXRA8
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,0.35527652084103245,1.137799063228997,0.35,0.7541130294035957,1.0,7/17,23.47%,TICAM1;NKIRAS1;RIPK3;NFKB1;NFKBIA;DHX9;NFKB2
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.2333938064052841,1.137522180184322,0.22857142857142856,0.7520403639620853,1.0,19/97,12.52%,NUP205;AGO1;H2BC15;H2BC17;POLR2K;TDRKH;NUP35;AGO4;H2AC4;NUP214;NUP37;PIWIL2;POLR2I;POLR2F;POLR2D;H2AZ2;POLR2H;RAN;H2BC3
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.20800274607383476,-1.1374930263029432,0.16,1.0,1.0,111/437,21.19%,APRT;CD33;ARMC8;TRAPPC1;SPTAN1;PGLYRP1;PPIE;ATP8A1;JUP;GOLGA7;MAPK14;HGSNAT;GLIPR1;HSPA6;PYCARD;XRCC5;PECAM1;ATP6V0C;FGL2;S100A11;PGM2;QSOX1;SERPINB10;SIGLEC14;GRN;GYG1;DIAPH1;PPIA;CDK13;CYBB;TNFAIP6;PIKFYVE;IDH1;IRAG2;TLR2;RNASE1;IQGAP1;TMEM179B;MMP28;MAPK1;SELL;RAB14;NCKAP1L;SERPINB1;CTSC;NRAS;IGF2R;PRCP;CST3;CEACAM6;FRK;DNAJC5;LOC112694756;ALDH3B1;MMP8;CAB39;SRP14;CXCR1;GNPDA1;ATP11B;ARL8A;SDCBP;GMFG;CD55;ARHGAP9;RAB18;DDOST;MOSPD2;LAMP1;MMP9;S100A9;TRPM2;PRKCSH;CD68;TCIRG1;AOC1;AP1M1;ADAM8;SURF4;CXCR2;CD93;FRMPD3;TOM1;IQGAP2;CLEC4C;PSMD3;ITGB2;FUCA1;PGM1;RAP2B;CTSB;DOK3;SIGLEC5;DLC1;CEACAM8;HSP90AA1;ACP3;FPR1;DYNLT1;CSTB;LTA4H;C5AR1;HEXB;CCT2;TMEM63A;DPP7;SIRPB1;TMED7-TICAM2;CLEC12A;PAFAH1B2;CHRNB4
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.3390354162491874,-1.136814138266486,0.3333333333333333,1.0,1.0,5/26,8.20%,KHSRP;CXCL8;EXOSC9;EXOSC8;CCL2
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,0.32709960464522114,1.1365440940439548,0.3,0.7523744898927589,1.0,4/15,13.75%,STS;COMT;UGT2B4;AKR1C1
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.2293507926389141,-1.136299445734086,0.24615384615384617,1.0,1.0,26/155,13.93%,CHD3;ZNF131;RORA;PHC3;NUP133;DNMT3B;PIAS3;TP53BP1;HDAC2;NR4A2;DNMT3A;RING1;NUP85;NUP210;NR2C1;BIRC5;PHC2;DNMT1;XPC;SMC5;L3MBTL2;CBX5;NR5A2;AURKA;CBX4;AREG
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.2694707544512033,-1.136048227285759,0.25,1.0,1.0,24/80,22.55%,NME7;AKAP9;CLASP1;CEP76;ACTR1A;CNTRL;DCTN3;CEP152;NEK2;CCP110;OFD1;PLK4;TUBGCP6;PRKAR2B;CDK1;CSNK1E;CKAP5;HSP90AA1;ALMS1;CDK11A;NINL;CEP41;PAFAH1B1;CEP192
prerank,KEGG_2021_Human__Ras signaling pathway,0.2169100953280324,1.1356740707478576,0.2,0.7522528027717025,1.0,42/159,19.76%,BCL2L1;ZAP70;PLA2G2C;PLCE1;RASSF5;IGF1R;GNB2;PDGFRA;RAPGEF5;RAP1A;FLT3LG;RAB5A;GNG5;ELK1;AFDN;HRAS;CALML4;SHC1;GNG3;PRKACB;PLD1;RRAS2;GRB2;GNG10;GNG7;RAB5B;PIK3CA;FGFR4;RASA2;SOS2;PIK3CB;CSF1;NFKB1;MAP2K2;CSF1R;PIK3R1;RAC1;PLA2G4B;RGL1;PDGFC;RASA3;PIK3CD
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,-0.31308544940573,-1.135176387772005,0.2692307692307692,1.0,1.0,4/28,7.24%,MAMLD1;HDAC2;HDAC6;HDAC10
prerank,KEGG_2021_Human__Gap junction,0.24922647849360444,1.134742550511332,0.1951219512195122,0.7523575867791488,1.0,24/61,26.41%,ADCY7;TUBB6;PDGFRA;MAP2K5;TUBB1;ITPR3;CSNK1D;HRAS;PRKACB;GRB2;TUBA1C;SOS2;TUBB2A;MAP2K2;MAPK7;TUBA1B;PDGFC;TUBB4A;PRKACA;MAP3K2;PRKCB;MAPK3;GUCY1B1;LPAR1
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.23544857372290473,1.133963505112008,0.25,0.7511713368778223,1.0,16/66,18.83%,NUP205;VRK2;TUBB6;CCNB2;NUP35;CC2D1B;NUP37;SIRT2;IST1;TUBA1C;RAN;TUBB2A;TMPO;LBR;PPP2R2A;TUBA1B
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.2569440641287676,-1.1333491505472222,0.29411764705882354,1.0,1.0,33/110,22.39%,ATP5PD;NDUFS7;ATP5F1D;NDUFB3;UCP2;NDUFAF6;NDUFAF1;COX5A;NDUFA5;COX7B;UQCR10;ATP5F1E;NDUFC1;ETFDH;NDUFS1;COX6A1;COA1;NDUFB1;NDUFAF2;SDHB;NDUFS3;ATP5MG;SCO2;TACO1;NDUFA11;NDUFB7;ATP5F1C;ATP5MF;COX8A;NDUFB4;ATP5F1B;SDHD;SDHA
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.32953817275534175,-1.133132051389223,0.27586206896551724,1.0,1.0,6/18,27.13%,CD3D;PAG1;LCK;HLA-DRB3;CD3E;PTPN22
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.3147708639840595,1.131330377472987,0.22857142857142856,0.7566965556745618,1.0,10/29,19.48%,IGF1R;FLT3LG;HRAS;GRB2;TRIB3;PIK3CA;FGFR4;PIK3CB;PIK3R1;PDPK1
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.2778473092478581,1.1302680319318967,0.3055555555555556,0.7573917096369407,1.0,10/37,15.00%,C3AR1;C1S;C4A;C1QB;TTF2;C4BPA;CD81;AKR1C1;CPNE1;CFH
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.32601037217057593,1.1286358301458557,0.29545454545454547,0.7604606103565942,1.0,4/20,9.54%,OPLAH;CYP27A1;GGT1;FDX1
prerank,KEGG_2021_Human__Hepatitis B,-0.2309393863820477,-1.1279345867818693,0.24285714285714285,1.0,1.0,26/140,15.33%,AKT1;IL6;MAPK8;CXCL8;MAPK14;FADD;PIK3R3;CASP8;STAT6;FAS;MAP2K6;BIRC5;TLR2;TIRAP;BAD;MAPK1;NRAS;ATF2;CREB3L2;YWHAQ;JUN;YWHAB;MMP9;MAP3K7;CREB1;MAP2K4
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.31660719275169996,1.1274244389331194,0.2857142857142857,0.7621249057757038,1.0,10/25,24.38%,HACD4;ACOX1;ELOVL3;SCD5;ELOVL5;ACOT7;SCP2;ELOVL6;FADS2;ELOVL7
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.20372604676755637,1.1273255514263492,0.23529411764705882,0.7591662795595804,1.0,24/174,9.65%,NUP205;EIF4A3;UBA7;IFITM2;IFI30;RIGI;NUP35;PRKCD;CD44;RPS27A;NUP214;NUP37;USP18;IFITM1;SP100;ISG15;SMAD7;TRIM14;GBP1;B2M;FCGR1A;EIF4A2;KPNA5;SOCS1
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.2924284484896121,1.1273233399491713,0.18421052631578946,0.7558511429676171,1.0,9/33,19.19%,AGO1;MDM4;RPS27A;AGO4;ID1;ETF1;UBB;MDM2;MOV10
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.24783503358739017,-1.1261554150235267,0.23076923076923078,1.0,1.0,32/106,22.39%,ATP5PD;NDUFS7;LHPP;COX10;ATP5F1D;NDUFB3;ATP6V0C;COX5A;SDHC;NDUFA5;COX7B;UQCR10;ATP5F1E;NDUFC1;NDUFS1;COX6A1;NDUFB1;SDHB;NDUFS3;ATP5MG;TCIRG1;NDUFC2-KCTD14;NDUFA11;NDUFB7;ATP5F1C;ATP5MF;ATP6V0A2;COX8A;NDUFB4;ATP5F1B;SDHD;SDHA
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.20061915641622652,-1.125376243538064,0.14925373134328357,1.0,1.0,72/381,17.02%,POU2F1;IL9R;SERPINB2;AKT1;CUL1;MAP3K8;IL6;PSMD8;RPS6KA1;PSMD5;MAPK8;RORA;ITGB1;CXCL8;BRWD1;PPP2CB;MAPK14;NFKBIB;H3C13;PIK3R3;IRF4;LRRC14;CASP8;ALPK1;STAT6;PPIA;CSF3R;NANOG;NLRC5;MAP2K6;BIRC5;RPS6KA5;TEC;IL15;IL2RG;FSCN1;CCL2;HCK;MAPK1;PDCD4;IL17RA;IL1R1;IL18BP;CCL3;PSMC5;MTAP;LCK;SOD1;TIFA;JUN;IL10;IL27;PELI1;TANK;F13A1;IKBIP;MMP9;S100A9;MAP3K7;DUSP6;FOXO1;GATA3;CREB1;IL13RA1;MAP2K4;IL18RAP;IL27RA;POMC;IL6R;PSMD3;ITGB2;RPS6KA3
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.3107704353780189,-1.1249325977205717,0.3064516129032258,1.0,1.0,12/40,14.67%,H2AX;DNMT3B;H2BC14;H2BC4;H3C13;DNMT3A;EZH2;DNMT1;H2AZ1;JARID2;H3-3B;RBBP4
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.26438524112904843,1.124754103458417,0.2702702702702703,0.7610487268465985,1.0,20/67,19.63%,UBA7;ATG5;RIGI;NKIRAS1;UBE2D2;RPS27A;TRIM4;ISG15;CYLD;DHX58;MAP3K1;TRAF6;TOMM70;RNF216;TAX1BP1;UBB;NFKB1;UBE2K;TKFC;NFKBIA
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.2523897845376485,-1.1246247837449672,0.296875,1.0,1.0,19/104,14.70%,CHID1;SPARC;ITIH4;VTI1B;ENDOD1;CD9;SCCPDH;PECAM1;QSOX1;PPIA;PIKFYVE;TAGLN2;TEX264;LOC112694756;SOD1;ABCC4;CD109;F13A1;CYB5R1
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.2733816959343057,-1.1244084183552105,0.3220338983050847,1.0,1.0,22/56,29.06%,RPS8;EIF4H;EIF3A;RPS11;EIF4A1;RPS10;EIF3K;RPS28;RPS14;RPS6;RPS27L;RPS7;FAU;RPS21;EIF3M;EIF2S2;EIF3L;RPS16;EIF4G1;EIF3J;RPS25;EIF1AX
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.26511734760877803,-1.122886707268954,0.30303030303030304,1.0,1.0,23/79,22.55%,NME7;AKAP9;CLASP1;CEP76;ACTR1A;CNTRL;DCTN3;CEP152;NEK2;CCP110;OFD1;PLK4;TUBGCP6;PRKAR2B;CDK1;CSNK1E;CKAP5;HSP90AA1;ALMS1;NINL;CEP41;PAFAH1B1;CEP192
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.24383626346531567,-1.122828387147543,0.288135593220339,1.0,1.0,25/112,18.74%,HOMER2;AKT1;IL6;PRKAG2;AGAP2;MAPK8;MAPK14;PTEN;PIK3R3;USP7;MAPK1;NRAS;PRKAG1;PLK4;IL10;FBXO32;FOXO4;FOXO1;SGK1;HOMER3;TGFB3;HOMER1;STK11;CSNK1E;FBXO25
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.2980446686534523,-1.1227767658845635,0.3333333333333333,1.0,1.0,10/32,22.07%,RMI2;XRCC3;DNA2;RAD51AP1;TOP3A;RAD51;SLX1A;MRE11;RMI1;RAD51B
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.3503550159792018,-1.122142464060616,0.39655172413793105,1.0,1.0,7/16,16.41%,RNASE1;EPHB3;SDCBP;EPHB2;NCK2;GIT1;EPHB1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.2119026872786045,-1.121494347980087,0.21621621621621623,1.0,1.0,64/278,18.98%,ARIH2;HECTD2;DZIP3;CUL1;PSMD8;KCTD6;PSMD5;KLHL25;BTBD1;FBXO44;UBE2L3;HERC5;HERC6;UBE2E2;RNF182;FBXL20;UBE3B;ZNRF2;GLMN;FBXL5;UBE2E3;HECW2;UBA3;RNF130;NEDD4L;TRIM36;UBE2E1;KEAP1;UBE2R2;SMURF1;FBXO21;CBLB;RNF19B;ANAPC11;PSMC5;RNF123;UBA6;KBTBD7;ANAPC5;UBE2W;TRIM41;FBXO32;LRRC41;FBXO2;UBE2O;TRIM11;UBE2Q1;TRAIP;UBE2S;UBE2D4;ASB2;FBXO15;NEDD4;PSMD3;MKRN1;ITCH;FBXL19;ASB1;UBE3D;FBXL12;FBXO41;RLIM;KLHL9;RNF14
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.3286397088244945,-1.1208513442664825,0.35185185185185186,1.0,1.0,7/21,21.31%,PMPCA;MCUB;SLC8B1;SPG7;PARL;LETM1;PHB2
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.236314249861047,-1.1201094923771826,0.28125,1.0,1.0,28/131,15.33%,CUL1;MAP3K8;RPS6KA1;MAPK8;PPP2CB;MAPK14;NFKBIB;FADD;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;TLR2;TIRAP;MAPK1;TIFA;JUN;LY86;PELI1;TANK;IKBIP;S100A9;MAP3K7;DUSP6;CREB1;MAP2K4
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.2867720426841175,1.119749324089333,0.25,0.7744318823753197,1.0,4/37,4.19%,PLOD1;COL6A2;COL6A3;COL28A1
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.259323186969753,1.1189466416437044,0.27906976744186046,0.7731965029632853,1.0,9/50,10.55%,FMNL3;OPHN1;ARHGAP35;ARHGAP5;SNAP23;FNBP1;VANGL1;FNBP1L;TRIO
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.22616795737501694,1.1188104184025707,0.1875,0.7707370023717771,1.0,15/81,10.45%,ADCY7;PPAN-P2RY11;GNB2;PDE4C;HRH2;RAMP1;GNG5;PDE7A;SHC1;GNG3;PRKACB;GNG10;GNG7;GRK2;PDE10A
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.2614407180081654,1.118524840533901,0.32432432432432434,0.768886520352782,1.0,14/55,13.04%,EIF4A3;SKIC3;HBS1L;EXOSC3;EXOSC6;LSM5;EIF4A2;LSM4;CNOT6;EXOSC7;DCP2;CNOT6L;CNOT11;PATL1
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.3180157096322724,-1.1184573266182325,0.3387096774193548,1.0,1.0,8/25,16.91%,PARP4;NAMPT;PARP16;NUDT12;RNLS;PARP6;NNMT;NMNAT3
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.31014404983875554,-1.1182442671270945,0.35185185185185186,1.0,1.0,6/28,14.52%,ST6GALNAC4;PARP4;ST3GAL4;PARP16;PARP6;PRKCSH
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.2441706342430434,-1.1152645569596973,0.25,1.0,1.0,11/82,9.89%,AKT1;IL6;MAPK8;CXCL8;MAPK14;PIK3R3;DIAPH1;CYBB;CCL2;MAPK1;NRAS
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.25190527694781367,1.1150587137216117,0.23529411764705882,0.7780697400648979,1.0,13/47,19.18%,ARHGAP35;RACGAP1;VRK2;ARHGAP5;CAPZB;VANGL1;ACTN1;AKAP12;TMPO;PIK3R1;LBR;ANKFY1;ARHGAP32
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.29641868381219294,-1.1147715515831995,0.34,1.0,1.0,12/41,23.92%,CTU1;QTRT2;ADAT3;TYW3;NSUN6;TRMT112;LAGE3;TRMU;THADA;URM1;TRDMT1;TRMT11
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.3242200983534621,-1.1146296000600155,0.296875,1.0,1.0,6/20,20.80%,AP2B1;AP1S2;LCK;AP2M1;AP1M1;AP1S1
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.25674847255455313,-1.1144923264266557,0.26785714285714285,1.0,1.0,23/77,21.63%,WDR43;RRP7A;RCL1;CSNK2A2;EIF6;SNORD3A;REXO2;RPP30;XRN2;NOL6;GTPBP4;LSG1;GNL3;WDR75;NXT1;UTP4;SNORD3B-2;RPP38;SNORD3B-1;WDR3;EFL1;EMG1;REXO1
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.3561978273752855,1.1143137342760292,0.30303030303030304,0.7774759000969949,1.0,5/16,11.14%,SKIC3;HBS1L;EXOSC3;EXOSC6;EXOSC7
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,0.26642382534635334,1.1139396481304782,0.25,0.7754092971161698,1.0,6/52,5.67%,TNKS2;PSMA5;PSMA4;PSME1;RPS27A;PSMC6
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.22874098637032986,-1.1138673897296372,0.22727272727272727,1.0,1.0,39/157,19.01%,IL6;RPS6KA1;MAP3K5;MAPK8;H2AX;PHC3;CXCL8;H2BC14;MAPK14;H2BC4;H3C13;RING1;TINF2;MAP2K6;UBE2E1;POT1;PHC2;DAND5;MAPK1;ANAPC11;EZH2;H1-0;H2AZ1;CDKN2C;JUN;MAPKAPK5;ANAPC5;H3-3B;CBX4;UBE2S;HIRA;RBBP4;MAP2K4;RPS6KA3;SCMH1;ANAPC15;MRE11;IGFBP7;H2AC7
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.29740407518294965,1.1125817896936068,0.225,0.7778798679004676,1.0,4/31,4.02%,CTSL;COL6A2;COL6A3;LOXL3
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.3590305960439434,-1.1108040863222246,0.3392857142857143,1.0,1.0,9/19,25.38%,ITGB1;CSNK2A2;ITGA9;RNASE1;MAPK1;FGFR1;ITGA5;MAP2K1;PKN1
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.36480544382702235,-1.1102641854186106,0.288135593220339,1.0,1.0,2/15,2.09%,PLXNA4;ITGB1
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.2701277411213829,-1.1098086446700206,0.29310344827586204,1.0,1.0,22/57,29.06%,RPS8;EIF4H;EIF3A;RPS11;EIF4A1;RPS10;EIF3K;RPS28;RPS14;RPS6;RPS27L;RPS7;FAU;RPS21;EIF3M;EIF2S2;EIF3L;RPS16;EIF4G1;EIF3J;RPS25;EIF1AX
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,0.26882056180283137,1.106590580231509,0.28888888888888886,0.7947221645343785,1.0,6/40,6.94%,CYP4B1;PTGDS;GGT1;HPGDS;CYP2C9;LTC4S
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.29454426391575916,1.1052029166372033,0.34285714285714286,0.7966747334788524,1.0,5/22,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.35364391188395605,-1.1049414463950151,0.3220338983050847,1.0,1.0,4/15,18.73%,PLXNA4;RNASE1;FES;HSP90AA1
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.33530150174603063,1.1043003100388324,0.3018867924528302,0.7962755230826604,1.0,6/16,20.76%,MTM1;PIK3C2A;INPP4B;MTMR2;MTMR12;VAC14
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,0.334943182989658,1.1039042690691365,0.2682926829268293,0.7942256213249337,1.0,4/15,14.75%,MLH1;POLR1B;POLD4;POLR1A
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.24713060734901726,-1.1027836447298913,0.2714285714285714,1.0,1.0,18/78,17.50%,AKT1;PRKAG2;SESN3;PTEN;COX5A;COX7B;UBL4A;REXO2;LAMTOR4;PRKAG1;GNPDA1;YWHAQ;COX6A1;YWHAB;GSR;SCO2;TACO1;GLS2
prerank,KEGG_2021_Human__Butanoate metabolism,0.31405805678170967,1.1002826570586168,0.32142857142857145,0.8053700637885469,1.0,7/19,19.03%,ACAT1;HMGCL;ABAT;ALDH5A1;AACS;HMGCS1;ACSM3
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.25749163933680363,1.0993198649011746,0.3684210526315789,0.8060679230253425,1.0,10/45,12.52%,H2BC15;H2BC17;POLR2K;H2AC4;POLR2I;POLR2F;POLR2D;H2AZ2;POLR2H;H2BC3
prerank,KEGG_2021_Human__Gastric acid secretion,0.24226001887487936,1.098745709133526,0.3076923076923077,0.8045647504517609,1.0,9/49,9.22%,ADCY7;HRH2;ITPR3;MYLK;ATP1B2;ACTG1;CALML4;CHRM3;PRKACB
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.26577027359954386,-1.0986223920584066,0.3275862068965517,1.0,1.0,11/55,13.15%,ST6GALNAC4;NANP;MVD;ST3GAL4;NEU3;NUS1;PGM3;CMAS;NUDT14;ALG5;ST8SIA6
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.29132349632194965,-1.0975095503610488,0.38333333333333336,1.0,1.0,10/33,22.07%,RMI2;XRCC3;DNA2;RAD51AP1;TOP3A;RAD51;SLX1A;MRE11;RMI1;RAD51B
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.3595548120150485,-1.0973202914716402,0.3888888888888889,1.0,1.0,2/16,0.84%,CUL1;MAP3K8
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.3085245963428542,1.0971680867051268,0.42105263157894735,0.8077008543645274,1.0,8/22,18.31%,RPS27A;HRAS;SHC1;GRB2;PIK3CA;CBL;UBB;PIK3R1
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.2134180553993781,1.095999668430217,0.25806451612903225,0.808482082993454,1.0,9/86,5.18%,NUP205;RBBP7;DYNC1LI2;H2BC15;H2BC17;NUP35;H2AC4;NUP214;NUP37
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.24644059853671055,-1.0959159810615358,0.31343283582089554,1.0,1.0,21/89,15.33%,MAP3K5;MAPK8;H2AX;PHC3;H2BC14;MAPK14;H2BC4;H3C13;RING1;MAP2K6;PHC2;MAPK1;EZH2;H2AZ1;CDKN2C;JUN;MAPKAPK5;H3-3B;CBX4;RBBP4;MAP2K4
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.22591791335869266,1.0956636617981133,0.2647058823529412,0.8063821189234861,1.0,10/63,10.02%,ADCY7;PPAN-P2RY11;GNB2;HRH2;RAMP1;GNG5;GNG3;PRKACB;GNG10;GNG7
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.24714928542336012,1.0947565033343831,0.3409090909090909,0.8068609638325532,1.0,7/57,5.67%,PSMA5;PSMA4;CCNB2;PSME1;GTSE1;RPS27A;PSMC6
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.20248154274877614,1.0947378798696699,0.2647058823529412,0.8037836196260794,1.0,33/146,19.50%,PSMA5;CCNH;CCND2;PSMA4;LYN;ORC4;PSME1;RPS27A;SKP1;E2F6;PSMC6;RRM2;POLR1B;CABLES1;LIN9;TK1;PSME2;MNAT1;PSMD11;POLA2;RBL1;SKP2;POLR1A;MCM6;PSMD6;CCNE1;UBB;PTK6;MCM4;PPP2R2A;ORC3;PSMC1;CCNE2
prerank,KEGG_2021_Human__DNA replication,0.28064906619301944,1.093965652282668,0.2702702702702703,0.8037208289363189,1.0,10/36,17.38%,FEN1;RFC5;RFC1;RNASEH1;LIG1;POLD4;RNASEH2A;POLA2;MCM6;MCM4
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.36166388801919147,-1.093102362947614,0.3076923076923077,1.0,1.0,8/21,20.70%,AKT1;SRF;MAPK1;EPGN;AREG;CREB1;TGFA;PTK2
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.3453065340384375,-1.0930316781915401,0.3469387755102041,1.0,1.0,5/17,13.86%,SPTAN1;WASL;IQGAP1;NCK1;NCK2
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.20591022901937306,1.0923297002341623,0.2857142857142857,0.806686340348673,1.0,46/157,22.40%,CAPZA2;KCNMA1;EBF1;RAB3A;EPS8L2;OR2T33;OR10H1;SDC2;MSN;TRIOBP;SCN1B;RDH11;OR6N1;ITPR3;CAPZB;CAMKMT;LPL;PDE6G;APOE;TWF2;TAS2R5;OR7D2;PDE6A;OR14J1;ESPN;AKR1C1;OR10G3;OR7G2;OR10H5;SCN9A;OR2A7;CASK;SNAP25;RDH10;CACNB2;OR2L2;OR10K1;TAS2R14;LRP10;SCNN1A;GNAL;ATP2B1;OR6J1;OR1F1;CYP4V2;PPEF1
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.3374108748213737,-1.0918719313757272,0.41379310344827586,1.0,1.0,6/21,19.51%,FGFR1OP2;CNTRL;FGFR1;ERLIN2;GAB2;STAT5B
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.23014747472494781,1.0913311257493112,0.2619047619047619,0.807205852068056,1.0,12/70,10.25%,ADCY7;GNB2;PDE4C;PRKCD;NBEA;ITPR3;GNG5;GNG3;PRKACB;GNG10;GNG7;GRK2
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.2966852292245523,-1.0910275989536617,0.36065573770491804,1.0,1.0,7/30,16.67%,LFNG;SEMA5B;B3GLCT;POMGNT1;SPON2;ADAMTS2;C1GALT1
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.23995278099110323,1.090847468765187,0.2894736842105263,0.8057022161875774,1.0,12/64,9.56%,BMAL1;RPS27A;SKP1;SREBF1;BHLHE40;CSNK1D;CPT1A;HIF1A;LIN9;ELOVL3;CARM1;MEF2C
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.2755993475995011,-1.0899065942555939,0.32786885245901637,1.0,1.0,16/45,20.91%,NANP;PGM2;GALT;PGM3;GALK1;CMAS;GNPDA1;HKDC1;HK3;GNPDA2;MPI;CYB5R1;PGM1;NANS;HEXB;UAP1
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,-0.2432842999202809,-1.089741920333515,0.3389830508474576,1.0,1.0,38/83,35.81%,ATP5PD;PRKAG2;ATP5F1D;DNAJC11;MAPK14;MBD4;SAMM50;CRTC1;ATP5F1E;CHCHD3;GLUD1;PRKAG1;ATP5MG;CREB1;CRTC2;IDH2;NR1D1;ATP5F1C;TWNK;ATP5MF;ATP5F1B;MICOS10;ATP5PF;TMEM11;CYCS;RXRA;CALM1;MTX1;SIRT5;CREBBP;SIRT3;CHCHD6;NCOA6;NCOR1;ESRRA;TBL1XR1;NCOA2;ACSS2
prerank,KEGG_2021_Human__Thermogenesis,-0.21896168722936185,-1.0890328848537878,0.2537313432835821,1.0,1.0,59/187,25.97%,ACSL5;ATP5PD;NDUFS7;PRKAG2;RPS6KA1;COX10;MAP3K5;ATP5F1D;NDUFB3;MAPK14;NDUFAF6;NDUFAF1;COX5A;SDHC;NDUFA5;COX7B;UQCR10;ACSL4;ATP5F1E;NDUFC1;NRAS;ATF2;NDUFS1;PRKAG1;CREB3L2;COX6A1;COA1;NDUFB1;NDUFAF2;SDHB;NDUFS3;FGFR1;ATP5MG;RPS6;CREB1;ACSL1;RPS6KA3;NDUFC2-KCTD14;NDUFA11;NDUFB7;ATP5F1C;GNAS;ATP5MF;COX8A;NDUFB4;ARID1A;ADCY3;ATP5F1B;SDHD;SDHA;NDUFS4;ACTL6A;ATP5PF;FRS2;KDM1A;PRKG1;NDUFB10;COX6B1;LIPE
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,0.2712040922980661,1.0885897347298554,0.25,0.8113229385898804,1.0,13/37,20.09%,SIGLEC15;GRAP2;SYK;HRAS;SHC1;CLEC5A;B2M;GRB2;PIK3CA;LCP2;PIK3CB;PIK3R1;BTK
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.2385560941420473,1.08798363046151,0.2619047619047619,0.8104501548116162,1.0,10/52,11.13%,AGO1;GNB2;AGO4;ITPR3;GNG5;PDE6G;GNG3;GNG10;GNG7;PDE6A
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.20203701560923076,1.0879785729832545,0.26666666666666666,0.8072966522637112,1.0,38/174,16.45%,TNKS2;PSMA5;PSMA4;H2BC15;H2BC17;RIGI;MDM4;PSME1;RPS27A;H2AC4;FKBP8;PSMC6;USP18;USP11;HIF1A;TOMM20;MAT2B;USP47;CYLD;SMAD7;PSME2;H2AC12;PSMD11;H2AC25;RHOT1;H2BC3;RCE1;TRAF6;TOMM70;SKP2;PSMD6;MUL1;PTRH2;SMAD1;ATXN7;H2BC11;H2AC21;UBB
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.31440270980398366,1.087241437576606,0.32,0.8062523128172192,1.0,5/19,12.06%,LYN;YES1;HRAS;GRB2;PIK3CA
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,0.32034601020469,1.0866404269305499,0.30952380952380953,0.806278519194909,1.0,6/21,16.45%,RPS27A;RAB5A;CTSG;VPS33B;PGK1;UBB
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.19035101053708808,1.0863435465729427,0.25,0.8047169315452508,1.0,39/219,12.52%,AGO1;H2BC15;H2BC17;IGF1R;POLR2K;TBP;EBAG9;FOS;GNB2;RARA;RARG;SREBF1;AGO4;H2AC4;RDH11;CRABP2;GNG5;CBFB;CPT1A;ZNF217;APOE;POLR2I;HRAS;POLR2F;XPO1;SHC1;CARM1;GNG3;ABCG1;GNG10;POLR2D;GNG7;ALDH1A2;CHD1;H2AZ2;POLR2H;PIK3CA;KPNA2;H2BC3
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.22666165991939247,1.0863354211535354,0.3170731707317073,0.8016337249109777,1.0,19/66,21.47%,PSMA5;PSMA4;ORC4;PSME1;RPS27A;SKP1;PSMC6;PSME2;PSMD11;SKP2;MCM6;PSMD6;UBB;MCM4;ORC3;PSMC1;MCM7;PSMA7;PSME4
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.30981288923212197,-1.0862103096154945,0.3492063492063492,1.0,1.0,2/21,0.57%,MAMLD1;AKT1
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.21523132720225965,-1.0849170440505869,0.31343283582089554,1.0,1.0,21/190,7.26%,MAMLD1;AKT1;RFNG;CUL1;PSMD8;PSMD5;RUNX1;TLE4;H2AX;H2BC14;H2BC4;H3C13;CCNC;HDAC2;ST3GAL4;JAG1;DTX4;LFNG;HDAC6;HDAC10;PSENEN
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,0.28452724826012793,1.084839612404582,0.3684210526315789,0.8035869241574763,1.0,10/31,20.33%,FEN1;RFC5;POLR1B;POLD4;POLA2;POLR1A;MCM6;MCM4;SLC19A1;MCM7
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.19479679089604326,-1.0845772020692188,0.25,1.0,1.0,80/459,14.97%,RHOB;CHID1;SERPINB2;AKT1;APBB1IP;SPARC;ITGA3;PPIL2;ITIH4;ITGB1;GP1BA;PDE1B;PPP2CB;VTI1B;MAPK14;ENDOD1;H3C13;ZFPM1;CD9;SCCPDH;PLA2G4A;TRPC6;PECAM1;HDAC2;PIK3R3;CD99L2;CD48;GNA13;ZFPM2;QSOX1;DOCK4;DGKA;PPIA;KIF4A;HBG2;PIKFYVE;PRKAR1B;CARMIL1;DGKQ;TAGLN2;RNASE1;PF4V1;MAPK1;BSG;RAC2;GYPE;SELL;TEX264;ITPR1;S100A10;NRAS;PRCP;MPL;CEACAM6;LOC112694756;LCK;SOD1;CBX5;PDE5A;PICK1;KIF6;CENPE;PRKAR2B;H3-3B;KIF5A;KIFC1;ABCC4;KIF13B;CD109;GYPB;F13A1;S100A9;GNB1;SLC16A3;HBG1;CYB5R1;KIF19;MERTK;GATA3;DGKZ
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.27523935801291993,-1.0840783757754509,0.390625,1.0,1.0,11/51,14.00%,NDUFS7;NDUFB3;NDUFAF6;NDUFAF1;NDUFA5;NDUFC1;NDUFS1;COA1;NDUFB1;NDUFAF2;NDUFS3
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.23174263592030916,1.0836996315430825,0.2727272727272727,0.8040509073404564,1.0,14/74,13.62%,TAF8;ELL2;POLR2K;TBP;ICE2;TAF5;RPAP2;POLR2I;POLR2F;POLR2D;PHAX;POLR2H;INTS13;SNAPC1
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.2620857641699821,1.0825818522986237,0.3409090909090909,0.8049851748959654,1.0,11/37,23.49%,AGO1;SREBF1;AGO4;APOE;ABCG1;TBL1X;MYLIP;MOV10;KDM3A;KDM1B;CETP
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,-0.33829648403478685,-1.0825298387378413,0.35185185185185186,1.0,1.0,4/20,11.40%,FUT4;LARGE2;B4GALT2;POMGNT1
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.2948999572935459,-1.0818762136836366,0.3225806451612903,1.0,1.0,7/40,6.56%,CERS2;SPHK2;CERK;NEU3;GLA;SPTLC2;UGT8
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.3559575793681137,-1.0814672880319924,0.3269230769230769,1.0,1.0,6/17,22.32%,MMP17;MMP28;MMP8;MMP9;KLK2;TIMP2
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.3302294068222803,1.0811911735379223,0.34146341463414637,0.8073284257987577,1.0,5/17,11.70%,ZFP36;EXOSC3;EXOSC6;EXOSC7;DCP2
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.3077591684462418,-1.0809468174640289,0.3389830508474576,1.0,1.0,8/23,22.07%,RMI2;DNA2;RAD51AP1;TOP3A;RAD51;MRE11;RMI1;RAD51B
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.24406008443910318,1.0809043493666903,0.3191489361702128,0.805139783120133,1.0,10/56,11.16%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;SUFU;PRKACB;PSME2;PSMD11
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.21298659311388352,1.080000895731583,0.34210526315789475,0.8055441517122293,1.0,20/110,12.52%,AGO1;H2BC15;H2BC17;POLR2K;TBP;EBAG9;FOS;AGO4;H2AC4;CBFB;ZNF217;POLR2I;POLR2F;CARM1;POLR2D;CHD1;H2AZ2;POLR2H;KPNA2;H2BC3
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.31252410410688747,-1.0799790896495256,0.35294117647058826,1.0,1.0,12/33,18.51%,PHC3;RING1;EZH2;L3MBTL2;EPC1;CBX5;RAD51;RBBP4;PCGF6;MAX;RYBP;CBX3
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.26895868773976456,-1.078702478416629,0.39344262295081966,1.0,1.0,21/68,22.55%,AKAP9;CLASP1;CEP76;ACTR1A;CNTRL;DCTN3;CEP152;NEK2;CCP110;OFD1;PLK4;PRKAR2B;CDK1;CSNK1E;CKAP5;HSP90AA1;ALMS1;NINL;CEP41;PAFAH1B1;CEP192
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.21826396716978866,1.0782582400565963,0.3333333333333333,0.808465832553093,1.0,10/94,6.90%,CAPZA2;DYNC1LI2;CTSL;IFI30;RACGAP1;CTSF;KLC1;DCTN2;CAPZB;ACTR10
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,0.23567055098792075,1.0782422269697232,0.2777777777777778,0.8055533819047273,1.0,16/68,16.02%,FEN1;H2BC15;H2BC17;APEX1;RFC5;H2AC4;NEIL1;POLR1B;NEIL3;POLD4;H2AZ2;H2BC3;MUTYH;POLR1A;PARP2;H2BC11
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.28457572590945496,1.0781659847296452,0.3333333333333333,0.803172102538146,1.0,13/41,19.73%,LTBP1;ITGB3;RPS27A;ITGAV;LTBP4;XPO1;SMAD7;ZFYVE9;PPP1CC;CBL;UBB;SMAD2;STUB1
prerank,KEGG_2021_Human__Base excision repair,0.26405382573055797,1.0779733308596542,0.3111111111111111,0.8009930216033678,1.0,9/33,15.60%,FEN1;APEX1;NEIL1;NEIL3;LIG1;POLB;POLD4;MUTYH;PARP2
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.2723281850517681,1.0776486416409394,0.4186046511627907,0.7993358138548198,1.0,10/43,12.91%,ALDH7A1;ACAT1;HMGCL;ABAT;ACAD8;MCEE;MMUT;HADHB;ALDH3A2;AACS
prerank,KEGG_2021_Human__Alzheimer disease,-0.20643250119714063,-1.0775604174731948,0.2777777777777778,1.0,1.0,40/292,11.10%,AKT1;ATP5PD;IL6;NDUFS7;PSMD8;TUBB3;WNT7B;MAP3K5;MAPK8;IDE;ATP5F1D;NDUFB3;ATG13;FADD;CSNK2A2;PIK3R3;COX5A;APBB1;CASP8;ULK1;SDHC;NDUFA5;FAS;COX7B;CYBB;PSENEN;FZD2;UQCR10;ATP5F1E;BAD;MAPK1;NDUFC1;ITPR1;ATG14;NRAS;TUBA8;SLC25A6;NDUFS1;PSMC5;PPP3CB
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.29898929782655315,-1.0764734867883248,0.3064516129032258,1.0,1.0,8/32,13.50%,VAMP1;VTI1B;USE1;STX1B;VAMP5;VAMP4;STX16;STX17
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.25915895319243526,-1.0757500150902384,0.3770491803278688,1.0,1.0,22/56,29.06%,RPS8;EIF4H;EIF3A;RPS11;EIF4A1;RPS10;EIF3K;RPS28;RPS14;RPS6;RPS27L;RPS7;FAU;RPS21;EIF3M;EIF2S2;EIF3L;RPS16;EIF4G1;EIF3J;RPS25;EIF1AX
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.21567147614822565,-1.0755358402760473,0.3384615384615385,1.0,1.0,30/182,12.65%,NME7;AKAP9;CLASP1;CEP76;NUP133;ACTR1A;PPP2CB;CNTRL;DCTN3;CENPN;DYNLL2;CSNK2A2;CENPF;CEP152;CENPI;NEK2;NUP85;CENPM;BIRC5;CCP110;WAPL;RAB33B;KNTC1;OFD1;PLK4;CENPO;CENPE;NEK9;TUBGCP6;PRKAR2B
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,-0.25490193470922523,-1.0740640538822401,0.26666666666666666,1.0,1.0,16/68,14.67%,H2AX;DNMT3B;H2BC14;H2BC4;H3C13;FADD;DNMT3A;CASP8;CDC25B;EZH2;DNMT1;H2AZ1;JUN;H3-3B;TANK;RBBP4
prerank,KEGG_2021_Human__GnRH secretion,-0.2828296658661285,-1.0739917042309277,0.3333333333333333,1.0,1.0,8/44,10.07%,AKT1;CACNA1I;PIK3R3;MAPK1;KCNN1;ITPR1;NRAS;GPER1
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.29877793878553205,-1.0732472468622565,0.35714285714285715,1.0,1.0,15/34,29.11%,ARPC1A;RNASE1;WASL;MAPK1;NCKAP1L;ACTR3;NCK1;WASF1;WAS;PTK2;ARPC5;WASF3;ABL1;CDC42;ABI1
prerank,KEGG_2021_Human__Yersinia infection,-0.22498493326968988,-1.0720191144483895,0.3283582089552239,1.0,1.0,21/128,12.06%,AKT1;IL6;RPS6KA1;MAPK8;ITGB1;CXCL8;MAPK14;PXN;PYCARD;PIK3R3;ROCK2;ARPC1A;MAP2K6;WASL;CCL2;MAPK1;RAC2;LCK;ACTR3;JUN;IL10
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.20981214487704522,1.0717092259616334,0.25,0.8179881047110809,1.0,32/101,24.90%,TSC2;PLCE1;ITGB3;MED12;MED30;ITGAV;PFKL;ATP1B2;HIF1A;ACTG1;HRAS;RCAN1;MED4;PRKACB;PIK3CA;NOTCH1;SLC9A1;PIK3CB;MDM2;MAP2K2;PIK3R1;PDPK1;PIK3CD;SLC2A1;MED17;PRKACA;MED27;MED14;PRKCB;MTOR;MAPK3;ATP1B1
prerank,KEGG_2021_Human__Mitophagy,-0.24541311482739542,-1.0716841210864052,0.3333333333333333,1.0,1.0,14/65,13.48%,USP8;MAPK8;CALCOCO2;RRAS;CSNK2A2;TBC1D15;ULK1;BCL2L13;NRAS;MRAS;JUN;FIS1;NBR1;FUNDC1
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.1968916287174315,1.071683276711027,0.2903225806451613,0.8151396988990481,1.0,30/167,12.52%,AGO1;H2BC15;H2BC17;IGF1R;POLR2K;TBP;EBAG9;FOS;GNB2;AGO4;H2AC4;GNG5;CBFB;ZNF217;POLR2I;HRAS;POLR2F;XPO1;SHC1;CARM1;GNG3;GNG10;POLR2D;GNG7;CHD1;H2AZ2;POLR2H;PIK3CA;KPNA2;H2BC3
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,-0.3007120285210538,-1.0716205402686416,0.4426229508196721,1.0,1.0,10/26,23.47%,MARCHF6;DERL2;UGGT2;AMFR;RNF139;PRKCSH;SYVN1;RNF185;UBC;EDEM1
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.22496347658641425,1.071550089125976,0.358974358974359,0.8127668561864254,1.0,19/58,21.55%,OPHN1;ARHGAP35;RACGAP1;PKN3;ROCK1;ARHGAP5;ARHGEF5;SNAP23;VANGL1;ECT2;ANLN;ARHGEF17;PRPF38B;ARHGEF12;PIK3R1;ARHGAP32;MCF2L;PREX1;STK10
prerank,KEGG_2021_Human__Melanogenesis,-0.24115143989049848,-1.0704815363704447,0.2727272727272727,1.0,1.0,29/63,33.17%,GNAO1;WNT7B;FZD2;MAPK1;NRAS;MC1R;CREB3L2;CREB1;POMC;GNAS;CAMK2A;ADCY3;GNAI1;PLCB2;KIT;DVL1;MAP2K1;TCF7;EDN1;PLCB1;CALM1;ADCY4;FZD1;ADCY9;GNAQ;CREBBP;GNAI3;CTNNB1;PLCB4
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.2203039860253033,-1.069748650821663,0.3181818181818182,1.0,1.0,31/141,18.73%,UBIAD1;AKT1;PARP4;COQ9;MMAB;PCCA;FLAD1;MTHFD1;MOCS3;NAMPT;COQ2;CD320;RFK;IDH1;PLB1;NFS1;DHFR2;PARP16;ACP5;NUDT12;RNLS;PARP6;NNMT;PDSS2;SLC19A3;MTHFD2;NMNAT3;PANK1;ENPP3;SLC46A1;HSP90AA1
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.27092594679388016,-1.0693916284332081,0.3448275862068966,1.0,1.0,17/40,35.35%,ZNF131;PHC3;PIAS3;RING1;PHC2;CBX4;SCMH1;PIAS4;NPM1;SUMO1;PHC1;SUMO2;CBX8;CREBBP;SAFB;COMMD3-BMI1;NCOA2
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.26284879461292104,-1.0683118760700125,0.3103448275862069,1.0,1.0,6/38,8.99%,RMI2;RAD9B;DNA2;RAD9A;RAD51AP1;TOP3A
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,0.2609771785784715,1.0675583261966946,0.34146341463414637,0.8253214689988213,1.0,9/35,15.57%,LYZ;GNLY;CD4;LTF;RO60;DEFA4;CTSG;ATOX1;S100A8
prerank,KEGG_2021_Human__Morphine addiction,0.24403050032679,1.0675020254667775,0.3488372093023256,0.8225225944402894,1.0,11/51,10.45%,ADCY7;GNB2;PDE4C;GNG5;PDE7A;GNG3;PRKACB;GNG10;GNG7;GRK2;PDE10A
prerank,KEGG_2021_Human__Ether lipid metabolism,-0.27871453649390454,-1.0668191893599293,0.43103448275862066,1.0,1.0,12/35,22.01%,PAFAH1B3;PLA2G4A;UGT8;SELENOI;CHPT1;PLB1;LPCAT2;PLD2;PLD4;PAFAH1B2;PLA2G4C;PAFAH1B1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.2176077179905248,-1.0667723059869845,0.30158730158730157,1.0,1.0,26/161,13.93%,CHD3;ZNF131;RORA;PHC3;NUP133;DNMT3B;PIAS3;TP53BP1;HDAC2;NR4A2;DNMT3A;RING1;NUP85;NUP210;NR2C1;BIRC5;PHC2;DNMT1;XPC;SMC5;L3MBTL2;CBX5;NR5A2;AURKA;CBX4;AREG
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.319998501379801,-1.0667058974741432,0.3888888888888889,1.0,1.0,11/24,27.95%,RORA;PIAS3;NR4A2;NR2C1;NR5A2;AREG;PIAS4;NR3C2;RXRA;SUMO1;NR1H2
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.2638100787356902,-1.0659043102938393,0.3770491803278688,1.0,1.0,17/44,27.67%,NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;TIFA;TANK;IKBIP;MAP3K7;S100B;UBC;NKIRAS2;CHUK;IRAK1;S100A12;TP53;NOD2
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.19668010537834277,1.0651347401636817,0.19230769230769232,0.8278427575866611,1.0,24/167,9.68%,CAPZA2;NAPSA;DYNC1LI2;CYTH4;RAB9A;RACGAP1;GALNT2;CYTH1;YKT6;KLC1;COPE;RINT1;DCTN2;CAPZB;BICD1;CYTH2;ACTR10;SEC22B;MAN2A2;COG8;RAB1B;COPB1;ZW10;KIF21B
prerank,KEGG_2021_Human__p53 signaling pathway,0.22391266561584633,1.0639948050805361,0.358974358974359,0.8290898465655926,1.0,6/68,2.73%,BCL2L1;CCND2;TSC2;MDM4;CCNB2;GTSE1
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.3319910734851466,-1.0639240239721086,0.3770491803278688,1.0,1.0,7/21,18.31%,MAPK14;CYBB;RNASE1;MAPK1;RAC2;S100A9;PRKCZ
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.25377107726294307,1.0636969544176498,0.36585365853658536,0.8240791219687817,1.0,10/55,11.16%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;SUFU;PRKACB;PSME2;PSMD11
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.25377107726294307,1.0636969544176498,0.36585365853658536,0.8240791219687817,1.0,10/55,11.16%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;SUFU;PRKACB;PSME2;PSMD11
prerank,KEGG_2021_Human__Platelet activation,0.2077003543775796,1.0626935264067108,0.2926829268292683,0.8250601561400993,1.0,17/105,9.22%,ADCY7;FCER1G;MYL12A;LYN;ARHGAP35;ITGB3;ROCK1;RAP1A;ITPR3;MYLK;SNAP23;SYK;GP9;ACTG1;NOS3;MAPK11;PRKACB
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.25692786276538715,-1.0619941911945967,0.38333333333333336,1.0,1.0,17/51,23.71%,H2AX;H2BC14;H2BC4;CENPN;CENPI;SMARCA5;CENPM;CENPO;H2AZ1;MIS18A;RBBP4;KNL1;MIS18BP1;H2AC7;RUVBL1;NPM1;OIP5
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.3172979034622153,-1.0617158099321322,0.4423076923076923,1.0,1.0,3/19,5.72%,MMAB;PCCA;CD320
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.24401045569106122,-1.0606779941402664,0.38095238095238093,1.0,1.0,25/85,22.55%,CUL1;AKAP9;CLASP1;CEP76;ACTR1A;CNTRL;DCTN3;CEP152;PPP1R12A;NEK2;CCP110;OFD1;PLK4;PRKAR2B;AURKA;CDK1;CSNK1E;CKAP5;HSP90AA1;ALMS1;NINL;CEP41;PAFAH1B1;UBC;CEP192
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.24080281763145245,-1.0603500970529904,0.4,1.0,1.0,18/93,12.06%,AKT1;IL6;MAPK8;MAPK14;RRAS;PYCARD;PIK3R3;PAK1;CASP8;MAPK1;CBLB;ITPR1;IRF9;NRAS;MRAS;PPP3CB;JUN;IL10
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.2160226539868734,-1.0586826911213256,0.3333333333333333,1.0,1.0,26/177,11.85%,POU2F1;AKT1;IL6;MAP3K5;MAPK8;CXCL8;MAPK14;HSPA6;PYCARD;PIK3R3;CASP8;ROCK2;FAS;CYBB;MAP2K6;TLR2;TIRAP;CCL2;BAD;MAPK1;ITPR1;NRAS;ABCA1;CCL3;PPP3CB;JUN
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.24799635176273135,1.0583462069917546,0.4,0.8383215665075213,1.0,5/35,7.93%,NUP205;NUP35;NUP214;NUP37;XPO1
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.3089743295594103,1.0576070679191976,0.3404255319148936,0.8378361561606519,1.0,4/22,7.66%,GATD3;YES1;CBFB;HEY1
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.265923585823809,1.0571154886113636,0.36585365853658536,0.8366080428365209,1.0,7/41,9.22%,ATP6V1E2;ATP6V1A;ATP6V1E1;ATP6V0A1;ACTG1;ERO1A;PRKACB
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.2105881963793329,1.0567229250292067,0.40476190476190477,0.8352135764017704,1.0,17/82,16.54%,PSMA5;CCNH;PSMA4;PSME1;RPS27A;SKP1;PSMC6;CABLES1;LIN9;PSME2;MNAT1;PSMD11;SKP2;PSMD6;CCNE1;UBB;PTK6
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.3211019346651255,1.0562412542643334,0.3269230769230769,0.8343954057363483,1.0,4/18,8.19%,GATD3;MAML3;HEY1;MAML2
prerank,KEGG_2021_Human__Salmonella infection,-0.20596317930266686,-1.0558281295925198,0.4,1.0,1.0,33/226,11.85%,RHOB;AKT1;IL6;TUBB3;TLR5;MAPK8;AHNAK;CXCL8;ACTR1A;MAPK14;RRAS;DCTN3;PYCARD;FADD;DYNLL2;PAK1;CASP8;ROCK2;ARPC1A;MAP2K6;TLR2;TIRAP;WASL;MAPK1;NCKAP1L;S100A10;TUBA8;MYL12B;ACTR3;EXOC7;KPNA4;ARL8A;JUN
prerank,KEGG_2021_Human__Phagosome,0.20686386837722914,1.0557526986690935,0.2857142857142857,0.8334526219775816,1.0,29/127,20.17%,DYNC1LI2;ATP6V1E2;CTSL;ATP6V1A;ATP6V1E1;TUBB6;ITGB3;TUBB1;RAB5A;ATP6V0A1;ITGAV;ACTG1;SEC22B;STX7;FCGR1A;TUBA1C;RAB5B;CLEC4M;ITGAM;ATP6V0E2;TUBB2A;MRC2;ATP6V0D1;CYBA;RAC1;TUBA1B;DYNC1H1;STX18;TUBB4A
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.2888643836846157,1.05543917514227,0.41025641025641024,0.8315641734366261,1.0,7/20,15.56%,HMGCR;ACAT1;PCYOX1;ZMPSTE24;PDSS1;RCE1;HMGCS1
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.25525942006516594,-1.055264643492965,0.38181818181818183,1.0,1.0,7/53,5.87%,MAPK8;H2AX;H2BC14;H2BC4;TP53BP1;APBB1;SMARCA5
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.21929630198596978,-1.054784134595174,0.35294117647058826,1.0,1.0,33/151,17.35%,CUL1;MAP3K8;RPS6KA1;TLR5;MAPK8;TLR8;PPP2CB;MAPK14;NFKBIB;FADD;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;RPS6KA5;TLR2;TIRAP;MAPK1;TIFA;JUN;LY86;PELI1;TANK;IKBIP;S100A9;MAP3K7;DUSP6;CREB1;MAP2K4;ITGB2;RPS6KA3;CTSB
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.2574070104370955,1.0542889790811103,0.3611111111111111,0.8326217303230324,1.0,5/34,7.93%,NUP205;NUP35;NUP214;NUP37;XPO1
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.29932806304259857,1.0533072992782546,0.3684210526315789,0.8330702446981949,1.0,7/21,18.30%,GATD3;MAML3;HEY1;MAML2;NOTCH1;WWC1;PLXND1
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.2264707301623627,1.0527591472624944,0.2826086956521739,0.8321877506659509,1.0,21/76,21.47%,PSMA5;PSMA4;LYN;PSME1;UBE2D2;RPS27A;SKP1;PSMC6;PSME2;PSMD11;TRAF6;PSMD6;UBB;NFKB1;PSMC1;PDPK1;NFKBIA;BCL10;PSMA7;RASGRP1;PSME4
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.3254849396363594,-1.052562991046784,0.42105263157894735,1.0,1.0,10/18,33.45%,TP53BP2;STEAP3;TRIAP1;BBC3;AIFM2;BNIP3L;ATM;TP53;CREBBP;BAX
prerank,Reactome_2022__Translation R-HSA-72766,-0.20552411875958593,-1.0525332319240261,0.35714285714285715,1.0,1.0,60/276,17.85%,RPS8;EIF4H;EIF3A;SEC61B;MRPS25;MRPS16;RPL15;RPS11;SEC61A2;RPLP2;QARS1;MRPL11;MRPS24;AARS2;EEF1G;MRPL44;SRP72;EIF4A1;EARS2;EEF1E1;MRPL23;SEC11A;RPL31;FARSA;RPS10;DARS1;SRP68;KARS1;MTFMT;MRPL41;MARS1;MRPL32;RPL39;MRPL55;MRPS31;RPL9;EIF3K;SRP19;MRPL43;SRP14;SRPRB;DTD1;RPS28;NARS1;RPS14;DDOST;TRMT112;CARS2;EIF2B5;RPS6;PARS2;RPS27L;MRPL38;CHCHD1;RSL24D1;MRPL1;TRAM1;IARS2;MRPS18C;GARS1
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.2325335802318439,1.050543391270899,0.3953488372093023,0.8375013968330677,1.0,15/76,11.86%,CCNH;ERCC4;POLR2K;RPS27A;RFC5;ERCC2;POLR1B;CUL4A;POLR2I;POLR2F;POLR2D;MNAT1;POLD4;COPS2;POLR2H
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.22864065262378042,-1.0503190556840982,0.36923076923076925,1.0,1.0,17/83,17.55%,KIAA0319;COPS3;GRK3;UBQLN2;CD3D;AP2B1;STAM;IGF2R;AP2M1;TOR1A;COPS6;VAMP4;EPGN;AREG;STON1;COPS7A;CLTC
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.1815996305411725,1.0501734278953325,0.26666666666666666,0.8357589291766816,1.0,36/238,12.26%,PUF60;SNRPG;ALYREF;NUP205;EIF4A3;HNRNPUL1;SF3A2;PPIL1;DHX38;POLR2K;THOC7;NUP35;SNRPE;NUP214;NUP37;THOC6;POLDIP3;POLR2I;POLR2F;SNRNP27;CPSF1;U2AF2;LSM5;NXF1;LSM4;POLR2D;PAPOLA;WTAP;SNRPA;RBMX;SRSF1;SRSF3;PQBP1;UPF3B;POLR2H;RBM22
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.22118586861999473,-1.0498368724267422,0.3888888888888889,1.0,1.0,42/165,22.40%,AKT1;ATP5PD;NDUFS7;MAPK8;ATP5F1D;NDUFB3;MAPK14;PDK2;PTEN;PIK3R3;COX5A;SDHC;NDUFA5;COX7B;CYBB;UQCR10;PDHA1;ATP5F1E;RAC2;NDUFC1;SLC25A6;NDUFS1;PDK4;COX6A1;NDUFB1;SDHB;NDUFS3;MMP9;GSR;NDUFC2-KCTD14;TGFB3;PRKCZ;NDUFA11;NDUFB7;ATP5F1C;CAMK2A;COX8A;NDUFB4;ATP5F1B;SDHD;SDHA;PLCB2
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.246496721181387,1.049040571951007,0.43243243243243246,0.8369963470128667,1.0,4/34,5.18%,NUP205;NUP35;NUP214;NUP37
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.24348761746790998,1.048725420184583,0.4411764705882353,0.8355209057401332,1.0,17/59,18.81%,POLR2K;RPS27A;POLR2I;HRAS;POLR2F;SHC1;GRB2;POLR2D;SPRY2;SPRED2;POLR2H;PIK3CA;FGFR4;CBL;UBB;PIK3R1;HNRNPH1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.30187973805569834,1.0484860452933866,0.3269230769230769,0.8333394365661615,1.0,5/23,11.22%,TXNL1;RHOBTB1;ROCK1;RBMX;COPS2
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.25021362030458044,-1.0480250167409486,0.34328358208955223,1.0,1.0,8/57,6.81%,RUNX1;SPI1;H2AX;H2BC14;H2BC4;H3C13;CEBPE;CSF3R
prerank,KEGG_2021_Human__Propanoate metabolism,0.2755816741890118,1.0478174468736972,0.41025641025641024,0.8333132910364436,1.0,6/31,9.76%,ACAT1;ABAT;ACOX1;MCEE;LDHA;MMUT
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,0.3250282934031914,1.0475112713755028,0.39473684210526316,0.8315303010922175,1.0,9/19,25.48%,STXBP2;CD4;CSF1;CSF1R;SNAP25;IL10RB;TYK2;JAK1;STX1A
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.2550759938286309,1.0461257612027124,0.4594594594594595,0.8334283002752207,1.0,5/34,7.93%,NUP205;NUP35;NUP214;NUP37;XPO1
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.21269214668811454,-1.0451431307203176,0.4117647058823529,1.0,1.0,47/173,22.62%,AKAP9;MARK4;ARF4;CLASP1;CEP76;ACTR1A;ARL13B;CNTRL;DCTN3;DYNLL2;IFT80;CEP152;PKD1;B9D1;NEK2;HDAC6;BBIP1;CCP110;OFD1;SEPTIN2;EXOC7;PLK4;NPHP4;PRKAR2B;EXOC5;CDK1;EXOC2;RAB11FIP3;WDR35;BBS9;BBS1;CSNK1E;CCT3;CKAP5;HSP90AA1;DYNLT2B;ALMS1;NINL;CCT2;CEP41;DYNC2I2;PAFAH1B1;TMEM67;TCTN1;ASAP1;CEP192;MKKS
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.298289160683217,-1.0436500845064653,0.39655172413793105,1.0,1.0,8/24,22.07%,RMI2;DNA2;RAD51AP1;TOP3A;RAD51;MRE11;RMI1;RAD51B
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.2764284938898806,-1.0435477433018305,0.4444444444444444,1.0,1.0,12/35,23.47%,MARCHF6;ENGASE;DERL2;UGGT2;AMFR;RNF139;DERL1;PRKCSH;SYVN1;RNF185;UBC;EDEM1
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.2785917416224646,1.0413471733530613,0.3673469387755102,0.8467415407248686,1.0,7/24,18.31%,PRKCD;ITPR3;SYK;FCGR1A;PIK3CA;PIK3CB;PIK3R1
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.2028579259885917,1.0412701274115126,0.43333333333333335,0.8439377607886935,1.0,36/128,23.07%,PSMA5;CCNH;PSMA4;ORC4;PSME1;RPS27A;SKP1;E2F6;PSMC6;RRM2;POLR1B;CABLES1;LIN9;TK1;PSME2;MNAT1;PSMD11;POLA2;RBL1;SKP2;POLR1A;MCM6;PSMD6;CCNE1;UBB;PTK6;MCM4;ORC3;PSMC1;CCNE2;MCM7;PSMA7;FBXO5;TYMS;PSMD2;DHFR
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.2817828774739958,1.0410688368822623,0.41025641025641024,0.8418129921561958,1.0,11/24,23.83%,IDNK;GLYCTK;PFKL;G6PD;PGD;GPI;RBKS;FBP1;PRPS2;PRPS1;TKTL1
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.27016734745621307,-1.0407874665541323,0.43333333333333335,1.0,1.0,11/39,18.35%,AP2B1;PSENEN;RNASE1;EPHA4;EPHB3;AP2M1;EPHB2;MMP9;EPHB1;CLTC;VAV3
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.3367026432604824,1.040681474405763,0.4230769230769231,0.8408954286399305,1.0,8/19,21.08%,MDM4;RPS27A;EHMT1;SETD9;UBB;MDM2;TTC5;PRMT5
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.2430167950874284,1.0394405697129083,0.43902439024390244,0.8428546402450694,1.0,6/51,5.67%,PSMA5;PSMA4;PSME1;RPS27A;CUL5;PSMC6
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.26536510353314874,1.0383092700627552,0.3333333333333333,0.843901756710403,1.0,6/29,10.02%,GNB2;GNG5;ARHGEF6;GNG3;GNG10;GNG7
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,0.2523878788779644,1.03635913366371,0.3684210526315789,0.847794107873017,1.0,4/33,5.18%,NUP205;NUP35;NUP214;NUP37
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.2346191178018185,1.0357856949946147,0.4166666666666667,0.8467065960517607,1.0,6/54,5.67%,PSMA5;PSMA4;MDM4;PSME1;RPS27A;PSMC6
prerank,KEGG_2021_Human__Circadian entrainment,0.22220934249990879,1.0354051541528473,0.5581395348837209,0.8453427635028117,1.0,10/57,10.02%,ADCY7;FOS;GNB2;ITPR3;GNG5;CALML4;GNG3;PRKACB;GNG10;GNG7
prerank,KEGG_2021_Human__Long-term depression,-0.26741874084002254,-1.0351043198275591,0.3684210526315789,1.0,1.0,16/44,25.28%,GNAO1;PPP2CB;PLA2G4A;GNA13;MAPK1;ITPR1;NRAS;GNA11;GNAS;PLA2G4C;GNA12;GNAI1;PLCB2;RYR1;MAP2K1;PRKG1
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.21286675700150473,1.0343511854552754,0.4117647058823529,0.8461665957440295,1.0,26/91,22.79%,PSMA5;PSMA4;PSME1;RPS27A;H2AC4;PSMC6;SMAD7;ASXL2;PSME2;H2AC12;PSMD11;OGT;H2AC25;ASXL1;PSMD6;H2AC21;UBB;PSMC1;UCHL3;INO80B;PSMA7;PSME4;SENP8;TGFBR2;KDM1B;PSMD2
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.18202424724610264,1.0333270734565774,0.375,0.847226447792147,1.0,30/218,11.16%,PSMA5;NUP205;DYNC1LI2;PSMA4;VRK2;TUBB6;B9D2;CCNB2;PSME1;NUP35;NUDC;CC2D1B;RPS27A;SKA1;SPC24;SGO2;CDCA8;NUP37;PSMC6;MAD1L1;SIRT2;ANAPC2;CENPA;XPO1;ZW10;PSME2;IST1;TUBA1C;ZWINT;PSMD11
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.2483135101294035,-1.0327877944321309,0.40350877192982454,1.0,1.0,7/54,5.87%,MAPK8;H2AX;H2BC14;H2BC4;TP53BP1;APBB1;SMARCA5
prerank,KEGG_2021_Human__Fatty acid degradation,0.2575367888565586,1.032395841431264,0.391304347826087,0.8476781451442171,1.0,8/36,12.44%,ALDH7A1;ACADL;ACAT1;ACOX1;CPT1A;HADHB;CPT2;ALDH3A2
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.18786960752022713,-1.0323114318629256,0.36231884057971014,1.0,1.0,87/386,18.87%,RHOB;HOMER2;FMNL1;CDC42EP2;UACA;SPTAN1;ARAP2;FRS3;JUP;ITGB1;PEAK1;KIF14;ARL13B;DST;FLOT2;JAG1;PIK3R3;ARHGAP10;ARHGDIB;GNA13;HINT2;SEMA4F;ROCK2;NDUFA5;SAMM50;DOCK4;DIAPH1;STAM;RHOC;CYBB;SH3PXD2A;ANKLE2;RNASE1;WASL;CCP110;IQGAP1;STEAP3;DDRGK1;RAC2;RHPN1;NCKAP1L;CDC42EP4;USP9X;ARHGAP23;LCK;RTKN;STK38;PDE5A;SLK;FAM169A;CDC42EP1;RNF20;SRRM1;FAM13B;ARHGAP9;MOSPD2;NCK1;NCK2;LMAN1;RASGRF2;NDUFS3;FAM91A1;ABL2;PRKCSH;RHPN2;GIT1;BASP1;PLD2;HNRNPC;CCT7;TMEM87A;ARHGAP4;RHOBTB2;IQGAP2;ARHGEF10;ARHGAP12;CPNE8;NHS;CLTC;DLC1;ARHGAP17;WASF1;TRIP10;VAV3;WAS;HSP90AA1;DEPDC1B
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.3419615826392489,-1.03227006581964,0.43103448275862066,1.0,1.0,6/16,28.28%,MBOAT1;PLA2G4A;PLBD1;PLA2G4C;MBOAT2;ABHD4
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.32462567003600373,-1.0320714815851533,0.4444444444444444,1.0,1.0,2/17,3.50%,FGFR1OP2;CNTRL
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.2324625842586106,1.0313308577650082,0.4838709677419355,0.8496055736654133,1.0,18/54,19.76%,CCND2;FOS;HRAS;SHC1;MAPK11;GRB2;SOCS1;CISH;PIK3CA;SOCS6;SOS2;PRLR;FOXO3;PIK3CB;NFKB1;MAP2K2;PIK3R1;PIK3CD
prerank,KEGG_2021_Human__Cholinergic synapse,0.20993581373427192,1.0312696016915603,0.358974358974359,0.8471388356105177,1.0,13/77,10.02%,ADCY7;FOS;GNB2;CREB3L4;ITPR3;GNG5;KCNQ5;HRAS;CHRM3;GNG3;PRKACB;GNG10;GNG7
prerank,KEGG_2021_Human__Huntington disease,-0.19845562689698226,-1.0278319638326232,0.3888888888888889,1.0,1.0,63/247,22.43%,ATP5PD;POLR2J2;NDUFS7;PSMD8;TUBB3;MAP3K5;MAPK8;ATP5F1D;NDUFB3;ATG13;ACTR1A;AP2B1;DCTN3;HDAC2;COX5A;CASP8;ULK1;SDHC;NDUFA5;COX7B;TAF4B;UQCR10;ATP5F1E;NDUFC1;GPX7;ITPR1;ATG14;TUBA8;SLC25A6;NDUFS1;PSMC5;SOD1;CREB3L2;AP2M1;COX6A1;NDUFB1;KIF5A;SDHB;NDUFS3;SLC1A3;CREB1;PSMD3;TAF4;NDUFC2-KCTD14;CLTC;BBC3;TRAF2;ATG101;HTT;NDUFA11;ATG2A;NDUFB7;ATP5F1C;COX8A;NDUFB4;KLC3;ATP5F1B;PSMB6;PSMD7;SDHD;SDHA;PLCB2;PSMD13
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.21992966074507028,1.027708764163777,0.36585365853658536,0.8571563545540958,1.0,16/66,16.45%,PLEKHG2;RPS27A;ARHGEF5;SQSTM1;ARHGEF6;OBSCN;TRIO;MAGED1;ECT2;ARHGEF4;TRAF6;SOS2;ARHGEF17;PRPF38B;ARHGEF12;UBB
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.3350305075773279,-1.027503368414494,0.3968253968253968,1.0,1.0,9/16,33.02%,FADD;CASP8;TANK;CFLAR;TRADD;TMED7-TICAM2;TNFRSF10A;LY96;FASN
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.2454073593407578,1.0274556729943365,0.4166666666666667,0.855472998703784,1.0,4/34,5.18%,NUP205;NUP35;NUP214;NUP37
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.19702111818930407,1.0268454479356366,0.391304347826087,0.8551418480589205,1.0,23/83,19.76%,INPP5B;PLCE1;MTM1;IP6K1;ITPR3;BPNT2;PPIP5K2;PPIP5K1;SYNJ1;DGKH;CALML4;PIK3C2A;PIK3CA;PIP5K1C;DGKD;PI4KA;INPP4B;PIK3CB;PIP4K2C;PIK3R1;MTMR3;MTMR2;PIK3CD
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,0.29780179979157495,1.0263564981636828,0.4222222222222222,0.8539080914632653,1.0,4/23,4.77%,PCYT1A;STARD7;SLC44A2;SLC44A1
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.2846155215228836,-1.0263507628577908,0.34545454545454546,1.0,1.0,3/27,2.29%,AKT1;APBB1IP;GP1BA
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.24773021261591727,-1.0263275312303612,0.4576271186440678,1.0,1.0,6/60,3.64%,MAMLD1;RUNX1;H2AX;H2BC14;H2BC4;H3C13
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.278847283411836,-1.0257828259968418,0.4067796610169492,1.0,1.0,11/40,14.67%,H2AX;DNMT3B;H2BC14;H2BC4;H3C13;DNMT3A;EZH2;DNMT1;H2AZ1;H3-3B;RBBP4
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.22374531284209748,1.0256629179803591,0.38095238095238093,0.8535055006942248,1.0,17/71,16.02%,RBBP7;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;POLR1B;POLR2F;H2AZ2;POLR2H;DDX56;H2BC3;POLR1A;TAF1C;H2BC11
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.22834146263462157,1.0255392376072308,0.37209302325581395,0.8514637112081237,1.0,5/50,4.85%,RAB3A;ATP6V1E2;ATP6V1A;ATP6V1E1;ATP6V0A1
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.18096566731167094,1.02513187830332,0.40625,0.8505257101736442,1.0,30/219,11.16%,PSMA5;NUP205;DYNC1LI2;PSMA4;VRK2;TUBB6;B9D2;CCNB2;PSME1;NUP35;NUDC;CC2D1B;RPS27A;SKA1;SPC24;SGO2;CDCA8;NUP37;PSMC6;MAD1L1;SIRT2;ANAPC2;CENPA;XPO1;ZW10;PSME2;IST1;TUBA1C;ZWINT;PSMD11
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.292826893943556,-1.0248925587553512,0.47368421052631576,1.0,1.0,5/31,8.20%,KHSRP;CXCL8;EXOSC9;EXOSC8;CCL2
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.2648793135564478,-1.0231591795400552,0.4716981132075472,1.0,1.0,19/49,29.06%,RPS8;EIF3A;RPS11;RPS10;EIF3K;RPS28;RPS14;RPS6;RPS27L;RPS7;FAU;RPS21;EIF3M;EIF2S2;EIF3L;RPS16;EIF3J;RPS25;EIF1AX
prerank,KEGG_2021_Human__Mineral absorption,0.24195926835125503,1.0228862390425302,0.4375,0.8557699959385944,1.0,14/36,24.90%,ATP7B;SLC40A1;VDR;ATP1B2;SLC30A1;HMOX2;ATOX1;TRPM7;MT1X;ATP2B1;MT2A;SLC31A1;ATP7A;ATP1B1
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,0.23495116304855795,1.0224095319824373,0.4523809523809524,0.8545146676123734,1.0,6/50,5.67%,PSMA5;PSMA4;PSME1;RPS27A;MED12;PSMC6
prerank,KEGG_2021_Human__Asthma,0.2713542913231931,1.0220965938535185,0.4722222222222222,0.853112664719384,1.0,2/22,5.47%,FCER1G;FCER1A
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.20375900593775842,-1.0213615610793958,0.48484848484848486,1.0,1.0,48/197,21.07%,WDR43;RRP7A;EBNA1BP2;RPS8;RCL1;ELAC2;RPL15;RPS11;RPLP2;TRMT10C;EXOSC9;NOP2;SPPL2A;RPL31;EXOSC8;RPS10;LTV1;RPP30;RPL39;UTP11;RPL9;DNAJC5;XRN2;NOL6;RRP36;RPS28;RPS14;WDR12;GNL3;TRMT112;RPS6;RPS27L;WDR75;NSUN4;MRM3;SENP3;RSL24D1;NOC4L;UTP4;RPP38;CSNK1E;RPS7;RPL35A;WDR3;FAU;DIMT1;EMG1;RPS21
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.1771494291597468,1.0212460516702062,0.391304347826087,0.8531048247567181,1.0,47/248,16.45%,TNKS2;PSMA5;PSMA4;H2BC15;H2BC17;ABRAXAS1;RIGI;MDM4;PSME1;UIMC1;RPS27A;TRIM4;H2AC4;FKBP8;MYSM1;PSMC6;USP18;USP11;HIF1A;TOMM20;MAT2B;USP47;CYLD;SMAD7;ASXL2;PSME2;H2AC12;VCP;PSMD11;OGT;H2AC25;RHOT1;H2BC3;ASXL1;RCE1;TRAF6;TOMM70;SKP2;PSMD6;MUL1;PTRH2;SMAD1;ATXN7;RAD23B;H2BC11;H2AC21;UBB
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.2039428919487238,1.0209529750814121,0.43243243243243246,0.8516390097180196,1.0,23/129,12.34%,FMNL3;OPHN1;ARHGAP35;RACGAP1;PLEKHG2;YKT6;DNMBP;ARHGAP33;GMIP;ARHGAP5;ARHGEF5;SNAP23;FNBP1;ARHGEF6;KTN1;VANGL1;FNBP1L;WIPF1;TRIO;ECT2;DEF6;ARHGEF4;ARHGAP45
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.3003760535889266,-1.020653741628075,0.4264705882352941,1.0,1.0,12/20,41.84%,AP2B1;AP2M1;PICK1;CAMK2A;DLG1;LGALS12;NSF;AP2A1;AKAP5;MYO6;PRKCA;CACNG8
prerank,KEGG_2021_Human__Glutamatergic synapse,-0.22630635358176635,-1.020284298444905,0.36363636363636365,1.0,1.0,30/65,32.27%,GNAO1;HOMER2;GRK3;PLA2G4A;MAPK1;ITPR1;PPP3CB;SLC1A3;GNB1;PLD2;HOMER3;GLS2;HOMER1;GNAS;PLA2G4C;ADCY3;GNAI1;PLCB2;PPP3CC;PLCB1;ADCY4;GLS;SLC1A7;SLC1A2;ADCY9;DLG4;GNAQ;CACNA1D;CACNA1A;GNAI3
prerank,KEGG_2021_Human__Alcoholism,0.19849220358653255,1.0201003397324064,0.47368421052631576,0.8522094997125318,1.0,33/140,17.37%,H2AC17;H2BC15;H2BC17;H3C15;GNB2;H3-3A;H3C1;H2AC4;H4C3;CREB3L4;GNG5;MACROH2A2;HRAS;CALML4;SHC1;GNG3;PRKACB;GRB2;GNG10;SLC29A1;GNG7;H2AC12;H3C10;H2AZ2;H2BC3;MACROH2A1;SOS2;CAMKK1;H2BC11;PPP1CC;H2AC21;H4C1;H2AB2
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.27497730949289617,-1.0194856632611635,0.32727272727272727,1.0,1.0,6/37,12.06%,IL6;CXCL8;CCL2;IL1R1;CCL3;IL10
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.23802493566454075,1.0184502135426898,0.4634146341463415,0.855369696099922,1.0,17/50,24.16%,ATP6V1E2;ATP6V1A;ATP6V1E1;WDR24;SLC38A9;RRAGB;LAMTOR2;RPTOR;FLCN;ATP6V0E2;SESN1;ATP6V0D1;ATP6V0E1;CASTOR1;DEPDC5;MTOR;RRAGD
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.26308166909736064,-1.017997582707079,0.42592592592592593,1.0,1.0,7/27,17.37%,MAMLD1;JAG1;PSENEN;GZMB;CREB1;MIB1;NEURL1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,-0.2580996402523979,-1.0173408861767128,0.42592592592592593,1.0,1.0,5/39,4.63%,ISYNA1;INPP1;IMPA1;ITPKC;PTEN
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.22374080876871513,-1.0169781523956358,0.3484848484848485,1.0,1.0,37/106,27.98%,RPS8;SEC61B;RPL15;RPS11;SEC61A2;RPLP2;SRP72;SEC11A;RPL31;RPS10;SRP68;RPL39;RPL9;SRP19;SRP14;SRPRB;RPS28;RPS14;DDOST;RPS6;RPS27L;RSL24D1;TRAM1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.2308973148420349,-1.01652748282585,0.4375,1.0,1.0,10/74,8.99%,RMI2;RAD9B;H2AX;H2BC14;H2BC4;DNA2;TP53BP1;RAD9A;TIPIN;TOP3A
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.23757713105173175,1.0158124140977425,0.43243243243243246,0.8625787318273169,1.0,15/53,18.81%,POLR2K;RPS27A;POLR2I;HRAS;POLR2F;SHC1;GRB2;POLR2D;SPRY2;POLR2H;PIK3CA;CBL;UBB;PIK3R1;HNRNPH1
prerank,KEGG_2021_Human__Adherens junction,-0.2440512038830706,-1.0148351474048278,0.3728813559322034,1.0,1.0,14/61,18.37%,CTNND1;ERBB2;CSNK2A2;PTPRF;WASL;IQGAP1;MAPK1;RAC2;RAC3;FGFR1;MAP3K7;NECTIN2;WASF1;WAS
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.190057617321848,-1.0142676904625652,0.41333333333333333,1.0,1.0,72/341,18.98%,ARIH2;HECTD2;DZIP3;CUL1;PSMD8;KCTD6;PSMD5;KLHL25;SEC61B;BTBD1;FBXO44;UBE2L3;HERC5;SEC61A2;HERC6;UBE2E2;RNF182;FBXL20;UBE3B;ZNRF2;GLMN;FBXL5;UBE2E3;HECW2;UBA3;CYBB;RNF130;NEDD4L;TRIM36;SEC24C;UBE2E1;KEAP1;UBE2R2;SMURF1;TLR2;TIRAP;FBXO21;CBLB;RNF19B;ANAPC11;ATG14;PSMC5;RNF123;UBA6;KBTBD7;ANAPC5;UBE2W;TRIM41;FBXO32;LRRC41;FBXO2;UBE2O;TRIM11;UBE2Q1;TRAIP;UBE2S;S100A9;UBE2D4;ASB2;FBXO15;NEDD4;PSMD3;MKRN1;ITCH;FBXL19;ASB1;UBE3D;FBXL12;FBXO41;RLIM;KLHL9;RNF14
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.2382967904378988,-1.0139487180710758,0.4482758620689655,1.0,1.0,11/56,13.48%,PRKAG2;PLIN3;ARL13B;DYNLL2;CSNK2A2;ULK1;HDAC6;MTERF3;PRKAG1;NBR1;FUNDC1
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.27821930330807704,1.0138359279874414,0.38181818181818183,0.8670907998078919,1.0,3/21,7.20%,INPP5B;PLCE1;SYNJ1
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.1944000818422909,-1.0137665089251702,0.4057971014492754,1.0,1.0,61/255,21.17%,COPZ2;ST6GALNAC4;ARF4;TRAPPC1;MARCHF6;SPTAN1;NANP;MCFD2;ASGR2;ACTR1A;MVD;DCTN3;ENGASE;DYNLL2;ST3GAL4;DAD1;NEU3;NUS1;ALG13;SEC24C;CTSC;DERL2;UGGT2;ALG6;AMFR;B4GALT2;RNF139;PGM3;CMAS;TFG;DERL1;NUDT14;COG2;ALG5;CD55;ST8SIA6;DDOST;STX17;SEC22C;AREG;LMAN1;PRKCSH;TRAPPC9;FUCA1;MPDU1;COG6;SYVN1;RNF185;CNIH2;TGFA;USO1;SRD5A3;NANS;ALG8;MAN2A1;LMAN2L;COPG2;UAP1;ALG10B;ANK1;MGAT5
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.2835511518717596,-1.0136582882094178,0.41509433962264153,1.0,1.0,8/27,15.13%,PLIN3;ARL13B;HDAC6;RNASE1;VPS37C;CHMP4B;RNF103-CHMP3;TSG101
prerank,KEGG_2021_Human__GnRH signaling pathway,0.20435200160940592,1.0134224168002854,0.43902439024390244,0.8660583465486459,1.0,12/71,9.49%,ADCY7;MAP2K7;PRKCD;ITPR3;ELK1;MAP3K3;HRAS;CALML4;MAPK11;PRKACB;PLD1;GRB2
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.2462894829361557,-1.0133341887303877,0.5079365079365079,1.0,1.0,8/55,8.64%,DHCR7;PMVK;MVD;MBTPS2;MBD4;SEC24C;GGPS1;DAND5
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.2931053790627672,1.0131240964899386,0.42,0.8642409249792185,1.0,6/27,10.11%,GNB2;GNG5;GNG3;GNG10;GNG7;TTF2
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.21826736051651777,-1.0125900952406335,0.47761194029850745,1.0,1.0,16/88,15.89%,ID2;AKT1;WNT7B;MAPK14;PIK3R3;PCGF5;NANOG;FZD2;MAPK1;NRAS;HOXA1;JARID2;FGFR1;PCGF6;SMAD5;BMPR2
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.24151371843068253,1.0124624796768893,0.39473684210526316,0.863936917842204,1.0,17/54,21.44%,RAB3A;RAB9A;RAB37;RAB29;RAB5A;RAB31;RAB22A;RAB1B;RAB5B;RAB8B;RAB2A;RAB15;RAB35;RAB24;RAB27B;RAB34;RAB23
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.2101407141911508,-1.0124115750086577,0.4027777777777778,1.0,1.0,23/103,18.03%,PARP4;MMAB;PCCA;FLAD1;MTHFD1;MOCS3;NAMPT;CD320;RFK;NFS1;DHFR2;PARP16;ACP5;NUDT12;RNLS;PARP6;NNMT;SLC19A3;MTHFD2;NMNAT3;PANK1;ENPP3;SLC46A1
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,-0.290179917013825,-1.011527362550185,0.453125,1.0,1.0,3/22,7.69%,WRAP53;TINF2;POT1
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.2509576166967138,1.0110032333446035,0.4444444444444444,0.866293681972678,1.0,3/27,5.18%,NUP205;NUP35;NUP37
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.2794747397823546,1.0109309583012631,0.4,0.8640437746731844,1.0,7/35,11.22%,TXNL1;RHOBTB1;ROCK1;ACTG1;ACTN1;RBMX;COPS2
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.25424025255307314,-1.0108859503945733,0.375,1.0,1.0,5/34,8.99%,RMI2;RAD9B;DNA2;RAD9A;TOP3A
prerank,Reactome_2022__Keratinization R-HSA-6805567,0.26489775701715085,1.0104209197723844,0.4888888888888889,0.8631474351152628,1.0,6/30,11.35%,TGM1;KRT8;RCAN1;ST14;KRTAP5-11;KRT18
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.22654551177462373,1.010414745304814,0.4146341463414634,0.8606604000203889,1.0,15/59,19.50%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;PSME2;PSMD11;SKP2;PSMD6;CCNE1;UBB;PTK6;PSMC1;CCNE2
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.31842168473478444,1.010140298877777,0.39285714285714285,0.8590392378954296,1.0,3/18,3.82%,GFAP;EEF1A1;RPS27A
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.3234509976111725,-1.0099090267075013,0.43859649122807015,1.0,1.0,5/16,21.31%,PMPCA;MCUB;SPG7;PARL;PHB2
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.23577816456363576,-1.0090422141966635,0.4307692307692308,1.0,1.0,26/78,25.19%,AKT1;ERBB2;PTEN;PIK3R3;TRAT1;RNASE1;BAD;RAC2;LCK;EPGN;AREG;FOXO4;FGFR1;FOXO1;CREB1;RICTOR;TGFA;NRG4;GAB2;PIK3AP1;PTPN11;FRS2;EGF;CHUK;CD19;KIT
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.3165569930486661,1.0087833176239143,0.48,0.8609698147530699,1.0,4/16,9.49%,PRKCD;HRAS;SHC1;GRB2
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.2444673449128827,1.0079330072759791,0.375,0.8614174700913867,1.0,5/36,7.93%,NUP205;NUP35;NUP214;NUP37;XPO1
prerank,KEGG_2021_Human__Prion disease,-0.20576812872094202,-1.007874800752864,0.42424242424242425,1.0,1.0,38/221,14.00%,ATP5PD;IL6;NDUFS7;PSMD8;TUBB3;MAPK8;ATP5F1D;NDUFB3;MAPK14;HSPA6;CSNK2A2;PIK3R3;COX5A;SDHC;NDUFA5;COX7B;CYBB;UQCR10;ATP5F1E;BAD;MAPK1;RAC2;NDUFC1;ITPR1;TUBA8;ATF2;SLC25A6;NDUFS1;PSMC5;SOD1;PPP3CB;CREB3L2;C8G;COX6A1;NDUFB1;KIF5A;SDHB;NDUFS3
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.19945035118259213,1.0077139719593473,0.3783783783783784,0.8598817127302005,1.0,36/108,24.16%,ATG5;DYNC1LI2;TSC2;ATG10;GABARAPL2;RPS27A;SQSTM1;TOMM20;SLC38A9;ATG4C;VCP;RRAGB;TOMM5;MAP1LC3B;LAMTOR2;TOMM6;UVRAG;RPTOR;TOMM70;WIPI2;MFN2;MFN1;UBB;PLIN2;MTMR3;WDR45B;PRKAA1;DYNC1H1;BECN1;ATG4D;PCNT;PGAM5;CHMP2A;TOMM7;MTOR;RRAGD
prerank,KEGG_2021_Human__Pyruvate metabolism,0.24959529261760577,1.0070254421367701,0.4,0.8601836358318529,1.0,7/34,12.44%,ALDH7A1;ACAT1;MDH1;LDHA;ACYP2;FH;ALDH3A2
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.33993536353780135,-1.006354878184192,0.5319148936170213,1.0,1.0,8/20,24.53%,UBE2E1;ANAPC11;ANAPC5;UBE2S;ANAPC15;CDC14A;CDC20;CDC23
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.2094222464460977,1.0046708101545676,0.46511627906976744,0.8673761292637827,1.0,11/86,9.22%,KCNMA1;ADCY7;PLA2G2C;CALD1;PRKCD;ROCK1;RAMP1;ITPR3;MYLK;CALML4;PRKACB
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.17972779105999076,-1.0043398541022857,0.45569620253164556,1.0,1.0,54/381,12.93%,RHOB;HCAR3;AKT1;GRK6;HEBP1;RPS6KA1;WNT7B;CMKLR1;ITGB1;GRK3;CCRL2;GPR132;PDE1B;CXCL8;PPP2CB;CXCR3;CRHBP;PLA2G4A;TRPC6;PIK3R3;NTSR1;DHX34;ACKR2;GPSM1;GNA13;ROCK2;PDE3B;DGKA;RHOC;TAS2R13;PRKAR1B;INSL3;SUCNR1;FZD2;DGKQ;ARHGEF37;CCL2;PLPPR2;MAPK1;ITPR1;NRAS;GPER1;MC1R;CXCL16;P2RY10;CCL3;OPN3;PPP3CB;CXCR1;UTS2R;GPR15;PRKAR2B;OXER1;CD55
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.1996473095111588,-1.004318767546543,0.4603174603174603,1.0,1.0,37/164,20.60%,IL9R;IL6;TNFRSF4;GDF11;CXCL8;CXCR3;TNFSF9;FAS;CSF3R;IL15;IL2RG;CCL2;PF4V1;IL17RA;IL1R1;MPL;CXCL16;CCL3;CXCR1;IL10;IL27;TNFRSF8;CXCR4;IL13RA1;IL18RAP;IL27RA;BMPR2;CXCR2;IL6R;LTBR;TGFB3;BMPR1A;CLCF1;IL12RB1;IL17RE;RELT;IL23A
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.22803654020785477,-1.0027355758139542,0.453125,1.0,1.0,24/85,23.60%,HEBP1;CCRL2;CXCL8;CXCR3;NTSR1;ACKR2;INSL3;CCL2;GPER1;MC1R;CXCL16;CCL3;CXCR1;UTS2R;CXCR4;CXCR2;POMC;C5;FPR1;C5AR1;SSTR2;PROK2;CXCR5;CX3CR1
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.215107641551197,-1.0014137140510373,0.55,1.0,1.0,43/133,24.69%,CUL1;PPIL2;UBE2L3;PIAS3;UBE2E2;UBE3B;UBE2E3;UBA3;NEDD4L;UBE2E1;KEAP1;UBE2R2;SMURF1;CBLB;ANAPC11;UBA6;ANAPC5;UBE2W;FBXO2;UBE2O;UBE2Q1;UBE2S;UBE2D4;DDB1;NEDD4;RHOBTB2;ITCH;SYVN1;KLHL9;PIAS4;ERCC8;XIAP;PRPF19;WWP1;CDC20;UBC;TRIM37;RNF7;DDB2;CUL4B;NHLRC1;CDC23;MID1
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.30732695760876527,-0.9999153285370538,0.5081967213114754,1.0,1.0,5/22,12.22%,SEC61B;SERP1;UBL4A;GET4;OTOF
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.22074401906426727,0.9998945338950994,0.44680851063829785,0.8797264787868221,1.0,18/63,21.47%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;CBFB;PSMC6;PSME2;PSMD11;SKP2;PSMD6;UBB;PSMC1;STUB1;PSMA7;NR3C1;PPARGC1B;PSME4
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.22536533888098165,0.9996455866910935,0.5,0.8780104339023428,1.0,17/79,16.25%,HS3ST3B1;CD44;SDC2;B3GNT2;ARSB;HPSE;B4GALT7;CSGALNACT2;GLB1;B4GALT4;HS6ST1;IDUA;HS3ST3A1;CHST12;HS2ST1;CHSY1;SLC9A1
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.22077705797280064,0.9992731091541215,0.4473684210526316,0.8767381223664917,1.0,6/54,5.18%,NUP205;RPP25;RPP14;NUP35;NUP214;NUP37
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.21892838274134413,-0.9980918716834184,0.47368421052631576,1.0,1.0,37/110,27.98%,RPS8;RPL15;RPS11;RPLP2;QARS1;AHCY;EEF1E1;RPL31;RPS10;DARS1;KARS1;MARS1;RPL39;GNMT;RPL9;RPS28;RPS14;NNMT;RPS6;RPS27L;GSR;RSL24D1;RPS7;RPL35A;SEPHS2;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.3113530164347131,-0.997683634725393,0.5245901639344263,1.0,1.0,10/20,27.30%,RGCC;PLAGL1;CNOT10;CNOT4;CDC25C;CNOT1;NPM1;PLK3;CNOT8;TP53
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.20023044146064137,0.9971705018163367,0.46808510638297873,0.8812406617657718,1.0,12/80,11.16%,PSMA5;PSMA4;AGO1;PSME1;SEPTIN7;RPS27A;AGO4;PSMC6;XPO1;PRKACB;PSME2;PSMD11
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.27877504614672427,0.9969808866275671,0.425531914893617,0.8792475120511303,1.0,7/24,17.59%,RPS27A;RFC5;POLR1B;POLD4;POLR1A;UBB;SLC19A1
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.2308785427598512,0.9964482404492488,0.5,0.8784485180206848,1.0,4/38,5.18%,NUP205;NUP35;NUP214;NUP37
prerank,KEGG_2021_Human__Wnt signaling pathway,-0.2206696294769564,-0.9963892400010148,0.4918032786885246,1.0,1.0,21/106,18.24%,CUL1;WNT7B;MAPK8;TLE4;CBY1;LGR4;CSNK2A2;PRICKLE2;ROCK2;FZD2;RAC2;CACYBP;PPP3CB;LRP5;JUN;RAC3;MAP3K7;SERPINF1;LGR6;FRAT1;CSNK1E
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.19949857869903087,-0.9960158038077965,0.4117647058823529,1.0,1.0,45/177,22.55%,NME7;CUL1;AKAP9;PSMD8;CLASP1;PSMD5;CEP76;ACTR1A;PPP2CB;CNTRL;DCTN3;FOXM1;PPME1;CENPF;CEP152;PPP1R12A;NEK2;CDC25B;FKBPL;CCP110;OFD1;PSMC5;PLK4;TUBGCP6;PRKAR2B;AURKA;RBBP4;CDK1;HMMR;PSMD3;CSNK1E;CKAP5;HSP90AA1;ALMS1;CDK11A;NINL;CEP41;CDC25C;LIN52;PSMB6;PSMD7;PAFAH1B1;UBC;PSMD13;CEP192
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.27307459358404684,0.9951504975568473,0.4782608695652174,0.8801914884963191,1.0,11/25,25.22%,ABAT;PPAT;ALDH5A1;ADSL;NIT2;GOT1;AGXT;GPT2;RIMKLB;DDO;GFPT1
prerank,KEGG_2021_Human__ABC transporters,0.2712317156119628,0.9949716331711803,0.47058823529411764,0.8783609081227,1.0,8/34,12.92%,ABCB1;ABCC10;ABCC2;ABCB4;ABCG1;ABCB9;ABCA5;ABCA13
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,0.20981624897701834,0.9941439769451182,0.4666666666666667,0.8778910570543625,1.0,13/78,11.16%,PSMA5;GATD3;PSMA4;PSME1;MAML3;RPS27A;SKP1;PSMC6;HEY1;MAML2;PSME2;ADAM10;PSMD11
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.2138133870838987,-0.9938046397529218,0.4393939393939394,1.0,1.0,14/103,9.89%,AKT1;RPS6KA1;MAP3K5;MAPK8;MAPK14;NFKBIB;PIK3R3;ARHGDIB;ZNF274;NTRK1;RPS6KA5;BAD;MAPK1;NRAS
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.20214003561528066,0.9934351758025445,0.4864864864864865,0.8777427766341244,1.0,26/84,22.88%,ALYREF;EIF4A3;HBS1L;RNGTT;CPSF1;NXF1;PAPOLA;NXT2;UPF3B;PPP2R3A;ETF1;PPP2R2D;CSTF2;PPP2R5C;PPP1CC;PPP2R5E;UPF3A;PPP2R2A;PABPC4;PABPN1L;NUDT21;SMG6;FUS;UPF1;CSTF2T;CSTF1
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.2589391083767977,-0.993086093840927,0.4426229508196721,1.0,1.0,7/51,5.54%,MAPK8;CXCL8;MAPK14;NFKBIB;FADD;SIKE1;CASP8
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.2670552715049082,0.9929327106474979,0.43902439024390244,0.8769593184951173,1.0,7/25,14.76%,ADCY7;PRKCD;NBEA;PRKACB;GRK2;KPNA2;CAMKK1
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.2121589981608016,0.9922800928362533,0.45161290322580644,0.8758279276112212,1.0,14/94,11.16%,PSMA5;CTSL;PSMA4;PSME1;PDIA3;RPS27A;PSMC6;ITGAV;SNAP23;SEC22B;B2M;FCGR1A;PSME2;PSMD11
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.2848929147420057,0.9922026898616338,0.5238095238095238,0.873683957973668,1.0,9/22,21.30%,ITGB3;RAP1A;SYK;SHC1;GRB2;RAPGEF3;TLN1;PDPK1;RASGRP1
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.21498405955643687,-0.9914637876088923,0.5079365079365079,1.0,1.0,39/106,29.45%,RPS8;EIF4H;EIF3A;RPL15;RPS11;RPLP2;EIF4A1;RPL31;RPS10;RPL39;RPL9;EIF3K;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;EIF3M;RPL18A;RPL19;RPL41;RPL7A;EIF2S2;RPL23;EIF3L;RPL36AL;RPS16;EIF4G1;MRPL13;RPL34;RPL12;EIF3J;RPS25;EIF1AX;RPL36
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.19592435054136745,-0.9911122906110046,0.5538461538461539,1.0,1.0,43/174,21.47%,OSBPL10;MBOAT1;RAB4A;PLA2G4A;CSNK2A2;PTEN;PIK3R3;PNPLA7;PIP4P1;ABHD3;CDS2;SELENOI;PTPMT1;PIKFYVE;CHPT1;PNPLA6;PLB1;RAB14;TNFAIP8L1;LPCAT2;LCLAT1;MTMR6;PRKCSH;RUFY1;PITPNM2;PLD2;BMX;PLBD1;PLEKHA3;PI4K2A;MFSD2A;LPIN1;MTMR14;PITPNM1;STARD10;PIK3R5;ACHE;PLEKHA1;PLEKHA8;PLD4;DDHD1;PLA2G4C;TNFAIP8
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.2947202177805238,0.9909736983132655,0.4883720930232558,0.8757915085935675,1.0,5/18,17.45%,LYN;HRAS;PRKACB;ICAM3;NFKB1
prerank,KEGG_2021_Human__Amoebiasis,-0.23099045201778004,-0.9908644309634367,0.4716981132075472,1.0,1.0,30/73,30.76%,IL6;CXCL8;PIK3R3;LAMC3;SERPINB10;TLR2;IL1R1;C8G;IL10;ITGB2;TGFB3;LAMB4;GNA11;SERPINB9;GNAS;PTK2;PLCB2;RAB5C;CD14;LAMC1;CD1E;PLCB1;CASP3;CD1D;GNA15;COL4A4;COL4A3;GNAQ;COL1A1;PIK3R2
prerank,KEGG_2021_Human__Tryptophan metabolism,0.25047480868280353,0.9902321648356669,0.4186046511627907,0.8757559819799663,1.0,12/31,26.71%,ALDH7A1;ACAT1;AFMID;KMO;ALDH3A2;IDO1;KYAT1;CYP1B1;KYAT3;ALDH9A1;INMT;KYNU
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.3304266875909133,0.9884256001861637,0.4888888888888889,0.8788215977495935,1.0,5/15,19.90%,TICAM1;RPS27A;TRAF6;UBB;NDUFA2
prerank,KEGG_2021_Human__Selenocompound metabolism,0.30871391978726104,0.988238139178832,0.4909090909090909,0.8771448230046504,1.0,7/16,24.61%,PSTK;MARS2;KYAT1;SEPSECS;SEPHS1;KYAT3;INMT
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,0.23208341308845967,0.9873565901456557,0.5526315789473685,0.8775216313336701,1.0,11/62,11.86%,POLR3K;POLR2K;TICAM1;NKIRAS1;RPS27A;POLR1D;RIPK3;POLR2F;POLR3D;POLR3H;POLR2H
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.24185414986421094,0.9870911491113642,0.4838709677419355,0.8758231582788774,1.0,4/34,5.18%,NUP205;NUP35;NUP214;NUP37
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.2048395643148501,0.9868893897812421,0.4594594594594595,0.8739272943747219,1.0,14/70,14.26%,NAPSA;RACGAP1;KLC1;COPE;RINT1;SEC22B;RAB1B;COPB1;ZW10;KIF21B;UBE2Z;TMED7;KIF22;COPA
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.2008053513537873,0.9868810664686694,0.575,0.8715607586870754,1.0,17/84,16.54%,PSMA5;CCNH;PSMA4;PSME1;RPS27A;SKP1;PSMC6;CABLES1;LIN9;PSME2;MNAT1;PSMD11;SKP2;PSMD6;CCNE1;UBB;PTK6
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,-0.24528186465197824,-0.9863091994019009,0.5178571428571429,1.0,1.0,10/54,14.13%,ST6GALNAC4;LARGE2;ST3GAL4;B3GNT8;SEMA5B;GALNT10;B3GLCT;POMGNT1;SPON2;ADAMTS2
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.25708174231812,0.9858614990520601,0.5,0.8725998536143348,1.0,8/33,13.45%,ITGB3;RAP1A;CNKSR2;WDR83;HRAS;MARK3;LAMTOR2;IL17RD
prerank,KEGG_2021_Human__Arachidonic acid metabolism,0.2486934545260052,0.9850155620846842,0.475,0.8734965676505013,1.0,6/38,6.94%,PLA2G2C;PTGDS;GGT1;HPGDS;CYP2C9;LTC4S
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.21103295516459164,-0.9849177773204548,0.3870967741935484,1.0,1.0,15/110,9.89%,AKT1;MAP3K5;MAPK8;PPP2CB;MAPK14;CERS2;SPHK2;PTEN;PIK3R3;GNA13;ROCK2;SPTLC2;MAPK1;RAC2;NRAS
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.22684014414070636,0.9844637544598351,0.5945945945945946,0.873195504927621,1.0,8/73,5.86%,ATP6V1E2;CTSL;ATP6V1A;ATP6V1E1;FOS;IL18;ATP6V0A1;ITGAL
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,-0.24802770913693395,-0.9842102679654448,0.46153846153846156,1.0,1.0,9/58,9.67%,CHD3;GATAD2A;H2BC14;H2BC4;H3C13;HDAC2;HDAC10;DPEP3;SAP18
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.22406614291073873,0.9833005723244773,0.5918367346938775,0.8745955762509747,1.0,6/51,5.67%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.20624754935573847,0.9831219269314853,0.4473684210526316,0.8728355597117705,1.0,15/88,12.52%,FEN1;H2BC15;H2BC17;POLR2K;RFC5;H2AC4;POLR1B;POLR2I;POLR2F;POLR2D;POLD4;H2AZ2;POLR2H;POLA2;H2BC3
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.1841998486850727,0.9831050435909577,0.4375,0.8705103509127424,1.0,24/122,15.74%,CAPZA2;NAPSA;DYNC1LI2;YKT6;COPE;DCTN2;CAPZB;CSNK1D;SPTB;ACTR10;SEC22B;COG8;RAB1B;COPB1;SEC24B;CNIH3;SEC24D;TRAPPC5;GOLGA2;FOLR2;TMED7;COPA;BET1L;TRAPPC2L
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.20970559505958003,-0.9827519025135085,0.44776119402985076,1.0,1.0,20/115,12.65%,AKT1;PRKAG2;MAPK8;FLOT2;PIK3R3;PDE3B;PTPRF;PRKAR1B;PHKB;BAD;MAPK1;CBLB;PHKA2;NRAS;PRKAG1;EXOC7;MKNK1;HKDC1;HK3;PRKAR2B
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.22666574108903764,0.9824160654570924,0.4375,0.8710634608836989,1.0,11/52,11.86%,CCNH;POLR2K;RPS27A;ERCC2;CUL4A;POLR2I;POLR2F;POLR2D;MNAT1;COPS2;POLR2H
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.19703881272673096,-0.9815026179133598,0.4852941176470588,1.0,1.0,45/179,22.55%,NME7;CUL1;AKAP9;PSMD8;CLASP1;PSMD5;CEP76;ACTR1A;PPP2CB;CNTRL;DCTN3;FOXM1;PPME1;CENPF;CEP152;PPP1R12A;NEK2;CDC25B;FKBPL;CCP110;OFD1;PSMC5;PLK4;TUBGCP6;PRKAR2B;AURKA;RBBP4;CDK1;HMMR;PSMD3;CSNK1E;CKAP5;HSP90AA1;ALMS1;CDK11A;NINL;CEP41;CDC25C;LIN52;PSMB6;PSMD7;PAFAH1B1;UBC;PSMD13;CEP192
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.173345681453653,0.981193790867608,0.5277777777777778,0.8727232047643684,1.0,23/168,10.02%,ADCY7;PPAN-P2RY11;LYN;GNB2;HRH2;IL18;C3AR1;RAMP1;GGT1;ITPR3;YES1;GNG5;SYK;ACTG1;CYSLTR1;FGR;GNG3;PRKACB;FCGR1A;GRB2;GNG10;WIPF1;GNG7
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.2683326116429622,-0.980967337505644,0.5576923076923077,1.0,1.0,11/34,25.50%,FADD;TRAF1;CASP8;SPPL2A;TANK;CFLAR;TRADD;XIAP;UBC;CHUK;CLIP3
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.17831844371400438,0.9807968467734376,0.4827586206896552,0.871423028414363,1.0,39/210,15.35%,PSMA5;RBBP7;FBXO11;PSMA4;FBXW4;CCDC22;PSME1;UBE2D2;RPS27A;SKP1;CUL5;DDA1;PSMC6;SQSTM1;FBXO7;FBXW9;KCTD7;HIF1A;CUL2;CUL4A;COMMD10;SPSB1;ASB7;CAND1;CISH;PSME2;VCP;PSMD11;COPS2;DCAF17;FBXO10;DCAF8;SOCS6;KLHL5;SKP2;WDTC1;PSMD6;ASB13;MUL1
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.23796046186703315,0.9806016785903792,0.47619047619047616,0.8700963602157713,1.0,9/53,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;HHAT;PSME2;VCP;PSMD11
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.20307993586414783,0.980240206134094,0.5555555555555556,0.8691436778336654,1.0,15/91,12.77%,PSMA5;ABCB1;PSMA4;PSME1;RPS27A;ABCC10;PSMC6;ABCC2;ABCB4;ABCG1;PSME2;VCP;PSMD11;ABCB9;ABCA5
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.26504839418424414,0.9800968517185226,0.5263157894736842,0.8673976605235048,1.0,9/28,19.48%,FLT3LG;HRAS;GRB2;TRIB3;PIK3CA;FGFR4;PIK3CB;PIK3R1;PDPK1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.23656761720917951,0.9800362720739976,0.48717948717948717,0.865295942125374,1.0,13/63,11.86%,CCNH;POLR2K;RPS27A;RFC5;ERCC2;POLR1B;CUL4A;POLR2I;POLR2F;POLR2D;MNAT1;POLD4;POLR2H
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.20626610117019384,-0.9789649203726519,0.42857142857142855,1.0,1.0,23/143,12.81%,HCAR3;HEBP1;CMKLR1;CCRL2;GPR132;CXCL8;CXCR3;NTSR1;DHX34;ACKR2;INSL3;SUCNR1;CCL2;PLPPR2;GPER1;MC1R;CXCL16;P2RY10;CCL3;OPN3;CXCR1;UTS2R;OXER1
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.21392324830501203,-0.9787576414014617,0.5409836065573771,1.0,1.0,37/100,30.08%,OSBPL10;MBOAT1;PLA2G4A;CSNK2A2;ABHD3;CDS2;SELENOI;PTPMT1;CHPT1;PLB1;LPCAT2;LCLAT1;PRKCSH;PITPNM2;PLD2;PLBD1;MFSD2A;LPIN1;PITPNM1;STARD10;ACHE;PLD4;DDHD1;PLA2G4C;PEMT;SLC44A4;LPIN2;MBOAT2;PCYT1B;GPD2;SH2D3C;GPD1L;ABHD4;MGLL;PISD;ACP6;GPAM
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.1833607121905917,-0.9780604226927455,0.4492753623188406,1.0,1.0,32/298,7.69%,AQR;XRCC1;TCEA1;RMI2;RAD9B;XRCC3;MAPK8;PPIE;COPS3;TDP1;H2AX;H2BC14;H2BC4;DNA2;UBE2T;INO80;PIAS3;XRCC5;TP53BP1;MBD4;APBB1;RAD9A;USP7;SMARCA5;POLL;PAXIP1;TINF2;ASCC2;ALKBH2;WDR48;RAD51AP1;POT1
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.2904304648571826,-0.9777294180186613,0.453125,1.0,1.0,4/24,7.82%,DHCR7;PMVK;MVD;GGPS1
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.3374293752081055,0.976374329318318,0.5,0.8743238364382901,1.0,5/15,18.76%,RAB3A;LIN7C;TSPOAP1;CASK;SNAP25
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,-0.2711172321296629,-0.9753156681991066,0.5081967213114754,1.0,1.0,4/30,8.11%,ST6GALNAC4;ST3GAL4;B3GNT8;GALNT10
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.2963053548958311,-0.9741129359998608,0.509090909090909,1.0,1.0,6/19,16.64%,PLXNA4;HDAC2;FBXO32;FOXO4;FOXO1;POMC
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.2551625994835704,0.9740409694490195,0.4186046511627907,0.8798057254208878,1.0,6/31,10.02%,GNB2;GNG5;RGS6;GNG3;GNG10;GNG7
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.2186122054268016,-0.9740246460194135,0.5303030303030303,1.0,1.0,20/85,19.01%,H2AX;H2BC14;H2BC4;H3C13;CD9;TINF2;POT1;TOP3A;DIDO1;CATSPER1;SUN1;H2AZ1;H3-3B;STAG3;RAD51;CATSPERB;SYNE2;MRE11;SUN2;H2AC7
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.24701620312720543,0.9736426086769043,0.3953488372093023,0.8787083610135713,1.0,4/34,3.71%,KCNMA1;EPS8L2;MSN;TRIOBP
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.30348091506934777,0.9735144425989553,0.4807692307692308,0.8767303418001856,1.0,5/16,19.90%,TICAM1;RPS27A;TRAF6;UBB;NDUFA2
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.22542742622365852,-0.9719949178514802,0.5522388059701493,1.0,1.0,36/90,31.01%,NDUFS7;NDUFB3;NDUFAF6;NDUFAF1;COX5A;NDUFA5;COX7B;UQCR10;NDUFC1;ETFDH;NDUFS1;COX6A1;COA1;NDUFB1;NDUFAF2;SDHB;NDUFS3;SCO2;TACO1;NDUFA11;NDUFB7;COX8A;NDUFB4;SDHD;SDHA;NDUFS4;NDUFB10;COX6B1;CYCS;COX16;COX6C;NDUFB5;NDUFAF3;COX20;NDUFAB1;UQCRC2
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,0.3007607213005143,0.9717464185588108,0.5333333333333333,0.8797398049356865,1.0,4/16,13.33%,ARSB;HPSE;GLB1;IDUA
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.22580928117482807,0.9712733915656953,0.5348837209302325,0.8790757720339443,1.0,6/54,5.67%,PSMA5;PSMA4;PSME1;RPS27A;CBFB;PSMC6
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,-0.25062997712211726,-0.9704875572557745,0.4666666666666667,1.0,1.0,18/38,30.76%,SPTAN1;PEAK1;DST;STAM;IQGAP1;USP9X;NCK1;NCK2;GIT1;CLTC;DEPDC1B;SRGAP2;PKN1;CDC42;PTK2B;HGS;STAM2;PIK3R2
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.1980391564340933,-0.9702578992432221,0.5079365079365079,1.0,1.0,27/157,12.91%,HSCB;IDE;SEC61B;PMPCA;COQ2;SERP1;IDH3G;SLC25A17;PEX14;SAMM50;TIMM13;UBL4A;IDH1;PEX12;CHCHD3;ACOT8;SLC25A6;USP9X;GET4;ACOX2;GRPEL1;OTOF;ATAD1;PEX2;PAOX;PEX26;FIS1
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.20169213033752914,-0.9701793292594522,0.4868421052631579,1.0,1.0,18/113,11.46%,AKT1;MYLK3;TRPC6;FXYD2;GNA13;ROCK2;PDE3B;PPP1R12A;MYLK4;SRF;BAD;MAPK1;ITPR1;ATF2;SLC25A6;PPP3CB;CREB3L2;PDE5A
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.23458251590764811,-0.9697024863491033,0.4426229508196721,1.0,1.0,7/63,3.85%,RUNX1;GP1BA;H2AX;H2BC14;H2BC4;H3C13;ZFPM1
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.22966930092871315,-0.9693302848522957,0.5774647887323944,1.0,1.0,9/65,9.89%,AKT1;RUNX1;SPI1;JUP;PIK3R3;CEBPE;BAD;MAPK1;NRAS
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.2912960172770667,0.9681647850177283,0.5217391304347826,0.8874381148967131,1.0,5/18,12.06%,CDK5R1;HRAS;SHC1;GRB2;PIK3CA
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.2526005410392115,-0.9681238692312469,0.4909090909090909,1.0,1.0,12/36,23.75%,COPS3;INO80;XPC;COPS6;TFPT;DDB1;COPS7A;UBC;RUVBL1;ACTL6A;DDB2;CUL4B
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.23679097019895365,-0.9664401340320167,0.6119402985074627,1.0,1.0,12/44,23.82%,HOMER2;BEGAIN;FLOT2;PTPRF;HOMER3;HOMER1;PPFIA1;PPFIBP2;DLG1;IL1RAP;APBA2;LIN7B
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.20973685577591034,-0.9660184455999347,0.5625,1.0,1.0,19/130,10.81%,CHD3;AKT1;PSMD8;PSMD5;ATN1;PHC3;GATAD2A;CSNK2A2;HDAC2;PTEN;USP7;RING1;DPEP3;PHC2;MAPK1;EZH2;FRK;LAMTOR4;PSMC5
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.26885842921240305,-0.9659769052281678,0.44776119402985076,1.0,1.0,14/26,34.85%,SLC25A17;ACOT8;ACOX2;CROT;AMACR;NUDT7;ECI2;ACBD4;MLYCD;CRAT;SLC27A2;ACAA1;ACBD5;PECR
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.28606637344909064,-0.9659031043477342,0.5166666666666667,1.0,1.0,7/27,19.51%,FGFR1OP2;CNTRL;NRAS;FGFR1;ERLIN2;GAB2;STAT5B
prerank,KEGG_2021_Human__Pertussis,-0.23086782906358982,-0.9656225661518181,0.5142857142857142,1.0,1.0,23/68,27.91%,IL6;MAPK8;ITGB1;CXCL8;MAPK14;PYCARD;TIRAP;MAPK1;JUN;IL10;ITGB2;C5;ITGA5;IL23A;TICAM2;IRF1;GNAI1;C1QC;CD14;IRAK1;NLRP3;CASP3;CALM1
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.2953493957588171,0.9645421419697904,0.5319148936170213,0.8961468862351466,1.0,5/21,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.29924545062905006,0.9643196875401326,0.47058823529411764,0.8947650052295365,1.0,6/18,18.31%,PDGFRA;HRAS;GRB2;PIK3CA;PIK3CB;PIK3R1
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.2042046418752223,-0.9639287861892384,0.5151515151515151,1.0,1.0,43/162,21.21%,ITGA3;MYLK3;ITGB1;PXN;RRAS;SSH2;PIK3R3;PAK1;PDGFD;GNA13;ROCK2;PPP1R12A;ARPC1A;DIAPH1;MYLK4;PIKFYVE;ITGA9;WASL;IQGAP1;MAPK1;RAC2;NCKAP1L;NRAS;MYL12B;MRAS;ACTR3;EZR;RAC3;FGFR1;CXCR4;GIT1;PPP1R12C;IQGAP2;ITGB2;WASF1;VAV3;ITGA5;ITGA1;PAK6;PTK2;TMSB4X;RDX;GNA12
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.22852492778254155,0.9636813576111269,0.5172413793103449,0.8946831136938642,1.0,7/40,12.12%,NUP205;NUP35;NUP214;NUP37;ISG15;KPNA5;KPNA2
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.1795627368354866,0.963572965476289,0.6111111111111112,0.8924417051744026,1.0,29/113,19.85%,ADCY7;FCER1G;CYTH4;TSC2;CYTH1;PDGFRA;FCER1A;CYTH2;SYK;HRAS;DGKH;SHC1;PLD1;RRAS2;GRB2;PIK3CA;PIP5K1C;DGKD;SOS2;PIK3R6;PIK3CB;ARF1;MAP2K2;PIK3R1;RAPGEF3;PLA2G4B;PDGFC;PIK3CD;DNM2
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.21586984398891992,-0.963451466350948,0.5138888888888888,1.0,1.0,21/92,19.97%,CHD3;ITGB1;GATAD2A;AP2B1;HDAC2;FXYD1;FXYD2;ROCK2;DPEP3;KEAP1;IL1R1;SAP18;AP2M1;SIGMAR1;NCK1;RBBP4;IL6R;CD79A;HSP90AA1;NFE2L2;BLNK
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.22436590531774075,-0.9632951892453262,0.5517241379310345,1.0,1.0,21/57,25.62%,IDE;PEX14;IDH1;PEX12;ACOT8;USP9X;ACOX2;PEX2;PAOX;PEX26;CROT;ACOT2;TYSND1;EPHX2;UBC;AMACR;ZNF260;NUDT7;ECI2;MLYCD;GSTK1
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.24603031033367057,0.96312765096171,0.5909090909090909,0.8914980215389862,1.0,10/28,18.31%,RPS27A;HRAS;SHC1;GRB2;SPRY2;PIK3CA;FGFR4;CBL;UBB;PIK3R1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.23708324614381002,-0.9615367310945276,0.5166666666666667,1.0,1.0,11/53,14.52%,ST6GALNAC4;PARP4;GOLGA7;ST3GAL4;DAD1;ZDHHC8;PARP16;ZDHHC9;DDOST;PARP6;PRKCSH
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.22145101029753886,0.9597140579857211,0.5555555555555556,0.8997960787749153,1.0,9/57,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;HHAT;PSME2;VCP;PSMD11
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.21646189347235456,0.9587981451954732,0.5918367346938775,0.9004059498534819,1.0,15/49,24.87%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;PSMD11;PSMD6;UBB;PSMC1;PSMA7;PSME4;PSMD2;CHEK1;PSMB7
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.2680173499244956,-0.9584115944922849,0.47619047619047616,1.0,1.0,11/25,34.34%,PPP2CB;FZD2;LRP5;FRAT1;LRP6;PPP2R5D;FZD1;AMER1;CTNNB1;AXIN1;PPP2R1A
prerank,KEGG_2021_Human__Pathways in cancer,-0.16877810920149708,-0.9583344657258638,0.6125,1.0,1.0,125/391,29.75%,TERC;AKT1;CUL1;IL6;ITGA3;RUNX1;WNT7B;MAPK8;ARNT2;SPI1;JUP;ITGB1;ERBB2;CXCL8;FADD;HDAC2;PTEN;JAG1;PIK3R3;TRAF1;LAMC3;CASP8;GNA13;STAT6;ROCK2;FAS;NTRK1;CSF3R;BIRC5;RPS6KA5;FZD2;IL15;IL2RG;KEAP1;DAPK2;BAD;MAPK1;RAC2;NRAS;TXNRD2;HGF;TFG;LRP5;JUN;RAD51;RAC3;MMP9;GSTM4;FGFR1;GNB1;PTGER2;CXCR4;FOXO1;IL13RA1;PLD2;MAX;MSH6;GSTM2;IL6R;GSTM5;TGFB3;PIM2;FRAT1;BBC3;TRAF2;LAMB4;HSP90AA1;TGFA;STAT5B;GNA11;IL12RB1;NFE2L2;GNAS;RALA;XIAP;IL23A;PTK2;CAMK2A;GNA12;LRP6;RALBP1;ADCY3;RASGRP4;ITGA6;GNAI1;CCDC6;PLCB2;STAT4;DDB2;MGST3;CTNNA1;LAMC1;EGF;CHUK;IL3RA;KIT;DVL1;MAP2K1;TCF7;IL7;STK4;CYCS;RXRA;F2R;ABL1;TP53;EDN1;PLCB1;POLK;PLCG2;CASP3;CALM1;ADCY4;SMAD4;IL2RB;FZD1;CDH1;E2F3;CDC42;HES1;ADCY9;COL4A4;GADD45A;COL4A3;JAK3
prerank,KEGG_2021_Human__Cellular senescence,-0.19698162309744652,-0.9579235944360891,0.5238095238095238,1.0,1.0,19/143,11.23%,AKT1;IL6;RAD9B;CXCL8;MAPK14;RRAS;FOXM1;PTEN;PIK3R3;RAD9A;MAP2K6;MAPK1;E2F5;ITPR1;NRAS;SLC25A6;MRAS;PPP3CB;TRAF3IP2
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.2530113382972369,-0.9575102927339473,0.55,1.0,1.0,6/42,8.64%,DHCR7;PMVK;MVD;MBD4;GGPS1;DAND5
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.2414856745791767,-0.9571050641083886,0.578125,1.0,1.0,18/52,25.19%,ERBB2;PIK3R3;TRAT1;RNASE1;RAC2;LCK;EPGN;AREG;FGFR1;TGFA;NRG4;GAB2;PIK3AP1;PTPN11;FRS2;EGF;CD19;KIT
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.20891462524125215,0.9568025530504521,0.5952380952380952,0.904714146263991,1.0,11/69,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ABCC2;ABCB4;LMBRD1;PSME2;VCP;PSMD11
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.20962655742889202,-0.9567232049611757,0.4925373134328358,1.0,1.0,12/81,11.85%,MAPK8;MAPK14;CD3D;NFKBIB;CD3G;JAG1;STAT6;IL2RG;MAPK1;LCK;PPP3CB;JUN
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,0.32353947058219823,0.9561693353250843,0.48717948717948717,0.9044172226259048,1.0,5/17,13.01%,PCSK5;LPL;APOE;ABCG1;TRNP1
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.20557008938717544,-0.9557166090317971,0.5757575757575758,1.0,1.0,39/107,29.45%,RPS8;EIF4H;EIF3A;RPL15;RPS11;RPLP2;EIF4A1;RPL31;RPS10;RPL39;RPL9;EIF3K;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;EIF3M;RPL18A;RPL19;RPL41;RPL7A;EIF2S2;RPL23;EIF3L;RPL36AL;RPS16;EIF4G1;MRPL13;RPL34;RPL12;EIF3J;RPS25;EIF1AX;RPL36
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,0.2398190549354264,0.9548870174507251,0.5142857142857142,0.9064393346337225,1.0,16/37,24.63%,EBF1;OR2T33;OR10H1;OR6N1;OR7D2;OR14J1;OR10G3;OR7G2;OR10H5;OR2A7;OR2L2;OR10K1;OR6J1;OR1F1;OR2G6;OR52K2
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.21205678766067707,0.9543392059787399,0.5294117647058824,0.9057278811373544,1.0,16/64,15.59%,TIMM23;CMC4;TIMM10;TOMM20;TIMM50;TIMM9;TIMM17A;TAFAZZIN;TOMM5;TOMM6;GRPEL2;COA4;TIMM10B;TOMM70;COA6;GFER
prerank,KEGG_2021_Human__Influenza A,-0.20151757601028197,-0.9539956473511397,0.5733333333333334,1.0,1.0,16/139,10.19%,AKT1;IL6;BCL2L2-PABPN1;CALCOCO2;CXCL8;NFKBIB;PYCARD;FADD;PIK3R3;CASP8;MX1;FAS;CCL2;MAPK1;IRF9;SLC25A6
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.15595773903449828,0.9538352972169987,0.7058823529411765,0.9051779539726773,1.0,90/500,16.54%,PCM1;PSMA5;FEN1;CCNH;NUP205;DYNC1LI2;CCND2;PSMA4;LYN;H2BC15;H2BC17;ORC4;VRK2;HAUS1;TUBB6;B9D2;CCNB2;PSME1;TUBGCP2;GTSE1;NUP35;NCAPG;NUDC;CC2D1B;RPS27A;SKP1;RFC5;SKA1;ESCO1;H2AC4;NUP214;E2F6;SPC24;SGO2;MAU2;CDCA8;NUP37;DCTN2;PSMC6;CSNK1D;RRM2;MAD1L1;SIRT2;CEP164;ANAPC2;CENPA;POLR1B;CABLES1;XPO1;LIN9;RAB1B;TK1;MCPH1;SET;CEP78;ZW10;PSME2;MNAT1;IST1;TUBA1C;ZWINT;POLD4;PSMD11;H2AZ2;RAN;POLA2;H2BC3;GOLGA2;RBL1;MAD2L1;NCAPG2;SKP2;NCAPH2;PPP2R2D;POLR1A;CEP290;MCM6;PSMD6;TUBB2A;CCNE1;RAB2A;NEK6;H2BC11;PPP2R5C;PPP1CC;HAUS8;BORA;PPP2R5E;UBB;PTK6
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.19605402872985098,0.9529717445354674,0.5833333333333334,0.9059225868111624,1.0,16/88,12.06%,ADCY7;EBAG9;FOS;RARA;PRKCD;CREB3L4;ITPR3;HRAS;CALML4;NOS3;SHC1;HSP90B1;PRKACB;GRB2;KRT18;PIK3CA
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.17350508695483655,0.9529574086772792,0.5666666666666667,0.9037406831061449,1.0,25/145,14.26%,CAPZA2;NAPSA;DYNC1LI2;MANEA;YKT6;COPE;DCTN2;CAPZB;CSNK1D;SPTB;ACTR10;SEC22B;MAN2A2;COG8;RAB1B;COPB1;SEC24B;B4GALT4;CNIH3;SEC24D;TRAPPC5;GOLGA2;FOLR2;TMED7;COPA
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.251661279990541,-0.9526420943861736,0.5666666666666667,1.0,1.0,11/50,17.02%,ID2;RPS6KA1;PPP2CB;MAPK14;SRF;RPS6KA5;MAPK1;DUSP6;CREB1;SGK1;RPS6KA3
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.24869832620949855,0.9525566965327094,0.5121951219512195,0.9028236815822417,1.0,7/32,13.21%,UGCG;STS;ARSB;SMPD3;SMPD1;GLB1;GM2A
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.2716927628853353,-0.9522416903474848,0.5818181818181818,1.0,1.0,12/27,33.41%,SPARC;APOL1;MSR1;DLC1;HSP90AA1;JCHAIN;COLEC12;FTH1;SCARF1;COL1A1;HSPH1;FTL
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.22032504342274725,0.95214674691214,0.6428571428571429,0.9017861820252444,1.0,6/51,5.67%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.29070131589350096,-0.9520268641518255,0.5666666666666667,1.0,1.0,6/18,23.52%,CUL1;MAPK1;RPS6;CLTC;MECP2;NPM1
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.23602893139212883,0.9518892572449648,0.5531914893617021,0.9005667003602317,1.0,6/29,9.49%,RAP1A;HRAS;SHC1;MAPK11;KIDINS220;GRB2
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.1827161177515617,0.9518112649033008,0.55,0.8985754061617509,1.0,17/127,11.16%,PSMA5;NUP205;PSMA4;PSME1;NUP35;RPS27A;SKP1;CUL5;NUP214;NUP37;PSMC6;CD4;XPO1;B2M;PSME2;HMGA1;PSMD11
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.3100848703670248,-0.9517567375497731,0.5714285714285714,1.0,1.0,6/20,18.34%,UBE2E1;ANAPC11;ANAPC5;UBE2S;CDK1;ANAPC15
prerank,KEGG_2021_Human__mTOR signaling pathway,0.18733313062278484,0.9497840669049998,0.6785714285714286,0.9025532855863457,1.0,39/124,24.43%,STRADA;CAB39L;ATP6V1E2;ATP6V1A;TSC2;ATP6V1E1;IGF1R;WDR24;RPS6KA2;SLC38A9;HRAS;GRB2;RRAGB;LAMTOR2;TTI1;PIK3CA;RPTOR;SOS2;SKP2;FLCN;PIK3CB;MAP2K2;PIK3R1;EIF4E;PRKAA1;PDPK1;PIK3CD;EIF4E2;WNT10B;CASTOR1;PRR5;DVL2;PRKCB;AKT1S1;DEPDC5;BRAF;MTOR;RRAGD;MAPK3
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.19286567859898962,-0.9492652511421351,0.6142857142857143,1.0,1.0,29/183,14.87%,GNAO1;AKT1;CUL1;MAPK8;MAPK14;PXN;CD3D;CD3G;FADD;PIK3R3;PAK1;CASP8;FAS;AP1S2;MAP2K6;TLR2;BAD;MAPK1;CGAS;RAC2;ITPR1;NRAS;PPP3CB;JUN;RAC3;MAP3K7;GNB1;CDK1;CXCR4
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.2289960478677227,0.9488805347617721,0.5581395348837209,0.9032295907772423,1.0,14/37,26.10%,BAIAP2L1;ARHGAP5;CAPZB;SNAP23;VANGL1;ACTN1;AKAP12;TMPO;PIK3R1;ARHGAP32;FARP1;SENP1;SOWAHC;LMNB1
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.22250865767988343,0.9487751958332845,0.6222222222222222,0.9013082412709125,1.0,7/47,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;PSMD11
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.30109164995349313,-0.9480275307754773,0.509090909090909,1.0,1.0,7/15,29.42%,BTG1;FOXO4;FOXO1;SMAD4;CCNG2;RBL2;GADD45A
prerank,KEGG_2021_Human__Autophagy,-0.1959535039638121,-0.946833672020941,0.5441176470588235,1.0,1.0,31/129,18.64%,AKT1;MAPK8;ATG13;PPP2CB;RRAS;PTEN;PIK3R3;ULK1;RUBCN;DAPK2;BAD;RAB33B;MAPK1;ITPR1;ATG14;NRAS;DEPTOR;MRAS;ZFYVE1;STX17;LAMP1;TANK;MAP3K7;TP53INP2;ATG9A;CTSB;SH3GLB1;STK11;CFLAR;MTMR14;ATG101
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.16802446066043933,0.9467150206041683,0.56,0.905003527331089,1.0,56/244,19.88%,BCL2L1;CCND2;TSC2;NR4A1;COL6A2;COL6A3;IGF1R;GNB2;IL4R;PDGFRA;ITGB3;PKN3;FLT3LG;CREB3L4;GNG5;ITGAV;SYK;ITGA4;HRAS;NOS3;HSP90B1;GNG3;GRB2;GNG10;GNG7;PIK3CA;TCL1A;FGFR4;PPP2R3A;RPTOR;COL9A3;SOS2;PPP2R2D;PRLR;CCNE1;PIK3R6;MAGI2;PPP2R5C;FOXO3;PPP2R5E;PIK3CB;MDM2;CSF1;NFKB1;MAP2K2;CSF1R;PIK3R1;RAC1;EIF4E;PPP2R2A;PRKAA1;PDGFC;PDPK1;CCNE2;PIK3CD;LAMA2
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.2611556979635946,-0.9458633406944421,0.5737704918032787,1.0,1.0,16/22,46.72%,PPP2CB;PRKAR1B;PPP3CB;PRKAR2B;PPP3CC;PPP2R5D;CALM1;PDE4D;PPP2R1A;PRKCA;PPP3CA;PPP2R1B;PPP1CA;PRKAR2A;PPP2CA;PRKAR1A
prerank,KEGG_2021_Human__Shigellosis,-0.18527677658883124,-0.9448092250505882,0.5616438356164384,1.0,1.0,40/224,14.96%,AKT1;CUL1;TLR5;MAPK8;ITGB1;CALCOCO2;CXCL8;MAPK14;PXN;NFKBIB;H3C13;PYCARD;PIK3R3;SEPTIN6;GLMN;ROCK2;ARPC1A;DIAPH1;H3C11;RPS6KA5;WASL;MAPK1;CGAS;IL1R1;ITPR1;ATG14;MYL12B;SEPTIN2;ACTR3;TIFA;TNIP1;JUN;HKDC1;HK3;H3-3B;CASP4;FOXO4;MAP3K7;UBE2D4;FOXO1
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,-0.20548450449178074,-0.9443447075101082,0.5806451612903226,1.0,1.0,19/75,18.35%,AP2B1;ROCK2;ARPC1A;PSENEN;RNASE1;EPHA4;WASL;EPHB3;MYL12B;ACTR3;AP2M1;SDCBP;EPHB2;NCK2;MMP9;GIT1;EPHB1;CLTC;VAV3
prerank,KEGG_2021_Human__Focal adhesion,-0.19229269620121653,-0.9433721535100357,0.6285714285714286,1.0,1.0,24/154,11.85%,AKT1;ITGA3;MAPK8;MYLK3;ITGB1;ERBB2;PXN;PTEN;PIK3R3;PAK1;PDGFD;LAMC3;ROCK2;PPP1R12A;DIAPH1;MYLK4;ITGA9;BAD;MAPK1;RAC2;MYL12B;HGF;COMP;JUN
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.1905929366804571,-0.942587520301541,0.6307692307692307,1.0,1.0,44/187,21.07%,WDR43;RRP7A;EBNA1BP2;RPS8;RCL1;RPL15;RPS11;RPLP2;EXOSC9;NOP2;SPPL2A;RPL31;EXOSC8;RPS10;LTV1;RPP30;RPL39;UTP11;RPL9;DNAJC5;XRN2;NOL6;RRP36;RPS28;RPS14;WDR12;GNL3;TRMT112;RPS6;RPS27L;WDR75;SENP3;RSL24D1;NOC4L;UTP4;RPP38;CSNK1E;RPS7;RPL35A;WDR3;FAU;DIMT1;EMG1;RPS21
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.18395157043813054,0.9424210466528528,0.7037037037037037,0.9149809061738454,1.0,51/180,22.99%,PUF60;SNRPG;ALYREF;EIF4A3;HNRNPUL1;SF3A2;PPIL1;DHX38;POLR2K;SNRPE;POLR2I;POLR2F;SNRNP27;CPSF1;U2AF2;LSM5;LSM4;POLR2D;PAPOLA;SNRPA;RBMX;SRSF1;SRSF3;PQBP1;UPF3B;POLR2H;RBM22;LSM8;SRSF11;CSTF2;HNRNPH2;SF3B3;MTREX;HNRNPA0;RBM5;SNRPB;CWC27;LSM7;HNRNPH1;SF3B2;NUDT21;SF3A3;SRSF6;DHX9;FUS;TFIP11;CSTF2T;SF3B1;CSTF1;SRSF9;CDC40
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,-0.2815130119065231,-0.941119075562131,0.4339622641509434,1.0,1.0,8/18,28.11%,SMURF1;ZFYVE16;SMAD5;BMPR2;BMPR1A;SKI;FSTL1;SMAD4
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.2337359310620557,-0.9409396614962576,0.5147058823529411,1.0,1.0,12/51,19.01%,H2AX;H2BC14;H2BC4;TINF2;POT1;DIDO1;SUN1;H2AZ1;STAG3;SYNE2;SUN2;H2AC7
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.28354837943846833,0.9399906975343726,0.5918367346938775,0.9198508709738048,1.0,5/17,18.31%,HRAS;GRB2;PIK3CA;TRIP11;PIK3R1
prerank,KEGG_2021_Human__Coronavirus disease,-0.1870586987026584,-0.939272960204613,0.647887323943662,1.0,1.0,58/188,27.98%,IL6;MAPK8;RPS8;CXCL8;TLR8;MAPK14;RPL15;NFKBIB;RPS11;RPLP2;PIK3R3;MX1;CYBB;RPL31;TLR2;CCL2;RPS10;MAPK1;CGAS;IRF9;RPL39;RPL9;C8G;JUN;RPS28;RPS26;RPS14;F13A1;MAP3K7;RPS6;RPS27L;RPS10-NUDT3;RSL24D1;IL6R;C5;RPL36A-HNRNPH2;RPS7;RPL35A;C5AR1;FAU;RPS21;RPL18A;C1QC;MASP2;RPL19;IFIH1;RPL41;RPL7A;OAS1;CHUK;RPL23;RPL36AL;RPS16;IRAK1;NLRP3;PLCG2;RPL34;RPL12
prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.2139125276081254,-0.9389386374495635,0.5079365079365079,1.0,1.0,15/64,19.70%,ID2;CUL1;PPP2CB;SMURF1;NBL1;MAPK1;E2F5;ZFYVE16;TGIF1;SMAD5;BMPR2;TGFB3;HAMP;BMPR1A;FBN1
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.2163285770866535,0.9387124361534604,0.7209302325581395,0.9209353557483898,1.0,7/49,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;PSMD11
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.1998426401755602,0.9382880444156476,0.6046511627906976,0.9202755910068355,1.0,17/80,17.59%,CCNH;ERCC4;RPS27A;RFC5;ERCC2;USP45;POLR1B;CUL4A;MNAT1;POLD4;COPS2;POLR1A;PARP2;RAD23B;UBB;CETN2;SLC19A1
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.23843523235267064,-0.9380244685897404,0.4423076923076923,1.0,1.0,5/37,8.99%,RMI2;RAD9B;DNA2;RAD9A;TOP3A
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.2274111973414899,0.9376796184759352,0.5853658536585366,0.9199233750978767,1.0,13/44,22.79%,PSMA5;PSMA4;PSME1;PSMC6;FCGR1A;PSME2;PSMD11;PSMD6;MRC2;PSMC1;PSMA7;PSME4;PSMD2
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.191199435867583,-0.9373808558180269,0.5797101449275363,1.0,1.0,24/125,16.64%,HCAR3;AKT1;MAPK8;RRAS;PIK3R3;FXYD1;PAK1;FXYD2;ROCK2;PDE3B;PPP1R12A;SUCNR1;BAD;MAPK1;RAC2;CREB3L2;JUN;ABCC4;RAC3;PTGER2;CREB1;PLD2;PDE3A;POMC
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.23429882078454026,0.9365263970091058,0.5434782608695652,0.9209997871577824,1.0,12/43,20.11%,GFAP;RPS27A;APOE;HRAS;SHC1;GRB2;COPS2;PIK3CA;WWOX;UBB;PIK3R1;MXD4
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.2258731884399828,-0.9365213646406026,0.5636363636363636,1.0,1.0,23/55,28.86%,CDC42EP2;JUP;ARL13B;WASL;IQGAP1;STEAP3;CDC42EP4;CDC42EP1;GIT1;CPNE8;DLC1;ARHGAP17;TRIP10;DEPDC1B;RHOQ;SCRIB;SRGAP2;PKN1;MPP7;CDC42BPB;VAMP3;CDC42;ITSN1
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",-0.2415254666918437,-0.9360196149965415,0.5076923076923077,1.0,1.0,9/41,14.62%,H2AX;H2BC14;H2BC4;MBD4;TINF2;POT1;H2AZ1;MPG;UNG
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,-0.17902339668779801,-0.9356992592239458,0.5970149253731343,1.0,1.0,18/240,4.36%,GNAO1;USP8;AKT1;CUL1;PSMD8;PSMD5;WNT7B;TLE4;RORA;CBY1;H2AX;H2BC14;PPP2CB;H2BC4;LGR4;AP2B1;H3C13;CSNK2A2
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.19168152243498643,0.9350085177606812,0.6,0.9233127310404636,1.0,22/112,15.02%,CCNH;RBBP7;H2BC15;H2BC17;POLR2K;TBP;POLR1F;POLR1D;H2AC4;ERCC2;POLR1B;POLR2F;SUZ12;MNAT1;H2AZ2;POLR2H;SAP30L;DDX56;H2BC3;MTF2;POLR1A;TAF1C
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.21440676125831976,0.9349504474794593,0.5813953488372093,0.9212335735267352,1.0,13/56,16.02%,H2BC15;H2BC17;H2AC4;CABIN1;ASF1A;H1-3;EP400;HMGA1;H2AZ2;H2BC3;H1-2;CCNE1;H2BC11
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.26514117701323464,0.9349376297512851,0.5714285714285714,0.9190740145740026,1.0,7/25,19.63%,RIGI;NKIRAS1;TRIM4;MAP3K1;TRAF6;NFKB1;NFKBIA
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.19058440851457767,-0.934730236112261,0.6216216216216216,1.0,1.0,23/151,11.54%,AKT1;WNT7B;ITGB1;ERBB2;MAPK14;PXN;RRAS;PIK3R3;PAK1;ROCK2;PPP1R12A;FAS;NANOG;FZD2;TLR2;IQGAP1;MAPK1;PDCD4;ITPR1;NRAS;MRAS;HGF;EZR
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.26608137670891746,0.9345735629209388,0.5789473684210527,0.9179772194683934,1.0,8/25,19.48%,FLT3LG;GRB2;TRIB3;PIK3CA;FGFR4;PIK3CB;PIK3R1;PDPK1
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.20700148634186166,-0.9345724495744993,0.6190476190476191,1.0,1.0,35/96,29.45%,RPS8;EIF3A;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;EIF3K;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;EIF3M;RPL18A;RPL19;RPL41;RPL7A;RPL23;EIF3L;RPL36AL;RPS16;MRPL13;RPL34;RPL12;EIF3J;RPS25;EIF1AX;RPL36
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.21492163560922836,0.9342691148331971,0.6428571428571429,0.9166757132397907,1.0,18/67,21.47%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;SUFU;PSME2;GRK2;SPOPL;PSMD11;CDC73;PSMD6;UBB;GLI1;PSMC1;KIF3A;PSMA7;PSME4
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.28654171903174686,0.9333619424679517,0.5675675675675675,0.9168467187622744,1.0,17/17,71.37%,CCND2;CCNE1;CCNE2;E2F2;CCND3;CDKN1A;CDK2;TFDP1;CDKN1B;E2F1;CDK6;CDK4;RB1;CCND1;TFDP2;CDKN1C;E2F3
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.1743584346178841,-0.9328000217262269,0.7391304347826086,1.0,1.0,113/403,25.41%,RHOB;PSMD8;CLASP1;RPS6KA1;PSMD5;PLXNA4;SPTAN1;AGAP2;MAPK8;RPS8;ITGB1;ERBB2;RPS6KA4;MAPK14;RPL15;AP2B1;RRAS;RPS11;RPLP2;GFRA2;TRPC6;CSNK2A2;PIK3R3;ROCK2;ARPC1A;KIF4A;RHOC;RPL31;PSENEN;RPS6KA5;ITGA9;RNASE1;EPHA4;WASL;EVL;RPS10;EPHB3;MAPK1;RPL39;NRAS;MYL12B;RPL9;PSMC5;PPP3CB;ACTR3;EZR;AP2M1;SDCBP;RPS28;RBM8A;EPHB2;RPS14;NCK1;NCK2;ABL2;MMP9;FGFR1;RPS6;CXCR4;RPS27L;CREB1;FES;GIT1;EPHB1;RSL24D1;PSMD3;RPS6KA3;CLTC;PDLIM7;SEMA6A;VAV3;RPS7;HSP90AA1;DOK4;RPL35A;CACNB1;NRP2;GAB2;ITGA5;ITGA1;FAU;VASP;PTK2;RDX;RPS21;ANK1;CACNB3;PSMB6;ABLIM3;PSMD7;SRGAP2;UBC;PSMD13;DLG1;NELL2;SCN11A;RPL18A;ARPC5;ALCAM;RPL19;PTPN11;ROBO3;RPL41;COL9A1;LAMC1;RPL7A;FRS2;NCBP1;PLXNC1;PRNP;MAP2K1;PKN1;RPL23
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,-0.26939599085642507,-0.9326790487993807,0.5,1.0,1.0,6/30,11.48%,H2AX;H2BC14;H2BC4;TINF2;POT1;H2AZ1
prerank,KEGG_2021_Human__Hippo signaling pathway,-0.19856687358314823,-0.9323008615258053,0.5666666666666667,1.0,1.0,21/111,18.31%,ID2;LATS2;TP53BP2;WNT7B;PPP2CB;PAK1;AMOT;BIRC5;FZD2;WTIP;RASSF4;YWHAQ;YWHAB;AREG;BMPR2;ITGB2;TGFB3;BBC3;CSNK1E;BMPR1A;PRKCZ
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.2402675894888596,-0.931874258073093,0.5,1.0,1.0,6/39,7.69%,H2AX;H2BC14;H2BC4;MBD4;TINF2;POT1
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.21019363941749808,0.9316562170367156,0.575,0.9194648338857301,1.0,24/83,18.59%,MYL12A;ARHGAP35;RASSF5;ROCK1;JAM3;MSN;RAP1A;ARHGAP5;ITGAL;ITGA4;AFDN;ACTG1;MAPK11;ACTN1;PIK3CA;ITGAM;RHOH;PIK3CB;CLDN9;PIK3R1;RAPGEF3;MYL5;CYBA;RAC1
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.28015912847106317,0.9316346912245439,0.5263157894736842,0.9173351952530088,1.0,3/20,5.07%,TICAM1;NKIRAS1;RIPK3
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,-0.22822817425162018,-0.9313048966039422,0.6,1.0,1.0,6/60,7.40%,IL6;PRKAG2;ITGA3;ITGB1;TPM2;ITGA9
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.29363539298829533,-0.9312543418147521,0.5079365079365079,1.0,1.0,5/18,14.16%,LRRC14;CASP8;NLRC5;TANK;IKBIP
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.21968590092829285,0.9310771477596581,0.5909090909090909,0.9169091970225044,1.0,6/52,5.67%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6
prerank,KEGG_2021_Human__Necroptosis,-0.19668236090839256,-0.9308708652929485,0.6086956521739131,1.0,1.0,32/133,21.15%,MAPK8;H2AX;PYCARD;PLA2G4A;FADD;VPS4B;CASP8;STAT6;FAF1;FAS;PPIA;CYBB;IRF9;SLC25A6;GLUD1;H2AC8;H2AZ1;CHMP4B;RNF103-CHMP3;H2AC16;CFLAR;TRAF2;MLKL;HSP90AA1;H2AC7;TRADD;CHMP1A;STAT5B;XIAP;CAMK2A;TICAM2;PLA2G4C
prerank,KEGG_2021_Human__Endocytosis,-0.1846509228075175,-0.9299949896700445,0.6533333333333333,1.0,1.0,49/234,17.55%,USP8;GRK6;ARF4;AGAP2;ARAP2;GRK3;RAB4A;AP2B1;HSPA6;SNF8;PIP5KL1;VPS4B;ACAP1;ARPC1A;STAM;PSD3;NEDD4L;IL2RG;SMURF1;WASL;SNX12;CBLB;DNAJC6;IGF2R;ACTR3;VPS37C;AP2M1;CXCR1;CHMP4B;SH3GLB2;KIF5A;ZFYVE27;RNF103-CHMP3;ZFYVE16;RUFY1;AGAP6;CXCR4;TSG101;GIT1;PLD2;RAB11B;PDCD6IP;CXCR2;RAB11FIP3;NEDD4;AGAP3;ITCH;SH3GLB1;CLTC
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.19649932905586548,-0.9287330277826705,0.6166666666666667,1.0,1.0,38/169,19.89%,AKT1;CR1L;GP1BA;H2AX;TLR8;H2BC14;MAPK14;H2BC4;H3C13;HDAC2;PIK3R3;H2BC7;H3C11;HDAC6;CYBB;CLCN5;HDAC10;TLR2;H4C11;MAPK1;RAC2;HAT1;SLC25A6;H2AC8;H2AZ1;H3-3B;CASP4;MAP3K7;HDAC11;H2AC16;HDAC9;ITGB2;C5;H3C4;FPR1;H2AC7;H3C8;C5AR1
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.1821527399473576,-0.9285083792914407,0.5384615384615384,1.0,1.0,17/185,5.97%,PSMD8;FOXP3;KCTD6;PSMD5;RUNX1;SPI1;GP1BA;H2AX;PHC3;H2BC14;H2BC4;H3C13;ZFPM1;CSNK2A2;LMO2;PCGF5;RING1
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.1854743871636661,-0.9282111642013113,0.6,1.0,1.0,50/194,22.43%,AKT1;PSMD8;UACA;PSMD5;TP53BP2;SPTAN1;MAPK8;FLOT2;FADD;DYNLL2;ARHGAP10;CASP8;REXO2;DAPK2;BAD;MAPK1;HMGB2;H1-0;PSMC5;GZMB;CHMP4B;YWHAQ;SDCBP;YWHAB;PELI1;CASP4;TANK;GNL3;RNF103-CHMP3;BMX;PDCD6IP;KPNA1;PSMD3;MAPT;BBC3;CFLAR;MLKL;HSP90AA1;TRADD;YWHAZ;XIAP;PTK2;IRF1;TMED7-TICAM2;OCLN;PSMB6;PSMD7;RRM1;UBC;PSMD13
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.2426889851949878,-0.9281230266509694,0.640625,1.0,1.0,7/34,14.31%,SERPINB2;PPIA;PDCD4;MTAP;SOD1;IL10;S100A9
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.290349948653757,0.9278256054072468,0.6363636363636364,0.9243399584492831,1.0,5/18,13.94%,SREBF1;CPT1A;LIN9;CARM1;TBL1X
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.23093155168181653,0.9272178352824586,0.6285714285714286,0.9239585555885362,1.0,10/41,15.00%,C3AR1;C1S;C4A;C1QB;TTF2;C4BPA;CD81;AKR1C1;CPNE1;CFH
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.21380159839227833,-0.9268183906921048,0.6451612903225806,1.0,1.0,6/65,4.65%,AKT1;MAP3K8;PPP2CB;CD3D;BTLA;PIK3R3
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,-0.3060623403709734,-0.9265515435476875,0.5535714285714286,1.0,1.0,7/15,31.25%,AKR1B15;POMC;HSD17B11;SRD5A3;STARD3NL;HSD17B12;STARD4
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.19674080382631995,-0.9262359401204102,0.5970149253731343,1.0,1.0,13/112,8.99%,XRCC1;RMI2;RAD9B;XRCC3;H2AX;H2BC14;H2BC4;DNA2;TP53BP1;RAD9A;RAD51AP1;TIPIN;TOP3A
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,0.1496062001692443,0.9261552328078653,0.7391304347826086,0.9249654855039117,1.0,68/500,12.18%,SLC39A3;SLC22A15;PSMA5;ADCY7;ABCB1;PCSK5;ATP6V1E2;SLC25A26;MCOLN2;PSMA4;ATP6V1A;SLC43A2;HFE;ATP6V1E1;PSME1;GNB2;ATP7B;SLC40A1;SLC28A2;AMN;FXYD7;CYB5R4;SLC44A2;RPS27A;SKP1;LCN15;ANKH;SLC44A1;ATP6V0A1;GNG5;SLC38A1;ABCC10;PSMC6;SLC45A3;ABCC2;LPL;ATP1B2;SLC30A1;WNK1;SLC16A7;APOE;CAND1;ABCB4;GNG3;PRKACB;TFR2;AQP9;ATP13A4;ABCG1;GNG10;SLC29A1;SLC7A8;BEST1;PSME2;GNG7;VCP;CA4;YME1L1;TRPV1;PSMD11;SLC6A13;ATP8B2;MAIP1;HMOX2;ABCB9;LRRC8A;SLC5A6;STOML2
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.17586997279055502,0.9249665924838523,0.7222222222222222,0.9264680090884223,1.0,34/150,19.72%,PSMA5;FEN1;PSMA4;H2BC15;H2BC17;ORC4;PSME1;RPS27A;SKP1;RFC5;H2AC4;PSMC6;ANAPC2;POLR1B;KPNA6;PSME2;POLD4;PSMD11;H2AZ2;POLA2;H2BC3;SKP2;POLR1A;MCM6;PSMD6;CCNE1;H2BC11;UBB;MCM4;SLC19A1;ORC3;PSMC1;CCNE2;H3C7
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,-0.21145287690340256,-0.9247764354186384,0.5740740740740741,1.0,1.0,12/69,15.25%,AKAP9;APBB1IP;DUSP10;TENT4A;NF1;IQGAP1;MAPK1;NRAS;MRAS;YWHAB;DUSP6;SND1
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.21788069918562666,-0.924140930920211,0.5357142857142857,1.0,1.0,13/77,11.16%,AKT1;PRKAG2;PDE3B;PHKB;PGAM1;PDHA1;PHKA2;ITPR1;PGAM2;ATF2;PPP3CB;PRKAG1;CREB3L2
prerank,KEGG_2021_Human__Cell adhesion molecules,0.19260026472442077,0.92357625503087,0.6,0.9280809274361173,1.0,12/109,7.33%,CD34;ICOS;JAM3;SDC2;NEGR1;GLG1;SELPLG;ITGAL;ITGAV;CD4;ITGA4;PDCD1LG2
prerank,KEGG_2021_Human__Retinol metabolism,-0.272089865550194,-0.9234957702371747,0.5272727272727272,1.0,1.0,1/19,0.02%,DHRS9
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.18638474771945074,-0.9233415500831034,0.5909090909090909,1.0,1.0,13/159,4.36%,USP8;AKT1;PSMD8;PSMD5;TLE4;CBY1;H2AX;H2BC14;PPP2CB;H2BC4;LGR4;H3C13;CSNK2A2
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.2381252754802187,0.9223223220556175,0.6,0.9296569976789718,1.0,10/33,19.48%,FLT3LG;HRAS;SHC1;GRB2;TRIB3;PIK3CA;FGFR4;PIK3CB;PIK3R1;PDPK1
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.18797643521127488,-0.922195006174705,0.6612903225806451,1.0,1.0,54/127,34.18%,MYLK3;CACNA1I;ERBB2;PDE1B;SPHK2;ITPKC;PDGFD;NTSR1;ASPH;NTRK1;MYLK4;PHKB;PHKA2;ITPR1;SLC25A6;HGF;PPP3CB;STIM2;ITPKB;FGFR1;CXCR4;P2RX7;SPHK1;GNA11;GNAS;CAMK2A;CD38;ADCY3;MCOLN1;P2RX5;PLCB2;RYR1;PPP3CC;EGF;F2R;PLCB1;PLCG2;CALM1;VDAC1;ADCY4;GNA15;ADCY9;PTK2B;CAMK1D;GNAQ;SLC25A4;CACNA1D;ADRB2;CACNA1A;PLCB4;PHKG2;CACNA1H;LTB4R2;SLC8A1
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.18783214982101443,0.9211572654330624,0.631578947368421,0.930816552974432,1.0,29/116,21.47%,PSMA5;FEN1;PSMA4;ORC4;PSME1;RPS27A;SKP1;RFC5;PSMC6;ANAPC2;POLR1B;PSME2;POLD4;PSMD11;POLA2;SKP2;POLR1A;MCM6;PSMD6;CCNE1;UBB;MCM4;SLC19A1;ORC3;PSMC1;CCNE2;MCM7;PSMA7;PSME4
prerank,KEGG_2021_Human__Small cell lung cancer,-0.20832028833612598,-0.9203512521174712,0.6029411764705882,1.0,1.0,7/79,5.30%,AKT1;ITGA3;ITGB1;PTEN;PIK3R3;TRAF1;LAMC3
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.2068655207874513,0.9202748236024969,0.6739130434782609,0.930921054523598,1.0,14/52,22.79%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;PSMD11;PSMD6;UBB;PSMC1;PSMA7;PSME4;DVL2;PSMD2
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.21002638302176851,-0.9200951832613388,0.6129032258064516,1.0,1.0,27/96,22.55%,AKAP9;MARK4;CLASP1;CEP76;ACTR1A;CNTRL;DCTN3;CEP152;B9D1;NEK2;CCP110;OFD1;SEPTIN2;PLK4;NPHP4;PRKAR2B;CDK1;CSNK1E;CKAP5;HSP90AA1;ALMS1;NINL;CEP41;PAFAH1B1;TMEM67;TCTN1;CEP192
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.1984655042497024,0.9196329000113673,0.5714285714285714,0.9306469119889822,1.0,9/83,6.32%,OPHN1;ARHGAP35;RACGAP1;VRK2;YKT6;BAIAP2L1;ARHGAP5;ARHGAP6;SNAP23
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.18363937248247686,-0.919419820476492,0.6619718309859155,1.0,1.0,24/186,11.16%,GNAO1;AKT1;IL6;CXCL8;MAPK14;PXN;FADD;PIK3R3;CASP8;GNA13;ROCK2;FAS;MAP2K6;CCL2;MAPK1;CGAS;RAC2;IL1R1;ITPR1;NRAS;ATF2;CCL3;PPP3CB;CREB3L2
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,0.2985834036353148,0.9187182629282353,0.5641025641025641,0.9306932790363952,1.0,4/15,16.89%,TNFSF14;TNFSF13B;CD40LG;TNFSF12
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.2608024889643109,-0.9181324952815211,0.6,1.0,1.0,11/29,26.89%,MCFD2;SEC24C;CTSC;AREG;LMAN1;CNIH2;TGFA;LMAN2L;PREB;SEC23A;SAR1B
prerank,KEGG_2021_Human__Other glycan degradation,-0.28931953506704133,-0.9175904826548822,0.5454545454545454,1.0,1.0,5/15,20.01%,ENGASE;NEU3;FUCA1;MAN2C1;HEXB
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.20842997531098736,-0.9170413590125706,0.6166666666666667,1.0,1.0,24/75,25.16%,MBOAT1;PLA2G4A;PNPLA7;DGKA;CDS2;SELENOI;DGKQ;CHPT1;PNPLA6;PLB1;LPCAT2;LCLAT1;DGKZ;PLD2;LPIN1;LCAT;ACHE;PLD4;PLA2G4C;DGKE;PEMT;LPIN2;MBOAT2;PCYT1B
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.19815573369447614,0.9166159622174884,0.625,0.9352563190028786,1.0,15/55,20.80%,BCL9;H2BC15;H2BC17;H2AC4;BCL9L;TLE2;KMT2D;H2AZ2;H2BC3;CDC73;H2BC11;LEF1;H3C7;TLE1;AXIN2
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.19500737193490966,0.9162127050957543,0.5897435897435898,0.9339918873798059,1.0,10/64,10.45%,KCNMA1;GNB2;ITPR3;GNG5;FGR;GNG3;GNG10;PDE9A;GNG7;PDE10A
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.22555788185632225,-0.9158427159540266,0.578125,1.0,1.0,7/40,12.12%,SDSL;DNMT3B;DNMT3A;AHCY;DNMT1;MTAP;MAT2A
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.24987018423333476,0.9158338735179793,0.5348837209302325,0.932963850447556,1.0,7/24,18.64%,EIF4A3;EIF4A2;CNOT6;CNOT6L;CNOT11;CNOT7;EIF4E
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.18831433734820008,-0.9157706154259824,0.6712328767123288,1.0,1.0,16/159,6.57%,ID2;IL6;RUNX1;ARNT2;SPI1;JUP;CXCL8;AFF1;H3C13;HDAC2;LMO2;TRAF1;CEBPE;CDK14;H3C11;NTRK1
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.1688789537553816,-0.9153822740563409,0.6712328767123288,1.0,1.0,54/364,14.00%,ATP5PD;IL6;NDUFS7;PSMD8;TUBB3;WNT7B;MAP3K5;MAPK8;ATP5F1D;NDUFB3;ATG13;ACTR1A;MAPK14;NEFL;DCTN3;UBE2L3;FADD;CSNK2A2;COX5A;CASP8;ULK1;SDHC;NDUFA5;FAS;COX7B;CYBB;MAP2K6;FZD2;UQCR10;ATP5F1E;BAD;MAPK1;NDUFC1;GPX7;ITPR1;ATG14;NRAS;TUBA8;SLC25A6;NDUFS1;PSMC5;SOD1;PPP3CB;DERL1;LRP5;COX6A1;ZFYVE1;NDUFB1;TOMM40L;KIF5A;SIGMAR1;TANK;SDHB;NDUFS3
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.1864708143960807,-0.9153752384378171,0.6875,1.0,1.0,41/177,21.07%,WDR43;RRP7A;EBNA1BP2;RPS8;RCL1;RPL15;RPS11;RPLP2;EXOSC9;SPPL2A;RPL31;EXOSC8;RPS10;LTV1;RPP30;RPL39;UTP11;RPL9;DNAJC5;XRN2;NOL6;RRP36;RPS28;RPS14;WDR12;GNL3;RPS6;RPS27L;WDR75;SENP3;RSL24D1;NOC4L;UTP4;RPP38;CSNK1E;RPS7;RPL35A;WDR3;FAU;EMG1;RPS21
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.17788118028852445,-0.9153079184593045,0.5882352941176471,1.0,1.0,32/200,14.87%,HCAR3;HEBP1;WNT7B;CMKLR1;CCRL2;GPR132;CXCL8;CXCR3;CRHBP;NTSR1;DHX34;ACKR2;TAS2R13;INSL3;SUCNR1;FZD2;CCL2;PLPPR2;GPER1;MC1R;CXCL16;P2RY10;CCL3;OPN3;CXCR1;UTS2R;OXER1;CD55;TAS2R60;GNB1;PTGER2;CXCR4
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.21999999373696358,0.9151039745789077,0.6857142857142857,0.9332632573340358,1.0,4/37,5.18%,NUP205;NUP35;NUP214;NUP37
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.2458719420566609,0.9141826659307909,0.5757575757575758,0.9333030918571777,1.0,7/25,18.85%,BMAL1;BHLHE40;LIN9;CARM1;TBL1X;NOCT;CLOCK
prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.20988947882450854,-0.913869104919181,0.576271186440678,1.0,1.0,7/66,7.09%,ISYNA1;INPP1;IMPA1;PIP5KL1;ITPKC;PTEN;PIKFYVE
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.20345097600411716,0.9137515628806343,0.6222222222222222,0.932226442334943,1.0,17/65,20.46%,OPHN1;ARHGAP35;VRK2;YKT6;ARHGAP5;ARHGEF5;KTN1;VANGL1;TRIO;DSG2;TMPO;PIK3R1;LBR;ARHGAP32;MCF2L;CYFIP1;PREX1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.25167223662616295,0.9126001732987659,0.6111111111111112,0.9329538486472759,1.0,4/26,8.55%,VPS37A;RPS27A;UBAP1;VPS37B
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.20970467533861284,-0.9122744296275136,0.6190476190476191,1.0,1.0,17/74,19.01%,H2AX;H2BC14;H2BC4;H3C13;TINF2;POT1;TOP3A;DIDO1;SUN1;H2AZ1;H3-3B;STAG3;RAD51;SYNE2;MRE11;SUN2;H2AC7
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.22804908264438217,0.9102249296629922,0.7105263157894737,0.9377239072728424,1.0,14/43,19.73%,PRKCD;RPS27A;CUL5;YES1;HRAS;RNF41;SHC1;GRB2;PIK3CA;UBB;PTK6;MEMO1;PIK3R1;STUB1
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.19589613448212442,-0.9088615980704755,0.6417910447761194,1.0,1.0,40/114,29.45%,RPS8;EIF4H;EIF3A;RPL15;RPS11;RPLP2;EIF4A1;RPL31;RPS10;RPL39;RPL9;EIF3K;RPS28;RPS14;EIF2B5;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;EIF3M;RPL18A;RPL19;RPL41;RPL7A;EIF2S2;RPL23;EIF3L;RPL36AL;RPS16;EIF4G1;MRPL13;RPL34;RPL12;EIF3J;RPS25;EIF1AX;RPL36
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.19684405817883932,-0.9085477615662252,0.6557377049180327,1.0,1.0,25/96,23.17%,GNAO1;NDUFS7;MAPK8;NDUFB3;MAPK14;NDUFA5;NAPEPLD;MAPK1;NDUFC1;ITPR1;NDUFS1;GABRG2;NDUFB1;NDUFS3;GNB1;NDUFC2-KCTD14;GABRR2;NDUFA11;NDUFB7;NDUFB4;ADCY3;GNAI1;DAGLB;PLCB2;NDUFS4
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.21407666307209788,0.907531784499991,0.6666666666666666,0.9435241184742941,1.0,20/60,20.09%,FCER1G;LYN;MAP2K7;FCER1A;SYK;HRAS;MAPK11;GRB2;PIK3CA;SOS2;LCP2;PIK3CB;ALOX5AP;MAP2K2;PIK3R1;RAC1;PLA2G4B;PDPK1;PIK3CD;BTK
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.19676573750584872,0.9073272480208233,0.6521739130434783,0.9420086050300667,1.0,11/89,8.19%,PSMA5;GATD3;PSMA4;PSME1;MAML3;RPS27A;CBFB;PSMC6;ITGAL;ITGA4;MAML2
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.17381091908101629,-0.9062710346532146,0.6164383561643836,1.0,1.0,55/331,15.12%,CHD3;AKT1;ST6GALNAC4;PARP4;RPS8;ITGB1;GOLGA7;GATAD2A;NUP133;TLR8;AP2B1;RPS11;HDAC2;ST3GAL4;FXYD1;DAD1;FXYD2;SIKE1;ROCK2;NUP85;NUP210;DPEP3;SEC24C;KEAP1;TLR2;REXO2;SNRPD3;RPS10;ZDHHC8;IL17RA;IL1R1;SAP18;ATG14;NLRP12;AP2M1;PARP16;CHMP4B;YWHAQ;RPS28;SNRPD2;CNBP;ZDHHC9;RPS14;YWHAB;DDOST;SIGMAR1;PARP6;NCK1;RNF103-CHMP3;GEMIN7;MAP3K7;PRKCSH;RBBP4;RPS6;RPS27L
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.2124213917293639,0.9050298406629548,0.6170212765957447,0.9464145091826818,1.0,7/49,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;PSMD11
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.2849625389183928,-0.9049452387348281,0.6666666666666666,1.0,1.0,13/23,44.68%,HSPA6;SERPINH1;DNAJB6;HSP90AA1;HSPA1A;CREBBP;HSPH1;HSBP1;DEDD2;HSPA1L;HSPA8;RLN1;EP300
prerank,KEGG_2021_Human__Olfactory transduction,-0.2255206085625997,-0.9048423035510086,0.59375,1.0,1.0,14/60,16.59%,OR2M3;GRK3;PDE1B;OR1A1;OR2B11;OR1I1;OR4F17;OR7A17;OR11G2;GNB1;RGS2;OR3A2;OR2AT4;SLC24A4
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.18208308328625894,0.904265761903105,0.6666666666666666,0.9461981438726824,1.0,12/139,4.01%,PSMA5;PSMA4;H2BC15;H2BC17;ORC4;ABRAXAS1;CCNB2;PSME1;UIMC1;GTSE1;RPS27A;RFC5
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.1847609748219997,0.9039650377991274,0.6666666666666666,0.9448277070845164,1.0,21/84,20.46%,PLEKHG2;RPS27A;ARHGEF5;SQSTM1;ARHGEF6;OBSCN;TRIO;MAGED1;ECT2;PRDM4;ARHGEF4;TRAF6;SOS2;ARHGEF17;PRPF38B;ARHGEF12;UBB;NFKB1;MCF2L;NFKBIA;PREX1
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.2381062566227682,-0.9034368091767782,0.5873015873015873,1.0,1.0,34/35,72.06%,FAS;PRF1;GZMB;HLA-DRB3;PTPRN2;PTPRN;IFNG;ICA1;HLA-DMB;HSPD1;HLA-DOA;FASLG;CD86;LTA;HLA-DMA;CD80;HLA-DQB1;HLA-DRB1;HLA-E;HLA-A;HLA-F;HLA-B;HLA-DPB1;TNF;HLA-DPA1;HLA-DQA1;HLA-C;HLA-DRB5;HLA-G;IL1B;HLA-DRB4;HLA-DRA;HLA-DOB;CD28
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.20745100539820716,0.9032211341720802,0.7021276595744681,0.9444753373079133,1.0,16/60,21.47%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;HRAS;PSME2;PSMD11;SPRED2;RASA2;PSMD6;UBB;PSMC1;RASA3;PSMA7;PSME4
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.2147082630469945,-0.9029537723136413,0.6615384615384615,1.0,1.0,34/80,33.18%,MRPS25;MRPS16;MRPL11;MRPS24;MRPL44;MRPL23;MTFMT;MRPL41;MRPL32;MRPL55;MRPS31;MRPL43;MRPL38;CHCHD1;MRPL1;MRPS18C;MRPL20;PTCD3;MRPL40;OXA1L;MRPS27;MRPL16;MRPL9;MRPL13;MRPL45;MRPS34;MRPL12;MRPL48;MTIF2;MRPL54;MRPL51;MRPL49;MRPS22;MRPL35
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.2633071812949191,-0.90290744733819,0.5535714285714286,1.0,1.0,4/30,3.64%,H2AX;H2BC14;H2BC4;H3C13
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.23564560262800843,0.9020273456483738,0.5161290322580645,0.9455268239060223,1.0,17/39,24.63%,EBF1;OR2T33;OR10H1;OR6N1;OR7D2;OR14J1;OR10G3;OR7G2;OR10H5;OR2A7;OR2L2;OR10K1;GNAL;OR6J1;OR1F1;OR2G6;OR52K2
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.2681588014614672,0.9014563212265405,0.6511627906976745,0.9448666560935057,1.0,3/17,7.54%,PRKCD;ITPR3;HRAS
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.17474853851569344,0.9000636200196628,0.7435897435897436,0.946135937648287,1.0,28/104,23.40%,CHRNE;P2RY6;HRH2;C3AR1;F2RL1;NPFF;CHRM3;S1PR2;CYSLTR1;GRIK2;UTS2B;S1PR4;TRPV1;LEPR;CTSG;PRLR;CNR2;RLN2;GHRL;UTS2;SSTR3;FPR3;PTGDR;NR3C1;ADRA1A;PTH2R;GABRP;CHRNA5
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.16546518275092498,0.8994134506853567,0.7575757575757576,0.945560928263603,1.0,16/136,10.13%,PSMA5;NUP205;PSMA4;PSME1;NUP35;SLC40A1;RPS27A;MAP4K2;NUP214;NUP37;PSMC6;ABCC2;ABCB4;LMBRD1;PSME2;VCP
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.1740649915627197,0.8988425731940669,0.6666666666666666,0.9448494933198359,1.0,18/125,11.16%,PSMA5;PSMA4;AGO1;PSME1;GNB2;RPS27A;AGO4;ITPR3;GNG5;PSMC6;PDE6G;GNG3;GNG10;CLTB;PSME2;GNG7;PDE6A;PSMD11
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,-0.2856717327256568,-0.8986894945388605,0.6610169491525424,1.0,1.0,3/20,7.58%,COX10;UROS;CPOX
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.26257733173665654,-0.898686670889596,0.6229508196721312,1.0,1.0,2/21,2.90%,AKT1;PPP2CB
prerank,KEGG_2021_Human__Tuberculosis,-0.18286586810250038,-0.8985034746043224,0.6527777777777778,1.0,1.0,41/148,27.91%,AKT1;IL6;MAPK8;CR1L;MAPK14;FADD;ATP6V0C;SPHK2;CASP8;TLR2;TIRAP;BAD;MAPK1;PPP3CB;IL10;LAMP1;CREB1;TCIRG1;CLEC4E;ITGB2;TGFB3;HLA-DRB3;SPHK1;TRADD;IL23A;CAMK2A;ATP6V0A2;CLEC7A;RAB5C;CD14;NFYB;LSP1;PPP3CC;RFX5;PLK3;CYCS;IRAK1;EEA1;NOD2;CASP3;CALM1
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,-0.24501972714296674,-0.8975430171016859,0.603448275862069,1.0,1.0,9/40,14.79%,H2AX;H2BC14;H2BC4;H3C13;NCAPD3;RAB33B;H2AZ1;H3-3B;CDK1
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.19722728516771926,-0.897074643136693,0.6923076923076923,1.0,1.0,29/113,20.78%,DUSP1;AKT1;MAP3K5;MAPK8;MAPK14;PECAM1;PIK3R3;MAP2K6;KEAP1;CCL2;SUMO4;RAC2;IL1R1;JUN;RAC3;MMP9;GSTM4;MAP3K7;MAP2K4;BMPR2;GSTM2;GSTM5;BMPR1A;PRKCZ;HSP90AA1;PIAS4;NFE2L2;PTK2;PLAT
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.1998361128593819,0.8965593896027755,0.673469387755102,0.9490779718895742,1.0,5/52,5.67%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6
prerank,Reactome_2022__M Phase R-HSA-68886,-0.1605806047043016,-0.8953651158331898,0.7468354430379747,1.0,1.0,51/360,13.09%,NME7;AKAP9;PSMD8;CLASP1;TUBB3;PSMD5;CEP76;H2AX;NUP133;H2BC14;ACTR1A;PPP2CB;H2BC4;CNTRL;DCTN3;H3C13;CENPN;DYNLL2;CSNK2A2;CENPF;CEP152;CENPI;GORASP2;NEK2;NCAPD3;NUP85;NUP210;CENPM;BIRC5;ENSA;ANKLE2;UBE2E1;CCP110;WAPL;RAB33B;MAPK1;KNTC1;ANAPC11;TUBA8;OFD1;PSMC5;PLK4;CENPO;H2AZ1;CHMP4B;CENPE;NEK9;TUBGCP6;PRKAR2B;ANAPC5;H3-3B
prerank,KEGG_2021_Human__Proteasome,0.2231095608545387,0.8950713576024283,0.6341463414634146,0.9513229404013333,1.0,8/44,15.09%,PSMA5;PSMA4;PSME1;PSMC6;PSME2;PSMD11;PSMD1;PSMD6
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.1837593314882199,-0.8947631875818586,0.7121212121212122,1.0,1.0,23/151,14.46%,IL6;ANTXR2;MAPK8;CXCL8;MAPK14;NAMPT;NFKBIB;PYCARD;FADD;TP53BP1;CASP8;CYBB;CCL2;MAPK1;ITPR1;IRF9;NLRP12;JUN;CASP4;TANK;MAP3K7;TRPM2;BRCC3
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.21521235862840804,0.8934688405903487,0.7142857142857143,0.9530885907977796,1.0,8/52,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;VCP;PSMD11
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.235630740329819,-0.8933993073234793,0.639344262295082,1.0,1.0,5/33,10.97%,AKT1;MAP3K8;PIK3R3;RNASE1;LCK
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.18702984084836027,-0.8925159371806931,0.6307692307692307,1.0,1.0,25/119,19.32%,KIAA0319;COPS3;GRK3;UBQLN2;CD3D;AP2B1;ARPC1A;STAM;WASL;DNAJC6;IGF2R;ACTR3;AP2M1;TOR1A;COPS6;VAMP4;EPGN;AREG;GAPVD1;STON1;COPS7A;CLTC;TRIP10;GAK;TGFA
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.22260051016039947,0.8918892925397162,0.6136363636363636,0.9551495276347371,1.0,11/38,18.89%,LYN;GRAP2;YES1;HRAS;GRB2;SOCS1;PIK3CA;SOCS6;CBL;PIK3R1;FER
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.17546990079313174,0.8912604224950925,0.696969696969697,0.9549196708198322,1.0,21/107,16.02%,NUP205;H2BC15;H2BC17;VRK2;CCNB2;NUP35;H2AC4;NUP214;NUP37;RAB1B;MCPH1;SET;H2AZ2;H2BC3;GOLGA2;NCAPG2;NCAPH2;PPP2R2D;RAB2A;NEK6;H2BC11
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.16394348847528875,0.891257574350905,0.7428571428571429,0.9528255487347009,1.0,26/259,6.93%,PSMA5;DYNC1LI2;PSMA4;H2BC15;H2BC17;ORC4;ABRAXAS1;MDM4;B9D2;CCNB2;PSME1;UIMC1;GTSE1;NUDC;RPS27A;RFC5;SKA1;SPC24;SGO2;CDCA8;NUP37;PSMC6;MAD1L1;ANAPC2;CENPA;POLR1B
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.17013547461153442,0.8911930134573426,0.7857142857142857,0.9509595550450647,1.0,51/188,22.99%,PUF60;SNRPG;ALYREF;EIF4A3;HNRNPUL1;SF3A2;PPIL1;DHX38;POLR2K;SNRPE;POLR2I;POLR2F;SNRNP27;CPSF1;U2AF2;LSM5;LSM4;POLR2D;PAPOLA;SNRPA;RBMX;SRSF1;SRSF3;PQBP1;UPF3B;POLR2H;RBM22;LSM8;SRSF11;CSTF2;HNRNPH2;SF3B3;MTREX;HNRNPA0;RBM5;SNRPB;CWC27;LSM7;HNRNPH1;SF3B2;NUDT21;SF3A3;SRSF6;DHX9;FUS;TFIP11;CSTF2T;SF3B1;CSTF1;SRSF9;CDC40
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.16451035234617617,-0.8901106393218617,0.8142857142857143,1.0,1.0,139/420,29.77%,RHOB;PSMD8;CLASP1;RPS6KA1;PSMD5;PLXNA4;SPTAN1;AGAP2;MAPK8;RPS8;ITGB1;ERBB2;RPS6KA4;MAPK14;RPL15;AP2B1;RRAS;RPS11;RPLP2;GFRA2;TRPC6;CSNK2A2;HDAC2;PIK3R3;ROCK2;ARPC1A;KIF4A;RHOC;RPL31;PSENEN;RPS6KA5;ITGA9;RNASE1;EPHA4;WASL;EVL;RPS10;EPHB3;MAPK1;RPL39;NRAS;MYL12B;RPL9;PSMC5;PPP3CB;ACTR3;EZR;AP2M1;SDCBP;RPS28;RBM8A;EPHB2;RPS14;NCK1;NCK2;ABL2;MMP9;FGFR1;RPS6;CXCR4;RPS27L;CREB1;FES;GIT1;EPHB1;RSL24D1;PSMD3;RPS6KA3;CLTC;PDLIM7;SEMA6A;VAV3;RPS7;HSP90AA1;DOK4;RPL35A;CACNB1;NRP2;GAB2;ITGA5;ITGA1;FAU;VASP;PTK2;RDX;RPS21;ANK1;CACNB3;PSMB6;ABLIM3;PSMD7;SRGAP2;UBC;PSMD13;DLG1;NELL2;SCN11A;RPL18A;ARPC5;ALCAM;RPL19;PTPN11;ROBO3;RPL41;COL9A1;LAMC1;RPL7A;FRS2;NCBP1;PLXNC1;PRNP;MAP2K1;PKN1;RPL23;RPL36AL;AGRN;RPS16;SREBF2;EIF4G1;ABL1;MRPL13;PFN2;GRB10;RPL34;RPL12;PSMB3;CDC42;PSMB10;RPS25;ITSN1;TYROBP;RELN;SH3KBP1;COL4A4;RPL36;SIAH2;COL4A3;EGR2;NCAM1
prerank,KEGG_2021_Human__Melanoma,-0.22953063756118902,-0.8898128433537075,0.5806451612903226,1.0,1.0,8/51,10.83%,AKT1;PTEN;PIK3R3;PDGFD;BAD;MAPK1;NRAS;HGF
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.2655477560997825,-0.8894496940484126,0.5964912280701754,1.0,1.0,16/22,45.55%,BBIP1;BBS9;BBS1;CCT3;CCT2;MKKS;BBS12;TTC8;CCT4;CCT5;SMOX;CCT8;BBS5;RAB3IP;BBS2;BBS10
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.20818102145659834,-0.8887473607143135,0.6851851851851852,1.0,1.0,14/68,16.99%,IL6;CXCL8;CXCR3;IL2RG;CCL2;PF4V1;CCL3;CXCR1;IL10;CXCR4;IL18RAP;CXCR2;IL6R;LTBR
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.21617658666997472,-0.8885252227679216,0.6666666666666666,1.0,1.0,22/51,31.27%,DUOX2;ASGR2;FXYD2;GPX7;ITPR1;ATF2;CREB3L2;CREB1;GSR;IYD;GNAS;ADCY3;PLCB2;ATP1A3;DUOX1;HSPA5;PLCB1;ADCY4;SLC5A5;ADCY9;GNAQ;TG
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,0.19789507409069645,0.8880248415795995,0.7291666666666666,0.9574314756112066,1.0,8/54,11.16%,PSMA5;PSMA4;PSME1;SLC38A1;PSMC6;PSME2;OAZ3;PSMD11
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.1953669706958848,-0.8877013732150946,0.746031746031746,1.0,1.0,10/77,9.34%,AKT1;RPS6KA1;MAPK8;MAPK14;PIK3R3;PDE3B;CDC25B;MAPK1;SPDYE18;ANAPC11
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.18415274660241068,-0.8875869811625197,0.6825396825396826,1.0,1.0,32/159,18.73%,CUL1;MARCHF6;MAP3K5;MAPK8;UBQLN2;SEC61B;SEC61A2;HSPA6;MBTPS2;DAD1;BAG1;SEC24C;EIF2AK1;DERL2;UGGT2;PPP1R15A;AMFR;DNAJC5;DERL1;DDOST;FBXO2;LMAN1;PRKCSH;UBE2D4;DNAJA1;TRAM1;DNAJA2;SEC63;TRAF2;SYVN1;RNF185;HSP90AA1
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.23484380713114814,0.8874743122025895,0.6470588235294118,0.9566263749919105,1.0,6/34,11.42%,DYNC1LI2;CREB3L4;RAB5A;DCTN2;PRKACB;RAB5B
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.22497303903575483,0.8861851778876075,0.627906976744186,0.9574291007670693,1.0,9/32,23.49%,AGO1;AGO4;APOE;ABCG1;TBL1X;MOV10;KDM3A;KDM1B;CETP
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.17630350019688296,-0.8852449502082195,0.6666666666666666,1.0,1.0,18/152,10.83%,GNAO1;CTNND1;AKT1;APBB1IP;ITGB1;MAPK14;RRAS;PIK3R3;PDGFD;DOCK4;MAP2K6;MAGI3;EVL;MAPK1;RAC2;NRAS;MRAS;HGF
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,0.21836418892830156,0.885226883236221,0.7096774193548387,0.9577128173688955,1.0,6/35,13.43%,IFT172;IFT27;WDR19;TTC21B;IFT122;TRIP11
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.22443011775715183,-0.8851572118420874,0.6379310344827587,1.0,1.0,4/53,1.32%,AKT1;CUL1;PSMD8;PSMD5
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.21566398729806202,-0.8846150408364277,0.6727272727272727,1.0,1.0,27/61,35.24%,CAPN5;MMP17;MMP28;BSG;CAPN3;MMP8;CXXC1;MMP9;ADAM8;CTSB;KLK2;CAPN7;TIMP2;COL9A1;PHYKPL;LAMC1;DCN;ADAM15;CASP3;PLG;TLL2;CAPN1;ADAM17;CAPN10;CAPNS2;MMP11;CAPN2
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.24993443717609365,-0.8841856994857343,0.6031746031746031,1.0,1.0,7/27,18.58%,GDA;ENTPD7;ENTPD6;NUDT9;ENTPD1;SCO2;DPYD
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.19797709565129598,0.8838992884284936,0.7804878048780488,0.958428493780112,1.0,6/60,4.85%,ATP6V1E2;ATP6V1A;LYN;ATP6V1E1;JAM3;ATP6V0A1
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.19311007261057958,0.8836040430498368,0.6216216216216216,0.9570338482250451,1.0,6/64,5.67%,TNKS2;PSMA5;PSMA4;PSME1;RPS27A;PSMC6
prerank,Reactome_2022__Influenza Infection R-HSA-168255,0.160322649639675,0.8829687430852909,0.696969696969697,0.9566696010445949,1.0,25/153,13.57%,NUP205;POLR2K;NUP35;RPS27A;NUP214;NUP37;RPL35;RPL4;RPL26;RPS3;POLR2I;POLR2F;RPL6;XPO1;ISG15;RPL18;DNAJC3;KPNA5;POLR2D;RPL37A;POLR2H;KPNA2;RAN;RPL14;RPL32
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.226561633896248,-0.8823062898193038,0.5573770491803278,1.0,1.0,7/41,11.73%,ATP8A1;FXYD1;FXYD2;ATP2C1;ATP13A2;ATP10A;ATP11B
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.1514191155727408,0.8820245038822307,0.8571428571428571,0.9567104141984059,1.0,90/448,18.48%,BCL2L1;ZNF700;ALYREF;TNFSF14;ZNF699;ZNF2;TSC2;ZNF12;ZNF473;ZNF543;ZNF41;PDIA3;ZNF433;TICAM1;ZNF571;ITGB3;ZNF208;ZNF563;RBAK;ZNF350;ZNF850;ZNF30;ZNF415;ZNF749;ZFP69;ZNF33B;ZNF836;ZIK1;ZNF677;ZNF816;SYK;ZNF717;SP100;ZNF91;ZNF19;ZNF627;ZNF331;ZNF180;ZNF273;ZNF222;PILRA;ZNF667;B2M;ZNF549;NXF1;ZNF514;PILRB;ZNF211;ZNF614;ZNF302;ZNF275;ZNF597;ZNF768;SRSF1;SRSF3;ZNF791;EIF2B3;PIK3CA;ZNF527;ZNF540;ZNF286A;ZNF283;ZNF212;ZNF616;ZNF304;TRAF6;ZNF517;EIF2AK4;ZNF441;ZNF101;ZNF333;ZNF155;CD74;PPP1CC;ZNF689;ZFP92;PIK3CB;ZNF544;ZNF426;ZNF83;ZNF404;NFKB1;ZNF419;ZFP30;ZNF782;ZNF684;ZNF8;PIK3R1;CFP;ZNF860
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,-0.2597234582241177,-0.8816863348635404,0.6,1.0,1.0,9/15,37.19%,TAS2R13;TAS2R60;TAS2R30;TAS2R3;TAS2R50;TAS2R20;TAS2R43;TAS1R3;TAS2R31
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.1991944505033762,-0.8796346886720313,0.7619047619047619,1.0,1.0,9/66,11.12%,ITGB1;PXN;PIK3R3;SEPTIN6;ARHGAP10;ARPC1A;WASL;SEPTIN2;ACTR3
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.18189629744393235,0.8796314924839789,0.6842105263157895,0.9606431210518748,1.0,10/95,6.50%,PSMA5;PSMA4;PSME1;UBE2D2;PRKCD;RPS27A;SKP1;ITPR3;PSMC6;SYK
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.23814528622358277,-0.8793310513854988,0.6206896551724138,1.0,1.0,5/31,10.97%,RHOB;PIK3R3;RNASE1;RAC2;LCK
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.17390305618243546,0.8783399199650971,0.7435897435897436,0.9619609009061371,1.0,15/95,10.02%,ADCY7;FOS;GNB2;MAP2K7;CREB3L4;GNG5;HRAS;NOS3;SHC1;MAPK11;GNG3;PRKACB;GRB2;GNG10;GNG7
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.1632830916448893,0.8783160725855774,0.7,0.9599588831865571,1.0,15/166,5.67%,BCL2L1;PSMA5;PPP1R13B;PSMA4;AVEN;PSME1;TICAM1;PRKCD;ROCK1;GSDME;RPS27A;MED12;APPL1;BCAP31;PSMC6
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.22758749548389773,-0.8781564627742947,0.6666666666666666,1.0,1.0,7/39,14.63%,DUSP2;DUSP10;PPP2CB;MAPK1;NRAS;YWHAB;DUSP6
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.16307062931947727,0.8774153831020471,0.7631578947368421,0.9600456751748788,1.0,16/175,7.15%,PLOD1;ADAM19;LTBP1;CTSL;COL6A2;COL6A3;ITGB3;JAM3;CD44;SDC2;LOXL3;COL28A1;ITGAL;ITGAV;LTBP4;ITGA4
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.23020299945963796,0.8771576416580621,0.6595744680851063,0.9588546540155359,1.0,6/27,17.16%,TFAP2E;APOE;CITED2;KCTD15;WWOX;KCTD1
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.26068862387220326,0.8766309379013024,0.675,0.9581201577214414,1.0,4/16,9.49%,HRAS;SHC1;MAPK11;GRB2
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,0.2563359159618057,0.8763706924868865,0.6136363636363636,0.9567527582385236,1.0,4/20,14.87%,LYN;SOCS1;CISH;PRLR
prerank,KEGG_2021_Human__African trypanosomiasis,-0.24833609978097682,-0.8744856848539283,0.64,1.0,1.0,4/26,12.06%,IL6;APOL1;FAS;IL10
prerank,KEGG_2021_Human__Longevity regulating pathway,-0.20140992938380287,-0.874403038906351,0.6491228070175439,1.0,1.0,13/83,11.16%,AKT1;PRKAG2;SESN3;ATG13;HSPA6;HDAC2;PIK3R3;ULK1;NRAS;ATF2;SOD1;PRKAG1;CREB3L2
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.1953790553100103,0.8743479966893174,0.6756756756756757,0.9595958347520396,1.0,10/63,10.61%,H2BC15;H2BC17;LYZ;RPS27A;H2AC4;APOE;SIAH1;LTF;B2M;ADAM10
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.20715854789535235,-0.8738845739183192,0.6842105263157895,1.0,1.0,22/78,25.19%,AKT1;ERBB2;PPP2CB;PIK3R3;TRAT1;RNASE1;MAPK1;RAC2;LCK;EPGN;AREG;FGFR1;TGFA;NRG4;GAB2;PIK3AP1;IL1RAP;PTPN11;FRS2;EGF;CD19;KIT
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.20009591956930028,-0.873738810137125,0.631578947368421,1.0,1.0,9/90,4.58%,PSMD8;PSMD5;RUNX1;SPI1;H2AX;H2BC14;H2BC4;H3C13;LMO2
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.20296452306110147,0.8732923330754927,0.8,0.9605533084341336,1.0,6/57,5.67%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.24258883409294854,-0.8727525044604135,0.7166666666666667,1.0,1.0,22/32,48.71%,MAPK14;CASP8;MAP2K6;CASP4;MAP3K7;ITCH;CHUK;IRAK1;NOD2;TAB1;BIRC3;MAPK13;CARD9;IKBKG;UBE2V1;RIPK2;BIRC2;IRAK2;NOD1;CASP2;CASP1;CASP9
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.18391573741203984,-0.8727396352189551,0.7627118644067796,1.0,1.0,39/106,30.33%,AKT1;PRKAG2;MYLK3;RRAS;SPHK2;JAG1;GNA13;PDE3B;MYLK4;MAPK1;ITPR1;NRAS;MYL4;MRAS;PRKAG1;GNB1;RPS6;BORCS8-MEF2B;SPHK1;ACTA2;PIK3R5;PLAT;ADCY3;GNAI1;KLF2;PLCB2;RYR1;MAP2K1;LIPE;GABARAP;PLCB1;CALM1;ADCY4;SMAD4;CDH1;ADCY9;HDAC5;PRKCE;GNAQ
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,0.17694506833958085,0.8718693888085521,0.7142857142857143,0.9622967487999681,1.0,10/79,9.65%,IFI30;PRKCD;CD44;SP100;SMAD7;TRIM14;GBP1;B2M;FCGR1A;SOCS1
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.20420285726599943,0.8701150789885349,0.8181818181818182,0.9645058668812501,1.0,6/56,5.67%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.20632738220812494,0.8700446294180075,0.6818181818181818,0.9626411791612226,1.0,10/43,16.54%,ARHGAP35;RPS27A;KHDRBS2;HIF1A;HRAS;CCNE1;PELP1;CBL;UBB;PTK6
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.19639682727142552,0.8698472057213951,0.7954545454545454,0.9614123254854483,1.0,7/48,11.16%,PSMA5;PSMA4;PSME1;PSMC6;PSME2;OAZ3;PSMD11
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.2646521458963087,-0.8685783542315632,0.6666666666666666,1.0,1.0,6/20,20.55%,TUBB3;CCT6B;TUBA8;CCT7;CCT3;CCT2
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,0.2531653752791412,0.8677229951286992,0.6857142857142857,0.9645495354574188,1.0,3/19,9.35%,TGM1;RCAN1;ST14
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.21613284350221962,0.8670865673618905,0.6470588235294118,0.9642078311347316,1.0,9/56,10.02%,GNB2;RAP1A;ITPR3;GNG5;CHRM3;GNG3;PRKACB;GNG10;GNG7
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.2522202782428178,-0.8660121466696206,0.7192982456140351,1.0,1.0,7/26,20.55%,TUBB3;PFDN2;CCT6B;TUBA8;CCT7;CCT3;CCT2
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.25970107337914417,-0.8658371297087987,0.6037735849056604,1.0,1.0,4/25,6.97%,PPP2CB;FOXM1;PPME1;CDC25B
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.2609007804452099,-0.8653855350976757,0.6363636363636364,1.0,1.0,2/19,6.52%,USP8;STAM
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.20609939535726438,0.8631504669993776,0.725,0.9711748936575737,1.0,9/45,12.88%,POLR2K;POLR2I;HRAS;POLR2F;GRB2;POLR2D;POLR2H;PIK3CA;FGFR4
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.17895937051329597,0.8631076945736316,0.75,0.9692638113393744,1.0,22/87,21.47%,PSMA5;PSMA4;ORC4;PSME1;RPS27A;SKP1;PSMC6;ANAPC2;PSME2;PSMD11;SKP2;MCM6;PSMD6;CCNE1;UBB;MCM4;ORC3;PSMC1;CCNE2;MCM7;PSMA7;PSME4
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.20602033194953281,-0.862910200211163,0.7169811320754716,1.0,1.0,10/54,12.71%,H2BC14;H2BC4;UBE2L3;PEX14;UBE2E1;PEX12;RNF40;DERL1;PEX2;RNF20
prerank,Reactome_2022__tRNA Processing R-HSA-72306,-0.17710949948899876,-0.8612004490017907,0.696969696969697,1.0,1.0,26/101,23.92%,CTU1;QTRT2;NUP133;ELAC2;TRMT10C;ADAT3;TYW3;NUP85;NUP210;RTCB;RPP30;NSUN6;TRMT112;LAGE3;TRMU;THADA;RPP38;RTRAF;XPOT;NUP93;CPSF4;URM1;POM121C;TRDMT1;COLEC12;TRMT11
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.19569900036437513,-0.861140616374671,0.7166666666666667,1.0,1.0,7/64,8.99%,RMI2;RAD9B;XRCC3;DNA2;RAD9A;RAD51AP1;TOP3A
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.2504733279500263,0.8608089297196563,0.6888888888888889,0.9723069903923295,1.0,4/23,7.40%,SDC2;RDH11;LPL;APOE
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.18378846780952549,-0.8607882154633856,0.765625,1.0,1.0,27/98,22.50%,PRKAG2;RPS6KA1;NEFL;AP2B1;PRKAR1B;RNASE1;MAPK1;NRAS;PRKAG1;GABRG2;AP2M1;PICK1;PRKAR2B;RASGRF2;GNB1;CHRNA2;CREB1;GIT1;RPS6KA3;GABRR2;MAPT;PPM1F;CAMK2A;CHRNB4;GNAI1;PLCB2;DLG1
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,0.2392038316661203,0.860608437145008,0.6842105263157895,0.9709183381347273,1.0,4/28,8.55%,VPS37A;RPS27A;UBAP1;VPS37B
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.19242338365675501,-0.8596725278573982,0.6612903225806451,1.0,1.0,34/110,25.26%,H3C13;ZFPM1;HDAC2;ZFPM2;DOCK4;KIF4A;HBG2;PRKAR1B;CARMIL1;RNASE1;CBX5;KIF6;CENPE;PRKAR2B;H3-3B;KIF5A;KIFC1;KIF13B;HBG1;KIF19;GATA3;SH2B2;KIF16B;MAFF;IRF1;DOCK11;KLC3;RAD51B;GATA1;MICAL1;KIF11;EHD2;KDM1A;JMJD1C
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.28438328922556066,-0.8593657057334118,0.6964285714285714,1.0,1.0,4/16,20.11%,PYCARD;P2RX7;PANX1;SUGT1
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.18552092793430955,0.859284254418579,0.7142857142857143,0.971908121504096,1.0,11/82,11.16%,PSMA5;PSMA4;PSME1;PDIA3;RPS27A;PSMC6;SNAP23;SEC22B;B2M;PSME2;PSMD11
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.16517309612679093,-0.8591001910517283,0.8055555555555556,1.0,1.0,52/203,23.20%,HOMER2;PRKAG2;RPS6KA1;BEGAIN;NEFL;AP2B1;FLOT2;SLC22A1;PTPRF;ABCC9;PRKAR1B;KCNC3;RNASE1;MAPK1;KCNN1;SYN3;NRAS;DNAJC5;PRKAG1;GABRG2;AP2M1;PICK1;KCNH2;PRKAR2B;RASGRF2;KCNB1;SLC1A3;GNB1;KCNK7;CHRNA2;CREB1;GIT1;RPS6KA3;HOMER3;PANX1;GABRR2;GLS2;HOMER1;MAPT;PPM1F;PPFIA1;CACNB1;ACHE;CAMK2A;CHRNB4;CACNB3;GNAI1;PPFIBP2;PLCB2;DLG1;IL1RAP;APBA2
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.19986137744256904,-0.8590075076660283,0.7333333333333333,1.0,1.0,23/85,25.19%,AKT1;ERBB2;PPP2CB;PTEN;PIK3R3;TRAT1;RNASE1;MAPK1;RAC2;LCK;EPGN;AREG;FGFR1;TGFA;NRG4;GAB2;PIK3AP1;IL1RAP;PTPN11;FRS2;EGF;CD19;KIT
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,0.2809370634560482,0.8584743929444351,0.74,0.9715812318809166,1.0,2/15,6.91%,ZAP70;CD4
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.1839961291541016,-0.8581977868677026,0.7384615384615385,1.0,1.0,12/108,8.99%,RMI2;RAD9B;XRCC3;H2AX;H2BC14;H2BC4;DNA2;TP53BP1;RAD9A;RAD51AP1;TIPIN;TOP3A
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.19053123128186372,-0.8575665944131317,0.7333333333333333,1.0,1.0,19/75,21.47%,RAB4A;PTEN;PIK3R3;PNPLA7;PIP4P1;PIKFYVE;PNPLA6;RAB14;TNFAIP8L1;MTMR6;RUFY1;BMX;PLEKHA3;PI4K2A;MTMR14;PIK3R5;PLEKHA1;PLEKHA8;TNFAIP8
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.20788627937606594,0.8573786427007571,0.6511627906976745,0.9724628516429541,1.0,7/44,11.87%,DDX11;TSPYL2;DNAJB11;SHC1;SRPRA;DNAJC3;ZBTB17
prerank,KEGG_2021_Human__Leishmaniasis,-0.2028249542318033,-0.8571505753584556,0.8245614035087719,1.0,1.0,13/71,17.20%,ITGB1;CR1L;MAPK14;NFKBIB;CYBB;TLR2;MAPK1;JUN;IL10;MAP3K7;ITGB2;TGFB3;HLA-DRB3
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,0.1953271042969227,0.8565205745827603,0.7027027027027027,0.9723924826956377,1.0,19/49,27.90%,SNRPG;POLR2K;SNRPE;POLR2I;POLR2F;POLR2D;SRSF1;POLR2H;SF3B3;SNRPB;SF3B2;SRSF6;SF3B1;ZCRB1;SNRNP40;SRSF7;GTF2F1;ZMAT5;RNPC3
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.2503018294099641,-0.8562178210938136,0.6595744680851063,1.0,1.0,6/25,17.37%,JAG1;DTX4;PSENEN;MIB1;ITCH;NEURL1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.22965009266996095,-0.8560433198305392,0.6666666666666666,1.0,1.0,5/35,5.90%,H2AX;H2BC14;H2BC4;H3C13;ORC6
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.17644901361936893,0.8554983861473747,0.8275862068965517,0.9725270363873103,1.0,6/67,5.18%,NUP205;NUP35;SLC40A1;MAP4K2;NUP214;NUP37
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.2073627911024171,0.8551075078919923,0.775,0.9713846833219384,1.0,16/49,23.01%,PLEKHG2;ARHGEF5;ARHGEF6;OBSCN;TRIO;MAGED1;ECT2;ARHGEF4;SOS2;ARHGEF17;PRPF38B;ARHGEF12;MCF2L;PREX1;ARHGEF40;ARHGEF39
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.24259647416595842,0.8551051508020676,0.631578947368421,0.9694063031115068,1.0,2/21,1.83%,COL6A2;COL6A3
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,-0.21865583269709798,-0.8536016721143476,0.7222222222222222,1.0,1.0,4/34,5.96%,UACA;JUP;ARHGDIB;ROCK2
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.2633693901507249,-0.8521158319435078,0.6428571428571429,1.0,1.0,9/24,24.53%,UBE2E1;ANAPC11;ANAPC5;UBE2S;CDK1;ANAPC15;CDC20;UBC;CDC23
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.1727332159462471,-0.8520081402638233,0.7727272727272727,1.0,1.0,20/153,11.60%,AKT1;GRK6;GRK3;CXCL8;PXN;CXCR3;NFKBIB;PIK3R3;PAK1;ROCK2;CCL2;BAD;HCK;PF4V1;MAPK1;RAC2;NRAS;CXCL16;CCL3;CXCR1
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.2225151555837661,0.8516196981119281,0.675,0.9754443305085989,1.0,10/31,18.31%,RPS27A;HRAS;SHC1;GRB2;SPRY2;SPRED2;PIK3CA;CBL;UBB;PIK3R1
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,0.22916711335768675,0.851247734567624,0.631578947368421,0.9741254087547389,1.0,6/24,17.45%,IL18;C3AR1;CTSG;ENTPD5;NT5E;NFKB1
prerank,Reactome_2022__S Phase R-HSA-69242,0.16043777015719207,0.8511681759392199,0.8611111111111112,0.9724320199612778,1.0,29/158,17.59%,PSMA5;FEN1;CCNH;PSMA4;ORC4;PSME1;RPS27A;SKP1;RFC5;ESCO1;PSMC6;ANAPC2;POLR1B;CABLES1;LIN9;PSME2;MNAT1;POLD4;PSMD11;POLA2;SKP2;POLR1A;MCM6;PSMD6;CCNE1;UBB;PTK6;MCM4;SLC19A1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.2828463382156914,-0.8511269304636736,0.6415094339622641,1.0,1.0,11/18,35.85%,REXO2;AURKA;CDK1;CDC25C;TP53;PRMT1;RBL2;GADD45A;TFDP2;BAX;CCNB1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.1863231892534248,-0.8506491262271567,0.7761194029850746,1.0,1.0,32/95,29.45%,IMPACT;RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;EIF2S2;RPL23;DDIT3;RPL36AL;RPS16;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.2451781537877078,0.8501791750099562,0.5581395348837209,0.9721352847062251,1.0,5/20,16.16%,ABHD5;DGAT2;PRKACB;GPAT2;PPP1CC
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.26259330218072274,-0.8501651726197127,0.6666666666666666,1.0,1.0,7/17,31.65%,IL6;IL6R;CLCF1;PTPN11;CCM2;SOCS3;CRLF1
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.18579221894453732,-0.8500281675920229,0.7894736842105263,1.0,1.0,14/94,12.13%,CLASP1;NUP133;PPP2CB;CENPN;DYNLL2;CENPF;CENPI;NUP85;CENPM;BIRC5;KNTC1;CENPO;CENPE;NEK9
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.17209182903948728,-0.8497839129594672,0.7464788732394366,1.0,1.0,16/181,7.86%,AKT1;IL6;PSMD8;MAPK8;MAPK14;CD3D;NFKBIB;CD3G;FADD;HDAC2;PIK3R3;CASP8;USP7;FAS;MAP2K6;TLR2
prerank,KEGG_2021_Human__Renin secretion,-0.2216533294011011,-0.8496655230572495,0.7272727272727273,1.0,1.0,20/40,33.17%,PDE1B;PDE3B;ITPR1;PPP3CB;PTGER2;CREB1;PDE3A;CTSB;GNAS;GNAI1;PLCB2;PPP3CC;EDN1;PLCB1;CALM1;GNAQ;CACNA1D;ADRB2;GNAI3;PLCB4
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.23872473207876674,0.8496086302575543,0.6530612244897959,0.9713858155746111,1.0,7/22,20.17%,TUBB6;CC2D1B;IST1;TUBA1C;TUBB2A;TUBA1B;TUBB4A
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.27457440734371985,-0.8495796444989143,0.6333333333333333,1.0,1.0,4/17,17.94%,PIGW;PIGF;PIGH;PIGB
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.21626436532635385,0.8492358845755468,0.7380952380952381,0.9702618482079722,1.0,4/38,5.20%,ADCY7;NR4A1;CREB3L4;ITPR3
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.15854155561348116,-0.8487861680628263,0.8548387096774194,1.0,1.0,36/246,14.96%,DUSP2;APBB1IP;IL6;PSMD8;CDC42EP2;PSMD5;SPTAN1;DUSP10;FRS3;MAPK6;GOLGA7;ERBB2;PPP2CB;NEFL;GFRA2;IL2RG;NF1;RNASE1;IQGAP1;MAPK1;NRAS;MRAS;PSMC5;JUN;ZDHHC9;KBTBD7;MAPKAPK5;EPGN;YWHAB;ARHGAP9;AREG;RASGRF2;FGFR1;DUSP6;CDK1;FOXO1
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.2014891756397183,-0.8485376954250922,0.746031746031746,1.0,1.0,33/80,33.18%,MRPS25;MRPS16;MRPL11;MRPS24;MRPL44;MRPL23;MRPL41;MRPL32;MRPL55;MRPS31;MRPL43;MRPL38;CHCHD1;MRPL1;MRPS18C;MRPL20;PTCD3;MRPL40;OXA1L;MRPS27;MRPL16;MRPL9;MRPL13;MRPL45;MRPS34;MRPL12;TUFM;MRPL48;MRPL54;MRPL51;MRPL49;MRPS22;MRPL35
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.24945542982617466,0.848046482530238,0.6808510638297872,0.9710010584236918,1.0,2/17,3.82%,TICAM1;RPS27A
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.2169622651764057,-0.8458367902764754,0.7164179104477612,1.0,1.0,6/44,8.00%,PHC3;NUP133;RING1;NUP85;NUP210;PHC2
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.28307747837229735,0.845413416651744,0.6666666666666666,0.9740685128442326,1.0,2/15,4.15%,RIGI;TRIM4
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.22394592066281538,-0.8451862081018342,0.6666666666666666,1.0,1.0,20/38,34.61%,SPTAN1;GFRA2;RPS6KA5;MAPK1;NRAS;FGFR1;CREB1;CACNB1;PTK2;CACNB3;COL9A1;PRNP;AGRN;COL4A4;COL4A3;NCAM1;CACNA1D;CACNA1H;CACNB4;PSPN
prerank,KEGG_2021_Human__Steroid biosynthesis,-0.2973639436274194,-0.8451113363989304,0.6885245901639344,1.0,1.0,8/16,30.33%,DHCR7;EBP;TM7SF2;LIPA;SOAT1;LSS;MSMO1;SC5D
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.18355562664104533,0.8439302881186017,0.7777777777777778,0.9753975514852424,1.0,27/71,27.82%,UGCG;DEGS1;STS;ARSB;SMPD3;PPM1L;SPNS2;SMPD1;GLB1;ALDH3A2;GM2A;ORMDL2;KDSR;DEGS2;SGMS2;SGMS1;EGFL7;CSNK1G2;CPTP;SGPP1;ARSG;VAPB;ESYT2;B3GALNT1;PLPP1;PRKD2;HEXA
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.27913069853747174,-0.8430327877244537,0.6935483870967742,1.0,1.0,6/19,21.17%,ST3GAL4;B4GALT2;ST8SIA6;FUCA1;MAN2A1;MGAT5
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.17801962488581977,-0.8426188903616482,0.7413793103448276,1.0,1.0,17/107,14.02%,CLASP1;NUP133;PPP2CB;CENPN;DYNLL2;CENPF;CENPI;NUP85;CENPM;BIRC5;UBE2E1;KNTC1;ANAPC11;CENPO;CENPE;ANAPC5;UBE2S
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.23512936448836974,-0.8424891371477387,0.7543859649122807,1.0,1.0,17/27,48.96%,PLA2G4A;LCLAT1;PRKCSH;PLD2;DDHD1;GPD2;GPD1L;ACP6;GPAM;GPAT3;AGPAT1;GPAT4;PLA2G12A;MIGA1;AGPAT4;AGPAT5;LPCAT1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.20436562875633005,-0.8423454559652026,0.6666666666666666,1.0,1.0,14/46,21.07%,RPS8;RPS11;SNRPD3;RPS10;RPS28;SNRPD2;RPS14;GEMIN7;RPS6;RPS27L;RPS7;DDX20;FAU;RPS21
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.22758648185309704,0.8421613467010584,0.7,0.977370418127397,1.0,3/24,5.21%,ALDH7A1;ABAT;ACOX1
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,-0.27013547740180194,-0.842141294033537,0.6666666666666666,1.0,1.0,2/15,4.39%,PIAS3;TP53BP1
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.16920379047324874,0.8418025593949073,0.75,0.9760713055531504,1.0,17/114,12.52%,FEN1;RBBP7;H2BC15;H2BC17;POLR2K;RFC5;H2AC4;CENPA;POLR1B;POLR2I;POLR2F;POLR2D;POLD4;H2AZ2;POLR2H;POLA2;H2BC3
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.1764013286531146,0.8404351750044171,0.7692307692307693,0.9769905573675721,1.0,8/91,5.67%,PSMA5;TNFSF14;PSMA4;TNFSF8;PSME1;RPS27A;SKP1;PSMC6
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.15272418437861354,-0.8404328968679035,0.8831168831168831,1.0,1.0,78/351,22.61%,RHOB;HCAR3;AKT1;GRK6;HEBP1;RPS6KA1;ITGB1;GRK3;GPR132;PDE1B;CXCL8;PPP2CB;CXCR3;PLA2G4A;TRPC6;PIK3R3;NTSR1;DHX34;GPSM1;GNA13;ROCK2;PDE3B;DGKA;RHOC;TAS2R13;PRKAR1B;INSL3;SUCNR1;DGKQ;ARHGEF37;MAPK1;ITPR1;NRAS;GPER1;MC1R;CXCL16;P2RY10;OPN3;PPP3CB;CXCR1;UTS2R;GPR15;PRKAR2B;OXER1;RASGRF2;TAS2R60;GNB1;PTGER2;CXCR4;DGKZ;CREB1;CXCR2;PDE3A;POMC;ARHGEF10;RPS6KA3;C5;ADM;VAV3;FPR1;RGS5;PIK3R5;GNA11;ITGA5;C5AR1;RGS3;GNAS;GNRH1;CAMK2A;CALCRL;GNA12;TAS2R30;GNAI1;DGKE;DAGLB;PLCB2;SSTR2;PROK2
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.1615686190021477,-0.8404084170823312,0.8428571428571429,1.0,1.0,44/294,14.00%,ATP5PD;NDUFS7;PSMD8;TUBB3;MAP3K5;ATP5F1D;NDUFB3;ATG13;NUP133;UBQLN2;ACTR1A;MAPK14;NEFL;DCTN3;COX5A;ULK1;SDHC;NDUFA5;NUP85;NUP210;HDAC6;COX7B;MAP2K6;ANG;UQCR10;ATP5F1E;BAD;NDUFC1;GPX7;ATG14;TUBA8;NDUFS1;PSMC5;SOD1;PPP3CB;DERL1;COX6A1;NDUFB1;TOMM40L;KIF5A;SIGMAR1;TANK;SDHB;NDUFS3
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,0.2167304323290606,0.840193912133365,0.6136363636363636,0.9757718078848382,1.0,8/31,20.33%,ORC4;POLR1B;POLA2;POLR1A;MCM6;MCM4;ORC3;MCM7
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.15546282471734446,-0.8399922423501145,0.9166666666666666,1.0,1.0,57/336,17.74%,CHD3;AKT1;JMY;PRKAG2;TCEA1;RMI2;TP53BP2;RAD9B;SESN3;RGCC;GATAD2A;PPP2CB;MAPK14;DNA2;CSNK2A2;BRD1;HDAC2;PTEN;PIP4P1;COX5A;RAD9A;USP7;PLAGL1;CNOT10;COX7B;UBL4A;CDK13;MAP2K6;BIRC5;DPEP3;REXO2;STEAP3;TOP3A;LAMTOR4;PRKAG1;GNPDA1;YWHAQ;JUN;COX6A1;MAPKAPK5;YWHAB;AURKA;RBBP4;CDK1;SGK1;CCNG1;TRIAP1;SUPT4H1;TAF1;GSR;SCO2;TAF4;TACO1;GTF2F2;ELOA;GLS2;STK11
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.24712469247588656,-0.8398181130544092,0.75,1.0,1.0,10/29,26.33%,SPARC;ITGB1;ITGA9;COMP;TGFB3;COL9A1;LAMC1;LMNB2;DCN;AGRN
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.1760951254864698,0.8376310289815814,0.8367346938775511,0.9792392108148843,1.0,11/82,8.94%,TBP;MDM4;CDK5R1;TAF2;RPS27A;RFC5;TAF5;POLR1B;SUPT16H;SSRP1;MAPK11
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.2418634850846928,-0.8371057345706187,0.7368421052631579,1.0,1.0,9/34,19.01%,H2AX;H2BC14;H2BC4;H3C13;H2AZ1;H3-3B;AREG;KLK2;H2AC7
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.2688632367611031,-0.8363864576246143,0.6538461538461539,1.0,1.0,3/17,9.97%,TUBB3;TBCA;TUBA8
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.19836041085119313,-0.8359575924484508,0.8059701492537313,1.0,1.0,17/61,21.83%,AKT1;ZDHHC7;PIK3R3;SRF;MAPK1;NRAS;EPGN;AREG;MMP9;GNB1;CREB1;SPHK1;PRKCZ;HSP90AA1;TGFA;PTK2;GNAI1
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.24425667043592253,0.8351490343948043,0.68,0.9824457089098043,1.0,4/20,16.15%,CDK5R1;PRDX2;GOLGA2;FOXO3
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.2303815270332108,0.834853122458889,0.7659574468085106,0.9810507128164322,1.0,10/28,23.12%,TUBB6;TTLL4;TUBA1C;SVBP;TUBB2A;VASH1;TUBA1B;TUBB4A;TTLL11;NICN1
prerank,KEGG_2021_Human__Lysosome,0.16620998052560546,0.834739500009881,0.7692307692307693,0.9792426238548975,1.0,19/120,13.33%,NAPSA;CTSL;AP4B1;CTSF;ARSB;AP3S1;ATP6V0A1;PLA2G15;AGA;NPC1;CLTB;SMPD1;GLB1;FUCA2;ABCB9;AP3D1;CTSG;GM2A;IDUA
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.222543243461815,0.833872216610655,0.7142857142857143,0.9788423728304768,1.0,9/34,20.67%,MYL12A;CALD1;MYLK;TPM4;ANXA1;MYL5;TLN1;MYL9;DYSF
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,-0.227052580834988,-0.8333181635652669,0.6923076923076923,1.0,1.0,2/28,2.98%,HOMER2;BEGAIN
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.18220414889563874,-0.8330779609711223,0.6721311475409836,1.0,1.0,30/88,29.45%,RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;GNL3;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.21457822052207662,0.8330635563729554,0.7674418604651163,0.9786644261956466,1.0,9/28,18.31%,RPS27A;HRAS;SHC1;GRB2;SPRY2;PIK3CA;CBL;UBB;PIK3R1
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.21612841351478174,0.8326281149052713,0.7317073170731707,0.977459096238453,1.0,8/36,14.76%,ADCY7;PRKCD;NBEA;ITPR3;PRKACB;GRK2;KPNA2;CAMKK1
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.23932382608850045,0.8324073691663237,0.7027027027027027,0.9762340443200151,1.0,9/21,31.57%,SDC2;B4GALT7;CHSY1;HSPG2;CHST6;B3GAT3;HEXA;GPC2;ST3GAL3
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.2787838207701963,-0.8322077410314885,0.6833333333333333,1.0,1.0,4/15,18.03%,MTHFD1;DHFR2;MTHFD2;SLC46A1
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.23531358714855927,0.8320168387008819,0.7209302325581395,0.9750381510914569,1.0,6/19,16.45%,RPS27A;GRB2;SPRY2;FGFR4;CBL;UBB
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,0.17596082896741522,0.8318420253048767,0.6976744186046512,0.9736278941465852,1.0,30/69,32.48%,NAPSA;AP4B1;AP3S1;SNX5;SNAP23;CLTB;PUM1;PIK3C2A;VAMP7;TBC1D8B;DNM2;SNX2;BLOC1S1;AP4E1;CHMP2A;PICALM;CTSZ;CLTA;GOLGB1;ARRB1;AP1G1;AP1M2;NECAP1;BLOC1S4;AP4S1;SORT1;SNX9;SNAPIN;AP3B1;ACBD3
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.22629927168342676,0.8306016785159066,0.6511627906976745,0.9741904394224328,1.0,7/33,14.78%,SDC2;ARSB;B4GALT7;CSGALNACT2;IDUA;CHST12;CHSY1
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.207615235691477,0.829799273054824,0.8048780487804879,0.9739266137118886,1.0,3/39,1.27%,STRADA;CAB39L;TSC2
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.15971791409523692,0.8296473252448778,0.8181818181818182,0.9723089439460727,1.0,22/136,12.64%,ADCY7;FOS;GSTA4;VDR;CREB3L4;HPGDS;RPS6KA2;CYP2C9;HRAS;HSP90B1;UGT2B4;PRKACB;KPNA6;GRB2;KPNA5;SULT1A3;GSTO1;PIK3CA;KPNA2;GSTM1;MGST2;GSTP1
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.1860353471458642,-0.8294961120413057,0.746031746031746,1.0,1.0,30/87,29.45%,RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;TRMT112;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.17026673248920168,0.8294861835173613,0.8157894736842105,0.9709631403661964,1.0,9/96,5.67%,PSMA5;GATD3;PSMA4;PSME1;RPS27A;SKP1;YES1;CBFB;PSMC6
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.18232366402491423,-0.829292292959657,0.7931034482758621,1.0,1.0,13/90,12.05%,CLASP1;NUP133;PPP2CB;CENPN;DYNLL2;CENPF;CENPI;NUP85;CENPM;BIRC5;KNTC1;CENPO;CENPE
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.24663307021382466,-0.8287986428571662,0.7111111111111111,1.0,1.0,9/26,24.53%,NEK2;UBE2E1;ANAPC11;ANAPC5;UBE2S;ANAPC15;CDC20;UBC;CDC23
prerank,KEGG_2021_Human__Gastric cancer,-0.19118763224152655,-0.8287198019681833,0.8070175438596491,1.0,1.0,37/96,34.54%,TERC;AKT1;WNT7B;JUP;ERBB2;PIK3R3;FZD2;MAPK1;NRAS;HGF;LRP5;TGFB3;FRAT1;LRP6;SHC4;DDB2;CTNNA1;EGF;DVL1;MAP2K1;TCF7;RXRA;TP53;POLK;SMAD4;FZD1;CDH1;E2F3;GADD45A;PIK3R2;CDKN2B;CTNNB1;AKT2;BAX;AXIN1;BAK1;RARB
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.16473733790626527,0.8283968189083017,0.8947368421052632,0.9713336782048686,1.0,25/107,21.01%,PSMA5;PSMA4;H2BC15;H2BC17;ORC4;PSME1;RPS27A;H2AC4;PSMC6;ANAPC2;KPNA6;PSME2;PSMD11;H2AZ2;H2BC3;MCM6;PSMD6;H2BC11;UBB;MCM4;ORC3;PSMC1;H3C7;MCM7;PSMA7
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.17093750963369278,0.828283873409131,0.7906976744186046,0.9696341098400508,1.0,11/76,10.63%,FBXW4;TUBB6;GNB2;GNG5;FBXW9;USP11;RGS6;GNG3;GNG10;GNG7;TUBA1C
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.21958268933758063,-0.8264221663272404,0.7777777777777778,1.0,1.0,14/38,30.76%,IL9R;PIK3R3;IL15;IL2RG;LCK;GAB2;STAT5B;STAT4;IL3RA;IL2RB;IL21R;PTK2B;JAK3;PIK3R2
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.17399089322759398,0.8263542784909393,0.8,0.9714942883836629,1.0,23/90,21.47%,PSMA5;PSMA4;PSME1;UBE2D2;RPS27A;SKP1;PSMC6;CD4;PSME2;PSMD11;PIK3CA;TRAF6;PSMD6;UBB;PIK3CB;NFKB1;PIK3R1;PSMC1;PDPK1;NFKBIA;BCL10;PSMA7;PSME4
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.16379835358901393,0.8261824194586496,0.8055555555555556,0.9698488486293692,1.0,22/124,16.45%,PSMA5;PSMA4;H2BC15;H2BC17;ORC4;PSME1;RPS27A;H2AC4;PSMC6;ANAPC2;POLR1B;KPNA6;PSME2;PSMD11;H2AZ2;POLA2;H2BC3;POLR1A;MCM6;PSMD6;H2BC11;UBB
prerank,KEGG_2021_Human__Insulin resistance,-0.18929917320945489,-0.8260247631271945,0.7758620689655172,1.0,1.0,16/91,17.02%,AKT1;IL6;PRKAG2;RPS6KA1;MAPK8;PTEN;PIK3R3;PTPRF;SLC27A5;PRKAG1;CREB3L2;MLX;FOXO1;CREB1;CRTC2;RPS6KA3
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.1636856020848481,-0.8259286651522072,0.828125,1.0,1.0,36/229,15.23%,CHD3;AKT1;PSMD8;PSMD5;ATN1;PHC3;ERBB2;GATAD2A;PPP2CB;CSNK2A2;HDAC2;PTEN;PIK3R3;USP7;RING1;TRAT1;DPEP3;PHC2;RNASE1;BAD;MAPK1;RAC2;EZH2;FRK;LAMTOR4;PSMC5;LCK;JUN;EPGN;CBX4;AREG;FOXO4;FGFR1;RBBP4;FOXO1;CREB1
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.21451105649882624,0.8257214574719364,0.6888888888888889,0.968855445374952,1.0,9/27,19.66%,SHC1;PRKACB;GRB2;DOK2;PIK3CA;PIK3CB;MAPK7;PIK3R1;RAP1GAP
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.17914561526842537,-0.8255789716623312,0.8032786885245902,1.0,1.0,47/118,33.78%,AKT1;PSMD8;MAP3K5;MAPK8;RORA;ATG13;PIK3R3;ULK1;KCNC3;ITPR1;ATG14;SLC25A6;PSMC5;CIC;PSMD3;TRAF2;ATG101;ATG2A;DAB1;TWNK;XBP1;PSMB6;PSMD7;PLCB2;PSMD13;RYR1;ADRM1;CYCS;PLCB1;VDAC1;PSMB3;RELN;PSMC4;RB1CC1;GNAQ;PIK3R2;PSMC2;SLC25A4;ATXN2;GTF2B;RBPJ;ATG2B;CACNA1A;AKT2;PLCB4;WIPI1;PSMA6
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.2116348946030166,0.825365874477424,0.725,0.9678897045453063,1.0,8/32,18.76%,RAB3A;ABAT;ALDH5A1;SLC6A13;LIN7C;TSPOAP1;CASK;SNAP25
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.16385296085921244,0.8248786536048064,0.8571428571428571,0.967070594774875,1.0,20/115,15.06%,ATP6V1E2;MCOLN2;ATP6V1A;ATP6V1E1;ATP7B;FXYD7;RPS27A;ATP6V0A1;ATP1B2;WNK1;ATP13A4;BEST1;TRPV1;ATP8B2;TRPV2;ANO8;ATP6V0E2;RYR3;TRPM7;ATP8A2
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.2504287481619941,-0.8245201901633361,0.6727272727272727,1.0,1.0,7/20,24.60%,JAG1;PSENEN;MIB1;NEURL1;YBX1;UBC;EGF
prerank,KEGG_2021_Human__Tyrosine metabolism,0.2526603849651353,0.8240525332107435,0.6739130434782609,0.9667777604970498,1.0,4/15,13.19%,HGD;COMT;GOT1;FAH
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.19303405739718557,-0.8238271145593988,0.796875,1.0,1.0,35/86,33.18%,MRPS25;MRPS16;MRPL11;MRPS24;MRPL44;MRPL23;MTFMT;MRPL41;MRPL32;MRPL55;MRPS31;MRPL43;MRPL38;CHCHD1;MRPL1;MRPS18C;MRPL20;PTCD3;MRPL40;OXA1L;MRPS27;MRPL16;MRPL9;MRPL13;MRPL45;MRPS34;MRPL12;TUFM;MRPL48;MTIF2;MRPL54;MRPL51;MRPL49;MRPS22;MRPL35
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.1792530100918304,-0.8235829113321094,0.7857142857142857,1.0,1.0,18/110,15.33%,CUL1;MAP3K8;PSMD8;PSMD5;NFKBIB;LRRC14;CASP8;ALPK1;NLRC5;MAP2K6;IL1R1;PSMC5;TIFA;PELI1;TANK;IKBIP;MAP3K7;MAP2K4
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,-0.23047533432503703,-0.8235593573239768,0.7213114754098361,1.0,1.0,7/34,14.05%,H2AX;H2BC14;H2BC4;TINF2;POT1;H2AZ1;MPG
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.17740293390276837,-0.8234580185771916,0.7868852459016393,1.0,1.0,37/90,33.17%,AKT1;MAPK8;MAPK14;PIK3R3;JUNB;MAP2K6;MAPK1;ITPR1;NRAS;ATF2;CREB3L2;CREB1;MAP2K4;STAT5B;GNA11;GNAS;PTK2;ADCY3;GNAI1;PLCB2;SSTR2;SHC4;MAP2K1;PLCB1;PLCG2;ADCY4;ADCY9;SOCS3;GNAQ;GHR;PIK3R2;CREBBP;CACNA1D;GNAI3;AKT2;SOCS2;PLCB4
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.2418952344668242,0.8221461716449967,0.6888888888888889,0.9685035059433651,1.0,7/20,23.97%,CPSF1;PAPOLA;CSTF2;NUDT21;CSTF2T;CSTF1;SYMPK
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.19770105784867464,-0.8219268999458605,0.8,1.0,1.0,15/55,25.27%,AKAP9;APBB1IP;TENT4A;IQGAP1;MAPK1;NRAS;YWHAB;SND1;FAM114A2;CAMK2A;TRAK1;FXR1;AGGF1;QKI;MAP2K1
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.19193738127476603,0.8215382332871742,0.7560975609756098,0.967830027522065,1.0,8/57,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;PSME2;VCP;PSMD11
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.18171440634713837,-0.8212977670437608,0.78125,1.0,1.0,31/90,29.45%,RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;NCBP1;RPL23;RPL36AL;RPS16;EIF4G1;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,KEGG_2021_Human__Arginine biosynthesis,0.26507352262360173,0.8210342692164876,0.7115384615384616,0.967111804958421,1.0,7/15,23.23%,NOS3;GOT1;ABHD14A-ACY1;ARG2;GPT2;ARG1;NAGS
prerank,KEGG_2021_Human__Pancreatic cancer,-0.19754121762862845,-0.8205571034100742,0.7638888888888888,1.0,1.0,24/74,29.42%,AKT1;MAPK8;ERBB2;PIK3R3;BAD;MAPK1;RAC2;RAD51;RAC3;PLD2;TGFB3;TGFA;RALA;RALBP1;DDB2;EGF;CHUK;MAP2K1;TP53;POLK;SMAD4;E2F3;CDC42;GADD45A
prerank,KEGG_2021_Human__Endometrial cancer,-0.20466408515626852,-0.8202257070954316,0.7627118644067796,1.0,1.0,7/54,9.89%,AKT1;ERBB2;PTEN;PIK3R3;BAD;MAPK1;NRAS
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.20140152061664923,-0.8201101115863468,0.8181818181818182,1.0,1.0,22/55,30.51%,ITGA3;ITGB1;GP1BA;LAMC3;ITGA9;COMP;GP1BB;THBS4;HMMR;LAMB4;ITGA5;ITGA1;ITGA6;ITGB7;COL9A1;LAMC1;THBS3;AGRN;RELN;COL4A4;COL4A3;COL1A1
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.20202998632609878,-0.8199544933349009,0.7192982456140351,1.0,1.0,13/48,20.22%,RAB4A;PTEN;PIK3R3;RAB14;MTMR6;RUFY1;BMX;PLEKHA3;PI4K2A;MTMR14;PIK3R5;PLEKHA1;PLEKHA8
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.2296825368256826,0.8187479818403263,0.675,0.969558769547023,1.0,9/26,21.90%,RPS27A;XPO1;SMAD7;ZFYVE9;PPP1CC;UBB;SMAD2;STUB1;TGFBR2
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.196520451119898,-0.8187384863603314,0.8,1.0,1.0,9/64,11.85%,AKT1;ARNT2;PIK3R3;PAK1;BAD;MAPK1;NRAS;HGF;JUN
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.19279072392662275,0.8184828785102815,0.7857142857142857,0.9681097565443767,1.0,9/45,14.61%,STT3A;DPM2;MAN2A2;ALG2;RPN2;STT3B;GANAB;MGAT2;DPM1
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,0.19645614634253333,0.8181038197956305,0.7906976744186046,0.9669718450058904,1.0,11/46,20.03%,DDX11;TSPYL2;DNAJB11;SHC1;SRPRA;DNAJC3;ZBTB17;ATP6V0D1;PLA2G4B;TLN1;ERN1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.17836662008570134,-0.817511111217062,0.8448275862068966,1.0,1.0,21/99,19.05%,ITGB1;CCNC;SRFBP1;NEDD4L;PPM1A;FSTL3;SMURF1;DAND5;MAPK1;E2F5;PPP1R15A;USP9X;ZFYVE16;TGIF1;SMAD5;BMPR2;TGFB3;BMPR1A;PRKCZ;SKI;YBX1
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.15658394198083103,-0.8164607050553488,0.9322033898305084,1.0,1.0,30/213,14.79%,DUSP2;APBB1IP;IL6;PSMD8;PSMD5;SPTAN1;DUSP10;FRS3;GOLGA7;ERBB2;PPP2CB;NEFL;GFRA2;IL2RG;NF1;IQGAP1;MAPK1;NRAS;MRAS;PSMC5;ZDHHC9;KBTBD7;EPGN;YWHAB;ARHGAP9;AREG;RASGRF2;FGFR1;DUSP6;CDK1
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.17988181444250292,-0.8162750313654988,0.8095238095238095,1.0,1.0,9/95,7.69%,AKT1;CUL1;PSMD8;PSMD5;TKT;CSNK2A2;UBL4A;IDH1;KEAP1
prerank,KEGG_2021_Human__Ribosome,-0.17394112344823223,-0.8160559877179249,0.7741935483870968,1.0,1.0,44/133,28.79%,RPS8;MRPS16;RPL15;RPS11;RPLP2;MRPL11;MRPL23;RPL31;RPS10;MRPL32;MRPL28;RPL39;MRPL2;RPL9;RPS28;RPS26;RPS14;RPS6;RPS27L;RPS10-NUDT3;RSL24D1;MRPL1;MRPS18C;RPL36A-HNRNPH2;RPS7;RPL35A;MRPL20;FAU;RPS21;RPL18A;RPL19;MRPL16;RPL41;RPL7A;RPL23;RPL36AL;MRPL9;RPS16;MRPL13;RPL34;RPL12;RNA5S1;MRPL12;RPS25
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.22618345081904276,-0.8159628550581867,0.6949152542372882,1.0,1.0,32/33,72.06%,FAS;PRF1;GZMB;IL10;HLA-DRB3;TG;CTLA4;HLA-DMB;CD40;HLA-DOA;FASLG;CD86;HLA-DMA;IL4;CD80;HLA-DQB1;HLA-DRB1;HLA-E;HLA-A;HLA-F;HLA-B;HLA-DPB1;HLA-DPA1;HLA-DQA1;HLA-C;HLA-DRB5;HLA-G;HLA-DRB4;HLA-DRA;HLA-DOB;TSHR;CD28
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.19551598771867063,-0.8153356503978216,0.7272727272727273,1.0,1.0,7/49,10.46%,CCNC;NEDD4L;PPM1A;DAND5;MAPK1;E2F5;USP9X
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.18605409840853018,0.8148167016204195,0.7906976744186046,0.9713765893471785,1.0,5/54,5.67%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.21271115677703417,0.8146783305292229,0.75,0.9697214985965275,1.0,5/36,7.43%,NR4A1;RARA;RARG;VDR;NR6A1
prerank,KEGG_2021_Human__Allograft rejection,-0.21949903298242188,-0.8143480274818401,0.7076923076923077,1.0,1.0,5/33,17.20%,FAS;PRF1;GZMB;IL10;HLA-DRB3
prerank,KEGG_2021_Human__Thyroid cancer,-0.2242058377192182,-0.8136730704806893,0.8214285714285714,1.0,1.0,16/35,34.25%,NTRK1;MAPK1;NRAS;TFG;CCDC6;DDB2;MAP2K1;TCF7;RXRA;TP53;POLK;CDH1;GADD45A;CTNNB1;BAX;BAK1
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.14816268666835317,-0.8136691250136363,0.9210526315789473,1.0,1.0,79/386,20.98%,ID2;USP8;AKT1;SPARC;ITGA3;RPS6KA1;FRS3;JUP;ITGB1;RAB4A;ERBB2;PPP2CB;MAPK14;AP2B1;ATP6V0C;PAG1;HDAC2;PIK3R3;PDGFD;LAMC3;STAT6;ROCK2;PDE3B;DIAPH1;STAM;NTRK1;CYBB;PSENEN;SRF;RPS6KA5;TEC;IL2RG;RNASE1;RANBP10;MAPK1;ITPR1;NCKAP1L;NRAS;LCK;GABRG2;AP2M1;CXXC1;MKNK1;EPGN;YWHAB;NCK1;NCK2;AREG;MMP9;FGFR1;DUSP6;THBS4;CREB1;FES;TCIRG1;SGK1;SH2B2;NEDD4;RPS6KA3;GTF2F2;ITCH;CLTC;WASF1;SPHK1;PRKCZ;VAV3;HSP90AA1;RICTOR;NRP2;TGFA;NRG4;GAB2;STAT5B;S100B;RALA;TPH1;PTK2;PLAT;ATP6V0A2
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.19612289407042294,0.8131278422619942,0.7872340425531915,0.9711353760979335,1.0,5/25,18.84%,TNKS2;CTBP1;PPP2R5C;PPP2R5E;KREMEN1
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,0.22350408785738501,0.8128680094121238,0.8,0.969860293294843,1.0,9/29,23.07%,E2F6;RRM2;LIN9;TK1;RBL1;CCNE1;FBXO5;TYMS;DHFR
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.25805780289567726,-0.8120538360966144,0.7321428571428571,1.0,1.0,5/15,19.55%,NUS1;GALT;GALK1;PGM1;SRD5A3
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.1591139243900511,0.8120509297803504,0.8461538461538461,0.9693120402716755,1.0,13/136,6.08%,PSMA5;PSMA4;PTPN4;PSME1;PTPN23;NKIRAS1;IL18;RPS27A;SKP1;PTPN9;PSMC6;USP18;SQSTM1
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.1650901022880374,0.8119395021760576,0.7894736842105263,0.9678358399310202,1.0,14/78,16.73%,NUP205;NUP35;MAP4K2;NUP214;NUP37;MDH1;PFKL;PRKACB;SLC37A1;HOOK2;PCNX4;PGK1;PGP;FBP1
prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.19310492870367968,-0.8119039891569677,0.7313432835820896,1.0,1.0,27/66,34.54%,AKT1;ERBB2;PIK3R3;BAD;MAPK1;NRAS;HGF;KIF5A;TGFA;STAT5B;DDB2;EGF;MAP2K1;STK4;RXRA;TP53;POLK;PLCG2;E2F3;GADD45A;JAK3;PIK3R2;EML4;AKT2;BAX;BAK1;RARB
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.18513835955408584,-0.8111425064536741,0.8873239436619719,1.0,1.0,16/85,15.42%,AKT1;MAPK8;PLA2G4A;PIK3R3;PDGFD;SLC22A1;DGKA;DGKQ;CHPT1;MAPK1;RAC2;NRAS;JUN;RAC3;DGKZ;PLD2
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.23626156296253484,-0.8091072773955454,0.7083333333333334,1.0,1.0,3/21,6.62%,ARL13B;DYNLL2;HDAC6
prerank,KEGG_2021_Human__RNA degradation,0.18454710659709198,0.8077759820153436,0.8461538461538461,0.9742785340041268,1.0,18/68,18.88%,TOB2;TOB1;EXOSC3;BTG2;EXOSC6;PFKL;LSM5;LSM4;CNOT6;EXOSC7;DCP2;CNOT6L;PATL1;LSM8;MTREX;CNOT7;LSM7;PABPC4
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.16844212200003464,0.8060105382466506,0.8974358974358975,0.9757635351969604,1.0,11/81,9.98%,LYN;PRKCD;ITPR3;YES1;SYK;NF2;ACTG1;FGR;FCGR1A;GRB2;WIPF1
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,-0.2635974589151582,-0.8059816270219322,0.7454545454545455,1.0,1.0,5/16,21.29%,FOXM1;CENPF;RBBP4;CDC25C;LIN52
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.1716484196754622,0.8055047058565004,0.8285714285714286,0.974792251299312,1.0,6/43,10.02%,GNB2;RAMP1;GNG5;GNG3;GNG10;GNG7
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.15491280388982018,-0.8053655215412504,0.8552631578947368,1.0,1.0,26/253,9.89%,AKT1;RFNG;ITGA3;WNT7B;ITGB1;HES2;PPP2CB;PXN;FADD;ATP6V0C;HDAC2;PTEN;JAG1;PIK3R3;HES6;LAMC3;LFNG;CASP8;MX1;FAS;ITGA9;FZD2;BAD;MAPK1;IRF9;NRAS
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.2588097626537824,-0.8042272636566108,0.7872340425531915,1.0,1.0,7/21,24.53%,UBE2E1;ANAPC11;ANAPC5;UBE2S;ANAPC15;CDC20;CDC23
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.15738469811466266,0.8029420221510207,0.8333333333333334,0.9774247275546686,1.0,15/110,9.56%,ADCY7;FOS;MAP2K5;ROCK1;EEF2;ITPR3;MYLK;ELK1;ACTG1;HRAS;CALML4;NOS3;RCAN1;PRKACB;MEF2C
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.14872147854286216,-0.8020898939620986,0.9714285714285714,1.0,1.0,91/304,28.97%,DUOX2;PSMD8;PSMD5;RPS8;RIDA;DLAT;SDSL;GCAT;RPL15;RPS11;RPLP2;QARS1;OAZ1;AHCY;EEF1E1;RPL31;DMGDH;PDHA1;TSTD1;RPS10;DARS1;SRR;KARS1;MARS1;DIDO1;RPL39;GNMT;RPL9;GLUD1;PSMC5;MTAP;RPS28;HPD;PAOX;RPS14;AMT;NNMT;RPS6;RPS27L;ALDH4A1;GSR;RSL24D1;IYD;PSMD3;GLS2;RPS7;RPL35A;CRYM;SEPHS2;OAZ2;ASL;FAU;TPH1;RPS21;LIAS;SOAT1;PSMB6;PSMD7;PEMT;BCAT1;PSMD13;RPL18A;DBT;RPL19;BHMT2;SLC36A4;RPL41;PHYKPL;RPL7A;SLC25A21;DUOX1;RPL23;IVD;HECA;RPL36AL;MCCC2;RPS16;AZIN1;MRPL13;GATM;ALDH18A1;HAAO;RPL34;NPRL2;RPL12;PSMB3;SLC5A5;PYCR2;PSMB10;RPS25;CARNS1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.2105669560230938,-0.801711620882537,0.8208955223880597,1.0,1.0,5/36,9.49%,FXYD1;FXYD2;ASPH;ABCC9;ITPR1
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.23817604365947156,-0.8013393367878294,0.7627118644067796,1.0,1.0,3/24,6.67%,TUBB3;PFDN2;CCT6B
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.16597784804968285,0.8011662867932176,0.8157894736842105,0.9784350192105657,1.0,26/107,21.47%,PSMA5;PSMA4;LYN;PSME1;RPS27A;SKP1;ITPR3;PSMC6;SYK;HRAS;GRB2;PSME2;PSMD11;CD79B;PSMD6;NFATC2;UBB;NFKB1;PIK3R1;PSMC1;NFKBIA;BCL10;BTK;PSMA7;RASGRP1;PSME4
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.2359164213585416,0.8009888704415767,0.6944444444444444,0.9769123438974148,1.0,2/23,1.53%,TNFSF14;TNFSF8
prerank,KEGG_2021_Human__Prostate cancer,0.16739220211793837,0.8006471422964052,0.8787878787878788,0.9756936195999593,1.0,24/86,19.76%,IGF1R;PDGFRA;CREB3L4;HRAS;HSP90B1;GRB2;IL1R2;PIK3CA;GSTP1;SOS2;ZEB1;CCNE1;PIK3CB;MDM2;ETV5;NFKB1;MAP2K2;LEF1;PIK3R1;PDGFC;PDPK1;CCNE2;NFKBIA;PIK3CD
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.14490223447057995,0.8004110825337394,0.96875,0.9745022684758853,1.0,40/219,16.97%,NUP205;PYGB;HS3ST3B1;NUP35;FUT2;CD44;SDC2;B3GNT2;RPS27A;MAP4K2;NUP214;ARSB;NUP37;MDH1;PYGL;GLYCTK;HPSE;PFKL;B4GALT7;PRKACB;CSGALNACT2;GLB1;B4GALT4;PHKG1;SLC37A1;HS6ST1;IDUA;HS3ST3A1;HOOK2;PCNX4;CHST12;PGK1;HS2ST1;CHSY1;PGP;SLC9A1;RBKS;UBB;FBP1;MAN2B1
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.18090157567148785,-0.7998354164306054,0.835820895522388,1.0,1.0,15/83,16.60%,APRT;GDA;ADA;UCK2;ENTPD7;AK1;DGUOK;ENTPD6;ADSS2;NUDT9;ENTPD1;CMPK1;GLRX;GSR;SCO2
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.16591382425054602,0.7997495000924005,0.875,0.9738640837137144,1.0,7/75,6.08%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;SQSTM1
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.1709948697012973,-0.7989304660346848,0.7777777777777778,1.0,1.0,8/106,5.76%,AQR;XRCC1;TCEA1;PPIE;COPS3;INO80;PIAS3;USP7
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.1926885603836484,-0.7977230020642285,0.8,1.0,1.0,23/54,31.64%,RMI2;UBE2T;WDR48;TOP3A;FAAP100;RAD51;RPA1;TELO2;RPA4;SLX1A;CENPS;RPA2;RMI1;FANCA;FANCC;RPA3;ATR;FAN1;POLK;HES1;REV3L;BRIP1;EME2
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.20677179375663615,-0.7973563106984614,0.8448275862068966,1.0,1.0,8/47,14.52%,ST6GALNAC4;PARP4;ST3GAL4;PARP16;CHMP4B;PARP6;RNF103-CHMP3;PRKCSH
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.2526647914952562,0.7960174816646151,0.8,0.9785008891157957,1.0,4/17,14.75%,FEN1;POLR1B;POLD4;POLR1A
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.18284751841541189,0.7953425709159717,0.8444444444444444,0.9777893944022046,1.0,7/43,14.22%,AGO1;PTPN4;AGO4;MEF2C;PPARG;TBL1X;NOTCH1
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.24174877843806958,0.7947259244847419,0.7555555555555555,0.9770804869421175,1.0,4/23,11.19%,TXNL1;ACTG1;ACTN1;RBMX
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.15422627807995096,-0.7941111644916344,0.9384615384615385,1.0,1.0,40/257,15.23%,CHD3;AKT1;PSMD8;PSMD5;ATN1;PHC3;ERBB2;GATAD2A;PDE1B;PPP2CB;CSNK2A2;HDAC2;PTEN;PIK3R3;USP7;RING1;PRKAR1B;TRAT1;DPEP3;PHC2;RNASE1;BAD;MAPK1;RAC2;ITPR1;EZH2;FRK;LAMTOR4;PSMC5;LCK;JUN;PRKAR2B;EPGN;CBX4;AREG;FOXO4;FGFR1;RBBP4;FOXO1;CREB1
prerank,Reactome_2022__Inflammasomes R-HSA-622312,0.22595901554766745,0.7930894050864264,0.7045454545454546,0.9778724250058605,1.0,1/21,0.28%,BCL2L1
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.15827275504010327,-0.7929222709891667,0.9,1.0,1.0,26/157,17.59%,APRT;MMAB;PCCA;HGSNAT;ADA;LFNG;CD320;AHCY;SEMA5B;GYG1;NUS1;ALG13;IDH1;B3GLCT;ALG6;GALT;GALK1;POMGNT1;SPON2;SLC37A4;ADAMTS2;GBE1;POMC;C1GALT1;PGM1;MPDU1
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.22491798665758006,-0.7926759380917398,0.7536231884057971,1.0,1.0,5/34,10.37%,RFNG;LFNG;GALNT10;B3GLCT;B4GALT2
prerank,KEGG_2021_Human__Parkinson disease,-0.1568756697341518,-0.7923114947997516,0.9436619718309859,1.0,1.0,48/208,22.43%,DUSP1;ATP5PD;NDUFS7;PSMD8;TUBB3;MAP3K5;MAPK8;ATP5F1D;NDUFB3;UBE2L3;COX5A;SDHC;NDUFA5;COX7B;UQCR10;ATP5F1E;NDUFC1;ITPR1;TUBA8;SLC25A6;NDUFS1;PSMC5;COX6A1;NDUFB1;KIF5A;SDHB;NDUFS3;PSMD3;NDUFC2-KCTD14;MAPT;NFE2L2;NDUFA11;NDUFB7;ATP5F1C;GNAS;CAMK2A;COX8A;NDUFB4;XBP1;KLC3;ATP5F1B;PSMB6;GNAI1;PSMD7;UBC;SDHD;SDHA;PSMD13
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.18832071191477576,0.7909784249871944,0.8095238095238095,0.9792506529785312,1.0,10/44,19.48%,COL6A2;COL6A3;PDGFRA;HRAS;GRB2;PIK3CA;COL9A3;PIK3CB;PIK3R1;PDGFC
prerank,KEGG_2021_Human__Spliceosome,-0.16219602986807694,-0.7906764598158196,0.8904109589041096,1.0,1.0,18/139,12.20%,AQR;LSM6;PRPF18;PPIE;WBP11;HSPA6;PLRG1;SF3B5;RBMXL1;PRPF3;SNRPD3;CCDC12;CDC5L;TXNL4A;EFTUD2;SNRPD2;RBM8A;PRPF40B
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.2041223602394902,-0.7905909608144974,0.8548387096774194,1.0,1.0,16/33,32.64%,AKT1;PIK3R3;PDE3B;PTGS1;GNAS;ADCY3;GNAI1;PRKG1;LIPE;ADCY4;MGLL;ADCY9;PIK3R2;ADRB2;GNAI3;AKT2
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.15646222264362503,0.7905707577795632,1.0,0.9781810449735292,1.0,21/165,11.16%,PSMA5;DYNC1LI2;PSMA4;B9D2;PSME1;NUDC;RPS27A;SKA1;SPC24;SGO2;CDCA8;NUP37;PSMC6;MAD1L1;ANAPC2;CENPA;XPO1;ZW10;PSME2;ZWINT;PSMD11
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.18278933456671587,-0.7902488191209157,0.8636363636363636,1.0,1.0,18/79,18.87%,ITGB1;PIK3R3;SAMM50;DOCK4;CYBB;ANKLE2;IQGAP1;RAC2;NCKAP1L;CDC42EP4;CDC42EP1;LMAN1;GIT1;PLD2;NHS;ARHGAP17;VAV3;DEPDC1B
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.1604976348368934,0.789899195580435,0.9428571428571428,0.9773862363635928,1.0,26/111,21.47%,ZAP70;PSMA5;PSMA4;PSME1;UBE2D2;RPS27A;SKP1;GRAP2;PSMC6;CD4;PSME2;PSMD11;PIK3CA;TRAF6;PSMD6;LCP2;UBB;PIK3CB;NFKB1;PIK3R1;PSMC1;PDPK1;NFKBIA;BCL10;PSMA7;PSME4
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.2217377818473827,0.7891924690910351,0.7837837837837838,0.9768422042617735,1.0,3/27,6.51%,AK2;NME3;RRM2
prerank,KEGG_2021_Human__Protein digestion and absorption,0.1895215043886,0.7889336453095273,0.7222222222222222,0.9755577297675952,1.0,8/49,14.13%,COL6A2;COL6A3;KCNN4;COL28A1;ATP1B2;SLC7A8;COL9A3;CTRL
prerank,KEGG_2021_Human__Tight junction,-0.16981600993316862,-0.7889046278066741,0.8852459016393442,1.0,1.0,17/129,11.85%,PRKAG2;RUNX1;MAP3K5;MAPK8;ITGB1;ERBB2;PPP2CB;ROCK2;ARPC1A;AMOT;NEDD4L;TUBA8;MYL12B;PRKAG1;ACTR3;EZR;JUN
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.17182995758591124,0.7887719927179873,0.9642857142857143,0.9740982149079187,1.0,11/63,13.14%,NAPSA;YKT6;CSNK1D;SEC22B;RAB1B;SEC24B;CNIH3;SEC24D;TRAPPC5;GOLGA2;FOLR2
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.17183172954379752,-0.788164427913421,0.855072463768116,1.0,1.0,54/156,30.94%,SLC22A16;SLC39A14;SLC39A1;SLC39A6;RUNX1;ARL2BP;SLC11A2;EMB;SLC29A4;SLC5A9;SLC13A5;SLC22A1;SLC16A10;SLC5A2;SLC8B1;BSG;SLC25A6;SLC6A15;SLC35D2;SLC1A3;SLC16A3;SLC4A5;SLC24A4;SLC9A4;SLC7A6;AHCYL2;MFSD4B;SLC2A9;SLC36A2;SLC24A1;SLC30A7;SLC26A11;SLC36A4;SLC44A4;SLC4A4;SLC15A3;SLC35B3;SLC26A6;SLC39A10;SLC35C1;SLC3A1;NLRP3;SLC6A1;CALM1;SLC1A7;SLC5A5;SLC1A2;SRI;SLC39A4;SLC4A2;SLC35A2;SLC27A4;SLC25A4;SLC2A6
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.25679806372672065,0.7877952631330934,0.7115384615384616,0.973854412323463,1.0,9/19,30.27%,HMGCR;CYP51A1;SCD5;NAB2;LAMA2;PXMP2;NAB1;WWTR1;UTRN
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.1739093098214698,-0.7875928562403216,0.84375,1.0,1.0,19/107,17.55%,ID2;RPS6KA1;FRS3;PPP2CB;MAPK14;AP2B1;NTRK1;SRF;RPS6KA5;RNASE1;MAPK1;NRAS;AP2M1;YWHAB;DUSP6;CREB1;SGK1;RPS6KA3;CLTC
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.18696353709243044,-0.7875148654272626,0.8363636363636363,1.0,1.0,9/67,9.49%,MAPK8;MAPK14;PLA2G4A;PIK3R3;NTRK1;TRPV3;MAP2K6;IL1R1;ITPR1
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.21265867697740148,0.787412413910301,0.7346938775510204,0.972738809643096,1.0,5/28,10.02%,GNB2;GNG5;GNG3;GNG10;GNG7
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.16165471731973674,-0.7871669342031254,0.9130434782608695,1.0,1.0,27/227,11.87%,CHD3;H2AX;RIOX2;GATAD2A;H2BC14;BRWD1;H2BC4;ASH1L;H3C13;BRD1;HDAC2;SETD3;DNMT3A;BRD8;JADE1;HDAC10;MORF4L1;DPEP3;KDM2B;HAT1;SAP18;EZH2;KAT14;COPRS;EPC1;H2AZ1;TAF5L
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.2102443440317311,0.7865091824546745,0.7575757575757576,0.9723196152333954,1.0,3/23,9.68%,SLC43A2;SLC38A1;SLC7A8
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.1810553907368254,-0.7856638488813402,0.8857142857142857,1.0,1.0,17/82,18.80%,AKT1;JUP;MAPK14;ROCK2;CYBB;RNASE1;ITPR1;NCKAP1L;NRAS;NCK1;NCK2;WASF1;SPHK1;PRKCZ;VAV3;HSP90AA1;RICTOR
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.24114432336871866,0.785268438628817,0.7368421052631579,0.9723924370062069,1.0,3/20,5.48%,PYGB;RPS27A;PYGL
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.23699888277754952,-0.7848989058987962,0.7321428571428571,1.0,1.0,10/25,35.75%,TRAF1;TANK;MAP3K7;TRADD;XIAP;CHUK;TAB1;BIRC3;RBCK1;USP25
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.22644956837104982,0.7840052875886647,0.8222222222222222,0.9726653105460945,1.0,9/24,25.01%,SLC38A9;RRAGB;LAMTOR2;RPTOR;EIF4E;AKT1S1;MTOR;RRAGD;RPS6KB1
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.1644196817818075,-0.7839412104095321,0.859375,1.0,1.0,35/159,18.87%,FMNL1;ARAP2;ITGB1;JAG1;PIK3R3;ARHGAP10;ARHGDIB;GNA13;DOCK4;CYBB;RNASE1;WASL;IQGAP1;NCKAP1L;CDC42EP4;ARHGAP23;CDC42EP1;FAM13B;ARHGAP9;RASGRF2;ABL2;PRKCSH;GIT1;PLD2;ARHGAP4;IQGAP2;ARHGEF10;ARHGAP12;NHS;DLC1;ARHGAP17;WASF1;VAV3;WAS;DEPDC1B
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.16592248176083374,-0.7834386441164167,0.9154929577464789,1.0,1.0,15/117,12.03%,AKT1;MAPK8;SPI1;MAPK14;PIK3R3;JUNB;MAP2K6;TEC;MAPK1;IL1R1;IRF9;LCK;PPP3CB;JUN;ACP5
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.18277760616040306,-0.7826870401448118,0.8524590163934426,1.0,1.0,21/57,32.23%,ARPC1A;RNASE1;WASL;MAPK1;NCKAP1L;ACTR3;NCK1;WASF1;VAV3;WAS;HSP90AA1;PTK2;ARPC5;WASF3;PKN1;ABL1;CDC42;ABI1;MYO9B;BAIAP2;TARP
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.17352910758058612,0.781456233918488,0.8888888888888888,0.9754921969121412,1.0,26/54,33.36%,NAPSA;AP4B1;AP3S1;SNX5;PUM1;PIK3C2A;VAMP7;TBC1D8B;DNM2;SNX2;BLOC1S1;AP4E1;PICALM;CLTA;GOLGB1;ARRB1;AP1G1;AP1M2;NECAP1;BLOC1S4;SORT1;SNX9;SNAPIN;AP3B1;ACBD3;VAMP8
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.22603514741116157,-0.7812743062269855,0.7592592592592593,1.0,1.0,4/35,3.64%,H2AX;H2BC14;H2BC4;H3C13
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.1901264205056697,0.7803907956676601,0.7777777777777778,0.9756255397225717,1.0,12/48,16.57%,ITGB3;JAM3;CD44;ITGAL;ITGAV;ITGA4;ITGAX;ITGAM;COL9A3;ITGAD;ITGAE;ICAM3
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.19094263988403504,-0.7800753047143167,0.8571428571428571,1.0,1.0,6/48,8.99%,RMI2;RAD9B;DNA2;RAD9A;RAD51AP1;TOP3A
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.2020105006054943,0.7799244104610313,0.8461538461538461,0.9746514809592157,1.0,10/40,18.30%,GATD3;MAML3;RPS27A;HEY1;MAML2;ADAM10;NOTCH1;WWC1;UBB;PLXND1
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.15424892332325094,-0.7795968884238077,0.8939393939393939,1.0,1.0,42/175,23.61%,HCAR3;HEBP1;PDE1B;CXCL8;PPP2CB;CXCR3;PLA2G4A;GPSM1;TAS2R13;PRKAR1B;SUCNR1;MAPK1;ITPR1;GPER1;CXCL16;OPN3;PPP3CB;CXCR1;PRKAR2B;OXER1;TAS2R60;GNB1;CXCR4;CREB1;CXCR2;POMC;C5;FPR1;RGS5;GNA11;C5AR1;RGS3;GNAS;CAMK2A;TAS2R30;GNAI1;PLCB2;SSTR2;CXCR5;HRH4;CX3CR1;TAS2R3
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.2190016656673769,0.7794325947253193,0.6976744186046512,0.9735924661909857,1.0,6/22,18.31%,HIF1A;SHC1;PIK3CA;PRDM1;PIK3CB;PIK3R1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.174891264054432,0.7778233596226374,0.8888888888888888,0.9740814219951229,1.0,8/63,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2;PSME2;PSMD11
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.17138989495826296,-0.776740389700597,0.9482758620689655,1.0,1.0,12/103,8.94%,CLASP1;NUP133;PPP2CB;CENPN;DYNLL2;CENPF;CENPI;NUP85;CENPM;BIRC5;WAPL;KNTC1
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.23412100723780482,-0.7753172804741589,0.6666666666666666,1.0,1.0,8/19,32.14%,E2F5;RBBP4;CDC6;MAX;LIN52;RBL2;LIN37;TFDP2
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.16823083303436787,0.7750509546738827,0.8604651162790697,0.9760000641602294,1.0,7/63,9.22%,ADCY7;NR4A1;CREB3L4;ITPR3;ATP1B2;CALML4;PRKACB
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,0.16841159987042287,0.7745249178319777,0.8947368421052632,0.9749222798964499,1.0,13/83,11.87%,DDX11;TSPYL2;DNAJB11;EXOSC3;CREB3L4;EXOSC6;SHC1;HSP90B1;SRPRA;DNAJC3;EXOSC7;DCP2;ZBTB17
prerank,KEGG_2021_Human__Oocyte meiosis,0.15621148038894653,0.7745036890834487,0.8666666666666667,0.9732777231110422,1.0,19/99,16.38%,ADCY7;IGF1R;CCNB2;FBXO43;SKP1;ITPR3;RPS6KA2;MAD1L1;ANAPC2;CALML4;MAPK11;PRKACB;SPDYC;CPEB4;MAD2L1;CCNE1;PPP2R5C;PPP1CC;PPP2R5E
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.25577654675389844,0.7743220723112427,0.8235294117647058,0.9718579862105462,1.0,2/16,5.49%,SULT1B1;BPNT2
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.1751538092087535,0.7737882874245948,0.9534883720930233,0.9708805667142955,1.0,6/64,5.67%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.14398332241229267,-0.7734127737632436,1.0,1.0,1.0,89/365,25.27%,MAMLD1;AKT1;CUL1;AKAP9;APBB1IP;PSMD8;FGFR1OP2;PSMD5;DUSP10;FRS3;ERBB2;PPP2CB;CNTRL;CCNC;HDAC2;TENT4A;PTEN;JAG1;PIK3R3;EEF1G;HDAC6;HDAC10;PSENEN;TRAT1;WDR48;GOLGA4;NF1;RNASE1;IQGAP1;BAD;MAPK1;RAC2;NRAS;DERL2;MRAS;PSMC5;LCK;TFG;LRP5;EPGN;YWHAB;AREG;FOXO4;FGFR1;HDAC11;DUSP6;ERLIN2;RPS6;FOXO1;CREB1;SND1;MIB1;HDAC9;PSMD3;GTF2F2;NEURL1;CLTC;SYVN1;HSP90AA1;RICTOR;TGFA;NRG4;GAB2;STAT5B;FAM114A2;CAMK2A;PIK3AP1;MECP2;TRAK1;LRP6;PSMB6;PSMD7;UBC;PSMD13;FXR1;AGGF1;PTPN11;ATIC;NPM1;QKI;POLR2J;FRS2;NCBP1;EGF;WDCP;CHUK;CD19;KIT;MAP2K1
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.16666750637646469,0.7732653940061035,0.9117647058823529,0.9699938768084077,1.0,5/90,2.74%,BCL2L1;ZAP70;TNFSF14;LYN;TICAM1
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.152802733659135,-0.7730198976029905,0.9305555555555556,1.0,1.0,39/249,15.12%,AKT1;ST6GALNAC4;PARP4;RPS8;GOLGA7;NUP133;TLR8;RPS11;ST3GAL4;DAD1;SIKE1;NUP85;NUP210;SEC24C;TLR2;REXO2;SNRPD3;RPS10;ZDHHC8;IL17RA;ATG14;NLRP12;PARP16;CHMP4B;YWHAQ;RPS28;SNRPD2;CNBP;ZDHHC9;RPS14;YWHAB;DDOST;PARP6;RNF103-CHMP3;GEMIN7;MAP3K7;PRKCSH;RPS6;RPS27L
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.17450141788715087,-0.7727755143332516,0.8333333333333334,1.0,1.0,17/95,17.55%,ID2;RPS6KA1;PPP2CB;MAPK14;AP2B1;NTRK1;SRF;RPS6KA5;MAPK1;NRAS;AP2M1;YWHAB;DUSP6;CREB1;SGK1;RPS6KA3;CLTC
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.18469189519114257,-0.7727021867630957,0.8125,1.0,1.0,12/52,20.60%,SERPINB2;PPIA;PDCD4;MTAP;SOD1;IL10;IL27;S100A9;IL27RA;IL12RB1;RALA;IL23A
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.20858951972307085,-0.7726828284783341,0.8333333333333334,1.0,1.0,21/40,33.24%,PDE1B;PLA2G4A;PRKAR1B;MAPK1;ITPR1;PRKAR2B;CREB1;GNA11;CAMK2A;GNAI1;PLCB2;PLCB1;CALM1;ADCY4;GNA15;ADCY9;GNAQ;GNAI3;CAMKK2;PLCB4;AHCYL1
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.15757792409281857,-0.7724322659124498,0.873015873015873,1.0,1.0,7/108,4.32%,LAIR2;CD33;ITGB1;CD3D;HCST;NCR3LG1;SLAMF7
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,0.14637357785078756,0.7720484631705534,0.9696969696969697,0.9702216414102752,1.0,20/134,13.57%,NUP205;POLR2K;NUP35;RPS27A;NUP214;NUP37;RPL35;RPL4;RPL26;RPS3;POLR2I;POLR2F;RPL6;RPL18;DNAJC3;POLR2D;RPL37A;POLR2H;RPL14;RPL32
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.16325634950633305,0.7713925788690115,0.8125,0.9694914566063272,1.0,17/87,17.11%,RAB3A;DENND5A;RAB9A;DENND2A;RAB5A;RAB31;RAB1B;MON1B;RAB5B;TRAPPC5;DENND6A;RAB3GAP1;ALS2CL;RAB8B;TRAPPC2L;DENND1B;RAB35
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.1908963535505972,-0.7705075995603179,0.8787878787878788,1.0,1.0,14/46,25.37%,MBOAT1;GLA;DGKA;ALDH1B1;DGKQ;LIPG;LCLAT1;DGKZ;LPIN1;AKR1A1;DGKE;LPIN2;MBOAT2;ALDH2
prerank,KEGG_2021_Human__Colorectal cancer,-0.17870224168247456,-0.7686757015181416,0.84375,1.0,1.0,25/82,28.11%,AKT1;MAPK8;PIK3R3;BIRC5;BAD;MAPK1;RAC2;NRAS;JUN;RAC3;AREG;MSH6;TGFB3;BBC3;TGFA;RALA;DDB2;EGF;MAP2K1;TCF7;CYCS;TP53;POLK;CASP3;SMAD4
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.1755873928350835,-0.7686603950405109,0.875,1.0,1.0,10/62,14.18%,NUP133;PPP2CB;BPGM;NUP85;NUP210;PGAM2;LOC112694756;GNPDA1;PGM2L1;GNPDA2
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.20091558162742718,-0.7681679442382285,0.8076923076923077,1.0,1.0,12/43,25.50%,FADD;TRAF1;CASP8;SPPL2A;TANK;MAP3K7;CFLAR;TRADD;XIAP;UBC;CHUK;CLIP3
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.24903657722212158,-0.7678459246762178,0.8297872340425532,1.0,1.0,5/17,22.12%,JAG1;PSENEN;MIB1;NEURL1;UBC
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.16442143557034947,0.7668135649487046,0.8387096774193549,0.973193831524891,1.0,9/76,9.56%,ADCY7;FOS;PDE4C;VDR;CREB3L4;ITPR3;PRKACB;PLD1;MEF2C
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.21464173660710847,0.7664463061719865,0.8157894736842105,0.9718540378223209,1.0,2/20,3.63%,AVEN;GSDME
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.17500203684495763,-0.7662343789621139,0.90625,1.0,1.0,23/89,24.00%,AKT1;PLA2G4A;SPHK2;PIK3R3;PAK1;ARPC1A;HCK;MAPK1;RAC2;ACTR3;PLD2;WASF1;SPHK1;VAV3;WAS;GAB2;VASP;ASAP3;PLA2G4C;ASAP1;ARPC5;MARCKSL1;WASF3
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.17841353359857906,-0.7661491472883587,0.8412698412698413,1.0,1.0,19/57,28.03%,SLC9B1;TRPC6;ASPH;TRPV3;NEDD4L;CLCN5;TRPM2;SGK1;WWP1;MCOLN1;UBC;TRPM6;RYR1;ANO6;TRPM4;CLCN3;SGK3;CALM1;ANO9
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.18087924801207578,-0.7658632762417743,0.8615384615384616,1.0,1.0,32/80,33.18%,MRPS25;MRPS16;MRPL11;MRPS24;MRPL44;MRPL23;MRPL41;MRPL32;MRPL55;MRPS31;MRPL43;MRPL38;CHCHD1;MRPL1;MRPS18C;MRPL20;PTCD3;MRPL40;OXA1L;MRPS27;MRPL16;MRPL9;MRPL13;MRPL45;MRPS34;MRPL12;MRPL48;MRPL54;MRPL51;MRPL49;MRPS22;MRPL35
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.2316326897252733,-0.7656509115679868,0.7755102040816326,1.0,1.0,4/26,9.61%,HSPA6;SERPINH1;HDAC6;DNAJB6
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.17612682541345953,-0.7648047597086174,0.847457627118644,1.0,1.0,10/76,11.59%,PSMD8;PSMD5;RORA;AP2B1;FZD2;SMURF1;RNASE1;RAC2;PSMC5;AP2M1
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.20239189767934324,0.7639532531571849,0.7391304347826086,0.9736351357697196,1.0,7/31,20.09%,LYN;ITPR3;SYK;GRB2;CD79B;PIK3R1;BTK
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.1545086406231858,-0.7625927411090142,0.9565217391304348,1.0,1.0,36/140,22.50%,PRKAG2;RPS6KA1;NEFL;AP2B1;SLC22A1;PRKAR1B;RNASE1;MAPK1;SYN3;NRAS;DNAJC5;PRKAG1;GABRG2;AP2M1;PICK1;PRKAR2B;RASGRF2;SLC1A3;GNB1;CHRNA2;CREB1;GIT1;RPS6KA3;GABRR2;GLS2;MAPT;PPM1F;PPFIA1;CACNB1;ACHE;CAMK2A;CHRNB4;CACNB3;GNAI1;PLCB2;DLG1
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.1476952497009684,-0.7623305989293238,0.9672131147540983,1.0,1.0,28/207,14.63%,DUSP2;APBB1IP;PSMD8;PSMD5;SPTAN1;DUSP10;FRS3;GOLGA7;ERBB2;PPP2CB;NEFL;GFRA2;IL2RG;NF1;IQGAP1;MAPK1;NRAS;MRAS;PSMC5;ZDHHC9;KBTBD7;EPGN;YWHAB;ARHGAP9;AREG;RASGRF2;FGFR1;DUSP6
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.16323811485788656,-0.7614696275553114,0.875,1.0,1.0,13/119,9.55%,AKT1;TRAPPC1;RAB4A;RIN3;DENND4B;DENND4C;DENND5B;TBC1D15;ULK1;TBC1D2;RAB33B;CHML;RAB14
prerank,KEGG_2021_Human__Breast cancer,-0.1697704120711275,-0.7612988640200313,0.8805970149253731,1.0,1.0,11/94,11.85%,AKT1;WNT7B;ERBB2;PTEN;JAG1;PIK3R3;FZD2;MAPK1;NRAS;LRP5;JUN
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,0.1970538255418303,0.7607277093403648,0.8918918918918919,0.9758853537407373,1.0,3/29,6.91%,ZAP70;GRAP2;CD4
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.20968826101483748,-0.7585094390760523,0.8113207547169812,1.0,1.0,14/34,32.76%,MAPK8;PIK3R3;MAPK1;HKDC1;HK3;PRKCZ;HK1;HK2;SOCS3;PRKCE;PIK3R2;CACNA1D;CACNA1A;SOCS2
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.16205317252893855,0.7580920758819514,0.975,0.9775455292188773,1.0,10/78,10.02%,ADCY7;GNB2;RAP1A;ITPR3;GNG5;CHRM3;GNG3;PRKACB;GNG10;GNG7
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.161043827645819,-0.7580613990183491,0.8870967741935484,1.0,1.0,34/110,27.98%,RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;SMG7;RPL39;RPL9;DCP1A;RPS28;RBM8A;SMG1;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;PNRC2;RPS21;RPL18A;RPL19;RPL41;RPL7A;NCBP1;RPL23;RPL36AL;RPS16;EIF4G1;MRPL13;RPL34;RPL12
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.20521084069587597,-0.757680867201621,0.8035714285714286,1.0,1.0,5/29,13.22%,APBB1IP;IQGAP1;MAPK1;NRAS;YWHAB
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.14975815118423932,-0.757652530048583,0.9605263157894737,1.0,1.0,17/166,9.89%,AKT1;IL6;CLEC2B;MAPK8;CXCL8;MAPK14;FADD;PIK3R3;CASP8;FAS;MAP2K6;HCK;MAPK1;ITPR1;IRF9;ATG14;NRAS
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.22238783391845857,0.7567968358977171,0.7435897435897436,0.9773700313802832,1.0,4/17,16.45%,RPS27A;GRB2;CBL;UBB
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.16569281999482405,-0.7561813502032162,0.8596491228070176,1.0,1.0,5/92,2.98%,GNAO1;AKT1;MAPK8;PPP2CB;MAPK14
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.1990892397697579,0.7555943899427546,0.7608695652173914,0.9772811043526216,1.0,6/26,18.31%,PDGFRA;HRAS;GRB2;PIK3CA;PIK3CB;PIK3R1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.19296266611809063,0.7544147847391169,0.7948717948717948,0.9773855779951103,1.0,3/36,4.15%,RIGI;RPS27A;TRIM4
prerank,KEGG_2021_Human__PPAR signaling pathway,0.17214122159631545,0.7542648122632583,0.8974358974358975,0.9759047375133418,1.0,14/50,22.67%,ACADL;CYP27A1;ACOX1;CPT1A;LPL;CPT2;PPARG;SCD5;HMGCS1;PLIN2;PDPK1;SCP2;FADS2;DBI
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.20451342506086154,-0.753304007867521,0.847457627118644,1.0,1.0,9/37,20.55%,WRAP53;FBXL5;CCT6B;KIF13A;XRN2;CCT7;SPHK1;CCT3;CCT2
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.23325721461874815,0.752828616704084,0.6944444444444444,0.9762250239084251,1.0,3/15,9.90%,CYP27A1;FDX1;CYP51A1
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.25562393339831424,-0.7526904418275868,0.819672131147541,1.0,1.0,9/15,30.50%,XRCC5;PPIA;CXCR4;KPNA1;LRIG1;BANF1;PSIP1;XRCC4;CCR5
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.17232807554871651,-0.7507213339735496,0.8636363636363636,1.0,1.0,11/90,12.46%,AKT1;IL6;ERBB2;PDK1;PIK3R3;CYBB;PDHA1;MAPK1;MKNK1;HKDC1;HK3
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.16990199928749175,-0.7500961742827595,0.8771929824561403,1.0,1.0,5/82,2.90%,CUL1;PSMD8;PSMD5;TLE4;PPP2CB
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,-0.2140018788847784,-0.749862296388895,0.8070175438596491,1.0,1.0,6/27,15.78%,E2F5;DYRK1A;RBBP4;CDK1;CDC6;MAX
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.1583885303473485,-0.7488200598961431,0.9552238805970149,1.0,1.0,15/94,13.64%,HCST;PIK3R3;PAK1;CD48;FAS;MAPK1;RAC2;PRF1;NRAS;GZMB;LCK;PPP3CB;KLRD1;KLRC3;RAC3
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,-0.18693926534462235,-0.74858237467985,0.8709677419354839,1.0,1.0,7/42,14.31%,SERPINB2;PPIA;PDCD4;MTAP;SOD1;IL10;S100A9
prerank,KEGG_2021_Human__Purine metabolism,-0.16471991774252184,-0.7470662006660123,0.9264705882352942,1.0,1.0,14/101,12.80%,APRT;NME7;PDE1B;GDA;ADA;PGM2;PDE3B;AK1;DGUOK;ENTPD6;ADSS2;PDE5A;NUDT9;ENTPD1
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.2422726754334655,-0.7466526196361183,0.8181818181818182,1.0,1.0,6/16,25.69%,FOXO4;FOXO1;STK11;BBC3;NFYB;DDIT3
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.1803257987458963,0.7466387705644315,0.8431372549019608,0.9816670720856555,1.0,9/40,18.31%,LYN;YES1;SYK;SHC1;GRB2;PIK3CA;CBL;PIK3CB;PIK3R1
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.1684962238839991,-0.7462889892401563,0.8666666666666667,1.0,1.0,30/88,29.45%,RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;SEPHS2;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.22436579954296998,-0.7453441607385601,0.7592592592592593,1.0,1.0,3/25,7.69%,CTC1;TINF2;POT1
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.21261095159512,-0.7434795692784495,0.8412698412698413,1.0,1.0,6/25,18.80%,AKT1;BAD;FOXO4;FOXO1;CREB1;RICTOR
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.1655106255609792,-0.7432054461033962,0.9032258064516129,1.0,1.0,30/88,29.45%,RPS8;RPL15;RPS11;RPLP2;EEF1G;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.23029807717308345,-0.7431349306818434,0.8275862068965517,1.0,1.0,7/19,24.58%,PPP2CB;MAPK1;MKNK1;FGFR1;UBC;PTPN11;FRS2
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.23527789710487862,-0.7422148808029031,0.8113207547169812,1.0,1.0,10/17,45.51%,PPP2CB;FRAT1;PPP2R5D;AMER1;CTNNB1;AXIN1;PPP2R1A;GSK3B;PPP2R1B;PPP2CA
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.23075555933148523,0.7421693204424917,0.8604651162790697,0.9852367070592003,1.0,1/15,0.82%,RAB3A
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.1663101320235033,0.7420720120409994,0.9347826086956522,0.9836462249320341,1.0,8/65,11.16%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2;PSME2;PSMD11
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.24640256867578852,-0.7419036406828017,0.7708333333333334,1.0,1.0,5/20,18.34%,UBE2E1;ANAPC11;ANAPC5;UBE2S;ANAPC15
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.22322227189588592,0.741205369959863,0.8780487804878049,0.9829530768205755,1.0,4/19,14.75%,FEN1;POLR1B;POLD4;POLR1A
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,-0.23470121636947452,-0.7402428449685637,0.8448275862068966,1.0,1.0,7/18,28.25%,CA2;FXYD2;GLUD1;GLS2;ATP1A3;SLC4A4;GLS
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.22853810646756553,-0.7399750165802739,0.7818181818181819,1.0,1.0,4/26,8.87%,PIK3R3;FXYD2;NEDD4L;MAPK1
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.16721100320526486,-0.7394934961249894,0.9130434782608695,1.0,1.0,18/89,19.30%,AKT1;JUP;MAPK14;ROCK2;CYBB;RNASE1;ITPR1;NCKAP1L;NRAS;NCK1;NCK2;WASF1;SPHK1;PRKCZ;VAV3;HSP90AA1;RICTOR;NRP2
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.18287809154492085,-0.7392356390613971,0.8095238095238095,1.0,1.0,5/49,7.69%,CTC1;DNA2;WRAP53;TINF2;POT1
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.23841819327657912,-0.738426394392359,0.8070175438596491,1.0,1.0,12/19,46.72%,MAPK14;MAP2K6;MAP3K7;IRAK1;NOD2;TAB1;MAPKAPK2;IKBKG;UBE2V1;RIPK2;IRAK2;NOD1
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.2027874794939946,0.7357411737829481,0.8181818181818182,0.9876684097844078,1.0,4/30,10.21%,ITGB3;SDC2;ITGAV;ACTN1
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.22352115668353564,-0.7356051440594383,0.8548387096774194,1.0,1.0,10/21,35.85%,PPP2CB;ORC6;CDK1;PRIM2;ORC5;PPP2R3B;TFDP2;MCM8;PPP2R1A;CCNB1
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.19268446756025132,-0.7354460193761652,0.8923076923076924,1.0,1.0,7/35,18.80%,AKT1;PPP2CB;USP7;CDK1;SGK1;CCNG1;RICTOR
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,0.21724872929988517,0.7340906985815543,0.813953488372093,0.9876480702036672,1.0,21/21,78.30%,ACAD8;BCKDHB;PPM1K;HSD17B10;SLC25A44;ACADSB;MCCC1;ALDH6A1;ECHS1;AUH;HIBCH;LDHD;BCKDK;BCKDHA;HIBADH;BCAT2;MCCC2;IVD;DBT;BCAT1;SOAT1
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.22416679601560152,0.7333488610704398,0.7727272727272727,0.9868460303332658,1.0,5/16,16.45%,RPS27A;GRB2;SPRY2;CBL;UBB
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.1648488775326996,-0.7333141139149747,0.9047619047619048,1.0,1.0,29/84,29.45%,RPS8;RPL15;RPS11;RPLP2;RPL31;RPS10;RPL39;RPL9;RPS28;RPS14;RPS6;RPS27L;RSL24D1;RPS7;RPL35A;FAU;RPS21;RPL18A;RPL19;RPL41;RPL7A;RPL23;RPL36AL;RPS16;MRPL13;RPL34;RPL12;RPS25;RPL36
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.1661918499069962,-0.7322041281834022,0.9122807017543859,1.0,1.0,11/85,10.46%,ITGB1;CCNC;SRFBP1;NEDD4L;PPM1A;SMURF1;DAND5;MAPK1;E2F5;PPP1R15A;USP9X
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.2209792014076482,-0.7320682868002847,0.8421052631578947,1.0,1.0,7/26,22.83%,DLAT;PDHA1;GNMT;AMT;ALDH4A1;LIAS;DBT
prerank,KEGG_2021_Human__Cushing syndrome,-0.15696339174344026,-0.7319494548299166,0.9516129032258065,1.0,1.0,38/102,33.66%,USP8;WNT7B;CACNA1I;FZD2;MAPK1;ITPR1;ATF2;CREB3L2;CDKN2C;CREB1;ASH2L;POMC;GNA11;GNAS;CAMK2A;ADCY3;GNAI1;PLCB2;NCEH1;DVL1;MAP2K1;TCF7;PLCB1;AHR;ADCY4;FZD1;E2F3;ADCY9;GNAQ;CACNA1D;CDKN2B;GNAI3;CTNNB1;PLCB4;PDE8A;AXIN1;CACNA1H;PBX1
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.15331937993010927,-0.731683786801319,0.9558823529411765,1.0,1.0,12/108,10.24%,IL9R;AKT1;IL6;PIAS3;PIK3R3;STAT6;STAM;CSF3R;IL15;IL2RG;IRF9;MPL
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.20267219524187785,-0.7310063101549656,0.8793103448275862,1.0,1.0,11/32,25.18%,CD3D;ADA;IL2RG;LCK;UNG;CD79A;DCLRE1C;BLNK;CD3E;RFX5;CD19
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.17733460083241825,-0.7299720615196774,0.896551724137931,1.0,1.0,17/42,34.45%,TP53BP2;BIRC5;STEAP3;TRIAP1;BBC3;NDRG1;AIFM2;TMEM219;BNIP3L;ATM;TP53;TNFRSF10A;CREBBP;TP53I3;FASN;BAX;CASP10
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.23386386226956424,-0.7291467916053254,0.8490566037735849,1.0,1.0,5/19,23.04%,CD3D;LCK;HLA-DRB3;CD3E;PTPN11
prerank,KEGG_2021_Human__Histidine metabolism,-0.24285202479900184,-0.7279885079570646,0.7678571428571429,1.0,1.0,5/16,16.31%,ALDH1B1;ALDH3B1;HDC;AOC1;CNDP2
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,0.23571272944347216,0.7274431866704495,0.8421052631578947,0.9913832906480193,1.0,5/15,23.61%,SERPINE2;TTF2;PROCR;PROS1;F8
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.2224068417404425,-0.727134387547415,0.8448275862068966,1.0,1.0,7/22,22.26%,TRPC6;DGKA;DGKQ;ITPR1;DGKZ;DGKE;DAGLB
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.1478501025986717,-0.7265547220176641,0.96875,1.0,1.0,57/181,28.79%,PSMD8;CLASP1;PSMD5;RPS8;RPL15;RPS11;RPLP2;RPL31;RNASE1;EVL;RPS10;RPL39;RPL9;PSMC5;PPP3CB;RPS28;RBM8A;RPS14;NCK1;NCK2;ABL2;RPS6;CXCR4;RPS27L;RSL24D1;PSMD3;RPS7;RPL35A;FAU;VASP;RPS21;PSMB6;PSMD7;SRGAP2;UBC;PSMD13;NELL2;RPL18A;RPL19;ROBO3;RPL41;RPL7A;NCBP1;PKN1;RPL23;RPL36AL;RPS16;EIF4G1;ABL1;MRPL13;PFN2;RPL34;RPL12;PSMB3;CDC42;PSMB10;RPS25
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.16042039532820462,-0.7258700686555873,0.9636363636363636,1.0,1.0,10/82,10.60%,TUBB3;WRAP53;PFDN2;CSNK2A2;FBXL5;TBCA;CCT6B;KIF13A;TUBA8;XRN2
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,-0.20934131970351574,-0.7255524006192868,0.9259259259259259,1.0,1.0,3/25,7.84%,RIOX2;H3C13;KDM2B
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.135758274006356,0.7202496834157872,0.8947368421052632,0.9971266235478061,1.0,41/145,24.58%,ATP6V1E2;ATP6V1A;ATP6V1E1;WDR24;RPS27A;RPL35;RPL4;RPL26;RPS3;SLC38A9;RPL6;RPL18;TRIB3;RRAGB;RPL37A;LAMTOR2;RPL14;RPL32;RPTOR;FLCN;EIF2AK4;ATP6V0E2;RPL22L1;SESN1;RPSA;RPS27;ATP6V0D1;RPS24;RPS15A;RPL30;ATP6V0E1;CASTOR1;RPL22;RPS20;RPL27A;RPL23A;DEPDC5;RPL11;MTOR;RRAGD;RPS23
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.17568093167694915,0.7201282935261881,0.8857142857142857,0.9955558922819389,1.0,7/51,9.53%,PCSK5;AMN;RPS27A;LPL;APOE;PRKACB;ABCG1
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.15432219248434226,0.7197083766440969,0.9361702127659575,0.9942212898874085,1.0,6/70,6.85%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,-0.18386040828955844,-0.719144505097174,0.8813559322033898,1.0,1.0,8/48,13.40%,H2AX;H2BC14;H2BC4;H3C13;TOP3A;H2AZ1;H3-3B;RAD51
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.18699687423422195,-0.7178845453908196,0.8709677419354839,1.0,1.0,8/55,12.18%,TPM2;FXYD2;COX5A;ASPH;COX7B;UQCR10;MYL4;COX6A1
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.21587293690617948,-0.7159855277516278,0.864406779661017,1.0,1.0,12/27,30.47%,STAM;EPGN;AREG;TGFA;UBC;EGF;SH3GL1;CDC42;SH3KBP1;HGS;STAM2;HBEGF
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.19717387765584116,0.7155245844807907,0.9230769230769231,0.9966415545507741,1.0,4/27,11.89%,PDIA3;B2M;SEC24B;SEC24D
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.1553020746279935,0.7143520243180905,0.9512195121951219,0.996020774699633,1.0,7/78,6.85%,PSMA5;PSMA4;PSME1;RPS27A;SKP1;PSMC6;ANAPC2
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.2016671868261951,0.7139053796113575,0.8571428571428571,0.9947756082667912,1.0,4/23,16.15%,CDK5R1;PRDX2;GOLGA2;FOXO3
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.15844766750793304,-0.7124131126479368,0.9354838709677419,1.0,1.0,9/77,11.10%,CUL1;PSMD8;PSMD5;NFKBIB;PPIA;CARD11;NRAS;PSMC5;PPP3CB
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.21488110844137706,-0.7102046703963536,0.8360655737704918,1.0,1.0,7/23,20.93%,FADD;CASP8;DAPK2;TANK;CFLAR;TRADD;TMED7-TICAM2
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,0.22370559857080133,0.710070475177959,0.825,0.9968701401410901,1.0,6/16,23.61%,SERPINE2;GP9;TTF2;PROS1;ZNF160;F8
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.1768198486276072,-0.7061521999984407,0.873015873015873,1.0,1.0,11/49,19.60%,PIGW;PIGF;PIGS;PGAP1;NRN1L;CD109;PIGH;GPLD1;PIGB;NTNG2;GPAA1
prerank,KEGG_2021_Human__Cholesterol metabolism,0.17853338161369506,0.7054735310547394,0.9069767441860465,0.9992490766630605,1.0,4/33,8.79%,CYP27A1;LPL;APOE;NPC1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.13803729322446945,0.7048643683916084,0.9705882352941176,0.9981917539743671,1.0,42/150,25.70%,PSMA5;EIF4A3;PSMA4;PSME1;RPS27A;RPL35;RPL4;RPL26;PSMC6;CUL2;RPS3;RPL6;RPL18;PSME2;PSMD11;RPL37A;UPF3B;RPL14;RPL32;ETF1;PSMD6;RPL22L1;UBB;RPSA;RPS27;UPF3A;PSMC1;RPS24;RPS15A;RPL30;PSMA7;PSME4;RPL22;RPS20;PSMD2;RPL27A;RPL23A;RPL11;RPS23;PSMB7;RPL21;ZSWIM8
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.14544923267691298,-0.704447414164549,0.9682539682539683,1.0,1.0,16/142,10.41%,BCL2L2;ERBB2;DNMT3B;HDAC2;PTEN;PIK3R3;DNMT3A;ZFPM2;CDC25B;RPS6KA5;FSCN1;MAPK1;PDCD4;EZH2;NRAS;DNMT1
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.19512594940167208,0.701565269868646,0.8260869565217391,0.999585665988491,1.0,17/17,80.51%,IL24;STAT2;IL10RB;TYK2;JAK1;IL20RB;STAT5A;STAT1;IFNLR1;STAT3;IL19;JAK2;JAK3;SOCS3;PTPN11;STAT4;STAT5B
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.15265047693978515,0.698547526350573,0.9302325581395349,1.0,1.0,6/70,6.85%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2
prerank,KEGG_2021_Human__Homologous recombination,0.17392220497430794,0.698307140611099,0.926829268292683,0.9994031578608868,1.0,3/41,2.69%,ABRAXAS1;XRCC2;UIMC1
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,-0.1597887739581356,-0.6969369679385683,0.9538461538461539,1.0,1.0,17/84,20.01%,LFNG;SEMA5B;NUS1;ALG13;B3GLCT;ALG6;GALT;GALK1;POMGNT1;SPON2;ADAMTS2;C1GALT1;PGM1;MPDU1;SRD5A3;ALG8;HEXB
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.17909245168808946,-0.6966634326028621,0.8923076923076924,1.0,1.0,7/43,13.78%,RAB4A;TBC1D15;ULK1;TBC1D2;RAB33B;TBC1D7;TBC1D10B
prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.15022143973606988,0.6962850517121955,0.972972972972973,0.9995290835907166,1.0,20/79,20.09%,LYN;FOS;SYK;IFITM1;HRAS;GRB2;PIK3CA;CD81;CD79B;SOS2;NFATC2;PIK3CB;NFKB1;MAP2K2;PIK3R1;RAC1;NFKBIA;PIK3CD;BCL10;BTK
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.15764931522051268,-0.6951194821052318,0.9661016949152542,1.0,1.0,9/75,10.89%,NUP133;HSPA6;SERPINH1;BAG1;NUP85;NUP210;MAPK1;DNAJB6;ST13
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.18522142072468345,-0.6943954991574621,0.8709677419354839,1.0,1.0,8/35,17.36%,KIF4A;KIF6;CENPE;KIF5A;KIFC1;KIF13B;KIF19;KIF16B
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.1596183258047075,-0.6941856921003093,0.9137931034482759,1.0,1.0,10/59,16.64%,ARNT2;CYB5B;AOC2;ALDH1B1;BPHL;CBR3;PAOX;AOC1;ADH5;POMC
prerank,KEGG_2021_Human__Serotonergic synapse,-0.16598688219993404,-0.6930988346627835,0.9473684210526315,1.0,1.0,6/64,9.89%,GNAO1;DUSP1;PLA2G4A;MAPK1;ITPR1;NRAS
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.22149173408054204,-0.6927533050320305,0.8245614035087719,1.0,1.0,9/15,45.51%,PPP2CB;PPP2R5D;AMER1;CTNNB1;AXIN1;PPP2R1A;GSK3B;PPP2R1B;PPP2CA
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.20924489336880017,-0.6924030878093543,0.8846153846153846,1.0,1.0,12/24,36.03%,GZMB;CHMP4B;CASP4;RNF103-CHMP3;IRF1;GSDMD;CYCS;TP53;CASP3;BAX;BAK1;HMGB1
prerank,KEGG_2021_Human__Fructose and mannose metabolism,0.17971692411827056,0.6921187497158616,0.9285714285714286,1.0,1.0,6/29,19.42%,GMDS;PFKL;PMM2;GMPPA;FBP1;TKFC
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.1973032020108564,0.6919988475937969,0.8409090909090909,0.9994710993341758,1.0,5/18,16.45%,RPS27A;GRB2;SPRY2;CBL;UBB
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.20610470977915873,0.6894212541053598,0.88,1.0,1.0,7/20,27.06%,CAMKMT;PDE6G;PDE6A;PPEF1;GNB5;NMT1;PDE6B
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.14807486571961195,-0.6890639386574597,0.9722222222222222,1.0,1.0,37/110,31.25%,DHCR7;PMVK;MVD;MBTPS2;MBD4;OSBPL3;SEC24C;GGPS1;DAND5;SLC27A5;ACOT8;ACOX2;TM7SF2;STARD5;AKR1B15;POMC;HSD17B11;PIAS4;SRD5A3;OSBPL9;STARD3NL;AMACR;ABCB11;NFYB;RXRA;SREBF2;SEC23A;SAR1B;MSMO1;HSD17B12;SCAP;GPAM;SLC27A2;SC5D;SUMO2;CREBBP;STARD4
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,-0.22566129086540834,-0.688299623843302,0.8113207547169812,1.0,1.0,3/16,14.12%,KCNC3;KCNH2;KCNB1
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.17195476029000595,-0.6881214700784412,0.8970588235294118,1.0,1.0,3/52,2.09%,ITGA3;JUP;ITGB1
prerank,KEGG_2021_Human__Hepatitis C,-0.15052911850393624,-0.6876405773907965,0.9571428571428572,1.0,1.0,12/124,9.89%,AKT1;PPP2CB;FADD;PIK3R3;CASP8;MX1;FAS;EIF2AK1;BAD;MAPK1;IRF9;NRAS
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,0.17266414197244884,0.6874548159353445,0.95,0.9999056252985188,1.0,10/43,18.31%,RPS27A;HRAS;SHC1;GRB2;ADAM10;SPRY2;PIK3CA;CBL;UBB;PIK3R1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.18154616378958569,0.6859814970469541,0.8666666666666667,0.999538373624421,1.0,4/33,8.25%,PRKCD;ROCK1;BCAP31;DBNL
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.1805273601296815,-0.6847435681400684,0.8888888888888888,1.0,1.0,7/36,18.80%,AKT1;PPP2CB;USP7;CDK1;SGK1;CCNG1;RICTOR
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.15134991026477626,0.6844669513554977,0.9333333333333333,0.998906622849703,1.0,6/71,6.85%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.1398933907149841,-0.6819425725180842,1.0,1.0,1.0,26/175,15.12%,AKT1;RPS8;NUP133;TLR8;RPS11;SIKE1;NUP85;NUP210;SEC24C;TLR2;REXO2;SNRPD3;RPS10;IL17RA;ATG14;NLRP12;YWHAQ;RPS28;SNRPD2;CNBP;RPS14;YWHAB;GEMIN7;MAP3K7;RPS6;RPS27L
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.140319978130236,-0.680606864406619,0.9696969696969697,1.0,1.0,17/166,11.03%,AKT1;CUL1;PSMD8;PSMD5;TKT;CSNK2A2;MBD4;COX5A;COX7B;UBL4A;CYBB;IDH1;KEAP1;GPX7;TXNRD2;PSMC5;SOD1
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.17620858827558097,-0.6800041239988494,0.8983050847457628,1.0,1.0,9/39,20.53%,CERS2;SPHK2;SPTLC2;ALDH3B1;SPTSSA;ORMDL1;SPHK1;SAMD8;CERT1
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.17358466317952675,-0.6797305893814117,0.9473684210526315,1.0,1.0,9/52,17.34%,MAPK14;PYCARD;CASP8;MAP2K6;CASP4;MAP3K7;P2RX7;PANX1;ITCH
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.22678200734493253,-0.6752602373399776,0.8166666666666667,1.0,1.0,5/19,23.83%,ACSL5;ACSL4;ACSL1;HACD2;HACD1
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.17744394606394912,0.6748283171934609,0.9302325581395349,1.0,1.0,5/33,10.64%,ITGB3;RAP1A;CNKSR2;HRAS;MARK3
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.1462849044878799,0.6747031236778385,0.9772727272727273,1.0,1.0,6/71,6.85%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.20790649330093824,0.6745330512442453,0.9130434782608695,1.0,1.0,4/19,12.06%,HRAS;SHC1;GRB2;PIK3CA
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.17532712464100156,0.6734039290245142,0.9473684210526315,1.0,1.0,6/35,14.52%,STT3A;MAN2A2;ALG2;RPN2;STT3B;MGAT2
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.20309973131474557,0.6721910810265089,0.9130434782608695,0.9995087773592137,1.0,4/20,12.06%,HRAS;SHC1;GRB2;PIK3CA
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.1897136822794165,0.6719276210951446,0.8837209302325582,0.9980533690343137,1.0,5/19,16.45%,RPS27A;GRB2;SPRY2;CBL;UBB
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.1600906787313088,0.6710659427650217,0.9111111111111111,0.9969663941341865,1.0,6/49,7.40%,SDC2;RDH11;CAMKMT;LPL;PDE6G;APOE
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.21778850753934245,-0.6710424928732522,0.9090909090909091,1.0,1.0,3/17,13.33%,ST3GAL4;B4GALT2;SLC35D2
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.1629554697189265,0.6699597654188774,1.0,0.9960443230765934,1.0,10/47,15.26%,ARID3A;BTG2;CARM1;CNOT6;CNOT6L;CNOT11;RBL1;ZNF385A;PCBP4;CCNE1
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.1925467201466655,-0.6680087932912562,0.8947368421052632,1.0,1.0,3/20,10.89%,AHCY;TSTD1;MTAP
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.15626710399241184,-0.6669764561857562,0.9482758620689655,1.0,1.0,13/73,19.40%,PHC3;NUP133;RING1;NUP85;NUP210;PHC2;XPC;SMC5;CBX4;SCMH1;NSMCE2;NUP93;PIAS4
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,-0.2218200620928533,-0.664894223115075,0.9122807017543859,1.0,1.0,6/22,26.06%,ST6GALNAC4;GALNT10;C1GALT1;GALNT4;ST6GALNAC1;POC1B-GALNT4
prerank,KEGG_2021_Human__Long-term potentiation,0.1590102636137368,0.6641126868518582,0.9347826086956522,0.9982472621207349,1.0,15/46,25.43%,RAP1A;ITPR3;RPS6KA2;HRAS;CALML4;PRKACB;PPP1CC;MAP2K2;RAPGEF3;PRKACA;PRKCB;CALM2;BRAF;MAPK3;ATF4
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.19550669842467067,-0.6639539931717036,0.9206349206349206,1.0,1.0,12/24,35.38%,OSBPL3;SLC27A5;ACOT8;ACOX2;OSBPL9;AMACR;ABCB11;RXRA;SLC27A2;OSBP;NCOA2;OSBPL1A
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.2266482295311965,-0.6638947100546951,0.8813559322033898,1.0,1.0,7/16,32.14%,E2F5;RBBP4;CDK1;LIN52;RBL2;LIN37;TFDP2
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,0.1928423855119364,0.6635749254697466,0.8888888888888888,0.9969641200034056,1.0,3/17,12.35%,SLC28A2;SLC29A1;GSTM1
prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.1521877764412478,-0.6613044082741911,0.9827586206896551,1.0,1.0,7/73,9.89%,AKT1;RUNX1;HDAC2;PIK3R3;BAD;MAPK1;NRAS
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.13685680016680865,0.6588286117728451,1.0,0.9984156418314064,1.0,14/103,14.24%,NUP205;RIGI;NUP35;TRIM4;NUP214;NUP37;LARP1;ISG15;B2M;SEC24B;SEC24D;KPNA2;TRAF6;TOMM70
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.18940401727168554,-0.657999866307723,0.9122807017543859,1.0,1.0,3/32,7.90%,ACSL5;PPT1;ACSL4
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.12959825670565378,0.6578449013774075,1.0,0.9973768868188533,1.0,22/127,16.45%,PLEKHG2;RPS27A;ARHGEF5;SMPD3;SQSTM1;TNFRSF10D;ARHGEF6;OBSCN;CYLD;TRIO;MAGED1;ECT2;PRDM4;ARHGEF4;NSMAF;TRAF6;SOS2;ARHGEF17;PRPF38B;TAX1BP1;ARHGEF12;UBB
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.13599491147762893,-0.6577869590587601,1.0,1.0,1.0,60/200,29.75%,AKT1;IL6;MAPK8;SPI1;CD3D;CD3G;PTEN;PIK3R3;SRF;IL15;IL2RG;CRTC1;MAPK1;IL1R1;ANAPC11;NRAS;ATF2;SLC25A6;LCK;PPP3CB;CREB3L2;CDKN2C;JUN;ANAPC5;CREB1;MAP2K4;CRTC2;ITGB2;LTBR;TGFB3;HLA-DRB3;PTTG2;STAT5B;RANBP1;GPS2;XIAP;ADCY3;CDC20;CD3E;DLG1;ELK4;NFYB;PPP3CC;CDC23;ATR;CHUK;MAP2K1;ATM;ESPL1;MAP3K14;TP53;VDAC1;ADCY4;SMAD4;IL2RB;E2F3;ADCY9;KAT2A;EGR2;JAK3
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.18854230269169478,-0.6569914968017218,0.9148936170212766,1.0,1.0,3/30,9.61%,HSPA6;SERPINH1;DNAJB6
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.14301748756379587,0.6563216448392201,0.9772727272727273,0.9966416551200532,1.0,6/73,6.85%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.1543904979022406,-0.6562302827803072,0.9402985074626866,1.0,1.0,17/56,28.94%,SERPINB2;CR1L;A2M;C8G;CD55;F13A1;ITGB2;C5;C5AR1;PLAT;C1QC;MASP2;CLU;F2R;CFHR2;CFHR1;PLG
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.15957020240200837,0.654491165549508,0.9361702127659575,0.9961085855683958,1.0,13/32,30.59%,AP4B1;CLTB;VAMP7;DNM2;BLOC1S1;AP4E1;CHMP2A;CTSZ;CLTA;ARRB1;AP1G1;AP1M2;AP4S1
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.16916892270478662,0.6537779039394442,0.9555555555555556,0.9949188846048532,1.0,9/39,19.19%,AGO1;AGO4;ANAPC2;EHMT1;VENTX;NFKB1;CSF1R;LEF1;MOV10
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.16612444367924722,-0.6536210016552011,0.9365079365079365,1.0,1.0,28/55,40.35%,MBD4;COX5A;COX7B;COX6A1;SCO2;TACO1;NFE2L2;COX8A;COX6B1;CYCS;RXRA;COX16;NLRP3;COX6C;COX20;CREBBP;BRIP1;STAP2;HM13;NCOA6;NCOR1;TBL1XR1;NCOA2;SCO1;SURF1;ABCC1;COX5B;CHD9
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.1541126721977487,-0.6523648868742732,0.9636363636363636,1.0,1.0,20/55,32.23%,ARPC1A;RNASE1;WASL;HCK;MAPK1;NCKAP1L;ACTR3;NCK1;WASF1;VAV3;WAS;PTK2;ARPC5;WASF3;ABL1;CDC42;ABI1;MYO9B;BAIAP2;TARP
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.14154026538983885,0.6518200909124735,1.0,0.9948284449882095,1.0,6/74,6.85%,PSMA5;PSMA4;PSME1;RPS27A;PSMC6;ANAPC2
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.1927789069489164,-0.6513237513619661,0.9019607843137255,1.0,1.0,4/33,7.69%,CTC1;DNA2;TINF2;POT1
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.18507599099388078,0.6509627211374159,0.8958333333333334,0.9936445620572701,1.0,6/23,20.31%,SCN1B;ITPR3;TAS2R5;SCN9A;TAS2R14;SCNN1A
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.1598744240715509,0.648859132365751,0.925,0.993258615521119,1.0,8/38,17.19%,ALDH7A1;NOS3;GOT1;ALDH3A2;SMS;CNDP1;ARG2;P4HA1
prerank,KEGG_2021_Human__Cocaine addiction,-0.19503056796016208,-0.6477130783808684,0.8301886792452831,1.0,1.0,7/25,21.83%,GPSM1;ATF2;CREB3L2;JUN;CREB1;GNAS;GNAI1
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.1994825620992668,0.6462541180442524,0.9302325581395349,0.9930522991429942,1.0,2/15,7.50%,NR6A1;TSC22D1
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.1883879368945513,-0.6460423221213102,0.9666666666666667,1.0,1.0,3/20,9.97%,PPP1R12A;RNASE1;MYL12B
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.12881553647957839,0.645531460309857,1.0,0.9919560127483262,1.0,16/141,10.26%,CYP4B1;ACADL;PTGDS;GGT1;HACD4;ACOX1;HPGDS;MCEE;CYP2C9;CPT1A;LTC4S;SYCP2;ELOVL3;MMUT;HADHB;MID1IP1
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.18457901320795903,-0.6447472661110024,0.9193548387096774,1.0,1.0,13/28,35.38%,OSBPL3;SLC27A5;ACOT8;ACOX2;STARD5;OSBPL9;AMACR;ABCB11;RXRA;SLC27A2;OSBP;NCOA2;OSBPL1A
prerank,KEGG_2021_Human__Viral myocarditis,-0.15824534158524434,-0.6439628234004,0.9666666666666667,1.0,1.0,13/52,27.90%,CASP8;RAC2;PRF1;CD55;RAC3;ABL2;ITGB2;HLA-DRB3;CYCS;EIF4G1;ABL1;EIF4G3;CASP3
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.15901512764982795,0.6425521356511988,0.9736842105263158,0.9916733646470476,1.0,10/54,15.81%,MSN;SKP1;KLC1;SQSTM1;SHC1;GRB2;RNASEH2A;PIK3CA;TPM4;BCL2A1
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.18791923408744346,-0.6423551301888623,0.8867924528301887,1.0,1.0,4/25,11.03%,CYBB;GPX7;TXNRD2;SOD1
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.21099553526761022,0.6410760639455213,0.8636363636363636,0.9908983785243467,1.0,5/15,18.60%,LSM5;LSM4;DCP2;PATL1;LSM7
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.14659277158981604,0.6396299409984707,0.967741935483871,0.9898303615531022,1.0,16/50,25.06%,UCKL1;UMPS;NME3;RRM2;TK1;RRM2B;ENTPD4;ENTPD5;NT5E;DCTD;NT5C;TK2;TYMS;TYMP;NT5C3A;UPP1
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.16817625881044307,-0.6394316922461437,0.9166666666666666,1.0,1.0,14/34,35.58%,WNT7B;FZD2;DDB2;DVL1;TCF7;TP53;POLK;FZD1;GADD45A;CTNNB1;BAX;AXIN1;BAK1;WNT10A
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.18739647818856467,0.6366891980797701,0.9038461538461539,0.9897097260745752,1.0,5/20,19.23%,SCN1B;ITPR3;TAS2R5;SCN9A;TAS2R14
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.22471456718132352,-0.63389104030662,0.8867924528301887,1.0,1.0,5/16,24.60%,ERBB2;NRAS;HSP90AA1;NRG4;EGF
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.16551721542615006,-0.6332888861767987,0.9672131147540983,1.0,1.0,9/34,23.13%,PCCA;ECI1;THEM5;ACOT9;HADH;ACOT2;MECR;ACAD10;PCCB
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.12595586149118299,-0.6330385432083355,1.0,1.0,1.0,35/188,20.56%,H2BC14;PXN;H2BC4;HDAC2;PIK3R3;TRAF1;CASP8;USP7;H2BC7;HDAC6;HDAC10;SRF;H4C11;BAD;MAPK1;IRF9;NRAS;ATF2;CREB3L2;YWHAQ;JUN;YWHAB;HDAC11;CDK1;CREB1;SND1;DDB1;HDAC9;LTBR;TRAF2;TRADD;STAT5B;RANBP1;YWHAZ;GTF2H3
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.16563005172560266,0.6311623678114774,0.9772727272727273,0.9905712828637488,1.0,5/36,10.64%,ITGB3;RAP1A;CNKSR2;HRAS;MARK3
prerank,KEGG_2021_Human__Glioma,0.13688245483040856,0.6310603008658223,1.0,0.9890774797749563,1.0,18/65,24.43%,IGF1R;PDGFRA;HRAS;CALML4;SHC1;GRB2;PIK3CA;SOS2;PIK3CB;MDM2;MAP2K2;PIK3R1;PIK3CD;PRKCB;CALM2;BRAF;MTOR;MAPK3
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.14365695945186838,-0.6301683447120376,1.0,1.0,1.0,19/85,22.43%,CUL1;PSMD8;PSMD5;NEK2;UBE2E1;ANAPC11;PSMC5;ANAPC5;AURKA;UBE2S;CDK1;PSMD3;ANAPC15;CDC14A;PSMB6;CDC20;PSMD7;UBC;PSMD13
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.18636334701030283,-0.629696731376343,0.95,1.0,1.0,3/27,8.04%,TLR5;TLR2;TIRAP
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.19071986173364336,0.6285962688525786,0.9333333333333333,0.9886258170961169,1.0,4/25,15.02%,GFAP;APOE;COPS2;WWOX
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.15794352721397964,0.6284750886204576,0.975609756097561,0.9871201777071272,1.0,9/40,18.85%,BMAL1;XPO1;LIN9;CARM1;MEF2C;TBL1X;MAFK;MEF2D;CLOCK
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,-0.1934686631364968,-0.6260685181160089,0.9183673469387755,1.0,1.0,8/18,30.25%,ALDH1B1;PANK1;ENPP3;DPYD;BCAT1;ALDH2;ENPP1;UPB1
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.170186900285577,-0.6259880258566896,0.9807692307692307,0.9996755782864761,1.0,7/30,22.12%,NEDD4L;PPM1A;MAPK1;USP9X;TGIF1;SKI;UBC
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.1870844185353565,0.6256230344579287,0.9523809523809523,0.9869656838090929,1.0,5/19,18.53%,SPAG9;MAPK11;MEF2C;BNIP2;MEF2D
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.21089847850799234,-0.6240247158564464,0.9152542372881356,0.9989689322552571,1.0,12/18,46.72%,MAPK8;MAP3K7;MAP2K4;IRAK1;NOD2;TAB1;IKBKG;UBE2V1;MAPK10;RIPK2;IRAK2;NOD1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.1616937043319396,0.6220738570541862,0.9473684210526315,0.987142887974936,1.0,2/29,4.25%,AGO1;AGO4
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.170271824821011,-0.6198087327281233,0.9824561403508771,0.9991944223652015,1.0,3/33,5.90%,RAD9B;RAD9A;ORC6
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,-0.13618641291293104,-0.6170785262294315,1.0,0.998864685739025,1.0,10/90,10.89%,NUP133;HSPA6;SERPINH1;BAG1;NUP85;NUP210;HDAC6;MAPK1;DNAJB6;ST13
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.19715873260815134,-0.6153899569997765,0.9215686274509803,0.998214060401421,1.0,4/20,15.93%,EXOC7;KIF5A;EXOC5;EXOC2
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.2014522016878808,-0.6148249462108306,0.8813559322033898,0.9968840486132037,1.0,4/15,22.12%,AP2B1;AP2M1;CLTC;UBC
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.17671899165952018,0.6142324824735933,0.8571428571428571,0.9892453918215468,1.0,8/20,27.25%,ANKH;LRRC8A;LRRC8E;LRRC8D;CTNS;BPNT1;NIPA2;MRS2
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.14314188528027808,0.6135832725462765,0.9318181818181818,0.9880200618111746,1.0,5/46,8.82%,PRKCD;ROCK1;BCAP31;DBNL;H1-3
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,-0.1517390317226136,-0.6070184511285579,0.9836065573770492,0.9988443016368717,1.0,9/47,16.64%,SEC11A;EXOC7;KCTD11;KIF5A;AOPEP;GNB1;EXOC5;EXOC2;POMC
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.1284100796320916,-0.598654781439027,1.0,1.0,1.0,14/121,12.30%,AKAP9;TPM2;FXYD1;FXYD2;TMOD4;ASPH;ABCC9;ITPR1;MYH3;MYL12B;MYL4;PDE5A;TMOD2;KCNH2
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,-0.1368834136536626,-0.5971319917283483,1.0,0.9996882367207097,1.0,11/101,11.87%,H2BC14;H2BC4;H3C13;BRD1;BRD8;JADE1;MORF4L1;HAT1;KAT14;EPC1;TAF5L
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.14605432825029568,0.5958788590426716,0.96,0.9934114486199608,1.0,15/35,29.94%,RPS27A;SMAD7;RNASEH2A;RBL1;UBB;SMAD2;TGIF2;CCNK;MAPK3;SMAD3;MEN1;RNF111;WWTR1;FURIN;E2F4
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.1254049211032101,-0.5958059360178137,1.0,0.998645216015315,1.0,35/130,28.64%,TERC;AKT1;WNT7B;PTEN;PIK3R3;FZD2;KEAP1;BAD;MAPK1;NRAS;TXNRD2;HGF;LRP5;GSTM4;GSTM2;GSTM5;TGFB3;FRAT1;TGFA;NFE2L2;ARID1A;LRP6;ACTL6A;SHC4;DDB2;MGST3;DVL1;MAP2K1;TCF7;TP53;POLK;PLCG2;SMAD4;FZD1;E2F3
prerank,KEGG_2021_Human__Taste transduction,-0.16678383815137993,-0.5950940530103135,0.9803921568627451,0.9973629734682632,1.0,17/33,37.19%,PDE1B;TAS2R13;TAS2R60;TAS2R30;PLCB2;TAS2R3;ENTPD2;PLCB1;ADCY4;TAS2R50;P2RY1;TAS2R20;CACNA1A;PLCB4;TAS2R43;TAS1R3;TAS2R31
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.21004764664313888,-0.5944495684268669,0.9838709677419355,0.99612285658391,1.0,7/16,30.27%,SLC27A5;ACOT8;ACOX2;AMACR;ABCB11;RXRA;SLC27A2
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.13984078046986687,0.593466705508259,0.9705882352941176,0.992531991793036,1.0,6/59,9.22%,ADCY7;ITGB3;ITGAV;ITGA4;ACTG1;PRKACB
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.19919632491132316,-0.593152226482346,0.8688524590163934,0.9951790611317943,1.0,11/18,45.09%,TRPC6;ITPR1;P2RX7;CALM1;SRI;SLC8A1;P2RX1;ATP2A2;P2RX4;ATP2A1;ATP2B4
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.1797949754730553,0.5926420288440643,0.9787234042553191,0.9913652619407375,1.0,7/21,27.06%,CAMKMT;PDE6G;PDE6A;PPEF1;GNB5;NMT1;PDE6B
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.17553000665066543,-0.5858478787613995,0.953125,0.995876444137526,1.0,4/27,14.14%,GP1BA;PF4V1;PRCP;F13A1
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.16452879410612506,-0.585772461432286,0.9230769230769231,0.9943906123554622,1.0,13/29,35.63%,NAMPT;NUDT12;NNMT;NMNAT3;ENPP3;NNT;CD38;ENPP1;NADK;SIRT5;SIRT3;NT5C1A;NADK2
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.13693525738740958,0.5835877274043333,1.0,0.9924605768971654,1.0,10/48,18.53%,POLRMT;GABPA;LIN9;CARM1;MEF2C;TBL1X;MTERF1;NRF1;TFAM;MEF2D
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.12557357304948866,-0.583193160478235,1.0,0.9937449480818256,1.0,37/103,34.34%,AKT1;PPP2CB;MAPK14;TPM2;FXYD2;RPS6KA5;MAPK1;MYL4;ATF2;CREB3L2;CREB1;CACNB1;PIK3R5;GNAS;CAMK2A;CACNB3;ADCY3;GNAI1;PLCB2;ATP1A3;KCNE1;PPP2R3B;PLCB1;PPP2R5D;CALM1;ADCY4;ADCY9;GNAQ;CACNA1D;ADRB2;TPM1;GNAI3;AKT2;PLCB4;CACNB4;SLC8A1;PPP2R1A
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,0.16443292654847078,0.5810893020781468,1.0,0.9916444700770475,1.0,6/25,19.08%,MDH1;SLC37A1;PCNX4;PGK1;FBP1;SLC37A2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.13912439318974723,-0.579643266994781,0.9705882352941176,0.9932782315038771,1.0,23/67,30.05%,SLC16A10;SLC8B1;SLC6A15;SLC1A3;SLC4A5;SLC24A4;SLC9A4;SLC7A6;AHCYL2;SLC36A2;SLC24A1;SLC26A11;SLC36A4;SLC4A4;SLC15A3;SLC26A6;SLC3A1;CALM1;SLC1A7;SLC5A5;SLC1A2;SRI;SLC4A2
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.1577403343169572,0.5782109172340103,0.9285714285714286,0.9909463356231886,1.0,5/26,16.45%,RPS27A;ARSB;GLB1;IDUA;UBB
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.17470312374009275,-0.5766531039913725,0.9661016949152542,0.9926109515348345,1.0,1/29,0.09%,ID2
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,0.15394606620881252,0.5761061798718939,1.0,0.9899429222196613,1.0,3/30,7.40%,AMN;RPS27A;APOE
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.17968277754685813,0.5704241993411772,0.9555555555555556,0.9898058899664693,1.0,15/17,61.62%,CLDN9;PARD6G;PARD6B;F11R;PARD3;PARD6A;PALS1;CLDN5;PRKCI;CLDN12;CRB3;PATJ;CLDN16;CLDN7;CLDN10
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.14790899332836865,-0.5684061757298098,1.0,0.9936346604703035,1.0,19/38,39.66%,AP2B1;FXYD2;AP2M1;CLTC;KLK2;GNAS;PLCB2;ATP1A3;PLCB1;ADCY9;GNAQ;RAB11A;AP2A1;PLCB4;SLC8A1;KLK1;PRKCA;ATP1A1;DNM3
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,-0.12922064916176548,-0.5669493632920622,1.0,0.992427684998528,1.0,19/71,28.16%,AKAP9;FXYD1;FXYD2;ASPH;ABCC9;ITPR1;KCNH2;KCNK7;KCNE3;CACNB1;CAMK2A;SCN11A;ATP1A3;RYR1;KCNE1;DMPK;NPRL2;CALM1;KCNK13
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,-0.14823650044645245,-0.5595280350587942,0.9848484848484849,0.9928705367223318,1.0,6/41,17.20%,IL6;IL15;IL10;CXCR4;LTBR;HLA-DRB3
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.17733321929370832,-0.5567363048892527,0.9666666666666667,0.992057306327032,1.0,4/19,19.69%,ALG13;ALG6;MPDU1;ALG8
prerank,Reactome_2022__RAF Activation R-HSA-5673000,-0.14313460046258752,-0.5516566717365016,1.0,0.9915472034547919,1.0,4/31,13.22%,PPP2CB;NRAS;MRAS;YWHAB
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.13776258510090003,-0.5419131297366755,1.0,0.992064444139142,1.0,16/57,29.29%,IFIT3;IFI35;IRF4;MX1;IRF9;IFI6;KPNA1;IRF1;PTPN11;RSAD2;OAS1;IRF5;GBP2;IFIT2;SOCS3;ABCE1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.14584205345715512,0.5359939401233392,1.0,0.9962969546094481,1.0,1/23,1.00%,CTSL
prerank,KEGG_2021_Human__Fatty acid elongation,0.14662523541466477,0.5345198102034451,0.9795918367346939,0.995213459256286,1.0,6/25,20.13%,HACD4;ELOVL3;HADHB;ELOVL5;ACOT7;ELOVL6
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,0.14563482450608609,0.5334153824707696,0.9629629629629629,0.9938468225743238,1.0,6/23,21.10%,SHC1;GRB2;PIK3CA;PIK3CB;PIK3R1;CSF2RB
prerank,KEGG_2021_Human__Amphetamine addiction,-0.136765390666721,-0.5229448378567275,1.0,0.9939291940993317,1.0,8/38,20.73%,HDAC2;ATF2;PPP3CB;CREB3L2;JUN;CREB1;GNAS;CAMK2A
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.15070178121889022,0.519383005167613,0.9791666666666666,0.9945817815039686,1.0,3/22,11.25%,B3GNT2;GLB1;B4GALT4
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.1467654824598166,-0.5188605054444186,0.967741935483871,0.9929570947723609,1.0,4/31,13.33%,ARL2BP;SLC29A4;SLC25A6;SLC35D2
prerank,KEGG_2021_Human__Cell cycle,-0.10415707666979153,-0.5119534752042485,1.0,0.9925981400694034,1.0,32/120,29.42%,CUL1;HDAC2;TTK;ORC6;CDC25B;ANAPC11;E2F5;YWHAQ;CDKN2C;CDC14B;ANAPC5;YWHAB;CDK1;CDC6;TGFB3;PTTG2;CDC14A;DBF4;ORC5;YWHAZ;CDC25C;CDC20;CDC23;ATR;ATM;ESPL1;ABL1;TP53;SMAD4;E2F3;RBL2;GADD45A
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.16510017278023836,0.50717223646925,0.9555555555555556,0.9948004632223711,1.0,6/15,31.13%,RPS27A;UBB;TGFBR2;F11R;PARD3;PARD6A
prerank,KEGG_2021_Human__Folate biosynthesis,-0.15048064614169712,-0.44755505472552715,1.0,0.9975129018217994,1.0,8/18,38.05%,DHFR2;TPH1;SPR;ALPL;GPHN;QDPR;PCBD2;FPGS
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.10312603218683773,0.4094396953789471,1.0,1.0,1.0,2/36,6.85%,CCND2;ANAPC2
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.09818134817910051,0.3904699485991355,1.0,0.999468539432476,1.0,1/38,0.91%,CCND2
